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Abstract 
 
Leishmania parasites are the causative agents of a diverse spectrum of infectious 
diseases termed the leishmaniases. These digenetic parasites exist as intracellular, 
aflagellate  amastigotes  in  a  mammalian  host  and  as  extracellular  flagellated 
promastigotes  within  phlebotomine  sand  fly  vectors  of  the  family  Phlebotominae. 
Within  the  sand  fly  vector’s  midgut,  Leishmania  has  to  undergo  a  complex 
differentiation  process,  termed  metacyclogenesis,  to  transform  from  non-infective 
procyclic  promastigotes  into  mammalian-infective  metacyclics.  Members  of  our 
research group have shown previously that parasites deleted for the L. (L.) major 
cDNA16 locus (a region of chromosome 23 that codes for the stage-regulated HASP 
and  SHERP  proteins)  do  not  complete  metacyclogenesis  in  the  sand  fly  midgut, 
although metacyclic-like stages can be generated in in vitro culture (Sádlová et al. 
Cell. Micro.2010, 12, 1765-79). To determine the contribution of individual genes in 
the locus to this phenotype, I have generated a range of 17 mutants in which target 
HASP and SHERP genes are reintroduced either individually or in combination into 
their  original  genomic  locations  within  the  L.  (L.)  major  cDNA16  double  deletion 
mutant. All replacement strains have been characterized in vitro with respect to their 
gene copy number, correct gene integration and stage-regulated protein expression, 
prior to phenotypic analysis.  
 
HASPA1 was not detected in cultured promastigotes, but was expressed in mouse 
isolated  amastigotes.  Parasite  mutant  lines  were  passaged  through  susceptible 
BALB/c mice, during which HASPA2 gene containing mutant lines, in the absence of 
a  HASPA1  gene,  were  shown  not  to  develop  lesions.  Mouse-passaged  parasites 
were used to infect the L. (L.) major specific sand fly vectors, Ph. (Ph.) papatasi and 
Ph. (Ph.) duboscqi. The progress of parasite metacyclogenesis was then monitored 
over twelve days, by midgut dissection and microscopy. Metacyclogenesis was not 
fully  recovered  in  any  of  the  replacement  mutants  tested.  Surprisingly,  HASPB 
protein expression could not be detected in the replacement mutants within the sand 
fly midgut, although HASPB protein was readily detected when the same parasite 
lines  were  cultured  in  vitro.  The  same  was  true  for  SHERP,  although  in  situ 
expression was recovered in the presence of a HASPB gene, which itself did not 
expressed  detectable  HASPB  protein  levels.  These  observations  suggest  a 
requirement  for  one  or  multiple  as-yet-unidentified  regulatory  component(s)  for 
HASPB expression within the sand fly midgut and these are not required in culture. 
Quantitative  PCR  data  suggested  HASPB  upregulation  to  be  essential  for 
metacyclogenesis completion, suggesting a sand fly specific function for HASPB. 4 
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1.  CHAPTER I. – Introduction 
 
1.1. The Leishmaniases 
Leishmaniasis is the general term for a diverse spectrum of infectious diseases 
caused by kinetoplastid parasite species of the genus Leishmania (Appendix 1). 
They are transmitted by phlebotomine sand flies of the sub-family Phlebotominae. 
The leishmaniases are among the most complex of all vector borne diseases and 
occur in the sub-/tropical regions of all continents except Antarctica. 
 
 Epidemiology of the Leishmaniases  1.1.1.
In 1991, Philippe Desjeux delivered a report to the World Health Organization 
(WHO) regarding the global burden of the leishmaniases (1). He considered 
82  countries  and  territories  to  be  endemic  to  at  least  one  form  of  human 
leishmaniasis. In 1996, Desjeux published a second review considering 88 
countries and territories to be endemic to the leishmaniases with 350 million 
people at daily risk of infection (Fig.1.1) (2). In 2012, Alvar et al. published the 
first  update  on  the  empirical  database  delivered  by  Desjeux  (1991) 
considering 98 countries and 3 territories on five continents as being endemic 
to at least one form of human leishmaniasis (3). Australia was not included in 
this list, because the recently discovered Leishmania species (spp.) infecting 
red kangaroos has not yet been shown to be human infective (4). At least 72 
of these 101 countries and territories are undeveloped countries, of which 13 
are  among  the  least  developed  in  the  world.  21  of  the  101  countries  and 
territories  belong  to  the  ‘New  World’  (the  Americas)  with  Brazil  being  the 
biggest disease hotspot followed by Colombia and Peru, while the remaining 
80 countries and territories belong to the ‘Old World’ (17 of those in Europe 
around the Mediterranean and Black Sea) – the main hotspots being East 
Africa, Iran, Afghanistan and South Asia (3).  
 
By  2004,  a  total  of  >12  million  leishmaniases  cases  had  been  registered 
worldwide  causing  an  estimated  2.4  million  disability-adjusted-life-years, 
although the number of unregistered case is estimated to be much higher (5). 
This  is  because  reporting  of  leishmaniasis  is  mandatory  in  only  33  of  all 
endemic countries (3). Annual incidence rates for new leishmaniasis case are 
currently estimated at between 0.9 – 1.6 million cases worldwide, which is still 
considered  to  be  underestimated  due  to  under-reporting  (3).  Many  cases 
occur in remote areas with low infrastructure and difficult access to medical 
facilities and, therefore, remain undetected, but also un- or misdiagnosis of17 
 
 
 
Fig.1.1 – Geographical distribution of leishmaniasis burden 
No recent map of global leishmaniasis burden incorporating the recently published 
update on leishmaniasis epidemiology from Alvar et al. (2012) is currently available; 
hence,  the  maps  shown  are  still  giving  an  incomplete  picture  of  the  real  global 
disease burden (3). A) shows the distribution of visceral leishmaniasis (VL) (6) and B) 
the distribution of all cutaneous leishmaniases (CL) forms (7). 
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infection  is  a  common  problem.  Studies  comparing  active  house-to-house 
surveys in endemic areas with official numbers showed that official numbers 
were on average 2 – 10-fold lower than those found by active case detection; 
in some cases even 40 – 47-fold lower (8, 9). Although levels of morbidity due 
to cutaneous leishmaniasis (CL) are much higher than levels of mortality due 
to visceral leishmaniasis (VL), an estimated ~70,000 annual deaths worldwide 
are associated with the leishmaniases (~59,000 deaths due to VL; rest due to 
complications with CL forms) (5). Although estimates of mortality are difficult 
since data are sparse and mostly from deaths in hospitals, the leishmaniases 
are considered the second most severe protozoan disease after malaria and 
the third most important vector-borne disease in the world (5, 10). 
 
The leishmaniases are traditionally sylvatic zoonoses and human infection is 
generally  considered  to  be  accidental  and  occurs  when  humans  invade 
endemic areas (11). However, since sand fly vectors were observed to adapt 
quickly to human induced environmental changes (12), they have adapted to 
peridomestic environments, bringing Leishmania spp., which are able to use 
domestic animals, in particular domestic dogs, as reservoirs, into the proximity 
of  human  habitats  (13).  Some  Leishmania  spp.  have  even  become 
anthroponotic in some parts of the world, such as the causative agent of VL in 
India, L. (Leishmania) donovani (14) and there are reports of anthroponotic 
CL due to L. (L.) tropica in Afghanistan (15). There are also observations of 
anthroponotic  behaviour  of  L.  (L.)  infantum,  primarily  in  human 
immunocompromised patients, like human immunodeficiency virus (HIV) co-
infected patients (16). Vector-independent Leishmania transmission by needle 
sharing between HIV positive intravenous drug users (IVDU) (17) and blood 
transfusions  from  asymptomatic  blood  donors  has  also  been  reported  (18, 
19). Fear of increased spread and parasite domestication of other Leishmania 
spp. in other parts of the world grows (20). Human movement and activity in 
formerly-sylvatic  endemic  areas  due  to  urbanization,  work  and  war  have 
contributed markedly to the spread of the disease, forcing parasite and vector 
domestication and displacement of sylvatic Leishmania reservoirs (5, 11). The 
increase of global travel and transport has added to disease spread (21).  
 
 Clinical Manifestations of Leishmaniasis  1.1.2.
Three basic forms of leishmaniasis are clinically distinguished based on the 
tissues involved: CL, mucocutaneous leishmaniasis (MCL) (Fig.1.2H) and VL 
(Fig.1.2J). CL is further subdivided into non-/self-healing localized cutaneous19 
 
 
 
 
Fig.1.2 – Images of different leishmaniasis pathologies 
A-C) Forearm with self-healing LCL skin lesions (22); D) Forearm with LRC (23); E) 
Forearm  with  non-self-healing  ulcerating  LCL  skin  lesion  (Archives  of  UCSF);  F) 
Dorsal view of DCL presenting male (24); G) Dorsal view of DL infected male (25); H) 
Severe MCL (26); I) PKDL (WHO 2013); J) VL (WHO 2004) 
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leishmaniasis  (LCL)  (Fig.1.2A-D)  and  the  more  unusual  forms,  diffuse 
cutaneous  leishmaniasis  (DCL)  affecting  several  body  parts  (Fig.1.2F)  and 
leishmaniasis recidiva cutis (LRC) (Fig.1.2E), a severe disease relapse in old 
scars.  There  is  evidence  that  another  CL  form  occurs  in  Brazil,  termed 
disseminated  cutaneous  leishmaniasis  (DL)  (Fig.1.2G),  which  should  be 
distinguished from DCL (25). Unusual CL forms are frequently misdiagnosed 
(27). In East Africa mucosal leishmaniasis (ML) is distinguished from MCL, 
because of its origin, but both affect the mucosa. MCL starts out as LCL, while 
ML  is  a  secondary  effect  of  VL  without  prior  cutaneous  involvement.  Post 
kala-azar  dermal  leishmaniasis  (PKDL)  (Fig.1.2I)  is  a  cutaneous  infection, 
which can occur in patients after resolution of VL as a relapse form (28).  
 
It is accepted that particular Leishmania spp. cause preferentially one disease 
type, but since disease development depends on the host immune response, 
too, some Leishmania spp. have been isolated in a broad variety of clinical 
manifestations  (Table  1.1).  For  instance,  L.  (L.)  amazonensis  has  been 
isolated from CL, MCL, PKDL and VL patients (29). The greatest global hot 
spots of LCL, DCL and DL cases (70-75%) are in Afghanistan, Algeria, Brazil, 
Colombia, Costa Rica, Ethiopia, Iran, North Sudan, Peru and Syria (3). MCL 
is primarily found in Brazil and >90% of all registered VL cases worldwide 
occur principally in Bangladesh, India, Nepal, Sudan and Brazil (3). 
 
 Immunopathogenesis  1.1.3.
The immunology of leishmaniasis is highly complex and not fully understood 
(30, 31). During Leishmania transmission to a new mammalian host by sand 
fly bite, 500 – 1000 metacyclic promastigotes are on average injected into the 
host‘s skin (32). In the mammalian host, parasites reside as amastigotes in 
phagolysosome-like structures, which are hostile environments designed for 
pathogen  degradation.  Leishmania  has  developed  special  mechanisms  to 
promote  its  survival  in  the  mammalian  host’s  macrophages  (33).  Before 
parasite reach the phagolysosome, however, they are immediately confronted 
with  the  host’s  alternatively  activated  complement  system  after  inoculation 
into the host skin. Metacyclics have a particularly dense lipophosphoglycan 
(LPG) coat, with specific side chain modifications and surface proteins, like 
gp63, which is the single most dominant surface protein in metacyclics. Gp63 
–  a  surface  glycoprotein  –  is  a  zinc-metalloprotease  that  converts  the 
complement protein C3b – one of the most potent immune opsonins, which 
binds to LPG with high affinity, while others like C5b-9 cannot (34, 35) – into 21 
 
Table 1.1 – Human infective Leishmania spp. according to disease tropism 
Subgenus   L.(Leishmania)   L.(Leishmania)   L.(Viannia)  L.(Viannia) 
Old World  L. donovani 
L. infantum 
L. tropica º 
L. major º 
L. major 
L. torpica  
L. killicki * 
L. aethiopica 
L. infantum 
 
   
New World  L. infantum  
(= L. chagasi) 
L. amazonenesisº 
L. mexicana º 
L. infantum  
(= L. chagasi) 
L. mexicana 
L. pifioni * 
L. venezuelensis 
L. gamhami * 
L. amazonensis 
L. braziliensis 
L. guyanensis 
L. panamensis 
L. peruviana 
L. shawi 
L. naiffi 
L. lainsoni 
L. lindenbergi 
L. colombiensis
+ 
 
L. braziliensis 
L. panamensis 
L. amazonensis º 
L. guyanensis º 
Principal 
tropism 
Viscerotropic  Dermotropic  Dermotropic  Mucotropic 
º Rare reported cases  *  Species  status  is  under 
discussion 
+  Taxonomic  position  is  under 
discussion 
This table was adapted from WHO control of leishmanasis (2010) 
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inactive C3b (iC3b) preventing its efficient binding to the Leishmania LPG coat 
and with that complement-mediated lysis (37). Protection against complement 
lysis is also achieved by shedding the  membrane attack complex  with the 
LPG from the surface of metacyclics (35). 
 
Once past the complement system, Leishmania parasites encounter cells of 
the innate and adaptive immune system. Macrophages are the most dominant 
innate immune cells in the skin and will attempt to clear Leishmania parasites 
by phagocytosis. This internalization of Leishmania parasites effectively hides 
them  from  the  humoral  branch  of  the  mammalian  immune  response. 
Leishmania have been shown to even possess mechanisms which actively 
enhance macrophage phagocytosis (38). However, for parasite persistence, 
nitric oxide (NO) synthesis needs to be prevented (30). Work done in L. (L.) 
major  mouse  (in  particular,  C57BL/6  and  BALB/c)  models  revealed  two 
distinct adaptive immunity pathways, which are predominantly mediated by T 
lymphocytes  (Fig.1.3).  One  pathway  is  the  T  helper  (Th)  1  response  by 
classically activating macrophages (CAMФ) and the other the Th2 response 
by alternatively activating macrophages (AAMФ). In the draining lymph nodes, 
which  are  crucial  for  mounting  a  Th1  response  (39),  naïve  T  cells  are 
stimulated  to  differentiate  into  CD4
+  Th1  and  Th2-type  effector  cells  by 
interleukin  (IL)  12  and  IL-4,  respectively,  which  are  mutually  exclusive, 
secreted from antigen presenting cells (APCs) (40). Th1 cells in turn produce 
tumor necrosis factor (TNF-α) and, in particular, interferon-γ (IFN-γ), which 
promotes nitric oxide synthase (NOS) generation via a toll-like receptor (41). 
NOS  synthesises  NOs  from  L-arginine  capable  of  killing  Leishmania 
parasites. Conversely, Th2 cells produce IL-4, IL-10, IL-13 and transforming 
growth  factor-β  (TGF-β),  which  promote  arginase-1  expression.  Arginase-1 
uses L-arginine as  substrate, too, to produce L-ornithine, which  is  the first 
building  block  for  polyamines  essential  for  Leishmania  survival  (42). 
Therefore, Leishmania parasites seek to promote Th2 cell responses for their 
survival  by  actively  manipulating  the  host  immune  response.  Excessive  L-
arginine  depletion  by  AAMФ  renders  T  cells  hyporesponsive  to  antigen-
stimulation  and  impairs  their  proliferation,  cytokine  production  and  T  cell 
receptor  signalling  (43).  The  emergence  of  IL-10  secreting  CD4
+  CD25
+  T 
regulator (Treg) cells during a Th2 cell response are important for Leishmania 
persistence,  too  (44).  IL-10  is  an  antagonist  of  IFN-γ  (45).  The  Th2  cell 
secreted TGF-β is also a potent IFN-γ antagonist (46). Interestingly, TGF-β is 
also produced by neutrophils after exposure to apoptotic promastigotes, which 23 
 
 
 
Fig.1.3 – Immune response to Leishmania parasites inside the mammalian host 
Schematic representation of the differences between Th1 and Th2 cell response to 
Leishmania.  If  IL-12  is  secreted  by  macrophages  (MФ)  and  antigen  presenting 
dendritic cells (DC) naïve T cell will differentiate into T helper (Th) 1 cells, which 
secret Interferon-ɣ (IFN-ɣ), and T regulator cells (Treg), which will secret IL-10, which 
both aid to the synthesis of nitric oxide synthase (NOS) for nitric oxide generation 
resulting in Leishmania killing. If IL-4 is secreted by antigen presenting cells instead 
of  IL-12,  then  IL-4  secreting  Th2  cells  and  transforming  growth  factor-α  (TGF-α) 
secreting Treg cells are generated, which promote Arginase-1 generation and parasite 
survival. The image was taken from Sharma & Singh (2009) (30).  
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are  inoculated  with  infective  metacyclics  into  the  host  skin  (47).  Apoptotic 
parasites have been proposed to be key in triggering the anti-inflammatory 
response,  abolishing  efficient  killing  of  phagocytized  viable  parasites.  This 
makes  parasite  apoptosis  an  important  process  during  transmission  (48). 
Macrophages also secrete TGF-β after Leishmania uptake (49). There may 
be  slight  variation  and  additional  processes  specific  for  some  Leishmania 
species compared to others, too, that promote parasite survival (33). 
 
Due to a lack of immunological studies, this dichotomy of T cell response in 
the  mouse  model  has  not  been  demonstrated  as  clearly  in  humans,  in 
particular  in  the  early  phases  of  disease.  Although  a  dichotomy  was  also 
reported in human patients, some postulated that a Th2 response precedes 
the Th1 response in LCL and may even be an essential prerequisite for an 
effective  Th1 response  (31).  Another  study  showed  that  elevated  levels of 
IFN-γ and TNF-α were not required in subclinical CL patients due to L. (V.) 
braziliensis to suppress pathology and parasite proliferation, but that in clinical 
CL  patients  persisting  high  levels  of  these  cytokines  increased  pathology 
without enhancing parasite proliferation (50). It also appears that a balance 
between antagonising cytokines is more important in humans, as shown in the 
case  of  IL-10  and  IFN-γ  in  VL  patients  (51).  However,  IFN-γ  and  TNF-α 
remain  the  primary  cytokines  involved  in  limiting  and  even  clearing 
Leishmania infections. It is suggested that a balance between Th1 and Th2 
cell responses is more relevant in humans (30). It has also been noted in VL 
patients  that  had  low  CD4
+  T  cell  levels  (<100  cells/ml)  at  follow-up  after 
treatment  were  indicative  for  disease  relapse  in  particular  in  HIV-positive 
patients,  although  other  factors  had  to  participate  in  the  control  of 
leishmaniasis relapse too (52). In humans, the L-arginine depletion is more 
likely to be mediated through arginase-1 from active degranulating or dying 
neutrophils  than  macrophages  (53)  and  immunosuppression  is  a  common 
feature in non-healing CL and VL (45).  
 
Leishmania derived secreted filamentous proteophosphoglycans (fPPG) and 
sand fly salivary proteins regurgitated together with the parasites by the vector 
have immunomodifying properties, too (54). For example, monocytes that can 
differentiate into mature macrophages are naturally recruited to the infection 
site due to the microvascular laceration caused by the sand fly bite and the 
presence of sand fly salivary proteins (55). 
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 Leishmania / Human Immunodeficiency Virus co-infection  1.1.4.
HIV  is  a  retrovirus  causing,  in  its  final  stages,  acquired  immunodeficiency 
syndrome (AIDS) (56). Globally, the number of people living with HIV is still 
growing (>34 million people by 2011 (56)) and >95% of HIV-positive cases 
are found in the developing world often in proximity to Leishmania endemic 
areas  (57). While  HIV  in  itself  does  not  cause  patient  death,  opportunistic 
infections in HIV-infected patients are often fatal. Although ‘officially’ still not 
recognised  as  a  HIV  associated  opportunistic  disease  (52),  Leishmania 
infection can be considered as an opportunistic disease in association with 
HIV  (58).  The  risk  of  developing  VL  after  infection  with  an  appropriate 
Leishmania spp. is considered to be 100 – 2,320 times higher for HIV co-
infected  patients  (58).  In  addition,  HIV  co-infection  decreases  Leishmania 
treatment success (59), changes Leishmania spp. associated pathology (57) 
and  accelerates  disease  progression  (59).  Both  pathogens  target  similar 
immune cells, resulting in synergistic detrimental effects on cellular immunity 
(60), and favour a strong Th2 response (57).  
 
Leishmania/HIV  co-infection  has  been  reported  in  35  Leishmania  endemic 
countries to-date (Fig.1.4) (57). On average 2 – 9%  of all reported VL cases 
worldwide  showed  HIV  co-infection  (61),  while  in  some  locations  (e.g.  in 
Ethiopia)  the  average  lies  at  15-30%  (62).  Since  the  introduction  of  highly 
active anti-retroviral therapy (HAART) in the European Union (EU) to combat 
the HIV pandemic, a clear decrease of leishmaniasis in HIV infected patients 
has  been  observed  within  the  EU  (63).  However,  it  is  not  clear  whether 
HAART  also  helps  to  reduce  VL  relapse  risk  (52).  There  is,  however,  a 
growing risk of co-infection due to urbanization of leishmaniasis in parallel to 
ruralisation  of  HIV  causing  greater  regions  of  disease  overlap  (57).  The 
epidemiological  importance  of  Leishmania/HIV co-infected  people  is  super-
reservoir formation (64). Studies showed that sand flies are more likely to get 
infected with L. (L.) infantum by feeding on immunosuppressed hosts than on 
immunocompetent ones due to increased circulation of parasitized monocytes 
in the skin (16).  
 
 Diagnosis of Leishmaniasis  1.1.5.
There  is  a  range  of  diagnostic  tools  available  to  establish  presence  of 
Leishmania  amastigotes  in  patient  samples.  Microscopic  observation  of 
amastigotes  in  macrophages  within  Giemsa-stained  tissue  samples  from 
lesions (CL)  or lymph nodes,  bone marrow and spleen (VL) has been the26 
 
 
Fig.1.4 – Geographical distribution of VL and HIV co-infection 
Distribution of leishmaniasis and HIV co-infection by countries with reported cases 
(65). 
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traditional form of diagnosis and remains broadly the gold standard (66). Its 
drawback is the low sensitivity of detection, making diagnosis of chronic lesion 
samples difficult, because of their lower amastigote counts compared to acute 
lesions (67). Histopathology of fixed lesion biopsies or of cultured parasites 
from these biopsies can be performed alongside the microscopy to increase 
certainty.  
 
Current  serological  field  tests  for  VL  diagnosis  are  the  easy-to-use  direct 
agglutination  and  immunochromatographic  dipstick  tests,  which  have  good 
diagnostic performance, but these tests are not applicable for CL diagnosis 
(68). The Montenegro skin test is occasionally used in scientific studies due to 
its high sensitivity and specificity, but is not used as a diagnostic tool in the 
field, because sophisticated culture facilities are required to raise the required 
antigens for the test (69). The development of molecular techniques has led to 
improved  accuracy  and  sensitivity  of  parasite  identification  (70,  71). 
Polymerase  chain  reaction  (PCR)-based  diagnosis  has  been  shown  to  be 
highly  sensitive  (>90%)  and  specific  (100%)  (72).  Conventional  PCR  in 
combination with restriction fragment length polymorphism (RFLP) analysis is 
probably the most commonly used PCR-based method, while real-time PCR, 
PCR-enzyme  linked  immunosorbent  assay  (ELISA)  or  PCR-
oligochromatography (PCR-OC) in combination with a gold-conjugated probe 
dipstick can also be employed (73). All these techniques are, however, time 
consuming  and  require  sophisticated  laboratory  equipment  and  trained 
personal  (72).  The  loop-mediated  isothermal  amplification  (LAMP)  in 
combination with SYBR green is more suitable for the field (74). If LAMP were 
used  as  a  substitute  for  the  PCR  in  a  thermocycler,  it  could  be  used  in 
combination with the other PCR based methods as a good field method for 
diagnosis (72). PCR-based approaches can also be used to assess cure from 
VL,  but  requires modifications for  CL,  where  >80%  of  scarred  lesions  test 
positive even 8 years after their clinical cure (75, 76). 
 
Medically differential diagnosis is essential since many other diseases often 
occur in the same endemic areas that show similar pathology spectra (e.g. 
skin cancer, tuberculosis, leprosy for CL and malaria, schistosomiasis for VL). 
Also, ~22 different human-infective Leishmania spp. with varying pathology 
complicates medical diagnosis. Identification of infecting Leishmania spp. is 
crucial  to  anticipate  likely  disease  progression  for  best  treatment  choice, 
because therapeutic responses may be Leishmania species-specific (72).  28 
 
 Treatment  1.1.6.
Trivalent antimonials were originally introduced by Vianna in 1912 in Brazil for 
CL treatment and in Italy by Di Cristina and Caronia in 1915 for VL treatment 
as the first commercially available drug. They were soon substituted with safer 
intravenously administered pentavalent antimonials in 1922 after successful 
treatment  of  VL  with  Hyper-Acid  Antimonyl  Tartrate  +  Urethane  (77). 
Pentavalent antimonials have been the most commonly used first line drugs 
ever since. Although safer than trivalent antimonials, pentavalent antimonials 
are still highly toxic compounds, which cause in patients a broad spectrum of 
side-effects during the 20 – 30 day treatment period. Pentavalent antimonial 
drug resistance is becoming a serious problem, too, in e.g. India and Nepal 
(78).  Alternative  drugs  are  amphotericin  B  (AMB),  lipid  formulation  of 
amphotericin B (L-AMB), miltefosine, paromomycin and pentamidine, which 
may  be  preferred  over  antimonials,  depending  on  the  success-rate  of  the 
respective drug against one or the other  Leishmania species. AMB and L-
AMB  are  preferentially  used  against  VL  in  areas  of pentavalent  antimonial 
drug resistance. L-AMB has so far shown a better safety profile than AMB and 
a very good success-rate (>88%) (79). It is recommended in Leishmania/HIV 
co-infected patients, although it did not prevent relapses (80). Miltefosine is a 
relatively safe and successful drug (64% cure rate), which has the benefit of 
being an oral compound (81). Its gastrointestinal side effects are amplified in 
HIV  co-infected  patients  and  its  potential  teratogenic  effects  make  it 
unsuitable for pregnant women. The choice of drug is not only related to the 
parasite species and patient, but is subject to regional preference (82). All of 
these drugs, however, are toxic and have a range of adverse side effects, 
what  makes  them  theoretically  inappropriate  for  treatment.  However,  no 
alternatives are available and  to-date there is still no prophylactic vaccine. 
Combination therapy and secondary prophylaxis have been suggested as the 
way  forward  to  avoid  increased  Leishmania  drug  resistance,  to  reduce 
treatment  time  and  quantities  of  drugs  administered  (83).  Secondary 
prophylaxis  has  been  shown  to  be  the  only  promising  tool  to  reduce 
leishmaniasis relapses, too (52). While drug resistance can originate within 
the parasite by repeated drug exposure (84), some studies showed that host 
genetic characteristics may be a source of drug resistance, too (85). 
 
The search for more appropriate drugs and drug targets is on-going. There 
are some alternative drugs in trial, but none have demonstrated their efficacy 
satisfactorily yet. 29 
 
 Vaccine development  1.1.7.
There  is  no  human  prophylactic  anti-Leishmania  vaccine  available  to-date. 
Vaccine  development  has  proven  to  be  difficult.  There  are  several 
requirements for an anti-Leishmania vaccine, which includes safety, easy low-
cost production preferably in endemic countries, induction of long-term T-cell 
responses  and  prophylactic  and  therapeutic  properties  ideally  with  cross-
protection properties against CL and VL, but so far cross-protection has been 
highly variable (86).  
 
Leishmanization, in which Leishmania parasite are inoculated artificially into 
the person’s skin to cause self-healing lesions, was the original vaccination 
strategy in practise (87). Although regionally very successful, leishmanization 
was largely abandoned, because of high safety risks and inapplicability in HIV 
or  immunosuppressive  drug  patients.  First-generation  vaccines  were  then 
based on attenuated parasites and parasite material, which showed increased 
security,  but  none  showed  sufficient  efficacy  for  large  scale  vaccination 
programmes  (88).  Alternative  approaches  (second-generation  vaccines) 
including recombinant proteins, polyproteins and DNA vaccines in liposomal 
formula  with  dendritic  cell  and  viral  delivery  systems  were  then  adopted; 
candidate  VL  vaccines  tested  are  reviewed  by  Evans  &  Kedzierski  (2012) 
(89)). The development of second-generation vaccines, however, has been 
hampered by the lack of adequate animal models with appropriate reagents 
(90). A limited number of recombinant Leishmania-proteins have been tested 
in the murine model against VL, among which are the L. (L.) donovani dp72 
(91), A2 cysteine proteinase (92), L. (L.) infantum BCG-LCR1 protein (93) and 
a KMP-HASPB recombinant fusion protein delivered as DNA in an adenoviral 
delivery  system  (94).  Multicomponent  vaccines  have  shown  so  far  the 
greatest  efficacy  against  VL.  To-date,  however,  the  LEISH-F1+MPL-SE 
vaccine  consisting  of  three  recombinant  Leishmania  polyproteins  (TSA-
LmSTI1-LeIF)  with  the  adjuvant  monophosphoryl  lipid  and  squalene  in  a 
stable emulsion (MPL-SE) is the only multicomponent human anti-Leishmania 
vaccine  in  clinical  trial,  but  is  not  promising  (95). This  vaccine  has  shown 
promising applications as immunotherapy in combination with chemotherapy 
in CL patients (96) and as a veterinary vaccine for dogs (97). For reservoir 
control  there  are  currently  two  veterinary  vaccines  commercially  available 
against canine visceral leishmaniasis, Leishmune
® and Leishtec
® (98).  
 
The  best  studied  DNA  vaccine  candidate  is  the  Leishmania  homologue  of30 
 
receptors  for  activated  C  kinase  (LACK)  (99),  which  induced  high  level 
production  of  IFN-ɣ  and  IL-10  (100).  The  vaccine,  however,  showed 
significant inconsistencies in its capacity to protect against Leishmania (101). 
LeishDNAVAX  is  another  DNA  vaccine  in  preclinical  trials  with  different 
delivery systems (102).  
 
The inclusion of sand fly saliva components into second-generation vaccine 
formulations  has  been  considered,  too,  due  to  their  immunomodulating 
properties  (103).  Experiments  have  shown  that  pre-exposure  to  saliva  or 
specific salvia components by injection or by repeated bites from uninfected 
sand  flies  conferred  some  protection  against  subsequent  challenges  with 
Leishmania  by  bites  of infected  sand flies  or  needle  challenge  (104,  105), 
although co-infection of parasites with sand fly saliva in naïve mice enhances 
Leishmania infection (106). 
 
With  the  increasing  availability  of  Leishmania  genome  sequences  (>80  to-
date) (107–109) reverse vaccinology becomes possible (110) increasing the 
identification  potential  in  combination  with  refined  algorithms  for  new 
Leishmania-specific antigens for vaccines. This may accelerate the discovery 
of an effective anti-Leishmania vaccine, in the longer term. 
 
1.2. Leishmania parasites 
Lieutenant-General Sir William Leishman, after whom the genus was named, was 
one of the first to isolate Leishmania parasites in kala-azar patients in India in 
1900. The Leishmania genus, together with 8 other genera, belongs to the family 
Trypanosomatidae (Fig.1.5) and was sub-divided by Saf'janova (1982) into the 
sub-genera  L.  (Sauroleishmania)  and  L.  (Leishmania)  (111);  the  latter  being 
further  divided  by  Lainson  &  Shaw  (1987)  into  the  L.  (Leishmania)  and  L. 
(Viannia)  sub-genera  (Fig.1.5)  (112).  These  two  subgenera  were  principally 
distinguished by parasite localization in the vector’s intestine (113); a distinction 
that was later supported by DNA sequence phylogenetic analysis and isoenzyme 
profiling  (114,  115).  While  L.  (Viannia)  spp.  migrate  first  to  the  hindgut  (HG) 
before developing towards the stomodeal valve (SV) (peripylarian development), 
L. (Leishmania) spp. have lost the HG colonization and colonize the abdominal 
midgut (AMG) of their vectors and begin their development from there towards the 
SV (suprapylarian development) (Fig.1.6) (116, 117). It has been proposed that 
the  peripylarian  development  is  more  primitive  than  the  suprapylarian 
development  and  evolved from the hypopylarian development  still observed in31 
 
 
Fig.1.5 – Taxonomic tree of the mammalian infective Leishmania spp. 
The tree was adapted from various sources (36, 118–120). There is an on-going polemic to the exact complex clustering due to different technical 
approaches. For instance, Asota et al. (2009, 121, 352) clustered L. (L.) tropica, L. (L.) killicki, L. (L.) major and L. (L.) aethiopica  into the same 
complex and merged the L. (V.) braziliensis and L. (V.) guyanensis complexes by cytochrome b gene sequencing. The five boxed Viannia spp. are 
still unassigned to a complex. The status and/or taxonomic position of species marked with an asterisk (*) are still under discussion. L. (L.) chagasi 
was accepted to be synonymous with L. (L.) infantum. Leishmania spp. found in the New World are in yellow; those found the Old World in green. 32 
 
 
Fig.1.6 – Differences in L. (Leishmania) spp. and L. (Viannia) spp. development 
in the sand fly 
At the top is a schematic of the suprapylarian development of L. (Leishmania) spp. 
starting within the blood meal in the abdominal midgut (AMG) and migrating forward 
towards the stomodeal valve (SV) as they differentiate. Below is the schematic of the 
peripylarian development of L. (Viannia) spp., which is proposed to be evolutionarily 
more primitive than the suprapylarian development. Here the parasites move first into 
the hindgut (HG) before they migrate forward into the thoracic midgut (TMG) and to 
the SV. The dotted arrows indicated differentiation steps that are still being debated.   33 
 
some  Sauroleishmania  species  (e.g.  L.  (S.)  ceramodactyli  (Adler  &  Theodor, 
1928) and L. (S.) agamae (David, 1929)) (120). It has been proposed that the 
genus  Leishmania  originated  from  monogenetic  intestinal  flagellates  of 
invertebrates (112) and that phlebotomine sand flies were the primitive host for 
the Leishmania ancestor (121).  
 
There are currently 31 species in the Leishmania genus (20 in the Leishmania 
subgenus & 11 in the Viannia subgenus) spread in several species complexes 
(36),  but  some  species  and  complexes  are  still  debated  (Fig.1.5).  Leishmania 
classification and species identification is difficult due to the extreme homogeneity 
of  genomes  (109),  which  is  greater  than  within  the  closely  related  species  of 
Trypanosoma cruzi (122), and the difficulty of morphological distinction between 
genus  members.  The  origin  of  the  Leishmania  genus  is  also  still  a  matter  of 
debate. There are several hypothesis including Neotropic (123, 124), Palaearctic 
(125, 126) and separate origins of the Leishmania and Viannia subgenera (127). 
 
 New World Model of Leishmania Origin  1.2.1.
In this model, it has been proposed that the origin of the Leishmania genus 
was in the Neotropics in the Palaeocene or Eocene 36 – 46 Million years ago 
(MYA)  (Fig.1.7),  because  of  the  greater  genetic  diversity  of  Leishmania 
species in the New World (123, 124) and the retention of the more primitive 
peripylarian  development  of  L. (Viannia)  spp.  (120).  Leishmania  may  have 
spread via island-hopping into the Nearctic as demonstrated by the spread of 
L. (L.) mexicana through the Caribbean (128) and some reservoir host then 
carried Leishmania via the Nearctic and Bering land bridge into Asia, before it 
became too cold for sand flies in the high north in the late Miocene (129). 
According to the New World model, the Leishmania and Viannia subgenera 
split  in  the  early  Miocene  probably  in  the  Nearctic,  while  Leishmania  and 
Sauroleishmania did not split until the second half of the Miocene, probably as 
a consequence of the adaptation of Sauroleishmania to lizards and Old World 
sand  flies  from  the  genus  Sergentomyia  (124).  The  Leishmania  subgenus 
diversified in Central and/or Southeast Asia during the Miocene (24-14 MYA) 
and spread to Europe and Africa (114, 124). L. (L.) infantum was eventually 
reintroduced into the New World from Europe in historic times (~500 years 
ago) (130). This model suffers due to inconsistencies with the current sand fly 
classifications, which are postulated to have originated in the Old World (131). 
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Fig.1.7 – Representation of evolutionary spread of Leishmania across the globe 
This figure has been taken from Lukes et al. (2007) (123). It shows chronologically 
the proposed spread of Leishmania spp. across the globe from the Neotropic via the 
Nearctic and the Bering land bridge into Asia and from there into Europe and Africa 
until the re-introduction of L. (L.) infantum into the New World in historic times. The 
time points mark particular diversification and spreading events. 
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 Old World model of Leishmania Origin  1.2.2.
This  model  proposes  an  Old  World  origin  of  Leishmania,  because  of  the 
proposed Palaearctic origin of the Phlebotomine sand flies in the Oligocene 
(potentially,  in  today’s  Lebanon)  based  on  scares  fossil  records  (131). 
Although  Leishmania  spp.  may  have  vector  species  of  not  closely  related 
sand fly species from Phlebotomus and/or Lutzomyia subgenera, Leishmania 
has  been  proposed  to  have  co-evolved  more  closely  with  their  sand  fly 
vectors than with their vertebrate hosts (132). Therefore, it has been proposed 
that the parasites could only have originated and spread together with sand 
flies  (126,  130).  It  is  important  though  to  distinguish  co-evolution  from  co-
adaptation,  which  is  difficult  without  well-supported  vector/parasite 
phylogenies (133). The Palaearctic origin of murid rodents in the Oligocene 
(134)  – the most important group of  zoonotic  Leishmania  reservoirs in the 
world today – also supports the Palearctic origins of Leishmania. In this model 
Leishmania  spread with its vectors and vertebrate  hosts  across Africa, the 
Mediterranean  Europe  and  Asia.  Sauroleishmania  split  first  from  the 
Leishmania genus due to the adaptation to lizards and stayed in Asia (111), 
while Leishmania spp. crossed the Bering land bridge into the Nearctic. Once 
the  Panamanian  land  bridge  was  established  Leishmania  spread  into  the 
Neotropic,  where  L.  (Viannia)  spp.  split  from  the  Leishmania  genus  and 
rapidly diversified due to the climate changes and population isolation events 
(125,  126).  Alternatively,  Leishmania  may  have  entered  the  Neotropic  via 
island-hopping  (135),  allowing  a  longer  period  for  diversification  of  the 
Leishmania genus in the Neotropic (125). In this model, it has been proposed 
that the peripylarian development of L. (Viannia) spp. is not more primitive 
than the suprapylarian one of L. (Leishmania) spp. (136).  
  
 Separate origins of L. (Leishmania) spp. and L. (Viannia) spp.  1.2.3.
In this model, it has been proposed that the sand fly genera Phlebotomus and 
Lutzomyia may have evolved in isolation ~120 million years ago during the 
Cretaceous period, while adapting to feeding on the spreading mammals from 
the original feeding on lizard (131). If the Leishmania and Viannia subgenus 
separated as early as ~90 million years ago (137), then L. (Viannia) spp. got 
separated  from  the  L.  (Leishmania)  spp.  with  their  Lutzomyia    and 
Phlebotomus  vectors,  respectively,  when  Gondwana  broke  up  (127).  The 
ancestor of the L. (L.) mexicana complex could have entered the Nearctic via 
the Bering land bridge after the split with Sauroleishmania, but prior to the 
Panamanian land bridge establishment (112), explaining the global spread of 36 
 
L. (Leishmania) spp. compared to restriction L. (Viannia) species to South and 
Central  America.  By  correlating  the  origins  of  the  sand  fly  genera  and 
Leishmania subgenera, this model supports the proposed African origin of all 
Old World Leishmania species, while permitting the early development of L. 
(Viannia) spp. in the Neotropics (127).  
 
 Leishmania and its reservoirs  1.2.4.
Leishmania has a broad reservoir host diversity reaching from insects over 
mammals to  even  plants  depending  on the  Leishmania  species.  Reservoir 
hosts are essential for the survival of Leishmania, because they represent the 
natural long-term source of continuous infection of sand fly vectors, which can 
spread  the  disease  to  new  reservoir  and  incidental  hosts.  A  reservoir  of 
infection  is  defined  as  “an  ecological  system  in  which  an  infectious  agent 
survives persistently” (138). A good reservoir host usually bears some or all of 
the  following  characteristics:  it  must  allow  for  parasite  persistence,  is 
abundant,  social,  long-lived,  develops  no  acute  disease,  the  parasites  are 
present in either the skin and/or the blood circulation, where a vector can pick 
them up. As a general rule, it is not in the interest of a parasite to cause harm 
to  its  host  and,  therefore,  these  natural  reservoirs  remain  generally 
asymptomatic to Leishmania infection. Natural mammalian parasite reservoirs 
are  species  from  groups  like  rodents,  canids,  edentates,  marsupials, 
procyonids, ungulates and even some primates among others (Appendix 1) 
(139). With the exceptions of L. (L.) donovani and L. (L.) tropica in some parts 
of the world, humans are incidental hosts of infection and acquisition of the 
parasites frequently happens when man invades endemic areas (139).  
 
 Leishmania lifecycle  1.2.5.
All  human  infective  Leishmania  spp.  are  obligate  digenetic  kinetoplastid 
protozoa, which live as extracellular flagellate forms (promastigotes) in sand 
fly  vectors  and  as  an  intracellular  aflagellate  forms  (amastigotes)  in 
mammalian  macrophage  phagosomes  (Fig.1.8)  (140).  Intracellular 
amastigotes  are  considered  to  be  the  dominant  morphological  form  in  a 
mammalian  host,  although  amastigote  morphology  may  differ  between 
Leishmania spp. (141) and other morphological amastigote forms may exist 
(142).  Promastigote  morphology,  however,  is  more  complex  and  several 
distinct  morphological  forms  are  distinguished  in  shape  and  order  of 
appearance: procyclic promastigotes (short, ovoid, slightly motile – cell body 
width ≥ 4 μm, cell body length < 7,5 μm), nectomonad promastigotes (long,37 
 
 
Fig.1.8 – Mammalian infective Leishmania digenetic lifecycle 
Mammalian infective parasites from the genus Leishmania exist as two obligate life-
cycle stages: as intracellular aflagellate amastigotes in the phagolysosomes of host 
macrophages and as extracellular flagellate promastigotes in the midgut of sand fly 
vectors of the family Phlebotominae. The image was adapted from Sacks & Noben-
Trauth (2002) and Kamhawi (2006) (143, 144). 
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slender, highly motile – cell body length > 14 μm), leptomonad promastigotes 
(short, broad formed, proliferating), metacyclic promastigotes (short, slender, 
highly motile, non-dividing, – cell body width < 4 μm, cell body length 7 μm < _ 
< 14 μm, flagellum length ≥2x body length) and haptomonad promastigotes 
(flaccid-looking, expanded flagellar tip, immobile) (Fig.1.9B) (140, 145, 146). 
The timing of appearance of the different morphological forms varies between 
Leishmania  spp.  in  vivo,  but  the  order  is  always the same.  In  culture,  the 
same  patterns  are  observed  on  inoculation  with  amastigotes,  but  parasite 
differentiation becomes rapidly desynchronised on subpassaging (145). The 
differentiation  of  promastigotes  from  procyclics  to  metacyclics  and  the 
accompanying migration towards the SV is termed metacyclogenesis. 
 
1.2.5.1.  Sand fly stage: Metacyclogenesis of L. (Leishmania) spp. 
The  timing  of  suprapylarian  metacyclogenesis  of  L.  (Leishmania)  spp. 
presented here is sourced from Sacks & Kamhawi (2001) and Kamhawi 
(2006)  (Fig.1.6  &  1.10)  (140,  144).  Parasite  differentiation  steps  are 
triggered  in  response  to  one  or  multiple  of  several  described 
microenvironmental  changes,  such  as  changes  in  temperature, 
tetrahydrobiopterin, absence of haemoglobin or oxygen, exposure to sand 
fly saliva and decrease in pH (147–150).  
 
Leishmania  amastigotes  are  taken  up  in  a  blood  meal  by  the  sand  fly 
vector. 12-18 h post blood meal (PBM), amastigotes transform within the 
peritrophic matrix (PM; described in more detail in 1.4.1.3) encapsulated 
blood meal into proliferative flagellate procyclics bearing a dense LPG coat, 
which  confers  resistance  to  midgut  conditions.  Temperature  drops  from 
~37 ºC to ambient temperature and pH increases from pH ~5 to pH ~8 
have  been  shown  to  trigger  this  transformation  (150),  although  the 
underlying molecular mechanisms remain unknown. ~50% of amastigotes 
may be destroyed during procyclic generation and procyclics will proliferate 
intensely  in  the  24-48  h  following  their  appearance  to  increase  their 
numbers  (151).  The  single flagellum  extending from the  flagellar  pocket  
permits  locomotion  within  the  vector’s  gut  lumen  (and  in  the  case  of 
nectomonads and leptomonads attach to the vector’s intestinal epithelia) 
(Fig.1.9A.1)  (152).  Proliferating  procyclics  form  rosette  shapes  and 
accumulate at the anterior end of the PM. Some procyclics persist even 
after  blood  meal  defecation  and  for  the  rest  of  the  sand  fly’s  life  span, 
although  it  is  not  clear  how  they  avoid  expulsion  since  they  are39 
 
 
Fig.1.9 – Schematic representation of Leishmania metacyclogenesis 
A. Parasites from the L. (Leishmania) sub-genus initially colonize the midgut from 
where  they  migrate  forwards,  while  undergoing  a  process  correlating  with 
differentiation.  1)  Midgut  epithelium  attachment of  nectomonads  by  insertion  of 
their flagellum in between the epithelial microvilli. 2) The promastigote secretory 
gel (PSG) plug was proposed to be essential for parasite transmission, blocking 
the  midgut  and  forcing  the  sand  fly  to  regurgitate  it  with  infective  metacyclic 
promastigotes immediately prior to blood feeding. 3) The stomodeal valve (SV) is 
a one way valve that prevents midgut contents from spilling back into the foregut. 
Haptomonads attach to the SV lining and disintegrate it by secreting chitinases. 
Adapted from Kamhawi (2006) and Warburg (2008) (144, 152). 
B. Schematic  representation  of  L.  (Leishmania)  spp.  differentiation  in the sand fly 
midgut. Two proliferative and three non-proliferative stages have been described. 
Although the succession of morphological forms from procyclics to nectomonads 
then leptomonads to metacyclics is generally accepted, it is still no clear whether 
haptomonads  differentiate  from  nectomonads  or  leptomonads,  but  due  to  their 
size, shape and timing of appearance it is more likely that they also differentiate 
from leptomonads like metacyclics. Adapted from Gossage et al. (2003), Bates & 
Rogers (2004) and Bates (2007) (145, 150, 153). 
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Fig.1.10 – Difference in LPG side chain composition between L. (L.) infantum 
(=chagasi) and L. (V.) braziliensis 
While the length of metacyclic LPG increases in both species the short procyclic LPG 
chain  of  L.  (L.)  infantum  (=chagasi)  has  many  β(1,3)glucose  residues,  which  are 
eliminated in the metacyclic LPG, the LPG of L. (V.) braziliensis does the opposite by 
increasing  the  number  of  β(1,3)glucose  residues  in  the  metacyclic  LPG.  Adapted 
from Soares et al. (2010) (154). 
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outcompeted for epithelial attachment by nectomonads (155).  
 
In culture, development of nectomonads from procyclics occurs principally 
in late exponential / early stationary phase in response to starvation due to 
nutrient depletion (145), which occurs after ~3 days PBM  within the PM 
prior the blood meal defecation. The PM ruptures by about day 3 PBM – 
probably  due  to  sand  fly  derived  chitinases  that  aid  excretion  –  and 
nectomonads  enter  the  ectoperitrophic  space  to  attach  to  the  intestinal 
epithelium. This attachment has been proposed to be essential for infection 
persistence (156). The speed of escape correlates with the height of initial 
infection levels (157). Nectomonads are also proposed to migrate into the 
thoracic midgut (TMG) and towards the SV, but the attachment/detachment 
kinetics of nectomonads, which are proposed to depend on changes in the 
LPG structure (158, 159), remain unknown. However, some nectomonads 
have been observed to remain unattached within the midgut lumen (117). It 
was,  therefore,  postulated  that  epithelium  attachment  may  serve 
environment  preadaptation  for  parasite  survival  and  continuation  of 
metacyclogenesis by, for instance, abolishing peristalsis by myoinhibitory 
neuropeptide secretion (160). During nectomonad migration, by day 4 – 5 
PBM,  nectomonads  begin  to  transform  into  leptomonads  (formerly  short 
promastigotes or haptomonads, but renamed as distinct forms (145, 161)), 
the second replicative promastigote form, which increase parasite numbers 
in the TMG/cardia generating massive infections by day 5 – 7 PBM (145). 
Leptomonads have been shown to secrete the promastigote secretory gel 
(PSG)  (Fig.1.9A.2)  (161).  Flaccid  looking  true  haptomonads,  a  terminal 
differentiation stage, are generated from leptomonads by day 5 – 7 PBM. 
They have a modified flagellum with which they can attach to the cuticle of 
the  SV  via  hemidesmosomes-like  structures  (Fig.1.9A.3)  (155). 
Haptomonads were proposed to be involved in the degeneration of the SV 
by  secretion  of  parasite  chitinases  allowing  infective  metacyclic 
promastigotes  to  migrate  into  the  sand  fly  foregut  (FG)  (162). 
Haptomonads never make up more than 10% of the total parasite load of 
an  infected  gut  and  may  also  be  found  attached  to  the  HG  and  FG 
depending on infecting Leishmania spp. (145).  
 
Mammalian infective metacyclics are also generated from leptomonads by 
day 5 – 7 PBM (145, 161). In vitro, this differentiation step can be induced 
by lowering the pH, anaerobic condition and tetrahydrobiopterin depletion 42 
 
(148, 149). Metacyclic LPG is commonly longer than the procyclic form and 
varies in side-chains and cap composition, providing protection against the 
mammalian  complement  system,  facilitating  release  from  the  midgut 
epithelium and preventing attachment to the PSG. The peak of metacyclic 
generation usually coincides with the sand fly’s search for another blood 
meal  allowing  for  optimal  parasite  transmission  into  a  mammalian  host 
(163). Therefore, metacyclogenesis is an essential prerequisite for parasite 
transmission to a mammalian host in vivo. By day 7 – 10 PBM, >60% of 
resident parasites are found near the SV and in the TMG (161). 
 
1.2.5.2.  Sand fly stage: Metacyclogenesis of L. (Viannia) spp. 
A lot less is known about the peripylarian metacyclogenesis of L. (Viannia) 
spp. (Fig.1.6). They have the same morphological life-cycle stages within 
their  sand  fly  vectors  (Lutzomyia  spp.)  as  L. (Leishmania)  spp.,  but  the 
direction  of  their  peripylarian  development  is  different.  Amastigotes  are 
taken up with the blood meal, differentiate within the PM enclosed blood 
meal into procyclics and then proliferate at the anterior end of the PM just 
like L. (Leishmania) spp., but once the nectomonads escape from the PM, 
the majority migrates  into the pyloric region of the  HG, where parasites 
attach to the cuticle as rarely dividing haptomonad-like forms just like at the 
SV (116, 164). This may be integral to the establishment of a persistent 
infection, because there is little evidence that  L. (Viannia) nectomonads 
actually attach to the midgut epithelium (165), although their LPG has been 
shown to bind (154). After the HG phase, there is a forward movement of 
nectomonads towards the SV  and differentiation first into leptomonads and 
then into haptomonads and metacyclics (116). However, the details of the 
kinetics of this forward migration have not been fully explored, although the 
end result of metacyclogenesis in the Viannia subgenus is very similar to 
what is observed in the Leishmania subgenus (153). The degradation of 
the SV and secretion of the PSG is proposed to occur for L. (Viannia) spp., 
too, so does the forward transmission during sand fly blood feeding. 
 
 The Leishmania cell surface  1.2.6.
The  cell  surface  of  Leishmania  parasites  changes  dramatically  between 
lifecycle stages. While the extracellular promastigote forms are covered in a 
dense  coat  of  predominantly  glycosylphosphatidylinositol  (GPI)-anchored 
glycoproteins,  LPG,  PPG  and  a  family  of  free  GPIs,  the  intracellular 
amastigotes are predominantly covered in a dense coat of free GPIs, lacking 43 
 
LPG  (166, 167). The GPI-anchored glycoproteins and LPG  are associated 
with different roles in the parasite’s life within the midgut; for instance, in the 
invasion of macrophages, evading complement lysis and the specific midgut 
attachment  of  promastigotes  (168,  169).  LPG  is  essential  for  the  sand  fly 
midgut  attachment  in  specific  vector  –  parasite  combinations,  but  not  in 
permissive vector – parasite ones (169, 170). 
 
1.2.6.1.  Glycosylphosphatidylinositol-anchors 
GPI-anchors  are  an  abundant  mean  for  all  eukaryotic  cells  to  tether 
proteins and other macromolecules to the plasma membrane. All examined 
Leishmania  spp.  have  the  same  completely  conserved  1-O-alkyl-2-lyso-
phosphatidyl(my)inositol anchor with C24 and C26 saturated aliphatic chains 
(171).  In  Leishmania,  GPI-anchors  are  used  predominantly  to  tether 
proteins and LPG to the cell surface and they represent the sole class of 
free glycolipids on the cell surface. By targeting the dolichol-phosphate-
mannose synthase (DPMS) of L. (L.) mexicana, it was determined that GPI 
synthesis is localized to a distinct tubular subdomain, termed the DPMS 
tubule, which appears associated with the subpellicular microtubules, the 
Golgi and the mitochondrion (172). The synthesis is tightly regulated to the 
parasite’s  developmental  stages.  GPI  synthesising  enzymes  are  down-
regulated  and  re-localized  to  the  multivesicular  tubule  lysosome  in 
promastigotes with the approach of stationary phase in culture (173). In 
culture,  the  onset  of  stationary  phase  coincides  with  the  initiation  of 
metacyclogenesis due to starvation. 
 
1.2.6.2.  Lipophosphoglycans 
LPG  is  the  largest  and  most  abundant  surface  glycoconjugate  of 
promastigotes, covering the entire cell surface and flagellum. LPG consists 
of  the  conserved  GPI-anchor  linked  to  a  conserved  glycan  core  region 
(Gal(α1,6)-Gal(α1,3)-Galf(β1,3)-[Glc(α1)-PO4]-Man(α1,3)-Man(α1,4)-
GlcN(α1))  to  which  a  capped  oligosaccharide  (Gal(β1,3)-Man(α1)-PO4) 
backbone  is  attached  (Fig.1.10)  (174).  The  backbone  varies  in  capping 
structure, in Glc(β1,3)-side-chain content and in length between different 
promastigote stages and Leishmania spp. (175). The backbone Glc(β1,3)-
side-chains  show  inter-  and  intra-species  specific  polymorphisms  in 
variability and size (154, 159, 174). Modes of LPG modification over the 
course of metacyclogenesis differ between Leishmania subgenera; while L. 
(Leishmania) spp. tend to reduce the number of side-chains towards the 44 
 
metacyclic stage, the L. (Viannia) spp. increase the number and length of 
metacyclic  LPG  Glc(β  1,3)-side-chains  (159,  165).  In  case  of  L. 
(Leishmania)  spp.,  the  reduction  of  the  side-chains  is  proposed  to  be 
responsible for the detachment of metacyclics from the midgut epithelium 
(159). The epithelium attachment is proposed to be parasite LPG – sand fly 
lectin dependent in specific parasite – vector combination (169) and it has 
been shown that L. (Leishmania) spp. nectomonads and leptomonads have 
higher  affinity  for  midgut  epithelia  attachment  than  procyclics  and 
metacyclics, a feature attributed to their LPG modification (155). This is not 
the case for L. (Viannia) spp., where metacyclic derived LPG was able to 
out-compete all promastigote forms in midgut epithelium attachment (154), 
suggesting  an  alternative  mechanism  for  metacyclic  midgut  epithelium 
detachment in L. (Viannia) spp., than for L. (Leishmania) species. LPG is 
important for parasite survival in the sand fly vector for all Leishmania spp., 
conferring  resistance  to  sand  fly  immune  responses  and  proteolytic 
digestion  (169),  while  metacyclic  specific  LPG  also  protects  against 
complement lysis in the human host (34, 35). 
 
1.3. Sand Fly Vectors 
Phlebotomine sand flies are diptera  insects from the Family  Psychodidae. Ph. 
(Ph.) papatasi was described by Scopoli in 1786 (originally Bibio papatasi) as the 
first of ~900 sand fly species described to-date (132, 176). All sand fly species 
belong  to  one  of  five  accepted  genera:  Phlebotomus  (Loew  1845)  and 
Sergentomyia (França & Parrot 1920) in the Old World and Brumptomyia (França 
& Parrot 1921) Lutzomyia (França 1924) and Warileya (Hertig 1948) in the New 
World (Fig.1.11). Experimental Leishmania transmission by sand fly bite to a new 
mammalian host was incontrovertibly demonstrated for the first time by Adler & 
Ber  (1941)  with L. (L.) tropica  in Ph. (Ph.) papatasi  (177)  and  by  Swaminath, 
Shortt  and  Anderson  (1942)  with  L.  (L.)  donovani  in  Ph.  (Euphlebotomus) 
argentipes  (178).  Only  ~70  of  all  described  sand  fly  species  have  ever  been 
associated  with  Leishmania  transmission to  mammals  and  all  of these  belong 
either  to  the  genera  Phlebotomus  (Old  World)  or  Lutzomyia  (New  World), 
although L (L.) major has been isolated from Sergentomyia spp. in East Africa 
(179, 180) and Iran (181). These species also take blood from mammals and not 
only  from  lizards  (182),  but  these  sand  flies  do  not  support  full  Leishmania 
development (183). There is also evidence that the vectors of Leishmania among 
marsupials in Northern Australia are ceratopogonid midges, while sand flies are 
scarce  or  absent  in  these  areas  of  natural  Leishmania  transmission  (184).  To45 
 
 
Fig.1.11 – Taxonomic tree of Leishmania transmitting phlebotomine sand flies 
All the medically relevant sand fly subgenera are listed together underneath the respective genus. Species of only seven of the twelve Phlebotomus 
subgenera and nine of the 25 Lutzomyia subgenera and species groups are suspected or proven Leishmania vectors. The relevant sand fly vector 
species can be found in Table 1.1. The tree is based on NCBI’s taxonomy browser and Killick-Kendrick (1999) (185). 46 
 
date, there is convincing evidence for only ~30 sand fly species to be natural 
vectors for one or several human infective Leishmania spp. (186). The criteria for 
incriminating a natural vector are detailed in Ready (2013) (132), but a necessary 
characteristic for a vector of human-infective Leishmania is anthropophilicity. The 
fact that some Leishmania spp. have several different, often not closely related 
sand fly species as vectors demonstrates great plasticity of the parasites in their 
sand  fly  vectors  and  suggests  that  Leishmania  may  spread  easily  by  quick 
adaption  to  a  new  sand  fly  vector  (132),  as  in  the  case  of  L.  (L.)  infantum 
adaptation to Lu. (Lu.) longipalpis. This is one of the reasons why vector control is 
so complicated as a measure for leishmaniasis control. 
  
Phlebotomine sand flies have a body length of about 2-3 mm and are covered in 
a  dense  coat  of  oily  hairs  and  bristles  (Fig.1.12).  Their  wings  have  a  very 
characteristic V-shape posture when resting, which distinguishes them from other 
members of small diptera Families. Their usual time of activity is twilight and night 
with peak times between 3:30am – 5:30am, but they also may fly and bite during 
the day when disturbed from their resting places or present in dense shades or 
under  sufficiently-day-light-reducing  cloud  cover.  Adult  sand  flies  are  primarily 
phytophagous  and  their  diet  is  sugar  from  plant  sap  and  perhaps  from  aphid 
honeydew (187). Only mature female sand flies feed on blood and mammalian 
vector species blood-feed at least twice throughout their adult life. Females are 
telmophages (pool feeders), feeding from lacerations inflicted on the host’s skin 
by inserting their saw-like mouthparts (186). Skin laceration has been proposed to 
promote up-take of amastigotes  by sand flies,  by releasing skin  macrophages 
and/or freeing amastigotes from damaged macrophages into the pool (153). 
 
 Sand fly Development  1.3.1.
Despite their importance as  Leishmania  vectors, not much is known about 
their natural behaviour and breeding sites of sand flies and most knowledge 
comes from laboratory observations. Sand flies occur in diverse environments 
from moist tropical rainforests to arid deserts. In nature, adult sand fly habitats 
do not necessarily coincide with breeding sites and it is proposed that female 
sand flies will find suitable breeding sites by recognition of natural attractants 
emitted by e.g. faeces and soil bacteria (188). In general, sand flies lay their 
eggs in organically rich moist soil protected from sunshine and rain, such as 
rain forest floor between tree roots and soiled animal shelters/burrows, but 
never in water as is typical for mosquitos. Davis (1967) published the most 
complete observation of the sand fly life stages (189). Briefly, the female sand47 
 
 
Fig.1.12 – Sand fly Phlebotomus (Phlebotomus) papatasi 
The  image  shows  Ph.  (Ph.)  papatasi  blood  feeding.  The  oily  hairs  on  thorax, 
abdomen and wings are visible, which cause the sand fly’s whitish appearance. The 
distinct V-shape of the wings is also discernible. The picture is an open source from 
the CDC homepage.   48 
 
fly scatters about 30-70 eggs around relatively dry or moist soil rich in organic 
matter,  which  will  be  the feeding  base for  the hatching  larvae. The  larvae 
hatch through a J-shaped fissure in the egg shell and pass through four larval 
instars before pupating and emerging as adult sand flies (Fig.1.13). None of 
these stages takes the phlebotomine sand fly to aquatic environments, which 
distinguishes  it from  other  haematophagous  dipterans,  like  mosquitos. The 
whole lifecycle takes about 20-40 days. Temperature and precipitation levels 
can vary the length of the lifecycle in particular in the larval stages. 
 
 Structure of the sand fly alimentary canal  1.3.2.
Warburg (2008) analysed the sand fly alimentary canal structure (Fig.1.14) in 
great detail by scanning electron microscopy (152). It begins with the cuticle-
lined FG that consists of the proboscis (mouthparts) followed by cibarium and 
pharynx,  which  both  have  pumping  activity  to  regulate  the  liquid food flow 
(Fig.1.15) (189, 190). The pumping activity is facilitated by the cibarial valve, 
which separates the cibarium from the pharynx, and the SV, which separates 
the pharynx from the TMG. The valves prevent the back-spill of liquid food. 
Just  ahead  of  the  SV  is  the  oesophagus,  where  the  diverticulum  (crop) 
attaches.  The  crop  is  a  storage  compartment  exclusively  for  sugar-based 
foods.  The  SV  has  chemosensory  activity  on  the  side  of the  oesophagus, 
where basiconic sensilla (sensory organs with conical base protruding from 
the cuticle in arthropods) are present (191). This allows the SV to direct fluids 
either into the crop or the gut. When the sand fly takes a sugar meal, only a 
small amount is initially directed into the midgut, the majority is diverted into 
the crop and is then released only gradually into the midgut, while blood is 
always directed into the midgut in its entirety and digested as a single batch 
(192). The gut that follows the SV  is divided into three sections that have 
different  embryological  origins:  the  TMG,  the  AMG  and  the  HG  (Fig.1.16). 
TMG  and  AMG  make  up  the  midgut,  which  is  lined  by  a  single  layer 
epithelium with densely packed microvilli, that is separated by a fine basal 
lamina from the hemocoel (193). The midgut epithelium secretes the PM and 
digestive  enzymes  and  is  involved  in  absorption  and  transport  of  nutrients 
(194). The HG is cuticle-lined, like the FG, and consists of pylorus, ileum and 
rectum  (152,  195).  While  nutrient  absorption  is  generally  restricted  to  the 
midgut, water and salt are re-absorbed in the HG from urine and faeces (194). 
Sand flies are small (2 – 3 mm in body length) and with that the size of a meal 
–  blood  or  sugar  –  is  usually  <0.8  µl  (196). This  is  an  important factor  in 
Leishmania  infection, because it is a limiting factor in how many parasites49 
 
 
Fig.1.13 – Sand fly development from the egg to the adult insect 
Phlebotomine sand flies are holometabolous insects developing from the egg through 
four larvae and one pupal stages to reach the adult stage (197). 
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Fig.1.14 – Schematic of the Ph. (Ph.) papatasi alimentary canal 
Foregut (FG), midgut (MG), hindgut (HG), proboscis or mouth parts (MP), cibarium 
(CI),  cibarial  valve  (CV),  pharynx  (PH),  esophagus  (ES),  stomodeal  valve  (SV), 
thoracic midgut (TMG), crop (CR), abdominal midgut (AMG), pylorus (PY), ileum (IL) 
and rectum (RE). Taken from Warburg and Schlein (1986) (198). 
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Fig.1.15 – Images of sand fly foregut 
A - B) The cibarium, that follows the proboscis (mouth parts) is narrow and smooth till the posterior part ahead of the cibarial valve (CV), where 
several rows of thorn like shorter and flexible longer cuticular appendages are localized, whose function is elusive (see B). The anterior pharynx 
following the CV is narrow and lined by smooth cuticular plates with longitudinal ridges. C) Posteriorly, the pharynx opens into the esophagus which 
also contains rows of appendages. Here the diverticulum (crop) is attached ahead of the stomodeal valve, which regulates the flow of food by the 
cuticle-lined sphincter ring muscle (SP). For Leishmania transmission, the parasites have to travel up the FG against the direction of flow. These 
scanning electron microscopy images were adapted from Warburg et al. (2008) (152). 
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Fig.1.16 – Image of dissected blood meal containing midgut 
The image shows the crop (D) filled with sucrose at the bottom. It attaches to the gut 
just ahead of the SV, which controls the influx into the midgut. The thoracic midgut 
(TM)  is  void  of  blood  as  can  be  seen  in  the  image  and  its  pH  remains  at  sugar 
digestion levels, while the abdominal midgut (AM) is filled with blood and has an 
alkaline pH, which peaks after blood uptake at about pH 8 and then declines again 
over the course of digestion (about pH 7.7 after 32 h). The image was take from 
Santos et al. (2008) (199). 
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could potentially be taken up with a blood meal. 
 
 Midgut Physiology  1.3.3.
To understand Leishmania metacyclogenesis, it is important to consider the 
physiological  conditions  and  structure  of  the  sand fly  midgut,  to  which  the 
parasites are exposed. Work done with the New World sand fly species Lu. 
(Lu.) longipalpis showed that the midgut was a highly dynamic environment 
(190).  Digestion  of  sugars  derived  from  plant  saps  is  the  main  alimentary 
source  for  sand  flies  throughout  their  adult  life  stage.  Since  digestion  is 
essentially an enzymatic process and enzyme activity is pH dependent, the 
pH is an important factor in the midgut environment and will be adapted to 
optimal digestive enzyme activity. Sugar digestion in the Lu. (Lu.) longipalpis 
midgut occurs at a pH of ~6, the optimal pH for the activity of the Lu. (Lu.) 
longipalpis midgut’s α-glucosidase (pH 5.8) (200). This optimal α-glucosidase 
pH of 5.8 in Lu. (Lu.) longipalpis is not a universal constant among sand flies. 
Dillon and El Kordy (1997) found that the optimal pH for the α-glucosidase in 
Old  World  species,  Phlebotomus  (Larroussius)  langeroni,  was  ~7.5  (196). 
This  may  suggest  significant  differences  in  midgut  physiology  between 
different sand fly subgenera or even species, which may aid the restriction of 
Leishmania spp. able to infect a specific sand fly species (199). α-glucosidase 
is a membrane bound enzyme and, interestingly, most of its activity is found in 
the TMG (199). The nutrients derived from the blood are almost entirely used 
for  egg  development,  instead  of  sand  fly  alimentation.  Since  blood  meal 
digestion  occurs at about  pH 8 and takes between 40  –  45 h in  Lu. (Lu.) 
longipalpis, the female sand fly requires sugar digestion during blood meal 
digestion for sustenance, too. This need is resolved in the split of the midgut 
into  two  distinct  environments.  While  the  blood  gets  digested  exclusively 
within the PM in the AMG, where the pH is changed to >8 within 10 min. after 
blood  uptake,  sugar  digestion  continues  to  occur  in  the  TMG  at  pH  6 
(Fig.1.16) (199). This explains why most of the α-glucosidase activity is found 
in the TMG even in unfed sand flies. Alkalization of the midgut is not unusual 
among insect species and, in particular, larvae of the suborder Nematocera, 
to which sand flies belong (201). It is proposed that at least two mechanisms 
are involved in midgut alkalization in Nematocera members. One is by CO2 
volatilization (199, 202), which may be the principal mechanism in vivo (203). 
It is necessary for the sand fly to turn off the mechanisms that maintain the pH 
6 in the midgut, otherwise CO2 volatilization by itself would be an insufficient 
mechanism for alkalinisation and it was subsequently shown that any ingested 54 
 
protein from blood at physiological levels could turn off the mechanism that 
maintains the pH 6 (203). A second mechanism has not been described in 
detail yet, but it was shown that the alkalization of the AMG also occurred 
significantly when blood was either depleted of CO2 and then pH corrected or 
replaced  completely  with  pH  indicator  dye  containing  solutions,  which 
excluded  CO2  volatilization  as  the  only  alkalization  process  (199,  202). 
Interestingly,  lowering  the  pH  of  cultures  was  shown  to  be  a  trigger  in 
metacyclogenesis (149, 204). 
 
1.4. Sand fly Vector and Leishmania Parasite  
The level of Leishmania infection within a sand fly population rarely exceeds 1.5% 
of the total population in endemic areas, although infection rates of humans and 
dogs in the same area are ~18.9% and ~46.7%, respectively (205). Apart from 
mammalian  host  availability,  aspects  of  the  sand  fly  vector  may  contribute  to 
limiting Leishmania infection in their populations. Leishmania parasites encounter 
various obstacles within the  sand fly midgut, which they need to overcome to 
establish sand fly infection, complete metacyclogenesis and, ultimately, achieve 
transmission to a new mammalian host. These challenges require extensive and 
complex interaction at the molecular level between parasites and their sand fly 
vectors (reviewed in (206)). If Leishmania infection is established successfully, 
however, adult sand flies stay infected for the rest of their adult life. 
 
 Manipulating host enzyme expression patterns  1.4.1.
The expression pattern of digestive midgut enzymes is dynamic and changes 
accordingly to whether a sugar meal or a blood meal is digested (Fig.1.17). 
Although no parasite mechanisms manipulating sand fly enzyme expression 
patterns have been discrebed in detail yet, distinct changes to the sand fly 
enzyme expression levels have been observed in the presence of Leishmania 
compared  to  their  absence.  For  example,  downregulation  of  digestive 
enzymes  protects  the  parasite  against  proteolytic  lysis,  an  additional 
protection to their LPG coat. It has been shown that L. (L.) mexicana survival 
is enhanced in Lu. (Lu.) longipalpis by experimental RNAi suppression of the 
major blood-meal induced trypsin (207). Active suppression or delay of the 
sand fly midgut trypsin peak activity and modulation of trypsin-like transcript 
levels  was  also  shown  for  L.  (L.)  major  and  L.  (L.)  infantum  in  Ph.  (Ph.) 
papatais and Lu. (Lu.) longipalpis, respecitvely (208, 209). Peritrophins are 
another group of proteins to be markedly down-regulated in the presence of 
Leishmania parasites. Peritrophins bind chitin fibers via several chitin-binding55 
 
 
 
Fig.1.17 – Changes in mRNA levels in the sand fly midgut transcriptome 
A number of predicted mRNA levels change during the switch from sugar to blood 
digestion in the sand fly midgut. The graphic groups identified sequences according 
to their biological function. Marked difference in sequence numbers can be observed 
between  sugar  fed,  blood  fed  and  L.  (L.)  major  infected  sand  flies  in  the  protein 
synthesis  machinery,  extracellular  matrix,  cytoskeleton,  heme  metabolism  and 
conserved  genes  of  unknown  function.  The  graphic  was  adapted  from  Ramalho- 
Ortigão et al. (2007) (208). 
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domains, building the scaffold of the PM (210). A marked reduction in their 
expression could weaken the PM facilitating the escape of Leishmania. Other 
proteins,  including  chymotrypsins,  microvilli  proteins  and  the  putative 
peptidoglycan recognition proteins (PGRPs), also showed different expression 
patterns between blood feed sand flies with and without Leishmania parasites 
(Table  1.2)  (208,  211).  Interestingly,  homologous  of  these  PGRPs  in 
Drosophila melanogaster and Anopheles gambiae were shown to be induced 
and  involved  in  their  immune  defences  against  bacterial  and  Plasmodium 
infections, respectively  (212, 213). There is also evidence that  Leishmania 
does  not  only  affect  expression  of  enzymes,  but  also  affects  their  activity 
directly.  During  the  genome  analysis  of  L.  (L.)  major,  serine  protease 
inhibitors (ISPs) were identified, which, however, seemed to have no potential 
targets  within  the  parasite  genome  (107).  The  ISPs  were  shown  to  be 
effective against sand fly midgut trypsin-like actrivity in vitro (214) and against 
vertebrate macrophage serine proteases, however, and one of them (ISP2) 
has been shown to enhance parasite survival in a murine model (215). Also 
secreted PPGs were shown to inhibit digestive enzyme activity (216). 
 
 Evading the sand fly’s complement system  1.4.2.
Not  much  is  known  about  the  sand  fly’s  immune  response  to  Leishmania 
infections. Examples from other parasite-vector relationships, however, have 
shown  a  series  of  complement  mechanisms,  including  secretion  of 
antimicrobial peptides (AMPs), NO, H2O2 and PGRPs, that confer control and 
elimination  of  midgut  infections  (212,  213,  217).  For  example,  anopheline 
mosquito vectors of the malaria parasite secrete a complement C3 protein-like 
molecule called thioester-containing protein 1 (TEP1) (218). TEP1 was shown 
to  eliminate  ~80%  of  all  Plasmodium  berghei  ookinetes  in  the  gut  of  the 
susceptible A. gambiae G3 strain (219). The mode of action of TEP1 is still 
unknown. Other defence mechanisms include the expression of nitric oxygen 
synthase  (NOS)  in  Plasmodium  invaded  gut  epithelial  cells  along  with 
peroxidases like heme peroxidases (HPX) and NADPH oxidases (NOX) (217, 
220). These enzymes generate nitric oxides (NOs) that act in toxic protein 
nitration. It was recently shown that sand flies can generate reactive oxygen 
species (ROS)  too, which are  used to combat microbial pathogens and to 
keep their commensal flora in check (221). It was shown that Leishmania is 
sensitive to ROS, but on infection with Leishmania, no increased ROS activity 
is  observed  in  the  sand  fly  midgut,  probably  because  Leishmania  do  not 
induce sand fly immunomechanisms by tissue damage and invasion of the57 
 
Table 1.2 – Manipulation of sand fly midgut enzyme up- and downregulation 
during blood meal digestion by L. (L.) major 
 
Black arrows indicate gene upregulation; red bars indicate gene downregulation. The 
numbers indicate cluster overrepresentation.  
The table was adapted from Ramalho-Ortigão et al. (2007) (208).  58 
 
hemolymph like Plasmodium spp. in mosquitos. Limiting effects of the sand fly 
immune response on Leishmania were demonstrated by the downregulation 
of  Caspar-like  genes,  which  act  as  negative  regulators  of  the  sand  fly’s 
immune  system  (222).  How  exactly  Leishmania  evades  the  sand  fly’s 
complement  system  is  unknown,  but  the  parasite’s  surface  PPG  was 
proposed to play a vital role (216). The parasites LPG may also be involved, 
although there is evidence that LPG may actually induce the secretion of sand 
fly defensin, an AMP, secreted by the epithelium, which is effective against 
microbes in the midgut (223). 
 
 Peritrophic Matrix  1.4.3.
The first defined physical obstacle for Leishmania parasites to overcome is 
the  PM  (also  known  as  the  peritrophic  membrane  (224)),  which 
compartmentalizes  the  midgut  into  an  ecto-  and  an  endoperitrophic  space 
(EnS) during blood digestion. The PM is an acellular envelope secreted by the 
intestinal epithelium of both AMG and TMG in most known haematophagous 
insects and consists of chitin, proteins and glycoproteins (Fig.1.18) (225, 226). 
The secretion of the PM is stimulated by the distension of the midgut due to 
the  consumption  of  blood  (227).  The  PM  protects  the  sensitive  midgut 
epithelium against pathogens and abrasion by food particles (210, 225, 226) 
and plays a role in heme detoxification (228). Involuntarily, the PM confers 
some  protection  to  Leishmania  amastigotes  within  the  EnS  by  preventing 
rapid diffusion of digestive enzymes, giving the parasite time to transform into 
LPG-covered procyclics (151).  
 
By day 3 – 4 PBM, the PM becomes a trap for Leishmania parasites due to 
blood meal defecation; if they are not able to escape the PM, which happens 
in  cases  of  non-permissive  infections,  the  parasites  will  be  excreted  (150, 
229). The efficacy with which different parasites strains escape the PM is a 
defining factor in their development within a vector species (157). Although 
Leishmania  accumulate  at  the  anterior  of  the  PM  and  secrete  their  own 
chitinases, which are essential in the degeneration of the SV (230), but are 
inhibited by haemoglobin (231), in most cases parasites escape into the AMG 
lumen  occurs  through  a  posterior  rupture  of  the  PM  caused  by  sand  fly-
derived chitinases (151). For some natural parasite-vector combinations, like 
L. (L.) major – Ph. (Ph.) papatasi, however, it has been observed that the 
escape from the PM can occur through a rupture at the anterior end by the 
use of the parasite-derived chitinase (232, 233), but that is not the case for L.59 
 
 
 
Fig.1.18 – Peritrophic matrix of a Phlebotomus papatasi female sand fly 
A)  Intact  PM  dissected  from  a  Phlebotomus  papatasi  midgut  24  h  PBM.  B  –  C) 
Midgut (mg) with PM fixed in 2.5% glutaraldehyde in cacodylate buffer & post-fixed in 
1%  osmium  tetroxide  in  cacodylate  buffer  48  h  PBM.    A  honey  comb  pattern  is 
observed on the PM from the impression of the removed midgut epithelium cells. C) 
Leishmania parasites are visible (*) within the blood meal (bm) (152). 
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(L.) major in Ph. (Ph.) duboscqi (156, 234). Parasite numbers decrease with 
the defecation of the blood meal initially and then stabilize due to the inability 
of  nectomonads  to  proliferate.  Numbers  increase  again  in  the  TMG  once 
proliferating  leptomonads  appear.  It  has  been  also  observed  that  in  most 
parasite  –  vector  combinations  the  development  of  procyclics  into 
nectomonads coincides with the breakdown of the PM (156).  
 
 Leishmania interactions with the sand fly alimentary canal  1.4.4.
It has been proposed that to establish a persistent infection in the sand fly 
midgut, Leishmania parasites must attach to the midgut epithelium to prevent 
their  excretion  (235).  This  made  the  topology  of  the  inner  surface  of  the 
alimentary  canal  very  important  to  the  development  of  Leishmania  (152). 
Leishmania  parasites  attach  to  the  midgut’s  single  layer  of  microvillar 
epithelium by insertion of their flagellum in between the microvilli (Fig.1.9A.1) 
(152). This anchoring is strengthened in case of L. (Leishmania) spp. by sand 
fly lectin-parasite LPG interactions against the peristaltic action of the midgut 
(169, 236, 237). It was also shown that nectomonads and leptomonads have 
much higher affinity for the intestinal epithelium binding than procyclics and 
metacyclics, which was attributed to their stage specific LPG modifications 
(155). Since different L. (Leishmania) spp. express differently modified LPG 
and different Phlebotomus spp. and Lutzomyia spp. present different lectins 
and  lectin-like  molecules,  it  was  observed  that  vectors,  whose  naturally 
infecting Leishmania spp. present highly branched, species-restricted LPGs, 
had a much greater parasite-specific affinity than those that were naturally 
infected with Leishmania spp. presenting unsubstituted or poorly substituted 
LPG (140, 238). In addition, an LPG-independent attachment mechanism has 
been  observed  in  permissive  parasite-vector  combinations  (239,  240). 
Leishmania parasites has also been observed to colonize the FG (pharynx, 
cibarium  and  mouthparts)  (117,  241).  Since  the  FG  does  not  have  a 
microvillar  epithelium,  but  is  cuticle-lined,  the mode  of  parasite  attachment 
here must differ from the mechanism in the midgut and is currently unknown. 
However,  colonization  of  the  FG  was  shown  to  be  non-essential  for  the 
transmission of parasites and, therefore, may be only a secondary effect of 
the parasite-induced destruction of SV (162, 198). In case of L. (Viannia) spp. 
much less is known about these processes. 
 
 Inhibiting sand fly gut peristalsis  1.4.5.
Lysate proteins from cultured Leishmania parasites are able to reversibly stall61 
 
and  even  completely  inhibit  intestinal  peristalsis  of  the  sand  fly  mid-  and 
hindgut (but not of the rectum) in a dose dependent manner (160, 242, 243). 
This  activity  peaks  in  late  log-phase  to  early  stationary  phase  parasites, 
coinciding  with  nectomonad  escape  from  the  PM.  Lysate  activity  is  then 
reduced as differentiation progressed. The capacity of the culture medium to 
inhibit peristalsis, however, persists much longer than that of parasite lysate, 
suggesting a parasite secreted inhibitor, whose activity could be abolished by 
trypsin  and  chymotrypsin  digests.  A  12  Kilo  Daltons  (KDa)  peptide  was 
identified,  termed  stambhanin,  which  was  proposed  to  be  the  active 
compound modulating this effect (160). Stambhanin is likely to function by 
high-jacking  a  common  ligand-receptor  pathway  for  the  insect’s  own 
neuropeptides that regulate the visceral muscle activity (244). This hypothesis 
was supported by the observation that L. (L.) major lysate proteins were also 
able to inhibit muscle contraction in oviducts and dorsal blood vessels even in 
non-Leishmania-vector insect species, like Aedes aegypti (242). Observations 
made in muscle tissues  taken from rodents inhibited by  Leishmania  lysate 
proteins  suggested  that  Stambhanin  either  inhibited  the  influx  or  promoted 
efflux  of  Ca
2+-ions  from  the  susceptible  muscle  (243).  Interestingly, 
Strambhanin peak activity in culture was proposed to coincided with a natural 
low level of trypsin and chymotrypsin in the midgut after blood meal digestion 
(245). Due to the lack of peristalsis, liquid accumulates in mid- and hindgut 
(160). After 30 min. of incubation with Leishmania lysate proteins, the midgut 
volume was enlarged by almost 50% and the HG by ~57%. This may allow 
unattached  parasites  to  swim  freely  in  the  liquid  medium  by  use  of  their 
flagellum. However, no in vivo work has been performed to confirm these in 
vitro results. 
 
 Promastigote secretory gel  1.4.6.
The  production  and  function  of  PSG  was  reviewed  extensively  by  Rogers 
(2012)  (246).  Its  secretion  was  proposed  to  be  a  universal  Leishmania 
mechanism (247, 248). PSG is a dense gelatinous matrix consisting mainly of 
fPPG, a high molecular weight glycoprotein, the largest molecule secreted by 
Leishmania spp. (3 – 6 nm in diameter and up to 6 µm in length), although 
other parasite and sand fly derived molecules may be incorporated into the 
PSG  (247,  248).  Filamentous  PPG  is  another  [Gal-Man-PO4]  repeat  unit 
containing phosphoglycans synthesised by Leishmania, like LPG and surface 
PPG, but is secreted from the parasite flagellar pocket (237, reviewed in 238). 
It comprises of a serine-rich protein backbone with LPG-like phosphoglycans 62 
 
attached to every second amino acid,  which make ~75% of the molecules 
total mass and giving the molecule its filamentous character (Fig.1.19) (250). 
Gel formation occurs at fPPG concentrations >10 mg/ml and L. (L.) mexicana 
was shown to secrete up to 1 g/ml of fPPG in Lu. (Lu.) longipalpis (161, 247, 
248).  
 
The  mature  PSG,  in  situ,  is  a  sausage-like  obstruction  in  the  entire  TMG 
distending  through  the  disintegrated  SV  into  the  FG  (Fig.1.9)  (161,  249). 
Nectomonads and leptomonads attach by a yet to be identified mechanism to 
the  PSG  scaffold,  while  metacyclics  can  transverse  the  PSG  unhindered 
accumulating  at  its  poles  to  be  in  an  ideal  position  for  transmission  (M.E. 
Rogers,  2013,  unpublished).  Leptomonads  are  by  far  the  predominant 
morphological parasite form found in the PSG, although nectomonads bind to 
PSG  with  higher  affinity,  but  it  was  proposed  that  most  parasites  have 
become  leptomonads  by  the  time  of  PSG  formation  (161).  PSG  can  be 
detected  as  early  as  day  2-3  PBM  and  peaks  at  around  day  5-7  PBM 
depending on Leishmania spp.-sand fly combination coinciding with the peak 
appearance of leptomonad forms in the sand fly (145, 161, 251).  
 
The  presence  of  the  PSG-plug  actively  manipulates  sand  fly  feeding 
behaviour causing difficulties in feeding (Fig.1.20), forcing them to probe more 
frequently, feed for longer and even change host more frequently, optimizing 
the  chance  of  parasite  transmission    (252,  253).  It  was  shown  that  the 
amounts of regurgitated PSG during feeding correlated to the level of parasite 
burden and to the number of parasites transmitted (254). 
 
Other  secreted  PPG  functions  included  parasite  protection  from  hydrolytic 
attack during blood meal digestion in early stage promastigotes, as shown in 
vitro  (169,  216),  and  support  of  metacyclic  invasion  of  macrophages  and 
parasite  survival  within  the  phagosomes  (54,  255).  PSG  also  manipulates 
mammalian host immune responses by inducing arginase-1 expression in the 
Th2  response  that  promotes  parasite  survival  (254).  PSG  is  also  able  to 
recruit  neutrophils  and  macrophages,  which  are  the  primary  target  cells of 
Leishmania infection, to the bite site (140, 254). Interestingly, PSG is even 
proposed to improve the transmission of parasites from the mammalian host 
to the sand fly (M. E. Rogers, unpublished). 
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Fig.1.19 – Filamentous proteophosphoglycan 
Structure  of  the  main  PSG  component,  filamentous  proteophosphoglycan  (fPPG), 
from two L. (Leishmania) spp. (246) 
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Fig.1.20 – Changes in sand fly feeding due to PSG-plug 
The pumping action of the pharynx is facilitated through the presence of the cibarial 
valve between proboscis and pharynx and the SV between pharynx and TMG. A-B) 
In uninfected sand flies blood gets pumped from the blood pool in the skin through 
the proboscis into the pharynx and from there through the SV into the TMG. C-D) In 
an infected sand fly the PSG plugs up the SV and prevents immediate blood uptake 
into the TMG, so that the blood mixes with the parasite infested PSG in the pharynx 
before being regurgitated again. This process is repeated a few times before the SV 
and  TMG  are  cleared  enough  for  blood  uptake.  In  this  fashion  parasites  are 
effectively introduced into the blood pool and the gelatinous PSG dissolves again in 
the blood pool. The image was modified from Rogers (2012) (246) 
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 The stomodeal valve  1.4.7.
The  SV  is  a  unidirectional  valve  that  prevents  reflux  of  midgut  contents, 
effectively forming a barrier between the midgut and the FG. It consists of “a 
cuticle-lined  sphincter,  which  projects  into  the  lumen  of  the  TMG  and  an 
additional  circular  lobe external  to  it”  (Fig.1.21A)  (152).  During  Leishmania 
infection, the SV becomes heavily colonized with flaccid-looking, non-motile 
haptomonads via hemidesmosome-like structure on their modified flagellum 
(Fig.1.9.A.3  &  1.21B).  It  has  been  shown  that  these  haptomonads secrete 
chitinases,  which  act  in  the  degradation  of  the  SV  permitting  metacyclics 
passage into the FG (54, 233, 256). The PSG was proposed to help to pry the 
SV apart, because it extends into the FG, but it is not clear, if this is only a 
consequence  of  SV  degradation.  SV  degradation  was  proposed  to  be 
essential  for  parasite  transmission,  despite  the  lack  of  clear  supporting 
evidence for this theory (162). 
 
 Bacterial midgut flora  1.4.8.
The  digestive  system  of  all  living  animals  is  home  to  a  variety  of 
microorganisms,  which  naturally  exist  there  and  make  up  the  commensal 
flora. Some of them are beneficial to the host as they support digestion and 
nutrient absorption, while others are more parasitic in nature.  The sand fly 
microbiota is a consequence of the sand fly’s life-style of visiting plants and 
animals  for  alimentation,  while  their  larvae  feast  on  detritus,  exposing  the 
insect to a multitude of microorganisms of the phyllosphere, soil and fauna 
(257). There is very little known about the  sand flies commensal flora and 
studies are only beginning to emerge (257–262), but a recent study in wild 
caught  Lu.  (Lu.)  longipalpis  showed  that  the  array  of  bacterial  phylotypes 
present in its midgut is comparatively limited (263) compared to other insects 
such  as  cockroaches,  termites  and  crickets  (264).  Among  a  set  of 
phyllosphere  bacteria,  it  was  found  that  sand  flies  also  carried  plant  and 
human bacterial pathogens, like Ralstonia spp. (causative agents of bacterial 
wilt) and Chryseobacterium meningosepticum (causative agents of neonatal 
meningitis), potentially acting as vectors for these pathogens, too (258, 263). 
Infection studies with different protozoan parasites have shown that bacteria 
in the midgut of insect vector species impact on the survival of the parasites in 
an either direct (by competition) or indirect manner (by modulating sand fly 
immune  responses).  Comprehensive  studies  addressing  this  topic  are  still 
few, however (221, 261, 265–270), although the idea of commensal bacterial 
in competition with Leishmania was first voiced by Theodor in 1957  (271).66 
 
  
 
Fig.1.21  –  Stomodeal  valve  of  un-/infected  Ph.  (Ph.)  papatasi  &  Ph.  (Ph.) 
duboscqi 
1) Semithin section of Ph. (Ph.) duboscqi embedded in LR White resin and stained by 
toluidine  blue.  The  filamentous  structures  of  the  SV  are  indicated  by  arrows.  2) 
Semithin section of Ph. (Ph.) duboscqi infected with L. (L.) major treated in the same 
way as in image 1. The  degradation  of the filamentous structures  is indicated  by 
arrows. Figures were adapted from Volf et al. (2004) (162) 
Abbreviations: cr, crop; cu, cuticle; mg, midgut; mg+l, midgut containing Leishmania; 
mu, muscles; ph, pharynx; sg, salivary glands; sv, stomodeal valve. 
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Evidence suggested that there is competition between Leishmania and certain 
bacteria, which can limit parasite infection in the sand fly (261, 265, 266).  
 
 Sexual reproduction of Leishmania  1.4.9.
It has been shown that Leishmania can reproduce sexually in the sand fly 
midgut (272), but it is not clear if this can also occur in the amastigote stage. It 
had been believed that Leishmania’s primary mode of reproduction was clonal 
(119, 273, 274), but experimental data (272, 275) and isolation of naturally 
occurring Leishmania hybrids (276–280) suggested that sexual reproduction 
may occur naturally within the sand fly midgut by either endogamy, autogamy, 
automixis or selfing, as suggested by the high levels of observed homogeneity 
in  Leishmania  populations  (281,  282).  Experimental  verification  of  genetic 
exchange within the sand fly was delivered by Akopyants et al. (2009) using 
two transgenic strains of L. (L.) major resistant to different antibiotics resulting 
in  hybrids  resistant  to  both  antibiotics  after  sand  fly  passage,  but  with 
kinetoplast  DNA  (kDNA)  maxicircles  content  derived  from  only  one  parent 
(272). Interestingly,  seven of 18 characterized clones from this study were 
triploid, rather than diploid. Aneuploidy is well tolerated by Leishmania and 
even exploited as a mean of gene copy multiplication (109). Sex in the sand 
fly indicated it as the primitive Leishmania host and field isolation of naturally 
occurring Leishmania hybrids (Old World: L. (L.) donovani/L. (L.) aethiopica 
(276); New World (280): L. (V.) braziliensis/L. (V.) panamensis (277); L. (V.) 
braziliensis/L.  (V.)  guyanensis  (278);  L.  (V.)  braziliensis/L.  (V.)  peruviana 
(279)) suggested that genetic exchange was not just occurring among closely 
related  Leishmania  strains,  but  is  also  possible  among  closely  related 
Leishmania  species.  Also,  the  isolation  of  different  parasite  strains/species 
from  the  same  mammalian  host  suggests  that  co-infection  of  multiple 
Leishmania  strains/species  occurs  in  the  same  sand  fly  allowing  natural 
hybrid  generation  (181).  However,  the  exact  mechanism  of  Leishmania‘s 
genetic exchange remains uncharacterized. 
 
 Transmission to a mammalian host  1.4.10.
In nature, L. (Leishmania) parasite transmission to a new mammalian host 
occurs during a second blood meal, which the sand fly seeks 1-2 weeks after 
the first blood meal, depending on species. Parasite transmission had been 
proposed to occur in two opposing ways: regurgitation of parasites from the 
TMG  during  blood  meal  uptake  (161,  248)  or  by  host  inoculation  with 
parasites present in the FG only on the insertion of the sand fly’s mouthparts 68 
 
into the host’s skin (252, 283, 284). With the characterization of the PSG the 
regurgitation model for parasite transmission was generated that incorporates 
all  the  available  data  on  parasite  transmission.  In  this  model,  the  TMG 
blockage by PSG forces sand flies to regurgitate the metacyclic loaded PSG-
plug before a blood meal can be taken, which may take several attempts and 
increases sand fly probing rates. This model also explains why at least 10x 
more parasites are found in bite sites than are present on average in the FG 
(54, 162). The SV degradation is considered to be important for successful 
parasite transmission, too. Once inoculated into the host skin, metacyclics are 
endocytosed  by  epithelial  macrophages.  Once  the  parasites  reach  the 
phagolysosomes,  they  begin  to  transform  into  amastigotes  (small,  round, 
aflagellate, proliferating) (145).  
 
Much less is known about transmission of L. (Viannia) spp., but it has been 
proposed  that  transmission  occurs  via  the  forward  route,  too,  which  was 
suggested by the observation that members of the Viannia subgenus do also 
secrete PSG or at least a PSG-like molecule in the TMG (117, 153). 
 
1.5.  The Leishmania genome  
The genome of L. (L.) major Friedlin VI strain (MHOM/IL/81/Friedlin) (FVI) was 
published as the first completely sequenced Leishmania genome in 2005 (107) in 
parallel with the genomes of the related human infective kinetoplastid parasite 
species, Trypanosoma brucei (285) and T. cruzi (286). The L. (L.) major genome 
consists  of  ~32.8  Mb  spread  over  36  chromosomes,  which  is  the  typical 
chromosome number for Old World Leishmania spp. (287) – some New World 
species  like  L.  (L.)  mexicana  and  L.  (V.)  braziliensis  have  only  34  and  35 
chromosomes,  respectively,  due  to  chromosome  fusion  events  (108).  All 
published trypanosomatid genomes are  sequence repeat rich – in T. cruzi up to 
50% of the whole genome (286) – and it was shown that of the 8272 protein-
coding genes identified in L. (L.) major’s genome, 6158 genes had orthologous in 
the T. brucei and  T cruzi genomes with a high level of synteny (288). Considering 
the  long  evolutionary  divergence  (>200  Million  years  (289))  between  the  two 
genera Leishmania and Trypanosoma, this high level of genome similarity was 
surprising  (288).  When  the  genome  sequences  of  L.  (L.)  infantum,  L.  (V.) 
braziliensis (108) and L. (L.) mexicana (109) were published, it was shown that 
the  content  of  Leishmania  species-specific  genes  within  the  genus  was 
surprisingly low (2, 14, 19 and 67 species-specific genes for L. (L.) mexicana, L. 
(L.) major, L. (L.) infantum and L. (V.) braziliensis, respectively), while 7392 genes 69 
 
were  shared  by  all four  species  with  conserved gene  synteny,  despite  the  46 
million years of evolutionary divergence (Fig.1.22) (109, 123). Compared to the L. 
(L.) infantum genome, all species-specific genes are either present or not clearly 
absent from analysed L. (L.) donovani strains (290). Further work showed that 
species-specific  genes  are  generally  conserved  among  members  of  the  same 
species complex and strains of the same species  (109). It was proposed  that 
these  few  species-specific  genes  encoding  predicted  proteins  of  mostly  yet 
unknown  functions  contribute  to  parasite  tropism  and  differences  in  pathology 
(108, 291), although transgenic studies have not broadly supported this to-date 
(292). Differential gene expression and/or structural and functional components of 
the  genome  may  be  important  for  parasite  pathology,  too  (293).  Leishmania 
genomes contain many highly repetitive tandem arrays, which pose a significant 
problem for automated and de novo genome assemblies, because they cause 
repeat collapses of unknown length,  as  has  been  shown for the  L. (L.) major 
cDNA16 locus and the L. (V.) braziliensis orthologous HASP locus (OHL) in the 
past (107, 293, 294).  
 
Leishmania parasite sequences show inter- and intra-specific variability in their 
ploidy  (109).  While  the  L.  (L.)  major  genome  is  diploid  with  the  exception  of 
chromosome 31, which is multiploid with intra-specific variation in chromosome 
number, the sequenced genomes of L. (L.) mexicana and L. (L.) donovani strains 
show a higher level of ploidy variation and the genome of L. (V.) braziliensis is 
generally  triploid  with  the  exception  of  chromosome  29  and  31,  which  are 
multiploid. It has been observed that Leishmania parasites can adjust their ploidy 
as  a  whole  or  for  particular  chromosomes,  without  suffering  any  fitness 
disadvantage, after genetic manipulation, growing in culture for long periods or 
after drug selection (295–297), suggesting that Leishmania uses this mechanism 
as an alternative to forming multi-gene-copy arrays to increase gene copy number 
(109), while eliminating undesired messenger RNAs (mRNAs) by stability factors 
and/or  protein  degradation  mechanisms  (298).  Unusual  for  eukaryotic  cells, 
Leishmania spp. and Trypanosoma spp. have their genes arranged in directional 
polycistronic gene clusters (PGCs), containing tens to hundreds of functionally 
unrelated protein-genes (107, 299). 
 
 Gene transcription  1.5.1.
Transcription of PGCs is constitutive (300) and polycistronic, catalysed by the 
trypanosomatid-specific RNA polymerase II (RNAP II), which shows several 
differences to RNAP II in other eukaryotes (107, 301). The only functionally 70 
 
 
 
 
Fig.1.22 – Gene conservation in Leishmania 
Venn diagram showing number of conserved genes in L. mexicana U1103, L. major 
Friedlin, L. infantum JPCM5, and L. braziliensis M2904 (109). 
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characterized  promoter in  the  Leishmania  genomes  is the  promoter  of  the 
splice-leader (SL) sequence genes (302) and transcription of PGCs can occur 
bidirectionally  from divergent  strand switch regions  (SSRs), which have no 
recognisable  promoter  motifs,  towards  convergent  SSRs  or  telomeres  by 
RNAP II (300, 303). Interestingly, TATA-less promoters in higher eukaryotes 
show similarities to divergent SSRs in trypanosomatids (304). 
 
Not  much  is  known  about  transcription  termination  in  trypanosomatids;  no 
protein factors have been identified yet. In case of RNAP II transcribed SL 
RNA genes, however, downstream T-tracks support transcription termination, 
but this is not the case for PGC transcription, where T-rich sequences are 
common  in  the  intergenic  regions  (305).  It  was  observed  that  transcription 
termination of PGCs coincided within tRNA genes at convergent SSRs (306), 
where  stable,  unmodified  H2A/H2B/H3V/H4V  octamers  were  bound,  which 
may support RNAP II transcription termination (307). Transcription terminating 
at convergent SSRs elegantly prevents RNAP II collisions in trypanosomatids.  
 
Polycistronic transcripts are co-transcriptionally processed into monocistronic 
mRNAs by 5’ trans-splicing and polyadenylation. In the former, a 39 – 41-
nucleotide (nt) splice-leader sequence with a hypermethylated guanosine cap 
(cap-4), far more complex than the typical m7G cap in other eukaryotes, is 
spliced onto the 5’-terminus of every mRNA (reviewed in (308) &(309)). The 
cap-4 structure is essential for 5’ trans-splicing and translation to occur (310). 
The efficiency of trans-splicing is proposed to depend on the length of the 
polypyrimidine tract (311) and the 5’ untranslated region (UTR) sequence of 
the  downstream  mRNA  (312).  There  are  no  consensus  polyadenylation 
signals in trypanosomatids, but polypyrimidine tracts flanking polyadenylation 
sites,  which  are  100  –  300  nt  upstream  of  5’  trans-splicing  sites,  help 
determine  polyadenylation  sites  supported  by  the  coupling  of  3’ 
polyadenylation to 5’ trans-splicing (313, 314). 
 
 Gene expression regulation  1.5.2.
The constitutive polycistronic transcription in trypanosomatids means that all 
genes within a PGC are initially transcribed at the same level, and regulation 
is achieved by post-transcriptional and translational events. In Leishmania 2 – 
9% of genes are regulated at the mRNA level and another 12 – 18% at the 
protein  level  (reviewed  in  (315,  316)).  It  has  been  proposed  that  in 
trypanosomatids  all  the  elements  of  post-transcriptional  regulation  are 72 
 
focused  in  RNA  regulons,  ribonucleoprotein  complexes  able  to  regulate 
mRNA fate, which are found in other eukaryotes, too (317). These control the 
large scale changes in transcriptome and proteome during life-cycle changes 
(316). Regulation at the mRNA level is characterized by at least three factors 
(Fig.1.23):  cis-acting  signals,  trans-acting  factors  and  mRNA  degradation 
machineries  (reviewed  in  (318)).  Among  cis-acting  signals  are  SIDER1  & 
SIDER2  motifs  in  the  3’  UTRs  of  target  mRNAs  (303,  315),  which  in 
conjunction with RNA-binding proteins (318) play an important part in mRNA 
de-/stabilization (319, 320). U-rich instability elements – similar to the AU-rich 
elements in mammalian 3’ UTRs – are also found in 3’ UTRs, although they 
are more common in Typanosoma spp. than Leishmania (321). These 3’ UTR 
elements may confer stability to stage-specific mRNAs in one life-cycle stage, 
while conferring instability in another as is the case for the URE in Leishmania 
amastin (321). Gene regulation mechanisms have been shown to take cues 
from environmental signals like chemical triggers, changes in temperature and 
pH, which have a global impact on mRNA regulation and translation within 
trypanosomatids (322). 
 
In Leishmania, mRNA and protein levels frequently do not correlate well and 
variations  in  protein  levels  are  often  greater  than  in  mRNA  levels  (323). 
Therefore,  post-translational  regulation  mechanisms  are  proposed  to  be  of 
increased importance in these parasites (324). 3’ UTR motives are important 
in  translation  regulation  in  trypanosomatids:  protein  factors  can  bind  to  or 
secondary  structures  may  be  formed  at  these  regions,  hindering  efficient 
translation (325). Trypanosomatid genomes also contain a large number of 
putative  kinases,  which  are  proposed  to  regulate  translation  by 
phosphorylation events (326). The relative importance of protein stability and 
sorting in gene regulation is still unknown, however.  
 
1.6. The L. (L.) major cDNA16 locus 
Differentially expressed genes may be involved in stage-specific developments, 
like metacyclogenesis, and are rare in Leishmania parasites (327, 328). A study 
using a complementary DNA (cDNA) library to screen L. (L.) major procyclic and 
metacyclic  promastigote  mRNA  extracts  for  differentially  expressed  genes, 
rendered  only  4  clones  from  25,000  independent  recombinants  as  being 
differentially  expressed  between  parasite  stages  (329).  The  LmcDNA16 
recombinant,  after  which  the  corresponding  locus  on  the  L.  (L.)  major 
chromosome 23 was named, was one of these four and recognised four distinct 73 
 
 
 
Fig.1.23 – Post-transcriptional gene regulation in Leishmania parasites 
a)  Polycistronic  transcription  from  divergent  SSRs  across  the  polycistronic  gene 
cluster (PGC). b) Polycistronic transcripts are processed into monocistronic mRNAs 
by  coupled  3’-polyadenylation  and  5’-trans-splicing,  which  adds  the  splicer  leader 
sequence  hypermethylated  guanosine  cap.  The  repression  of  SL-sequence 
transcription during stress was implicated as mean of post-transcriptional regulation 
of protein genes. c) Secondary splicing was implicated as another mean of gene 
regulation.  Only  after  the  secondary  splice  event  can  the  mRNAs  be  translated 
successfully.  The  location  of  this  event  has  not  been  established  yet.  d)    This 
constitutive degradation pathway was proposed to work by release of poly(A)binding 
proteins (PABs) followed by 3’-poly(A)-degradation and 3’exsosomal degradation of 
the  mRNA  with  cytosolic  processing  bodies  (P-bodies).  e)  The  deadenylation-
independent regulated degradation pathway was proposed to act in the degradation 
of stage-specifically regulated and instable mRNAs. f) 3’ UTR elements like SIDER1, 
SIDER2  and  U-rich  instability  elements  (UREs)  can  prevent  effective  mRNA 
translation  in  a  life-stage  specific  manner.  Translation  regulation  by  g)  protein 
degradation,  h)  protein  targeting  for  degradation  and  i)  post-translational  protein 
modifications,  like  phosphorylation  have  all  been  implicated  as  means  of  gene 
regulation. The image was taken from Haile (2007) (315). 
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transcripts of varying expression levels between life-cycle stages, since renamed 
as the HASPA1, SHERP, HASPB and HASPA2 genes (Fig.1.24). The cDNA16 
locus was sequenced and assembled manually (accession no. AJ237587) and its 
organization confirmed by Southern blotting and hybridization across the region. 
According to Flinn & Smith (1992), HASPA1 is the most upstream gene in the 
LmcDNA16  locus  in  L.  major,  followed  by  two  identical  copies  of  SHERP 
(SHERP1 and SHERP2), then HASPB followed by HASPA2 (Fig.1.25.A) (330). 
Comparative  studies  have  since  shown  that  all  HASP  and  SHERP  genes  are 
found in the same chromosomal region in all L. (Leishmania) spp., while in L. 
(Viannia) spp., related but divergent sequences are found (108, 294, 331).  
 
In  L.  (L.)  major,  deletion  of  the  entire  cDNA16  locus  prevented  completion  of 
metacyclogenesis within the sand fly vector (146), but not in culture (332) and did 
not  perturb  the  parasite’s  virulence  in  vitro  or  in  vivo  (332).  Because  of  this 
deletion, mutant metacyclogenesis was stalled mostly in the nectomonad stage 
and  parasites  never  colonised  the  SV.  The  overexpression  of  the  entire 
LmcDNA16 locus by episomal replacement into the null background, however, 
caused  avirulence  in  the  deletion  mutant  and  both  null  and  overexpression 
mutants were sensitive to complement-mediated lysis (332). 
 
 HASPA1, HASPA2 and HASPB  1.6.1.
HASP  stands  for  Hydrophilic  Acylated  Surface  Protein  (331).  HASPA1, 
HASPB and HASPA2 are highly related members of the same gene family, 
but non-identical (330). All three HASPs share the same N-terminal (first 17 
amino acids) and C-terminal (last 35 amino acids) regions, but differ in the 
central section (Fig.1.25.B & C) (333, 334). The HASP N-terminus contains a 
SH4 domain, which is co-translationally N-myristoylated at glycine 2, which 
targets the proteins transiently to the cytosolic side of the Golgi, where it gets 
post-translationally palmitoylated at cysteine 5 (335). This dual acylation has 
been shown to be sufficient and essential for HASPB trafficking to the cell 
surface and its tethering, in the absence of a secretory signal sequence, a 
GPI-anchor  consensus  sequence  or  a  membrane  spanning  domain  (336–
340). This was shown by substitution of either glycine 2 or cysteine 5, which 
caused the HASPs to become exclusively cytosolic and trapped at the Golgi, 
respectively  (335).  HASPB  was  observed,  however,  to  be  shed  by 
metacyclics  in  vitro  (336).  Therefore,  the  HASPs  were  classified  as  non-
classically secreted proteins that were transferred to the cell surface from the 
cytosolic  phase  of  the Golgi  by  a  Golgi-vesicle-independent  mechanism  to 75 
 
 
 
 
Fig.1.24 – Schematic of regulation of HASP and SHERP genes 
There is only reliable data for HASPB and SHERP upregulation at the protein level 
(331,  341). HASPA1 and HASPA2 regulation has only been shown at the mRNA 
level to-date (330). Based on the available data, HASPA2 is up-regulated as early as 
the  procyclic  stage  after  differentiation  from  amastigotes  and  is  continuously 
expressed until the differentiation into amastigotes. SHERP is up-regulated in the late 
leptomonad stage and peaks in the metacyclic stage, while HASPB and HASPA1 are 
up-regulated  in  the  metacyclic  stage  and  both  continue  to  be  expressed  in  the 
amastigote stage, but are down-regulated after differentiation into procyclics. HASPB 
can be detected even weeks after macrophage infection (communication from Helen 
Price) and its metacyclic specific expression among promastigotes was shown by 
confocal microscopy (146). The peak expression of HASPB varies slightly between L. 
(Leishmania) spp.; e.g. in L. (L.) major HASPB expression peaks in the metacyclic 
stage (331), while in L. (L.) mexicana it peaks in the amastigote stage (294). The 
image was adapted from Oliveira et al. (2009) (342).   76 
 
 
 
Fig.1.25 – L. (L.) major cDNA16 locus and its genes 
A) Schematic representation of the LmcDNA16 locus and its 5 genes (not to scale) 
(330). B) Schematic comparison between HASPA1/2 (Gene A/C) and HASPB (Gene 
B) structure. The repeat region in HASPB resides between amino acid 62 and 142, 
while only a short sequence is present between amino acids 17 and 36 in HASPA1 
and HASPA2. C) Sequence alignment of HASPB and HASPA1/2 based on the amino 
acid  sequence  in  L.  (L.)  major.  The  5.5x  PKEDGHA  and  PKNDDHA  repeats  in 
HASPB are between amino acid 62 and 142 (334). 
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the flagellar pocket and then by membrane shedding to the cell surface (336, 
343–346). The SH4 domain was also found in other non-classically secreted 
proteins, like the Src protein family members (347). Observations made in live 
metacyclics showed that HASPB could recycle from the cell surface back to 
the flagellar pocket and transfer from the cell surface to the flagellum surface, 
but not vice versa (336). It has been proposed that phosphorylation of the 
threonine 6 in the SH4 domain promoted internalisation of mammalian SH4 
domain bearing proteins (340). Deletion of this phosphorylation site, however, 
had  no  effect  on  HASPB  localization  to  the  plasma  membrane  (336).  An 
unusual  characteristic  of  all  three  HASPs  is  their  abnormal  migration  in 
sodium dodecyl sulphate (SDS) polyacrylamide gel electrophoresis, making 
them appear about twice their predicted molecular mass, a property attributed 
to the acidity and the high proline/lysine content of these proteins (334). 
 
1.6.1.1.  HASPA1 and HASPA2 properties 
HASPA1  and  HASPA2  genes  (formerly  known  as  gene  A/C  protein 
[GA/CP])  have  substantial  sequence  identity  with  identical  5’  UTRs  and 
open reading frames (ORFs), but distinct 3’ UTRs. Both code for 74 amino 
acid proteins with a predicted mass of 7.6 KDa each, which bear a protein-
specific  19 amino acid sequence  in their  central region (334). They are 
highly  hydrophilic  with  a  low  pI  of  about  4.2.  However,  their  RNA 
expression pattern is distinct from one another (330). HASPA2 is already 
present at low levels in early log-phase promastigotes and more strongly 
expressed in metacyclic promastigotes, but undetectable in amastigotes. In 
contrast, HASPA1 is expressed in metacyclics only and is then maintained 
in amastigotes (329, 331). No function has yet been assigned to HASPA1 
and HASPA2. 
 
1.6.1.2.  HASPB properties 
HASPB  (formerly  known  as  gene  B  protein  [GBP])  is  also  a  highly 
hydrophilic protein consisting of 177 amino acids (about 18.7 KDa) with a 
pI of almost 4.8 (333). Conversely to HASPA1 and HASPA2, HASPB has 
an  extensive  proline  rich  repeat  region  between  its  N-terminal  (first  62 
amino acids) and C-terminal (35 amino acids) region, which makes up 45% 
of the protein (Fig.1.25.C). In L. (L.) major, this repeat region consists of 
5.5  tandem  repeats  of  a  2x  7-amino  acid  sequences  (PKEDGHA  and 
PKNDDHA). Most amino acids in this repeat region and the C-terminus are 
hydrophilic with merely a few strongly hydrophobic amino acids at the N-78 
 
terminus.  Despite  its  overall  hydrophilicity,  HASPB  fractionates  with  the 
parasites  LPG  and  glycoinositolphospholipids  (GIPLs)  (333),  but  no 
interaction  between  HASPB  and  LPG  could  be  demonstrated  (337). 
HASPB  also  contains  two  potential  N-linked  glycosylation  sites,  which, 
however, were shown to be unmodified by N-glycanase treatment (333). 
The specific function of HASPB remains unclear, although there are strong 
indicators for an importance in the progression of metacyclogenesis (146). 
In L. (L.) major, HASPB is up-regulated strongly in metacyclics and then 
continuously expressed in amastigotes, but this pattern is not universal; in 
L. (L.) mexicana, HASPB expression occurs later and peaks in amastigotes 
rather than metacyclics (294). 
 
 SHERP1 and SHERP2 properties  1.6.2.
SHERP  stands  for  Small  Hydrophilic  Endoplasmic  Reticulum-associated 
Protein and the gene (formerly known as gene D) codes for a small (6.2 KDa), 
acidic (pI 4.6) protein, which is highly expressed in metacyclic parasites (341). 
SHERP is expressed from two tandem repeated copies within the LmcDNA16 
locus  (Fig.1.25.A)  (330),  which  share  98.8%  identity  and  100%  identity 
throughout the ORF in L. (L.) major. The protein itself is hydrophilic, lacks 
transmembrane domains and has a high α-helical content with a helix-turn-
helix  (HTH)  motif,  which  gives  the  protein  a  globular  fold.  However,  the 
secondary structure of SHERP is condition dependent. In an aqueous solution 
of anionic lipids or detergent SHERP has a highly unordered structure. In a 
mixture of neutral and anionic phospholipids (DOPC and DOPG) in equimolar 
amounts  or  if  an  amphipathic,  anionic  detergent  (SDS)  is  added  to  the 
solution, the protein adopts its mainly α-helical structure (348). This suggested 
that SHERP’s structure is dependent on an anionic environment, which may 
drive its function. SHERP is a membrane associated protein, which localises 
to the cytosolic phase of the endoplasmic reticulum (ER) and mitochondrial 
membranes, where it is in close proximity to phospholipids (341). Due to the 
orientation  of  its  residues,  SHERP  is  amphiphilic,  when  folded,  which 
suggests  protein-protein  interaction  abilities.  The  protein  also  contains  two 
potential phosphorylation sites, which, however, do not appear to be utilized in 
vivo. SHERP’s association with the ER and mitochondrial membranes was 
proposed to be exclusively by weak protein-protein interactions with yet to be 
identified targets. One potential target could be subunit B of the vacuolar H
+-
ATP synthase protein complex, which functions in subcellular compartment 
acidification and to which SHERP can bind stably (KD = 2.0 ﾱ 0.1 μM) (348). 79 
 
This  may  be  relevant  for  metacyclic  parasites  due  to  the  importance  of 
autophagy for differentiation (349). Autophagy is a cellular process common 
to  eukaryotic  cells.  It  serves  firstly  as  a  survival  mechanism  during  cell 
starvation by recycling cytoplasmic constituents, secondly as a mechanism for 
clearance  of  damaged  and  redundant  cellular  constituents  and  thirdly,  is 
involved  in  cell  re-modelling  during  differentiation  (350).  Leishmania 
metacyclogenesis  is  essentially  a  cell  differentiation  process  under  cell 
starvation  conditions  and  a  functional  autophagosomal  system  has  been 
shown to be essential for completion of metacyclogenesis (349). 
 
1.7. Leishmania (Viannia) braziliensis Orthologous HASP Locus 
Comparative studies have shown that in L. (Viannia) spp., different but related 
genes  are  present  in  the  same  chromosomal  context  as  the  cDNA16  locus 
(Fig.1.26) (108, 331). According to chromosomal assemblies from GeneDB, there 
are two  different ORFs (LbrM.1110  and  LbrM.1120)  in this  orthologous  HASP 
locus  (OHL)  in  L.  (V.)  braziliensis,  similar  to  those  found  in  the  same 
chromosomal region in the related insect parasite, Leptomonas seymouri (294). 
Analysis  of  these  two  ORFs  in  L.  (V.)  braziliensis  showed  structural  and 
biochemical similarities of the protein products to the HASPs in L. (Leishmania) 
spp.  (294).  Both  ORFs  contained  a  N-terminal  SH4  domain  required  for  N-
myristoylation  and  palmitoylation  (Fig.1.27)  and  at  least  LbrM.1110  has  been 
shown to localize to the cell surface of the rudimentary flagellum in amastigotes, 
but not in metacyclics (294). These proteins contain a varying number of central 
tandem repeats, which consist of 30 nt per repeat and have antigenic properties, 
like those of HASPB. LbrM.1110 expression patterns were similar to L. (L.) major 
HASPB expression patterns. Southern blot analysis of the HindIII/XhoI-digested 
genomic  DNA  (gDNA)  of  L.  (V.)  braziliensis,  L.  (V.)  guyanensis  and  L.  (V.) 
peruviana suggested that the currently available sequence of the locus (~7 Kb in 
length) was falsely assembled by automated analysis with reference to the L. (L.) 
major genome (294). Tandem repeat collapses of a highly conserved ‘AB’- motifs 
(~3,2 Kb) were found to be responsible (294). Similar misassemblies had also 
occurred in the cDNA16 locus of L. (L.) major. To-date the misassembled OHL 
has not been corrected in TriTrypDB.   80 
 
 
 
 
Fig.1.26 – OHL alignment to cDNA16 locus 
Alignment of the OHL and cDNA16 locus region on chromosome 23 of Leishmania 
and Trypanosma spp. LbrM.23.1110 and LbrM.23.1120 (red box) are not conserved 
in the genomes of any L. (Leishmania) spp. presented here, which have the HASP 
and SHERP genes (black box) in place of the OHL locus genes. Image taken from 
TryTripDB. 
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Fig.1.27  –  ClustalW  alignment  of  LbrM.1110  and  LbrM.1120  amino  acid 
sequences   
The red boxes mark the glycine
2 (G) and the cysteine
5 (C) of the N-terminal SH4 
domain essential for N-myristoylation and palmitoylation, respectively. The green box 
marks the internal tandem repeat areas (10 amino acids = 30 nucleotides per repeat). 
Adapted from Depledge thesis (2009). 
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1.8. Project aims 
The study of metacyclogenesis is key to the understanding of Leishmania spp. 
transmission from the sand fly vector to a mammalian host. This event has been 
studied in members of the L. (Leishmania) sub-genus and it has been shown that 
the genes of the cDNA16 locus are essential for metacyclogenesis completion, 
although their functions, interaction and individual importance to the process are 
not yet known. To date, metacyclogenesis has not been investigated in the L. 
(Viannia) subgenus, which bears genes of divergent sequence to the cDNA16 
genes in the same chromosomal region with predicted protein products bearing 
structural and biochemical similarities to the HASPs.  
 
The  main  focus  of  this  study  is  the  function  of  HASPs  and  SHERP  in 
metacyclogenesis within the sand fly vector. Several questions will be addressed: 
 
  Is  there  one  particular  key  player  among  the  HASPs  and  SHERP  for 
metacyclogenesis completion? 
 
  Is  there  an  interdependence  between  the  HASPs  and  SHERP  in  their 
expression regulation? 
 
  Are there differences in the expression patterns of HASP and SHERP genes 
between in vitro and in vivo development? 
 
   Are there specific vector components that influence HASP and SHERP gene 
regulation? 
 
  What parasite processes are affected by HASPs and SHERP deletion in vivo 
and does this knowledge lead to hypotheses on their function? 
 
  What is the true sequence, gene content and arrangement of the OHL in L. 
(V.) braziliensis and what further parallels can be drawn to the cDNA16 locus? 
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2.  CHAPTER II. – Materials and Methods 
 
2.1. In silico work 
A set of online tools, softwares and databases were used in this study, which are 
all listed in Table 2.1.  
 
 Databases  2.1.1.
NCBI’s PubMed and Google Scholar were the main search engines used for 
the literature review. TriTrypDB, GeneDB and NCBI were the main databases 
searched for DNA sequences. 
 
 Primer design  2.1.2.
All primers were designed with the Primer3plus web program (351, 352) with 
the exception of the quantitative Real Time – PCR (qPCR) primers, which 
were designed with the Primer Express software (Applied Biosystems [AB]). 
All primers were purchased from Sigma-Aldrich. 
 
 The Basic Local Alignment Search Tool (Blast)  2.1.3.
The  BLASTn  tool  on  the  NCBI  and  TriTrypDB  homepages  was  used  to 
identify  sequence  identities  and  similarities  in  the  published  genomes  of 
Leishmania  spp.  (353).  BLAST  exploits  a  substitution  matrix  to  search  for 
sequences  of  a  specific  length  that  contain  one  or  several  high-scoring 
sequence pairs (HSPs), which are in turn calculated by a scoring matrix, that 
finds homologues in the query sequence to score above a threshold value, 
which is dependent on the speed and sensitivity of the search. From these 
HSPs, the program extends the sequence in either direction to achieve an 
alignment  of  the  query  sequence  to  the  found  sequences,  which  need  to 
exceed another threshold to be considered. 
 
 CLUSTAL Sequence alignments  2.1.4.
Multiple  DNA  and  protein  sequence  alignments  were  performed  using 
CLUSTALW2 - Multiple Sequence Alignment program hosted by EBI (354, 
355).  CLUSTAL  differs  from  BLAST  by  not  searching  a  database,  but  by 
merely  aligning  two  or  several  given  sequences  to  a  best  fit.  For  that 
submitted sequences are pairwise aligned and stored in a distance matrix, for 
which a phylogenetic tree is created based on a neighbour-joining clustering 
algorithm that successively aligns sequences starting from the most closely 
related sequences. 84 
 
Table 2.1 - Bioinformatics tools used in this study 
Site  URL  Used for 
BLASTn (NCBI)  http://blast.ncbi.nlm.nih.go
v/Blast.cgi?PROGRAM=bl
astn&BLAST_PROGRAM
S=megaBlast&PAGE_TYP
E=BlastSearch&SHOW_D
EFAULTS=on&LINK_LOC
=blasthome 
Basic  Local  Alignment 
Search Tool (BLAST)  
Calculator  for 
determining  the  number 
of copies of a template 
http://www.uri.edu/researc
h/gsc/resources/cndna.ht
ml 
Determining the number of 
copies of a template 
CAP3  Sequence 
Assembly Program 
http://pbil.univ-
lyon1.fr/cap3.php 
Sequence assembly 
ClustalW2  http://www.ebi.ac.uk/Tools/
msa/clustalw2/ 
Nucleic  Acid  sequence 
alignment 
Fragment  Size 
Calculator 
http://www.basic.northwest
ern.edu/biotools/SizeCalc.
html 
DNA  fragment  size 
calculation  on  Southern 
blots 
GeneDB  http://www.genedb.org/Ho
mepage 
Genomic  sequence 
searches 
Google Scholar  http://scholar.google.co.uk/  Literature searches 
Nucleic  Acid  Sequence 
Massager 
http://www.attotron.com/cy
bertory/analysis/seqMassa
ger.htm 
Manipulation  of  nucleic 
acid sequences 
Molarity Calculator  http://www.graphpad.com/
quickcalcs/molarityform.cf
m 
Conversion  and 
calculation of molarity 
ORF Finder   http://www.bioinformatics.o
rg/sms2/orf_find.html 
Open  Reading  Frame 
identification 
Primer3Plus  http://www.bioinformatics.n
l/cgi-
bin/primer3plus/primer3plu
s.cgi 
Primer design 
PubMed  http://www.ncbi.nlm.nih.go
v/pubmed 
Literature searches 
TheLabRat  http://www.thelabrat.com/r
estriction/index.shtml 
Source  of  restriction  sites 
and enzymes 
Transcription  and 
Translation Tool 
http://www.attotron.com/cy
bertory/analysis/trans.htm 
Conversion  of  DNA 
sequences  to  mRNA 
sequences  to  protein 
sequences and vice versa 
TriTryp  http://tritrypdb.org/tritrypdb
/ 
Genomic  sequence, 
homologous  and  other 
searches 
Uniprot  http://www.uniprot.org/taxo
nomy/ 
Taxonomy searches 
Webcutter  http://rna.lundberg.gu.se/c
utter2/ 
Identification  of  restriction 
sites 
WHO  http://www.who.int/en/  Source of information 
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 Sequencing Data Analysis  2.1.5.
DNA sequencing data were analysed employing Sequence Scanner software 
v1.0 (AB) and to convert them into fasta format files, which were submitted to 
the  CAP3  Sequence  Assembly  Program  hosted  by  PBIL,  France  (356)  for 
assembly  into  larger  contigs.  These  contigs  were  then  analysed  either  in 
CLUSTALW2 or BLASTn. 
 
 Restriction Site Determination Tools  2.1.6.
Vector  NTI  was  used  to  visualize  DNA  sequences  and  to  plan  plasmid 
assemblies and restriction digests (Version 11 - Invitrogen) (357). Webcutter 
(version 2.0) was also used to analyse DNA sequences for restriction sites 
(Heiman, 1997) (358). 
 
 Other Computer Softwares  2.1.7.
ZEN  light  (Zeiss)  was  used  for  confocal  microscopy  and  image  analysis; 
ImageJ  (359)  for  Giemsa  stained  parasite  image  analysis;  StepOne™ 
Software  (Version  2.2.2)  (AP)  for  qPCR  analysis;  FlowJo  (Tree  Star,  Inc.) 
software  for  flowcytometer  data  analysis;  SPSS  v.19  &  v.20  (IBM)  for 
statistical  data  analysis;  SigmaPlot  (Systat  Software  Inc.)  and  Prism 
(GraphPad  Software)  for  graph  generation;  Mendeley  (Mendeley  Ltd.)  for 
citations  (360);  Sequence  Massager  (supported  by  cybertory.org)  for 
sequence manipulation. 
 
2.2. Leishmania manipulation 
 
 Leishmania species and strains used  2.2.1.
All Leishmania strains used in this study are listed in Table 2.2. L. (L.) major 
Friedlin VI (FVI) (MHOM/IL/81/Friedlin/VI) was used as a wild type and is the 
parental line to all mutant lines generated and used in this study. All cDNA16 
locus gene replacements were done by homologous recombination into the 
former  cDNA16  locus  in  the  L.  (L.)  major  4.8  ΔcDNA16  double  deletion 
mutant (LmjcDNA16 dKO) (ΔcDNA16::HYG/ΔcDNA16::PAC), generated from 
FVI previously (332). 
 
L. (V.) braziliensis 2904 (Lbr2904) (MHOM/BR/75/M2904) was used as a wild 
type for the  study  of the  orthologous  HASP  locus (OHL)  and served as  a 
parental line for the attempted full OHL deletion. L. (V.) braziliensis LTB300 
(MHOM/BR/83/LTB300)  and  gDNA  from  several  clinical  L.  (V.)  braziliensis86 
 
Table 2.2 – Leishmania mutant strains 
Species  Strain  Type  Source  Mutation  Cultured  gDNA 
Leishmania (Leishmania) 
major  MHOM/IL/81/Friedlin/VI  Reference strain 
Smith lab 
cryobank 
  √  √ 
L. (L.) major 
  cDNA16 dKO  Mutant line  ΔcDNA16::HYG/ΔcDNA16::PAC  √  √ 
L. (L.) major 
  cDNA16 sKI  Mutant line  ΔcDNA16::HYG/ΔcDNA16::PAC/ΔPAC::cDNA16+NEO
  √  √ 
L. (L.) major  HASPB sKI  Mutant line 
Generated 
in this 
study 
 
ΔcDNA16::HYG/ΔcDNA16::PAC/ΔHYG::HASPB+NEO
 (or 
ΔPAC::HASPB+NEO)  √  √ 
L. (L.) major  SHERP sKI  Mutant line  ΔcDNA16::HYG/ΔcDNA16::PAC
/ΔHYG::SHERP2+NEO (or 
ΔPAC::HASPB+NEO)  √  √ 
L. (L.) major  S2+HB sKI  Mutant line  ΔcDNA16::HYG/ΔcDNA16::PAC/ΔHYG::SHERP2+NEO/ΔP
AC::HASPB+BSD  √  √ 
L. (L.) major  S2/HB sKI  Mutant line  ΔcDNA16::HYG/ΔcDNA16::PAC/ΔPAC::SHERP2-
HASPB+BSD  (or ΔHYG::SHERP2-HASPB+BSD)  √  √ 
L. (L.) major  HASPB dKI  Mutant line  ΔcDNA16::HYG/ΔcDNA16::PAC/ΔHYG::HASPB+NEO/ 
ΔPAC::HASPB+BSD  √  √ 
L. (L.) major  HASPA1 sKI  Mutant line  ΔcDNA16::HYG/ΔcDNA16::PAC/ΔPAC::HASPA1+BSD (or 
ΔHYG::HASPA1+BSD)  √  √ 
L. (L.) major  HASPA2 sKI  Mutant line  ΔcDNA16::HYG/ΔcDNA16::PAC/ΔPAC::HASPA2+NEO (or 
ΔHYG::HASPA2+NEO)  √  √ 
L. (L.) major  HASPA1/2 sKI  Mutant line  ΔcDNA16::HYG/ΔcDNA16::PAC/ΔPAC::HASPA1-
HASPA2+NEO (or ΔHYG::HASPA1-HASPA2+NEO)  √  √ 
L. (L.) major  HA1+HB sKI  Mutant line 
ΔcDNA16::HYG/ΔcDNA16::PAC/ΔHYG::HASPB+NEO/ 
ΔPAC::HASPA1+BSD
  √  √ 
L. (L.) major  HA2+HB sKI  Mutant line  ΔcDNA16::HYG/ΔcDNA16::PAC/ΔPAC::HASPA2+NEO/ΔH
YG::HASPB+BSD  √  √ 
L. (L.) major  HA1/2+HB sKI  Mutant line  ΔcDNA16::HYG/ΔcDNA16::PAC/ΔPAC::HASPA1-
HASPA2+NEO/ΔHYG::HASPB+BSD  √  √ 
L. (L.) major  HA1+S2 sKI  Mutant line  ΔcDNA16::HYG/ΔcDNA16::PAC/ΔHYG::SHERP2+NEO/ΔP
AC::HASPA1+BSD  √  √ 
L. (L.) major  HA2+S2 sKI  Mutant line  ΔcDNA16::HYG/ΔcDNA16::PAC/ΔPAC::HASPA2+NEO/ 
ΔHYG::SHERP2+BSD  √  √ 
L. (L.) major  HA1/2+ S2 sKI  Mutant line  ΔcDNA16::HYG/ΔcDNA16::PAC/ΔPAC::HASPA1-
HASPA2+NEO/ΔHYG::SHERP+BSD  √  √ 
L. (L.) major  HA1+S2/HB sKI  Mutant line  ΔcDNA16::HYG/ΔcDNA16::PAC/ ΔPAC::HASPA1+BSD/ 
ΔHYG:: SHERP2-HASPB+SAT  √  √ 87 
 
Species  Strain  Type  Source  Mutation  Cultured  gDNA 
L. (L.) major  HA2+ S2/HB sKI  Mutant line  Generated 
in this 
study 
ΔcDNA16::HYG/ΔcDNA16::PAC/ΔPAC::HASPA2+NEO/ 
ΔHYG:: SHERP2-HASPB+BSD  √  √ 
L. (L.) major  HA1/2+ S2/HB sKI  Mutant line  ΔcDNA16::HYG/ΔcDNA16::PAC/ΔPAC::HASPA1-
HASPA2+NEO/ΔHYG:: SHERP2-HASPB+BSD  √  √ 
Leishmania (Viannia) 
braziliensis
  MHOM/BR/75/M2904  Reference strain  Smith lab 
cryobank    √  √ 
L. (V.) braziliensis 
  OHL sKO  Mutant line 
Generated 
in this 
study 
ΔOHL::BSD/OHL  √  √ 
L. (V.) braziliensis  MHOM/BR/84/LTB300  Clinical isolate  Smith lab 
cryobank    √  √ 
L. (V.) braziliensis 
  MHOM/BR/2004/EGS  Clinical isolate 
Dr. S. 
Uliana 
USP, 
Brazil 
 
Clinical isolate (Lbr 1)    √ 
L. (V.) braziliensis 
  MHOM/BR/2006/GDL  Clinical isolate  Clinical isolate (Lbr 2)    √ 
L. (V.) braziliensis 
  MHOM/BR/2006/HPV  Clinical isolate  Clinical isolate (Lbr 3)    √ 
L. (V.) braziliensis 
  MHOM/BR/2003/IMG  Clinical isolate  Clinical isolate (Lbr 4)    √ 
L. (V.) braziliensis 
  MHOM/BR/2006/PPS  Clinical isolate  Clinical isolate (Lbr 5)    √ 
L. (V.) braziliensis 
  MHOM/BR/2006/BES  Clinical isolate  Clinical isolate (Lbr 7)    √ 
L. (V.) braziliensis 
  MHOM/BR/2005/RPL  Clinical isolate  Clinical isolate (Lbr 8)    √ 
L. (V.) braziliensis 
  MHOM/BR/2006/UAF  Clinical isolate  Clinical isolate (Lbr 9)    √ 
L. (V.) braziliensis 
  MHOM/BR/2005/WSS  Clinical isolate  Clinical isolate (Lbr 10)    √ 
L. (V.) braziliensis 
  MHOM/BR/2006/EFSF  Clinical isolate  Clinical isolate (Lbr 11)    √ 
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isolates (Table 2.2) provided by the Universidade de São Paulo were used, 
too.  The  OHL  single  and  double  deletion  mutants  were  generated  by 
homologous recombination in Lbr2904. 
 
All newly generated mutants were passaged through BALB/c mice to restore 
their infectivity (see 2.2.5) before sand fly infections were undertaken. 
 
 Culture media and culture conditions  2.2.2.
All  Leishmania  strains  were  routinely  cultured  in  1x  medium  199  (M199) 
supplemented with 10% heat inactivated Foetal Calf Serum (FCS; Gibco) and 
penicillin-streptomycin (332). Medium was filter-sterilized and stored at 4 – 8 
°C.  FVI,  LmjcDNA16  dKO,  Lbr2904  and  Lbr300LBT  were  grown  in  M199 
without  antibiotics,  LmjcDNA16  sKI,  LmjHASPB  sKI,  LmjSHERP2  sKI, 
LmjHASPA2 sKI, LmjHASPA1/2 sKI were grown in M199  + neomycin (NEO) 
(40  μg/ml),  LmjS2/HB  sKI,  LmjHASPA1  sKI  and  LbrOHL  sKO  M199  + 
blasticidin  (BSD)  (10  μg/ml),  LmjS2+HB  sKI,  LmjHASPB  dKI,  LmjHA1+HB 
sKI, LmjHA1/2+HB sKI, LmjHA2+HB sKI, LmjHA1+S2 sKI, LmjHA1/2+S2 sKI, 
LmjHA2+S2 sKI, LmjHA1/2+S2/HB sKI and LmjHA2+S2/HB sKI in M199 + 
NEO (40 μg/ml) + BSD (10 μg/ml) and LmjHA1+S2/HB sKI in M199 + BSD 
(10  μg/ml)  +  streptophricin  (SAT)  (100  µg/ml).  All  strains  were  maintained 
either at 26°C in M199 cultures or at 23°C in M199 on biphasic rabbit blood-
agar slopes (329). 
 
 Splitting and passaging Leishmania parasites in vitro  2.2.3.
For  M199  inoculation  from  cryo-samples,  the  cryo-samples  were  thawed 
quickly, checked by haemocytometer for vitality and either poured onto blood 
slopes and kept at 23°C for 24h prior to inoculation into M199 cultures or 500 
µl of the cryo-sample were immediately inoculated into 10 ml M199 and kept 
at 26 °C.  
 
For M199 inoculation with amastigotes, draining lymph nodes were removed 
from infected BALB/c mice and ground up in a sterile sieve or petri dish with 
sterile syringe plungers to release amastigotes, which were washed with pre-
warmed (26°C) M199 into 10 ml culture flasks. The cultures were immediately 
used  for  a  1:10  dilution  into  10  ml  M199  as  back-ups.  Cultures  were 
maintained at 26°C until motile promastigotes appeared.  
 
All cultures were passaged at day 2-4 with 2-3 drops into fresh 10 ml M19989 
 
and kept at 26°C. 
 
Parasites  passaged multiple  times (>10x)  under  axenic  conditions  become 
avirulent  (361).  To  restore  virulence  L.  (L.)  major  strains  were  passaged 
through BALB/c mice (see 2.2.5). No culture was passaged more than 10 
times in vitro in this study.  
 
 Cryo-samples  2.2.4.
850 μl of cultured parasites in early to mid-log phase (day 2-3 culture) were 
aliquoted with 136 μL 50% glycerol (filter-sterilized) (6.25:1) into labelled 1ml 
cryo-vials  (NUNC)  and  placed  into  an  isopropanol-filled  double  walled 
container  (Mr.  Frosty)  for  slow  freezing  at  -80  °C  for  24  –  48  h,  before 
transferring samples into a liquid nitrogen tank for long term storage. For short 
term storage, cryo samples were kept at -80 °C.  
 
 Artificial mouse infection with L. (L.) major  2.2.5.
 
2.2.5.1.  L. (L.) major passage through BALB/c mice 
Parasite  passage  through  mice  has  been  described  elsewhere  (293). 
Briefly,  female  BALB/c  mice  (6-8  weeks  of  age)  were  purchased  from 
Harlan and kept and treated according to ethical standards enforced by the 
UK Home Office. For mouse infections, 3x10
8 stationary-phase (day 6-7 
culture) parasites were spun down for 10 min. at 3,200 rpm (~2,200 x g) in 
a  Sorvall  Legend  RT  centrifuge  and  washed  once  in  10  ml  phosphate 
buffered saline solution (PBS) and once in 1 ml sterile PBS for 5 min. at 
4,600 rpm (~2,000 x g) in a Sorvall Pico centrifuge. Washed parasites were 
re-suspended  in  PBS  to  a  final  concentration  of  3x10
7  parasites/30  μl. 
3x10
7 parasites (30 μl) were subcutaneously injected into the right footpad 
of female BALB/c mice, which were sacrificed after severe footpad swelling 
occurred.  The  right  draining  popliteal  lymph  node  was  dissected  and 
amastigotes were harvested as described above (see 2.2.3). 
 
2.2.5.2.  Amastigote generation and isolation 
The protocol was adapted from Paape et al. (2011) (362). BALB/c mice 
were infected with 10
7 stationary phase L. (L.) major cells from day 6 post 
inoculum (p.i.) cultures in 30 µl PBS by needle inoculation on both sides of 
the base of the tail. After lesions had developed (8-10 weeks p.i.), mice 
were sacrificed according to UK Home Office guidelines and lesion material 90 
 
was  excised  with  a  scalpel,  weighed  and  force  through  a  70  µm  cell 
strainer into homogenization buffer (20 mM HEPES-KOH, pH 7.3, 0.25 M 
sucrose  supplemented  with  cOmplete  Mini  proteinase  inhibitor  cocktail 
[Roche]). The suspension was centrifuged at 2,200xg for 10 min. and the 
cell pellets were suspended in 1 mL homogenization buffer. Amastigotes 
were released from amastigotes by forcing the cell suspension through a 
25-gauge needle. Nuclei were removed by centrifugation at 100xg for 2 
min. The supernatants were loaded onto a discontinuous sucrose gradient: 
1 mL each of 20, 40, and 60% (w/w) sucrose in HEPES saline (30 mM 
HEPES-KOH, pH 7.3, 0.1 M NaCl, 0.5 mM CaCl2, 0.5 mM MgCl2) (363), 
centrifuged  for  25  min.  at  700xg.  Amastigotes  were  isolated  from  the 
40/60% sucrose interface, diluted in PBS and centrifuged for 10 min. at 
2,200xg.  Cells  were  suspended  in  an  appropriate  amount  of  PBS  and 
Laemmli buffer (20 ml 0.5 M Tris-HCl [pH 6.8], 3.08 mg DTT, 40 ml SDS 
[10%], 50 mg Bromophenol Blue, 20 ml Glycerol [100%] and sterile Milli-Q 
water (MQH2O) to 100 ml) and boiled for 10 min. at 95 °C before freezing 
the samples at -20 °C. 
 
 Leishmania homologous recombination mutant generation  2.2.6.
 
2.2.6.1.  Transfection 
Parasite  transfection  using  a  Human T-Cell  Nucleofection™ kit  (Amaxa) 
was described previously (364). Briefly, recombinant DNA plasmids were 
amplified  in  Escherichia  coli,  the  DNA  was  extracted  as  midi-preps 
(Qiagen) according to the supplier’s protocol, restriction digested, the DNA 
was  gel purified  using a Qiagen kit according to the  supplier’s protocol, 
ethanol  precipitated  and  suspended  in  sterile  MQ  H2O  to  a  final 
concentration of ~1 μg / μL. ~2 x 10
7 log-phase parasite cells were spun 
down in one falcon tube per transfection at 3,200 rpm (2,200xg) for 10 min. 
at room temperature in a Sorvall Legend RT centrifuge. The supernatant 
was removed and cells were washed once in 10 ml PBS and once in 1 ml 
PBS  in  Eppendorf  tubes.  Cell  pellets  were  suspended  in  100  μL 
Nucleofection™ solution (AMAXA) and 5 μl DNA (4-5 μg) were immediately 
added. Samples were then transferred into AMAXA cuvettes, which were 
placed into the Nucleotranfector™ II machine (AMAXA) and the program 
U-033 was applied for electroporation. Transfected cells were transferred 
into 10 ml pre-warmed M199 medium and incubated at 26 °C overnight. 
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2.2.6.2.  Leishmania clone selection 
The following morning, antibiotics for selection were added as required to 
the overnight cultures and the cultures were incubated for another 2 – 3 h 
at 26 ºC. Transfected parasites were spun down at 3,200 rpm (2,200xg) for 
10  min.  at  15  °C  and  the  supernatant  was  removed.  Cell  pellets  were 
suspended in the residual M199 medium (100 – 200 µl) in the tube and 
were then spread on M199-agar plates, which had been poured by mixing 
25 ml of pre-warmed (37 °C) 2x M199 containing Biopterin (1.2 µl / ml) and 
the  antibiotics  for  selection  as  required  (control  plates  did  not  contain 
antibiotics) with 25 ml of 2% Agar kept at 56 °C. The cells were spread with 
sterile spreaders (not until dry) and the plates were left to dry at the surface 
just enough that the parasites could not swim freely, but the flagella could 
move. The plates were sealed and incubated at 26 °C for 10 – 21 days and 
checked regularly for colony growth. 
 
2.2.6.3.  Growing up parasite clones 
Antibiotic resistant Leishmania colonies were observed as early as 7 days 
of incubation with L. (L.) major. They were picked and used to inoculate 
100 μL 1x M199 medium + respective antibiotics on 96-well plates. Plates 
were  sealed  with  parafilm  and  incubated  at  26  °C  until  dense  parasite 
growth was observed (usually 3 – 4 days). Cultures were diluted 1:2 with 
100  μL  fresh  1x  M199  medium  +  respective  antibiotics  and  100  μL  of 
culture were transferred into 1.5 ml fresh 1x M199 medium + respective 
antibiotics on 24-well plates, which were sealed and incubated at 26 °C 
until dense parasite growth was observed (usually 2-3 days). 500 μL were 
transferred into 5 ml fresh 1x M199 medium + respective antibiotics on 6-
well plates, which were sealed and incubated at 26 °C until dense parasite 
growth was observed (usually 2-3 days). These cultures were then used to 
inoculate new cultures in flasks, to produce cryo-samples and for gDNA 
extraction for parasite clone screens.  
 
 Parasite measurements  2.2.7.
Giemsa  stained  parasites  from  sand  fly  gut  smears  were  measured  with 
respect  to  flagellum  length,  cell  body  length  and  cell  body  width  on 
microscope images using the software Image J. For each strain 60 images 
from parasites derived from the AMG and TMG, respectively, were taken per 
dissection day (day 5/6, 9 & 12 PBM) per glass slide. Three glass slides were 
imaged per condition totalling 180 measured parasites per midgut section per 92 
 
dissection  day.  Four  morphological  forms  were  distinguished  according  to 
Walters et al. (1993) (365) and Cihakova & Volf (1997) (157): (i) procyclics: 
body width >4 mm and body length <7.5 mm; (ii) nectomonads: body length 
≥14 mm; (iii) Leptomonads: body length < 14 mm and flagellar length < 2 
times body length; (iv) metacyclic promastigotes: body length < 14 mm and 
flagellar  length  ≥2  times  body  length.  Haptomonads  could  not  be 
distinguished from Leptomonads by measurement. 
 
 Growth Assay  2.2.8.
Parasites  were  inoculated  into  10  ml  1x  M199  to  a  final  concentration  of 
~5x10
5 parasites / ml and incubated at 26 °C. Starting right after inoculation, 
10  µl  of  culture  were  extracted  every  24  h,  mixed  with  490  µl  1% 
Formaldehyde  in  saline  solution  for  day  0,  1  &  2  p.i.  or  990  µl  1% 
Formaldehyde in saline solution for day 3, 4, 5, 6 & 7 p.i. and parasites were 
counted on a haemocytometer. Concentrations per ml were calculated and 
plotted on a log-scale scatter graph. 
 
 Osmotaxis Assay  2.2.9.
The osmotaxis assay was described previously (366, 367). Briefly, plain glass 
capillary tubes (75 mm length, 0.8 inner / 1 mm outer diameter) were filled 
with wash and incubation (WIS) buffer (30 mM β-glycerophosphate disodium 
salt, 87 mM NaCl, 27 mM KCl, 2 mM CaCl2, 2 mM MgCl2, 0.004% enriched 
Bovine  Serum  Albumin  [pH  7.1])  containing  1%  agarose  and  100  mM  of 
sucrose,  or  not,  leaving  exactly  1  cm  void  (~5  µl).  Once  the  agarose  had 
settled,  the  remaining  void  was  filled  with  WIS  buffer  and  the  filled  glass 
capillary  tubes  were  submerged  horizontally  in  WIS  buffer  in  a  Petri  dish, 
which  was  left  for  ~30  min.  at  room  temperature  on  a  rocking  table  to 
establish a sucrose gradient (control tubes were incubated on a separate Petri 
dish, too).  
 
Parasites were grown to late log-phase / early stationary-phase in 1x M199 or 
5% sucrose/PBS. They were harvested by centrifugation and washing the cell 
pellet  twice  in  WIS  buffer  before  suspending  the  cell  pellet  to  a  final 
concentration of ~2.5x10
7 cells / ml in WIS buffer. The cell suspension was 
transferred into a 7 ml universal tube. 
 
The  equilibrated  glass  capillary  tubes  were  submerged  into  the  parasite 
suspension at a slight angle with the WIS buffer filled end. 6 capillary tubes 93 
 
with 100 mM sucrose and 6 without sucrose were used per strain. The tubes 
without sucrose were used as a negative control to normalize the data. The 
universals were sealed with parafilm and incubated at 26 °C for 1 h. The WIS 
buffer in the filled void of the capillary tubes (~5 µl) was removed, mixed with 
195  µl  1%  Formaldehyde  in saline  solution  (1:40  dilution)  for  sample from 
tubes with attractant (+ve) or 95 µl 1% Formaldehyde in saline solution (1:20 
dilution)  for  sample  from  control  tubes  without  attractant  (-ve)  in  0.5  ml 
Eppendorf tubes and the parasites were counted on a haemocytometer.  
 
The  assay  was  repeated  3  times  on  different  days  and  the  attraction 
coefficient (AC) calculated in two distinct ways for each repeat:  
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The  results  were  plotted  and  compared.  The  standard  deviation  for  each 
strain and P-values were calculated.  
 
2.3. DNA Manipulation Protocols 
 
 DNA sequencing and processing  2.3.1.
All DNA sequencing was performed by technical staff in the Genomics lab of 
the  Technology  Facility  (TF)  of  the  University  of  York  using  an  Applied 
Biosystems  3130  sequencer.  Plasmid  samples  were  submitted  at  100-150 
ng/µl concentrations and primers at 3.2 µM. A complete list of primers used in 
this study can be found in Appendices 2 – 6.  
 
 Genomic DNA extraction  2.3.2.
Two different procedures were used for gDNA extraction depending on the 
quantity and quality of gDNA needed. 
 
2.3.2.1.  Phenol/chloroform gDNA extraction 
Parasites were grown in 50 ml cultures to a density of 2-3x10
7 cells/ml and94 
 
spun down at 3,200 rpm (2,200xg) for 10 min. at 15 °C in a Sorvall Legend 
RT centrifuge. Cell pellets were washed twice  in 40 ml sterile PBS and 
spun down as above before re-suspending cells thoroughly in 9 ml  Net 
buffer (1 ml 0.5M Tris pH 8.0, 10 ml 0.5M EDTA, 1 ml 5M NaCl, 38 ml 
sterile MQ H2O). 1 ml of 10% SDS was added and samples were mixed by 
inversions before incubation with 40 μl RNaseA (10 mg/ml) for 30 min. at 
37 °C. 200 μL Proteinase K (600 mAU/ml) were added and samples were 
incubated at 55 °C overnight. 
 
Samples were retrieved the following day and 1 volume Phenol/Chloroform 
(1:1) (Sigma/Fisher  Scientific)  was  added,  mixed  by  inversion  and  spun 
down at 3,200 rpm (~2,200xg) for 20 min. at room temperature in a Sorvall 
Legend RT centrifuge. The aqueous layer was transferred into a fresh tube 
and the steps repeated. 1 volume Chloroform was added to the aqueous 
layer and spun down as above. The transferred aqueous layer was ethanol 
precipitated (see 2.3.8.), the gDNA pellet dried and re-suspended in MQ 
H2O for immediate use or 1x TE buffer for storage at 4 – 8 °C. 
 
2.3.2.2.  Genomic DNA extraction by blood and tissue kit (Qiagen) 
Smaller amounts of gDNA were extracted by Blood and Tissue kit (Qiagen) 
according to the supplier’s protocol. Genomic DNA extracts were eluted in 
200  µl  AE  buffer  (Qiagen).  If  concentration  of  gDNA  was  required,  an 
ethanol precipitation step was  used  and the gDNA pellet  was either re-
suspended in MQ H2O for immediate use or in 1x TE buffer for storage at 4 
– 8 °C. 
 
 PCR amplifications  2.3.3.
Examples of all PCR profiles are listed in Table 2.3. 
 
2.3.3.1.  Conventional PCR 
For conventional PCR reactions, GO-Taq
® polymerase (Promega) or Taq 
polymerase (NEB) were used according to the supplier’s protocol. The high 
fidelity  KOD  hot  start  DNA  polymerase  (Novagen)  was  used  for  DNA 
amplifications for cloning. Reactions were set up and run according to the 
supplier’s protocol (Table 2.3A&B). 
 
2.3.3.2.  Long range PCR 
KOD  XL  DNA  polymerase  (Novagen),  KAPA  long  range  hot  start  DNA95 
 
Table 2.3 – PCR profile 
 
A)  Taq (NEB) and GO-Taq polymerase (Promega) 
 
 
B)  KOD hot start DNA polymerase (Inovagen) 
 
 
C)  KOD XL DNA polymerase (>12 Kb) (Inovagen) 
 
 
D)  KAPA long range hot start DNA pol. (>15 Kb) (KAPAbiosystems) 
 
 
Stage  Temperature  Cycle #  Duration 
Initial denaturing step  95 °C    3 min 
       
Denaturing  95 °C 
30 – 35 x 
30 – 60 sec 
Annealing  55 – 65 °C  30 – 60 sec 
Extension  72 °C  1 min / Kb 
       
Final Extension  72 °C    5 min 
       
Final step  4 °C    ∞ 
Stage  Temperature  Cycle #  Duration 
Initial denaturing step  95 °C    2 min 
       
Denaturing  95 °C 
30 – 35 x 
30 – 60 sec 
Annealing  55 – 65 °C  30 – 60 sec 
Extension  72 °C  1 min / Kb 
       
Final Extension  72 °C    5 min 
       
Final step  4 °C    ∞ 
Stage  Temperature  Cycle #  Duration 
Initial denaturing step  94 °C    3 min 
       
Denaturing  94 °C 
25 – 30 x 
30 sec 
Annealing  55 – 65 °C  5 sec 
Extension  70 – 74 °C  8-10 min / Kb 
       
Final Extension  74 °C    10 min 
       
Final step  4 °C    ∞ 
Stage  Temperature  Cycle #  Duration 
Initial denaturing step  94 °C    2 min 
       
Denaturing  95 °C 
10 x 
25 sec 
Annealing  55 – 65 °C  15 sec 
Extension  68 °C  1 min / Kb 
       
Denaturing  95 °C 
25 x 
25 sec 
Annealing  55 – 65 °C  15 sec 
Extension  68 °C  1 min / Kb + 
      20 sec / cycle 
       
Final Extension  72 °C    1 min / Kb 
       
Final step  4 °C    ∞ 96 
 
E)  DyNAzyme™ EXT DNA Polymerase 
 
F)  qPCR with Power SYBR
® Green PCR master mix (AB) 
   
Stage  Temperature  Cycle #  Duration 
Initial denaturing step  94 ºC    2 min 
       
Denaturing  94 ºC 
10x 
30 sec 
Annealing  55 ºC  30 sec 
Extension  70 ºC  40 sec / Kb 
       
Denaturing  94 ºC 
20x 
30 sec 
Annealing  55 ºC  30 sec 
Extension  70 ºC  40 sec / Kb + 
      20 sec / cycle 
       
Final Extension  70 ºC    5 – 10 min 
       
Final step  4 ºC    ∞ 
Stage  Temperature  Cycle #  Duration 
Initial denaturing step  95  ºC    20 sec 
       
Extension/Detection:       
Denaturing  95  ºC 
40x 
3 sec 
Annealing/Extension  60  ºC  30 sec 
       
Melting Curve:       
Denaturing  95  ºC 
1x 
15 sec 
Annealing/Extension  60  ºC  1 min 
Denaturing  95  ºC  15 sec 97 
 
polymerase (KAPA biosystems) and DyNAzyme™ EXT DNA Polymerase 
were  used for  high fidelity  long  range  PCRs  according to  the  supplier’s 
protocols (Table 2.3C, D & E). 
 
2.3.3.3.  Reverse transcriptase – PCR 
Prior  to  the  reverse  transcriptase-PCR  (RT-PCR),  RNA  was  treated  for 
removal of DNA with the DNA-free kit (Ambion) according to the supplier’s 
protocol. Briefly, 4 μg of RNA were added to 5 μL 10x rDNase I buffer and 
0.5 μL rDNase I (2 units/μL) in a 50 μL reaction and left to incubate for 15 
min. at 37 °C. 5 μL rDNase I inactivation buffer were added and left to 
incubate for 2 min. at room temperature to stop the reaction. The reaction 
mix was then spun down at 10,000 rpm (~9,500xg) for 1 min. in a Sorvall 
Pico centrifuge and the liquid phase was transferred to a fresh tube. RT-
PCR was done with the Omniscript kit (Qiagen) according to the supplier’s 
recommendations.  Briefly,  10  μL  DNase-treated  RNA,  2  μL  RNase-free 
water,  2  μL  10x  Omniscript  buffer,  2 μL  dNTPs  (5 mM),  2  μL  oligo dT 
primers  (10  μM),  1  μL  RNase  inhibitor  (10  units/μL),  1  μL  Omniscript 
reverse transcriptase were added to a single Eppendorf tube and incubated 
at 37 °C for 1 h. The sample was then either used in a qPCR or frozen at -
20 °C. 
 
RT-PCR  was  also  performed  with  the  Transcriptor  First  Strand  cDNA 
Synthesis  Kit  (Roche),  which  later  substituted  the  Omniscript  kit,  using 
random primers in 20 μl reactions according to the supplier’s protocol. The 
reaction  was  performed  at  room  temperature  for  10  min.  followed  by 
incubation at 55 °C for 30 min. Samples were stored at -20 °C. 
 
2.3.3.4.  Quantitative Real Time – PCR 
DNA  template  for  the  qPCR  reactions  was  either  complementary  DNA 
(cDNA) from DNase-treated RNA or RNaseA treated gDNA. The starting 
material was prepared in serial-dilution to have between 1,000,000 – 10 
molecules  per  µl.  Molecule  numbers  per  µl  sample  were  calculated 
according to the following formula: 
 
1)                    ⁄  
       
                                          ⁄   
 
2)                
   ⁄                      ⁄                            
   ⁄   98 
 
For the qPCR Power SYBR
® Green PCR Master Mix (AB) was used and 
primers  were  diluted  to  a  final  concentration  of  300  nM  per  reaction. 
Reactions were prepared in 25 µl aliquots in triplicate in optical 96-well 
plates (AB). The loaded plate was sealed and spun for 2 min. at 4,000 rpm 
(~2,100xg) in a Hettich Universal 32-A centrifuge to ensure that all liquid 
was at the bottom of the wells. The plates were then run in a Prism7000 
machine (AB) (Table 2.3F) and the results analysed in Prism7000 system 
software (AB). 
 
 PCR product purification  2.3.4.
PCR products were purified using a PCR purification kit (Qiagen) according to 
the supplier’s protocol. PCR products were eluted in 30 – 50 µl elution buffer. 
Purified PCR products were either used right away or were frozen at -20 ºC in 
elution buffer. 
 
 Plasmid construction  2.3.5.
A list of all plasmids constructs generated in this study can be found in Table 
2.4. DNA constructs for homologous recombination in Leishmania were built 
in pCR
®2.1-TOPO
® vector plasmids (Invitrogen) by a multi-step protocol that 
incorporated the following steps: 
 
2.3.5.1.  3’ A-overhang addition 
Proof-reading DNA polymerases, like KOD polymerase, have exonuclease 
activity  and  do  not  leave  a  3’-mono-A-overhang  like,  for  instance, 
conventional  Taq-polymerase.  The  auto-ligating  pCR
®2.1-TOPO
®  vector 
(Invitrogen)  exploits  the  3’-mono(A)-overhang  for  initial  DNA  fragment 
integration.  Since  proof-reading  DNA  polymerase  were  used  for  DNA 
fragment  generation  for  homologous  recombination  constructs,  it  was 
necessary to add 3’-mono-A-overhang after the PCR. Briefly, 0.7-1 unit of 
Taq polymerase (NED) was added to purify PCR products together with 
dATPs  (final  concentration  200  nM)  and  10  x  Taq  polymerase  buffer 
according to supplier’s recommendations. Samples were incubated at 72°C 
for  8-10 min.  and  then transferred  to  ice. The product  was  immediately 
used for integration into the pCR
®2.1-TOPO
® vector (Invitrogen) according 
to supplier’s protocol. 
 
2.3.5.2.  Restriction digests protocols 
All restriction enzymes used in this study are listed in Table 2.5 and were99 
 
Table 2.4 – Plasmids 
Plasmid Name  Vectors used  Inserted Gene  Antibiotic Marker  Restriction 
Sites  Comment 
Leishmania (L.) major constructs: 
pHASPB(I)  pSP6-T3
  HASPB  Neomycin (NEO)  HindIII / XmaI  Homologous recombination; gene replacement 
pHASPB(II)  pCR2.1
®-TOPO
®  HASPB  Blasticidin (BSD)  ApaI / HindIII  Homologous recombination; gene replacement 
pSHERP(I)  pSP6-T3  SHERP2  Neomycin (NEO)  HindIII / XmaI  Homologous recombination; gene replacement 
pSHERP(II)  pCR2.1
®-TOPO
®  SHERP2  Blasticidin (BSD)  ApaI / HindIII  Homologous recombination; gene replacement 
pS2+HB (I)  pCR2.1
®-TOPO
®  SHERP2 & HASPB  Blasticidin (BSD)  ApaI / HindIII  Homologous recombination; gene replacement 
pS2+HB (II)  pCR2.1
®-TOPO
®  SHERP2 & HASPB  Streptothricin (SAT)  ApaI / HindIII  Homologous recombination; gene replacement 
pHASPA1  pCR2.1
®-TOPO
®  HASPA1  Blasticidin (BSD)  ApaI / HindIII  Homologous recombination; gene replacement 
pHASPA2  pCR2.1
®-TOPO
®  HASPA2  Neomycin (NEO)  ApaI / BamHI  Homologous recombination; gene replacement 
pHASPA1/2  pCR2.1
®-TOPO
®  HASPA1 & 2  Neomycin (NEO)  ApaI / BamHI  Homologous recombination; gene replacement 
pHASPA-HIS  pET-28a+  HASPA (ORF)      For Protein Production 
pHASPB-GFP 
pCR2.1
®-TOPO
® & 
pcDNA3.1/CT-
GFP-TOPO® 
HASPB – GFP fusion 
protein 
Streptothricin (SAT)  ApaI / BglII  Homologous recombination; gene replacement 
Leishmania (V.) braziliensis constructs: 
pOHL KOI  pCR2.1
®-TOPO
®  -  Blasticidin (BSD)    Homologous recombination; OHL deletion 
pOHL KOII  pCR2.1
®-TOPO
®  -  Streptothricin (SAT)    Homologous recombination; OHL deletion 
pOHL KOIII  pCR2.1
®-TOPO
®  -  Neomycin (NEO)    Homologous recombination; OHL deletion 
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either purchased from Promega or New England Biolabs (NEB). Reactions 
were  performed  according  to  the  guidelines  of  the  supplier.  As  a  brief 
example, 2 – 3 μL of respective restriction enzyme (20 – 30 U) were added 
to a 100 μL reaction containing ~5 μg DNA, 10 μL of (10x) reaction buffer, 
1 μL 25 mM BSF and rest MQ H2O. The reaction was incubated at 37 °C 
for 3 h. All restriction digests were performed under the same conditions.  
 
2.3.5.3.  DNA ligation 
Subsequent DNA fragment integration into plasmids required conventional 
DNA ligations, which were performed according to the supplier’s protocol 
(NEB). Insert and vector DNA were used in a molecular 3:1 ratio. 40 – 50 
ng of plasmid vector DNA were used per reaction and the required amount 
of insert DNA was calculated according to formula: 
 
                 
               
                                    
 
  
 
Briefly, a 20 μL reaction contained, apart from the insert and vector DNA, 2 
μL T4 ligation buffer (NEB), 1 μL T4 DNA ligase (NEB) and MQ H2O. The 
samples were incubated for 10 min. and 60 min. at room temperature for 
sticky and blunt-end ligation, respectively, and were then heated to 65°C 
for 10 min. for inactivation. 
 
2.3.5.4.  Transformation of chemically competent E. coli cells 
Transformation of chemically competent E. coli DH5α, XL-1 cells or One 
Shot
® TOP 10 cells (Invitrogen) was performed according to the supplier’s 
protocol. Briefly, 2 – 10 μL ligated plasmid DNA were added to 50 μL One 
Shot
® TOP 10 cells or 100 μL DH5α or XL-1 cells previously thawed slowly 
on ice. Cells were incubated with plasmid DNA for 30 min. on ice and then 
heat shocked at 42 °C in a heat block for 30 – 45 s for membrane-poration. 
Tubes were immediately replaced on ice for another 2 min. 250 μL SOC or 
SOB medium were added to the cells and they were incubated for 1 hour at 
37 °C and 225 rpm in an Eppendorf tube placed in a horizontal position. 
Eventually, cells were spread in either 50 μl or 100 μl aliquots onto pre-
warmed Luria-Bertani (LB) agar ampicillin or kanamycin plates (50 ml LB-
agar + 50 μl (1000x) ampicillin or kanamycin) with sterile spreaders under 
sterile condition until dry. The plates were incubated at 37 °C overnight. 
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Table 2.5 – Restriction Enzymes used in this study 
Restriction Enzyme  Supplier  Species in which applied  Reaction Conditions  Restriction Site 
ApaI  Promega  Leishmania (L.) major  37 °C + BSA  GGGCCˇC 
BamHI  Promega  Leishmania (L.) major  37 °C + BSA  GˇGATCC 
EcoRV  Promega  Leishmania (L.) major  37 °C + BSA  GATˇATC 
HindIII  Promega  Leishmania (L.) major, Leishmania (V.) braziliensis  37 °C + BSA  AˇAGCTT 
NotI
  Promega  Leishmania (V.) braziliensis  37 °C + BSA  GCˇGGCCGC 
PstI  Promega  Leishmania (V.) braziliensis  37 °C + BSA  CTGCAˇG 
PvuI  Promega  Leishmania (L.) major  37 °C + BSA  CGATˇCG 
PvuII  Promega  Leishmania (L.) major  37 °C + BSA  CAGˇCTG 
SacI
  Promega  Leishmania (L.) major, Leishmania (V.) braziliensis  37 °C + BSA  GAGCTˇC 
SalI
  Promega  Leishmania (L.) major  37 °C + BSA  GˇTCGAC 
XbaI  Promega  Leishmania (L.) major  37 °C + BSA  TˇCTAGA 
XhoI  Promega  Leishmania (L.) major, Leishmania (V.) braziliensis  37 °C + BSA  CˇTCGAG 
XmaI  NE Biolobs  Leishmania (L.) major  37 °C + BSA  CˇCCGGG 
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2.3.5.5.  Plasmid extraction from cultured E. coli cells 
Mini- and MidiPreps (Qiagen) were performed for plasmid isolation from 
transformed E. coli cells grown in LB medium according to the supplier’s 
protocol. Plasmid DNA from MiniPreps was eluted in 30 – 50 µl elution 
buffer and either used right away or stored at -20°c. Plasmid DNA from 
MidiPreps  was  eluted  in  5  ml  of  a  special  elution  buffer  (Buffer  QF  – 
Qiagen),  to  which  3.5  ml  of  isopropanol  was  added  for  plasmid  DNA 
precipitation (see supplier’s manual). 
 
 Gel electrophoresis  2.3.6.
Ultrapure  agarose  (Invitrogen)  or  SeaKem
®  Gold  agarose  (Lonza)  was 
dissolved in 1x Tris acetate EDTA (TAE) buffer to a 0.8% -1.2% or 0.3%-0.5% 
agarose content, respectively, by heating in a microwave (Panasonic) until the 
solution was clear. For UV visualization, SYBR
® safer (Invitrogen; 1:13333) 
was added to hand warm liquid agarose. The agarose was poured into trays 
and left to set for >20 min. at room temperature. The solidified agarose gel 
was submerged in 1x TAE buffer in an electrophoresis tank (BioRad) and run 
at 80-100 V for 1-2 h or at 20 V overnight (for Southern blots). Agarose gels 
for UV visualization in a Syngene G:BOX either contained SYBR
® safer or 
were submerged in Ethidium  Bromide solution (1:10,000) for 15 min. on a 
shaker  at  room  temperature.  Gels  to  be  visualized  on  a  light  table  were 
submerged in 1x TAE buffer – Methylene Blue (Sigma) solution on a shaker 
for ~1 h at room temperature or overnight at 4 ºC. 
 
 DNA agarose gel extraction  2.3.7.
DNA bands were extracted from Methylene blue stained agarose gels using a 
gel  purification  kit  (Qiagen)  according  to  the  supplier’s  protocol.  DNA  was 
eluted by 30 – 50 µl elution buffer. 
 
 Ethanol precipitation  2.3.8.
Ethanol  precipitation  has  been  described  elsewhere  (368).  Briefly,  sodium 
acetate, 6H2O (BDH) was added from a 3 M stock (pH5.1) to DNA samples to 
a final-concentration of 0.3 M. 2 volumes of ice-cold 100% ethanol (Fisher 
Scientific) were added and mixed in by inverting the tube, and the samples left 
on ice for 20-30 min., prior to centrifugation in an Eppendorf 5415 R centrifuge 
at 4 °C for 10 min. at full speed. Supernatants were removed and DNA pellets 
washed twice in 550 ml 70% ethanol (Fisher Scientific) and spun down at 
room temperature for 2 min. at full speed in a Sorvall Pico centrifuge. DNA 103 
 
pellets were dried either in a flowhood at room temperature (sterile) or in a 
vacuum  centrifuge  at  30  °C  for  5-10  min.  (not  sterile)  and  were  then  re-
suspended in sterile MQ H2O. Genomic DNA suspensions were stored in 1x 
TE buffer at 4 °C, while DNA fragments and plasmids were frozen at -20 °C. 
 
 Southern blot  2.3.9.
Genomic DNA (>10 µg) was SacI-digested in 100 ml reactions overnight. The 
digested gDNA was purified and concentrated by ethanol precipitation and 4-5 
μg of digested gDNA were run on a long agarose gel (0.35-0.8% agarose as 
required) at 20 V overnight (20-24 hours). The agarose gel was submerged in 
Ethidium Bromide solution (1:10,000) as described for UV light visualization. 
For  DNA  degeneration,  gels  were  bathed  in  0.5  M  NaOH  /  1.5  M  NaCl 
solution on a shaker for 30-60 min. The gels were rinsed briefly in distilled 
H2O before transfer to neutralising solution (0.5 Tris / 1.5 NaCl, pH 8) for 60 
min. on a shaker. The gel was rinsed and mounted for DNA blotting on to an 
activated positively charged nylon membrane (Roche; activation for 10 min. in 
20x SSC [3M NaCl, 0.3M sodium citrate, pH7.2]) (Fig.2.1). 
 
The nylon membrane was briefly rinsed in 2x SSC solution the following day, 
left to dry on blotting paper and then cross-linked by UV light (160 Joules per 
cm
2).  The  cross-linked  nylon  membrane  was  then  treated  with  the 
nonradioactive  digoxigenin  (DIG)  system  from  Roche  according  to  the 
supplier’s guidelines. Briefly, membranes were pre-hybridised in 20 ml DIG-
easy-hyb  solution  (Roche)  at  42  °C  in  a  rolling  tube  for  at  least  4  hours. 
Hybridization with a DIG-labelled probe in DIG-easy hub solution occurred at 
42 °C in a rolling tube overnight. All DIG-probes used in this study (5’ UTR, 
HASP,  HASPA,  SHERP,  NEO,  BSD,  HYG,  PAC,  BLE,  OHL1,  OHL2  and 
OHL3) were generated with the DIG-DNA labelling kit (Roche) according to 
the  supplier’s  instructions.  The  following  day,  the  nylon  membrane  was 
washed twice for 15 min. in 2x SSC + 0.01% SDS at room temperature and 
twice  for  15  min.  in  pre-heated  0.5x  SSC  +  0.01%  SDS  at  68  °C.  The 
membrane was then rinsed in 1x Washing buffer (Roche), blocked for at least 
30 min. with 25 ml blocking buffer (Roche) and for 30 min. with 25 ml blocking 
buffer  containing  Anti-digoxigenin  antibody  conjugated  with  alkaline 
phosphatase  (AP)  (1:12,500)  (Roche)  on  a  shaker.  The  membrane  was 
washed  twice  for  15  min.  in  washing  buffer  on  a  shaker  before  applying 
detection buffer (Roche) for 2-5 min. CDP-star ready-to-use solution (Roche) 
was applied to the membrane and incubated in the dark for 5 min. Excess104 
 
 
 
Fig.2.1 – Southern blot set-up 
A  wick  cut  from  filter  paper  was  placed  over  a  glass  slide  resting  on  an  open 
Tupperware box with its end hanging into 20x SSC filling the box. The gel was placed 
on top of a cut to size piece of filter paper on top of the wick. On top of the gel, a 
nylon membrane, a second sheet of filter paper cut to size and at least 5 cm of paper 
towels were stacked finished by a weight of ~600 g. The blot was left overnight for 
DNA transfer onto the nylon membrane. 
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CDP-star  was  removed  and  the  membrane  exposed  to  x-ray  films 
(Amersham)  for  varying  amounts  of  time.  The  films  were  developed  in  an 
automated developer (Konica Minolta SRX-101A). 
 
 Amplification of genomic DNA extracts  2.3.10.
The  illustra™  GenomiPhi™  V2  DNA  amplification  kit  was  used  for 
amplification  of  gDNA  samples from  L.  (V.)  braziliensis  clinical  isolates  for 
Southern blot analysis according to the supplier’s protocol. Briefly, at least 10 
ng/µl of template gDNA were mixed with 9 µl sample buffer and heated to 
95°C for 3 min. Samples were transferred onto ice before incubation at 30 °C 
for 1½-2 h with 9 µl reaction buffer and 1 µl enzyme mix. Samples were then 
heated to 65 °C for 10 min. for enzyme inactivation and transferred back on 
ice before further use.  
 
2.4. mRNA Manipulation Protocol 
 
 mRNA extraction from cultured parasites  2.4.1.
1  ×  10
7  parasites  were  pelleted  by  centrifugation  and  were  suspended  in 
residual culture before lysis in 1 ml TRIZOL
® Reagent by repetitive pipetting. 
Samples were left for 5 min. to incubate at room temperature before either 
freezing the sample at -80 °C or immediate extraction. 0.2 ml chloroform were 
added to samples per 1 ml of TRIZOL
® Reagent used. Tubes were shaken 
vigorously by hand for 15 seconds and then incubated for 2 – 3 min. at room 
temperature. The samples were centrifuged at ~12,000×g for 15 minutes at 4 
°C. The aqueous phase was transferred to a fresh tube. RNA was precipitated 
by mixing 0.5 ml of isopropanol per 1 ml of TRIZOL
® Reagent used for the 
initial lysis to the sample and the mix was incubated at room temperature for 
10 minutes followed by centrifugation ~12,000×g for 10 min. at 4 °C. The RNA 
pellet was washed once with 1 ml 75% ethanol per 1 ml of TRIZOL
® Reagent 
used per sample by vortexing followed by centrifuge at ~7,500×g for 5 min. at 
4 °C. The supernatant was removed and the RNA pellet was air dried for 5-10 
min. at room temperature. The RNA was dissolved in RNase-free water and 
incubated for 10 minutes at 55 – 60 °C. 
 
 mRNA extraction from midgut derived parasites  2.4.2.
The  Magnetic  mRNA  Isolation  Kit  (NEB)  was  used.  20  infected  sand  fly 
midguts were dissected into 50 μl IP buffer (150 mM NaCl, 10 mM Tris [pH 
7.5], 0.05 mM EDTA, 1 mM DDT in MQ H2O) with 1μl RNasin (2U; Promega) 106 
 
in an Eppendorf kept on ice. The samples were homogenized, snap frozen on 
dry ice with 70% ethanol and thawed on ice. 250 μl Lysis buffer were added 
prior  to  DNase  treatment  (AB)  according  to  the  supplier’s  protocol.  mRNA 
extraction was done with the Magnetic mRNA Isolation Kit (NEB) according to 
the supplier’s protocol. The mRNA was eluted from the magnetic beads with 
50 μl elution buffer for 2 min. at 50 °C. Samples were either used immediately 
for RT-PCR or stored at -80 °C. 
 
2.5. Protein studies 
 
 Protein extraction  2.5.1.
Leishmania parasites were collected by centrifugation in amounts as required 
from day 2 to day 7 cultures. Cell pellets were washed once in 1 ml PBS and 
re-suspended in 25 μL PBS before adding 25 µl Laemmli buffer (20 ml 0.5 M 
Tris-HCl [pH 6.8], 3.08 mg DTT, 40 ml SDS [10%], 50 mg Bromophenol Blue, 
20 ml Glycerol [100%] and sterile MQ H2O to 100 ml). Samples were heated 
to 95 °C for at least 10 min. Whole lysates were either directly loaded onto 
SDS-Polyacrylamide Gel Electrophoresis (PAGE) or stored at -20ºC (332). 
 
 Western / Immunoblotting  2.5.2.
Varying  amount  of  whole  cell  lysates  were  separated  by  SDS-PAGE  as 
described  (332)  and  blotted  by  electroblot  onto  Immobilon
®  transfer 
membranes (Millipore). Membranes were blocked overnight in PBS / 0.05% 
TWEEN / 5% milk and then probed with polyclonal antisera from rabbits in 
PBS / 0.05% TWEEN / 5% milk using either HASPA (non-affinity purified anti-
HASP ab) and HASPB (non-affinity purified anti-HASP ab or ab336 (333)) or 
SHERP (anti-SHERP ab (341)) for 2 h. Membranes were washed 3x for 10 
min. in PBS / 0.05% TWEEN and probed with a goat anti-rabbit HRP antibody 
(Sigma).  Membranes  were  washed  again  3x  for  10  min.  in  PBS  /  0.05% 
TWEEN, treated with ECL plus or ECL prime (Amersham) according to the 
supplier’s  guidelines  and  were  exposed  to  x-ray  films  (Amersham).  As  a 
protein  loading  control,  membranes  were  re-probed  with  rabbit  polyclonal 
antiserum against N-myristoyl transferase (NMT) (369). 
 
 Ponceau S stain of immunoblot membranes  2.5.3.
For the visualization of protein bands on an immunoblot, the membrane was 
transferred  directly  from  the  electroblotter  into  a  Ponceau  S  solution  (1:10 
dilution  of  2%  3-hydroxy-4-[2sulfo-4-(sulfophenylazo)-phenylazo]-2,7-107 
 
naphthalene disulfonic acid in 30% trichloroacetic acid) prior to blocking. The 
membrane was stained for 10 min. at room temperature on a shaker and then 
gradually destained in PBS until protein bands became visible. 
 
 Promastigote secretory gel (PSG) extraction  2.5.4.
PSG extraction was adapted from Rogers et al. (2009) (254). Briefly, ten sand 
fly  midguts  were  dissected  in  a  drop  of  sterile  PBS  and  the  TMGs  were 
transferred into an Eppendorf tube containing 50 μL PBS. The samples were 
centrifuged 6x at 10,000xg for 5 min. and the supernatant was transferred into 
fresh Eppendorf tubes every time. The PSG suspensions were stored at -20 
°C until use. 
 
 PSG detection by Dot-blot  2.5.5.
Nitrocellulose membrane was activated in 100% methanol for 30 – 45 sec. 
and was then washed in distilled H2O for 2 min. prior to washing it in PBS for 
5 – 10 min. and then drying briefly. Drops of 2 – 5 μL of PSG extract were 
applied to a moist nitrocellulose membrane placed on a stack of moist blotting 
paper  and  left  to  soak  in  for  a  few  minutes.  The  membrane  was  briefly 
transferred onto a stack of dry blotting paper and was then blocked with PBS / 
0.05% TWEEN / 5% milk overnight, prior to further treatment as specified in 
2.5.2. 
 
 Biotinylation assay  2.5.6.
The  biotinylation  assay  was  preceded  by  cell  sorting  of  AMCA-Sulfo-NHS 
(sulfosuccinimidyl-7-amino-4-methylcoumarin-3-acetate)  (Pierce,  Perbio 
Rockford) – an amine-reactive fluorophore – labelled (live/dead labelled) cells 
in  a  modular  flow  cytometer  (MoFlo)  to  distinguish  between  intact  and 
damaged cells. The live/dead labelling method is described elsewhere ((336); 
see also 2.7.3.2.). The cell sorting by MoFlo was performed in the Cytometry 
lab of the Technology Facility of the University of York. 
 
The biotinylation assay is described elsewhere (335). Briefly, sorted live cells 
were washed 3x in 1 ml ice cold PBS (pH 8) and re-suspended in ice cold 
PBS (pH 8) to an approximate concentration of 10
8 cells / ml. Biotin solution 
was freshly prepared from a solid Sulfo-NHS-SS-biotin (sulfosuccinimidyl-2-
[biotinamido]ethyl-1,3-dithiopropionate) stock (Thermo Scientific) in ultrapure 
water to a final concentration of 10 mM (e.g. 2.2 mg / 360 μL) and was added 
immediately to  a final concentration of 1 mM to the cell suspension. Cells 108 
 
were  incubated  for  5  min.  on  ice  before  quenching  the  reaction  by  three 
washes in 1 ml ice cold Tris Buffered Saline (TBS; pH 8) + 50 mM NH4Cl + 50 
mM glycine. Parasites were washed one more time in 1 ml ice cold TBS (pH 
8) to remove traces of quenching solution. Cells were lysed in 200 µl PBS (pH 
7) + 1% SDS containing one cOmplete Mini, EDTA-free tablet (Roche) / 10 
ml) and boiled for 3-5 min. The volume was adjusted to 1 ml by addition of 
PBS (pH 7) + 2% Triton X-100 (Sigma). Streptavidin resin was warmed to 
room temperature, shaken and 100 µl transferred to an Eppendorf tube per 
extraction  reaction.  The  resin  was  spun  briefly  and  the  supernatant  was 
removed.  The  cell  lysate  was  poured  onto  the  streptavidin  beads  and 
incubated for 1 h on a wheel shaker at room temperature. The streptavidin 
beads were washed at least 5x in 1 ml PBS (pH 7) + 0.1% SDS and spun 
briefly at 750 rpm. 1 volume of 2x Laemmli buffer was added to the beads and 
the  sample  boiled  for  10  min.  before  loading  the  supernatant  onto  a  12% 
SDS-PAGE for a Western blot. Alternatively, samples were frozen at -20 °C 
and re-boiled before use. 
 
2.6. Sand fly manipulation 
The establishment and maintenance of sand fly colonies were done by the staff at 
the Charles University, Prague, CZ. Procedures can be viewed in Volf & Volfova 
2011 (370). 
 
 Sand fly strains  2.6.1.
For sand fly infection studies, the specific sand fly vector, Ph. (Ph.) papatasi, 
and the permissive vector, Ph. (Ph.) duboscqi, were used (Table 2.6). The 
adult sand flies were maintained in net cages (Fig.2.2 B) at ~26 °C in humid 
conditions on a 50% sucrose solution with 14 hours of light and 10 hours of 
dark photoperiods per day as described by Benkova and Volf (2007) (371). 
Cotton wool was drenched in the 50% sucrose solution and small portions of it 
were offered to the sand flies on small glass dishes, which were placed inside 
the cages. These were replaced every other day. The net cages were kept in 
transparent plastic sacks, which also contained an open Petri dish containing 
moist cotton wool for humidity. 
 
 Artificial sand fly infections  2.6.2.
Methods  for  artificial  sand  fly  infections  are  described  elsewhere  (146).  In 
detail, parasites were grown to day 3 p.i. in 2 ml M199 cultures at 23 °C and 
were collected by centrifugation at 5,000 rpm (~2350xg) for 5 min. at room 109 
 
Table 2.6 – Sand Fly Vector Strains used in this study 
Genus  Subgenus  Species  Origin 
Phlebotomus  Phlebotomus  papatasi  Turkey 
Specific vector for L. (L.) major; belongs to the same subgenus and is closely 
related to Ph. (Ph.) duboscqi (females are morphologically indistinguishable) 
(372) 
Phlebotomus  Phlebotomus  duboscqi  Senegal 
More permissive vector for L. (L.) major; belongs to the same subgenus and 
is closely related to Ph. (Ph.) papatasi (females are morphologically 
indistinguishable) (372) 
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Fig.2.2 – Artificial sand fly feeding method 
A) Double walled glass feeder. B) Sand fly net cage attached to a metal frame kept in 
a plastic bag with moist cotton wool on a Petri dish for humidity. C) Infected blood 
loaded lass feeders attached to 37 °C water bath by tubing. D) Net cages attaché to 
loaded glass feeder for sand fly infection. 
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temperature in a Jouan BR4i centrifuge. Cell pellets were washed once in 1 
ml sterile saline solution and were re-suspended in 1 ml fresh sterile saline 
solution. 10 μl were diluted in 990 μL 1% Formaldehyde in saline solution 
(1:100) and 10 μl of this dilution were applied per side of a haemocytometer 
(Brückers). Parasites were counted on 5x 16 tiles (= 0.5 μl) on each half of the 
haemocytometer  under  the  light  microscope.  Parasite  counts  per  ml  were 
established  by  summing  counts  from  both  halves  (parasites  /  μl)  and 
multiplying by 10
2 (1:100 dilution in 1% Formaldehyde solution) and by 10
3 (to 
get to one ml). 
 
For  experimental  infection,  1x10
6  parasite  cells  /  ml  were  used:  for  3  ml 
infected blood, 300 μl parasite suspension in saline solution (1x10
7 parasites 
in total) were diluted (1:10) in 2700 μl heat-inactivated rabbit blood (35 min. 
incubation at 56°C). The required volumes of available parasite suspensions 
were calculated according to the formula: 
 
                                    
               
                                              
 
Sand flies were fed with infected blood through sterile glass feeders (Fig.2.2 
A)  covered  with  a  chick-skin  membrane.  Chick-skins  were  prepared  by 
removal of the dorsal and ventral skin of plugged chicks with sterile scissors 
and forceps. The skins were washed once in sterile saline solution in a Petri 
dish  and  the  attached  adipose  tissue  was  removed.  The  skins  were 
transferred  into 70%  ethanol and left for  a few minutes before transferring 
them into fresh sterile saline solution. Skins were spread, exterior face down, 
in  individual  Petri  dishes,  sealed  and  were  stored  at  -20  °C.  Skins  were 
defrosted  before  attaching  them  to  the  glass  feeders  with  parafilm  under 
sterile  conditions.  Infected  blood  was  loaded  onto  the  feeder  and  it  was 
verified that none leaked out. Loaded feeders were attached by tubing to a 37 
°C water bath to keep the blood at physiological temperature (Fig.2.2 C). Net 
cages containing female sand flies were attached to the feeders and were left 
wrapped in plastic bags in the dark for 1 – 2 h to feed (Fig.2.2 D). CO2 was 
exhaled into the cages to stimulate blood feeding. 
 
 Sand fly midgut dissection and analysis  2.6.3.
This procedure is described elsewhere (146). Briefly, 10 – 15 sand flies per 
infection were collected by aspirator on day 2, 5 or 6, 9 and 12 PBM (later 
only on day 6 and 12 PBM). Sand flies were stunned by cold in a collection 112 
 
vessel  and  their  midguts  were  dissected  in  sterile  saline  solution  by  first 
removing head, legs and wings with a small needle with 90° angle and then 
pulling the midgut out by gently tearing off the rear two abdominal segments 
with  the  needle.  Dissected  midguts  were  split  into  AMG  and  TMG  and 
analysed separately under the light microscope for parasite localization and 
infection  load.  AMG  and  TMG  were  smeared  on  the  slides  by  pressing  a 
cover  slip  onto  them.  The  gut  smear  glass  slides  were  air-dried  and 
specimens were fixed with 100% methanol at room temperature. 
 
Parasite  loads  were  established  (1)  by  light  microscopy,  scoring  as  either 
uninfected,  light  (<100  parasites/gut),  moderate  (100-1000  parasites/gut), 
heavy (>1000 parasites/gut) (according to Myšková et al. (2008) (373)) or very 
heavy  (>>1000  parasites/gut)  infection  and  (2)  by  qPCR  as  described  by 
Sádlová et al. (2010) (146). 
 
 Gene regulation in culture  2.6.4.
Sand flies were fed with heat inactivated blood and were allowed to live for up 
to 12 days PBM. 50 blood fed midguts were dissected at day 6 and 12 PBM 
into 200 μL M199 + Amikin (250 μg/ml) + penicillin (60 μg/ml) + fluorocytosin 
(1.5 mg/ml). The midguts were homogenised and filter through a 0.22 μm filter 
spinning column (Ultrafree – MC, GV dutapore 
®). The midgut extract was 
added  to  4  ml  of  M199  and  1  ml  was  aliquoted  into  culture  tubes.  FVI, 
LmjcDNA16 dKO, LmjcDNA16 sKI and LmjHASPB sKI were inoculated into 
the 1 ml medium, respectively, and were left to grow for 6 days. Cell were 
pelleted and washed twice in PBS before suspending in 25 μl PBS. 25 μl of 2x 
SDS-loading dye was added and the samples were boiled for 10 min. at 95 °C 
before storage at -20 °C.  
 
2.7. Microscopy 
 
 Giemsa stained gut slide analysis by light microscopy  2.7.1.
For light microscopic imaging of parasite cells at day 5, 6, 9 and 12 PBM, gut 
smears on glass slides were stained for 20 min. with a 1:20 dilution of Giemsa 
(Sigma-Aldrich)  and  briefly  rinsed  with  water  before  analysis  under  the 
Olympia BX51 upright light microscope at a 1000x magnification (100x oil-
immersion). 130 images per slide (65 of AMG smear, 65 of TMG smear) were 
taken  with  an  Olympus  DP70  camera  using  the  DP  controller  software 
(Olympus) and parasite cells were measured for morphological analysis using113 
 
Image J software. 
 
 Confocal microscopy  2.7.2.
For  the  confocal  analysis  of  immunostained  samples  on  glass  slides,  an 
upright Zeiss LSM 510 and invert LSM 710 META confocal microscope was 
used. 
 
2.7.2.1.  Fixed parasite antibody staining 
The procedure is described elsewhere (374). 1x10
7 parasites were spun 
down, washed and suspended in PBS. 1 volume 4% formaldehyde was 
added  to  the  cell  suspension  and  incubated  for  15  min.  at  room 
temperature  before  washing  twice  in  PBS.  For  the  first  protocol,  fixed 
parasite cells were suspended in 200 μL PBS. Wells (1.5 cm x 1.5 cm) 
were marked on poly-lysine glass slide with a Pap pen (Sigma) and ~5x10
6 
and ~5x10
5 cells were applied per well per sample. Slides were left for 30 
min.  for  parasites  to  settle  and  attach.  The  liquid  was  removed  and 
samples were incubated for 15 min. with 100 μL Triton-X in PBS (0.2%) per 
well for plasma membrane permeabilization. Liquid was removed and wells 
were washed once with 100 μL PBS per well. Samples were blocked with 
Image-iT FX signal enhancer (Invitrogen) for 30 min. Liquid was removed 
again and samples were washed once with 100 μL PBS per well. Samples 
were  incubated  for  1  hour  with  the  anti-HASPB  336  or  anti-SHERP 
antibody and the slides were washed at least 3x for 5min. in PBS. Samples 
were  incubated  in  the  dark  for  1  hour  with  the  Alexa  Fluor
®  488  Dye 
(Invitrogen)  secondary  anti-rabbit  antibody  diluted  1:250  in  PBS.  Slides 
were washed at least 3x for 5 min. in PBS in the dark before drying and 
sample mounting with 10 – 15 μL of Vectashield
® or Mowviol
® with 4', 6-
diamidino-2-phenylindole (DAPI; Vector). Mowviol was prepared by heating 
6 g Glycerol and 2.4 g Mowviol 4-88 [Hoechst. Calbiochem.] in 6 ml MQ 
H2O and 12 ml 0.2 M Tris [pH 8.5] to 50 °C and repeatedly inverting the 
mixture at regular intervals until everything had dissolved. The mixture was 
centrifuged at 5000xg for 15 min. and aliquoted for storage at -20 °C or 4 
°C (for aliquots in use). Samples were covered with coverslips and sealed 
with nail polish and were either immediately analysed or stored at 4 °C for 
next day analysis. 
 
2.7.2.2.  Live / dead staining 
This protocol was described previously (294, 336). 1x10
7 washed parasites 114 
 
were  suspended  in  95  μL  PBS  and  5μl  AMCA-Sulfo-NHS 
(sulfosuccinimidyl-7-amino-4-methylcoumarin-3-acetate)  (Pierce,  Perbio 
Rockford) – an amine-reactive fluorophore – and incubated for 10 min. on 
ice to stain dead cells bright blue. The AMCA reaction was quenched by 
addition of 10 μL of 100 mM Tris (pH 8.5) and incubation for 5 min. on ice. 
Samples were washed 3x in 1% cold fatty acid free BSA/PBS. Washed 
parasites  were  suspended  in  100  μL  1%  BSA/PBS  for  20  min.  at  RT. 
Triton-X100 was added to 0.1% final concentration for cell permeabilization 
when required. Cells were washed once in 1% BSA/PBS and suspended in 
100 μL 1% BSA/PBS with the anti-HASPB antibody (336) (1:200) for a 30 
min.  incubation.  Cells  were  washed  at  least  3x  for  5  min.  in  PBS  and 
suspended in 4% formaldehyde in PBS for a 15 min. incubation on ice for 
fixation. Cells were washed once for 5 min. in PBS and were suspended in 
100 μL 1% BSA/PBS with the Alexa Fluor
® 488 Dye (Invitrogen) secondary 
anti-rabbit  antibody  for  1  hour  incubation  at  RT  in  the  dark.  Cells  were 
washed 3x for 5 min. in PBS and were suspended in 200 μL PBS. Wells 
(1.5 cm x 1.5 cm) were marked on poly-lysine glass slides with a Pap pen 
(Sigma) and 100 μL of cell suspension were loaded per well and incubated 
for 30 min. in the dark. Parasites were mounted as described in 2.7.2.1. 
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3.  Chapter III. – Generating Leishmania HASP and SHERP replacement 
mutants 
 
3.1. Introduction 
The diploid L. (L.) major cDNA16 locus contains four distinct contiguous genes, of 
which one, SHERP, occurs in two copies (Fig.1.25A). These genes – unusual for 
Leishmania parasites – were shown to be stage specifically regulated (Fig.1.24) 
(329, 330). Previously published work on the L. (L.) major cDNA16 locus had 
shown that full deletion of this locus did not show any significant phenotype in in 
vitro  culture  or  mice  (332).  Conversely,  when  the  L.  (L.)  major  cDNA16  null 
mutant (LmjcDNA16 dKO) was introduced into the alimentary tract of its specific 
sand fly vector, Ph. (Ph.) papatasi, metacyclogenesis was stalled primarily in the 
nectomonad stage. This phenotype was rescued by the replacement of the full 
cDNA16 locus back into its original position on chromosome 23 (LmjcDNA16 sKI) 
(146). Another mutant line containing only a single HASPB gene on an episome 
in  the  null  mutant  background  was  tested  in  the  same  study,  with  the  data 
suggesting that HASPB on its own might be sufficient to rescue the parental strain 
(L. (L.) major Friedlin VI [FVI]) phenotype. However, it was shown that HASPB 
was  overexpressed  in  this  episomal  replacement  mutant.  Episomes  are 
circularized  strands  of  independently  replicating  DNA,  not  unlike  bacterial 
plasmids. Unusually for eukaryotic cells, Leishmania parasites are able to express 
genes on episomes and amplify them independently from the genome, although 
with  the  drawback  of  being  unregulated  and  often  overexpressed.  Episomal 
genes have been shown to generate overexpression phenotypes that may differ 
strongly from the wild type phenotype, when the gene(s) in question are regulated 
and expressed at physiological levels (332).  
 
To confirm that the observations from Sádlová et al. (2010) were also true for 
regulated HASP and SHERP genes expressed at physiological levels and not an 
overexpressor phenotype, wild type gene regulation of these target genes had to 
be  re-established.  It  had  been  shown  previously  that  gene  replacement  by 
homologous  recombination  back  into  the  original  cDNA16  locus re-established 
wild type gene regulation (146, 332). In this study, individual gene deletion from 
the cDNA16 locus was technically not possible due to high levels of sequence 
similarity  in  the  intergenic  regions  between  the  HASP  and  SHERP  genes. 
Therefore, gene replacement into the null background of LmjcDNA16 dKO was 
chosen. Nine genes constructs containing HASPs and/or SHERP ORFs plus their 
native  flanking  sequences  were  synthesised  to  generate  17  mutant  lines  with 116 
 
either one or several HASP and SHERP genes replaced into the cDNA16 locus in 
the null background.  
 
3.2. Recombinant construct generation 
Nine gene constructs were generated containing HASP and/or SHERP gene(s) 
and either a neomycin (NEO), blasticidin (BSD) or streptophricin (SAT) selectable 
antibiotic resistance gene flanked by the flanking sequences of the L. (L.) major 
endogenous  DHFR  gene  for  constitutive  marker  expression  (Table  2.4).  Two 
HASPB  (HASP–NEO-KI,  HASPB–BSD-KI),  two  SHERP  (SHERP–NEO-KI, 
SHERP–BSD-KI),  two  HASPB+SHERP  (S2/HB–BSD-KI,  S2/HB–SAT-KI),  one 
HASPA1  (HASPA1–BSD-KI),  one  HASPA2  (HASPA2–NEO-KI)  and  one 
HASPA1+HASPA2 (HASPA1/2–NEO-KI) construct were synthesized. Due to high 
levels of sequence similarity, it was not possible to amplify SHERP1 individually 
and  only  SHERP2  was  used  in  the  construct  generation.  Since  both  SHERP 
ORFs have 100% identity, while the gene copies have 98.8% identity (341), it was 
considered sufficient to use only the SHERP2 copy in the construct and mutant 
generation.  
 
Apart from the HASPB–NEO-KI and the SHERP–NEO-KI constructs, which were 
generated  by  recycling  the  existing  cDNA16  locus–NEO
 construct  plasmid  by 
construct substitution, all other gene constructs were generated by assembly in 
the  pCR2.1
®-TOPO
®  vector  (Invitrogen).  Generally,  an  antibiotic  resistance 
marker (NEO, BSD or SAT) with the DHFR flanking regions, a 3’cDNA16 locus 
flank, HASPs and/or SHERP gene(s) and a 5’cDNA16 flank were cloned in that 
order  step-by-step  into  the  pCR2.1
®-TOPO
®  vector  to  generate  the  constructs 
(Fig.3.1). The individual construct components were amplified by high fidelity PCR 
from either L. (L.) major gDNA or from other pre-existing plasmids, purified and 
verified by sequencing. The first construct component was integrated by 3’ mono-
(A) overhangs, while other construct components were integrated by restriction 
enzyme digestion of plasmid and construct component followed by a DNA ligation 
step.  After  each  integration  step,  plasmids  were  transformed  into  chemically 
competent E. coli XL-1 cells, which were plated out on ampicillin or kanamycin 
agar plates and incubate at 37 ºC overnight. The E. coli colonies were picked the 
following day and checked by PCR screens for correct component integration. 
Selected  clones  were  cultured  overnight,  the  plasmids  extracted  by  Mini-  or 
MidiPreps  (Qiagen)  and  verified  by  DNA  sequencing  for  correct  construct 
assembly. These steps were repeated until the full construct was assembled. 
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Fig.3.1 – Plasmids constructed for homologous recombination 
Schematic  representation  of  the  plasmids  generated  containing  the  HASP  and 
SHERP  gene  constructs  for  homologous  recombination  into  the  original  cDNA16 
locus  in  the  LmjcDNA16  dKO  null  background.  ORFs,  orange;  other  elements 
(flanking region, UTRs, origins), green.  
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Completed construct-containing plasmids were amplified in 20 ml LB cultures of 
transformed  E.  coli  cells  overnight  at  37  ºC  and  were  extracted  by  mini-  or 
MidiPreps (Qiagen). 20 – 30 μg of purified plasmid were digested by required 
restriction enzymes for construct excision (Table 2.4) and the digests were then 
run on 1% agarose gels for gel  purification and  extraction by Qiagen kit. The 
purified constructs were then ethanol precipitated and re-suspended in sterile MQ 
H2O to a final concentration of ~1 µg / µl. 
 
3.3. L. (L.) major HASP and SHERP gene(s) mutant generation 
The purified gene constructs were used for transfection by the AMAXA system 
into L. (L.) major mutant lines generating a series of different genotypes (Fig.3.2). 
17  new  mutant  strains  were  generated;  these  are  summarized  in  Table  2.1 
together  with  all  other  Leishmania  lines  used  in  this  study.  LmjHASPB  sKI, 
LmjSHERP  sKI,  LmjS2/HB  sKI,  LmjHASPA1  sKI,  LmjHASPA1/2  sKI  and 
LmjHASPA2 sKI were based on the LmjcDNA16 dKO mutant; LmjS2+HB sKI and 
LmjHA1+S2 sKI were based on the LmjSHERP sKI mutant; LmjHASPB dKI and 
LmjHA1+HB sKI were based on the LmjHASPB sKI mutant; LmjHA1+S2/HB sKI  
was based on the LmjHASPA1 sKI mutant; LmjHA1/2+HB sKI, LmjHA1/2+S2 sKI 
and  LmjHA1/2+S2/HB  sKI  were  based  on  the  LmjHASPA1/2  sKI  mutant; 
LmjHA2+HB sKI, LmjHA2+S2 sKI and LmjHA2+S2/HB sKI were based on the 
LmjHASPA2 sKI mutant (Fig.3.3). Newly transfected mutant parasite lines were 
grown on Medium 199 (M199)-agar plates containing the appropriate antibiotic for 
up to 14 days for selection. Clones were picked as early as day 7 post plating and 
were grown up in sequentially increased amounts of M199 (100 µl → 1.5 ml → 5 
ml → 10 ml M199) before extensive clone screening. 
 
All  SHERP  containing  mutants  only  contained  a  single  copy  of  SHERP2. 
LmjHASPB  dKI  contained  two  copies  of  HASPB  to  ensure  that  HASPB  was 
expressed at parental strain levels, distinct from the LmjHASPB sKI strain, which 
only contained a single HASPB gene copy. LmjS2+HB sKI and LmjS2/HB sKI had 
the same genotype, but are distinct, because LmjS2+HB sKI has the SHERP and 
HASPB gene in separate constructs in the cDNA16 allele on neighbouring alleles, 
while LmjS2/HB sKI has both genes in one construct on the same allele in the 
former cDNA16 locus. Since it was known from Flinn et al. (1992) and Keen et al. 
(unpublished) that polycistronic gene transcription and post-transcriptional gene 
regulation were important for HASP and SHERP gene expression and regulation 
from the original cDNA16 locus, we wanted to know if HASPB and SHERP gene 
regulation was different if genes were replaced individually or polycistronically.120 
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Fig.3.2 – Schematic representation of mutant genotypes 
The schematic shows the linear constructs used for homologous recombination into 
the L. (L.) major cDNA16 locus, alignment with the mutant genotypes found in Table 
2.1. For each construct, the structure of the 2 diploid alleles is shown. The wild type 
cDNA16 locus is shown at the top of the figure. 
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Fig.3.3 – Relationships of L. (L.) major wild type and mutant lines used in this study 
The L. (L.) major Friedlin I (FVI) strain was used as the wild type. The LmjcDNA16 dKO and LmjcDNA16 sKI strains are described in McKean et al. 
(2001) and Sádlová et al. (2010), respectively. All other mutant strains were generated in this study. The diagram shows the relationships between 
the strains (large boxes) and which construct was used to generate them (coloured small boxes).    123 
 
The LmjcDNA16 dKO and LmjcDNA16 sKI  mutants had already been generated 
and used in previous work (146, 332). 
 
 Screening the L. (L.) major cDNA16 mutant genes  3.3.1.
Given the complexities of Leishmania genome structure and regulation, it was 
essential to check each construct for correct integration of their transgenes. 
Transfected  parasite  clones  were  therefore  screened  for  correct  construct 
integration by conventional PCR and Southern blot. Integrated construct copy 
numbers were assessed by qPCR and protein expression and regulation by 
time course Western blots. 
 
3.3.1.1.  PCR screen of L. (L.) major cDNA16 mutant genes 
Selecting mutants solely by PCR is error prone in aneuploid organisms of 
considerable  genomic  complexity.  Therefore,  PCR  was  only  used  as  a 
simple  positive/negative  screen  for  construct  integration.  The  forward 
primer  (Lmj-H/S-F)  was  chosen  upstream  of  the  integration  side  on 
chromosome 23, while the reverse primers (Lmj-HASPB-R, Lmj-SHERP2-
R or S2+HB-R) were within the construct (Fig.3.4). Primers Lmj-HASPB-R, 
Lmj-SHERP2-R and S2+HB-R were used when HASPB, SHERP or one of 
the  HASPAs  followed  the  5’flanking  region,  respectively.  Single  gene 
constructs,  SHERP-NEO-KI,  SHERP-BSD-KI,  HASPB-NEO-KI,  HASPB-
BSD-KI, HASPA1-BSD-KI, HASPA2-NEO-KI and double gene constructs 
S2/HB-BSD-KI and HASPA1/2-NEO-KI were expected to generate single 
bands of ~1.95 Kb, ~2.2 Kb ~1.8 Kb, ~1.8 Kb ~1.9 Kb, ~2 Kb, ~2.3 Kb and 
~1.9 Kb, respectively, after amplification with the required primers. Mutant 
strains containing two constructs in the cDNA16 locus allele were checked 
for  both.  If  the  reverse  primer  Lmj-HASPB-R  was  used  in  mutants 
containing  the  S2/HB  sKI  construct,  a  ~4  Kb  fragment  was  generated. 
Fig.3.5  shows  gel  images  of  selected  L.  (L.)  major  mutant  clones  that 
showed  correct  construct  integration.  These  were  further  analysed  by 
Southern blotting. 
 
3.3.1.2.  Southern blots of L. (L.) major cDNA16 genes mutant 
Southern  blotting  and  hybridization  is  the  only  method  that  can 
unequivocally  demonstrate  correct  gene  construct  integration  and  also 
show the presence of random construct integration or episomes in addition 
to  the  correctly  integrated  construct.  Therefore,  Southern  blots  were 
employed as a refined screen of PCR positive clones. For this analysis,124 
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Fig.3.4 – Schematic representation of PCR screen 
A  forward  primer  (Lmj-H/S-F,  purple  arrow)  binding  up-stream  of  the  construct 
integration site within the wild type genomic DNA and a reverse primer (S2+HB-R, 
orange arrow [FVI, LmjHASPA1 sKI, LmjHASPA2 sKI, LmjHA1+HB sKI, LmjHA1+S2 
sKI,  LmjHA1+S2/HB  sKI,  LmjHA2+HB  sKI,  LmjHA2+S2  sKI,  LmjHA2+S2/HB  sKI, 
LmjHA1/2+HB sKI, LmjHA1/2+S2 sKI, LmjHA1/2+S2/HB sKI], LmjHASPB-R, green 
arrow  [LmjHASPB  sKI,  LmjHASPB  dKI,  LmjS2+HB  sKI,  LmjHA1+HB  sKI, 
LmjHA2+HB sKI, LmjHA1/2+HB sKI], LmjSHERP2-R, burgundy arrow [LmjSHERP 
sKI, LmjS2+HB sKI, LmjS2/HB sKI, LmjHA1+S2 sKI, LmjHA2+S2 sKI, LmjHA1/2+S2 
sKI LmjHA1+S2/HB sKI, LmjHA2+S2/HB sKI, LmjHA1/2+S2/HB sKI]) binding down-
stream of the integration site within the construct, were used for PCR amplification. In 
each case, a fragment could only be amplified, if the respective gene construct had 
been integrated into the former cDNA16 locus. Fragments of 1,925 bp, 2,021 bp, 
1,798 bp and 1,963 bp were expected for HASPA1, HASPA2 HASPB and SHERP, 
respectively. The wild type control (FVI) generated a 2,040 bp fragment. 
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Fig.3.5 – PCR screen for construct integration in Leishmania mutant strains 
The  images  show  selected  mutant  clones  screened  positively  for  construct 
integration.  Reverse  primers  were  commonly  chosen  depending  on  the  gene 
following the 5’ flank in the construct (LmjSHERP2-R for SHERP; LmjHASPB-R for 
HASPB; S2/HB-R for HASPA1 & HASPA2). In E)  S2/HB-R was also used in the 
S2/HB-NEO/BSD-sKI construct. Expected band sizes are listed in the Table. In the 
case of clones that were probed with more than one set of primers, the gene probed 
for is written behind the given clone name. 
 
Table 3.1 – Expected band sizes according to primer pair used 
Primer Pair  Construct  Approx. size 
(Kb) 
Lmj-H/S-F & LmjSHERP2-R 
SHERP-NEO/BSD-sKI  1.95 
S2/HB-NEO/BSD-sKI  2.3 
Lmj-H/S-F & LmjHASPB-R 
HASPB-NEO/BSD-sKI  1.8 
S2/HB-NEO/BSD-sKI  4 
Lmj-H/S-F & S2/HB-R 
HASPA1-BSD-sKI  1.9 
HASPA1/2-NEO-sKI  1.9 
HASPA2-NEO-sKI  2 
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gDNA was extracted from up to 10 ml day 5 cultures, which generally had a 
density  of  3  –  3.6  x  10
7 cells  /  ml,  with  the  Blood  and  Tissue  kit  from 
Qiagen, which yielded approximately 10 – 20 µg of gDNA. Where larger 
amounts of gDNA were required, the gDNA was extracted by a phenol-
chloroform protocol from 50 ml day 5 cultures.  
 
Extracted gDNA was digested by SacI, run on a long 0.8% agarose gel 
overnight  and  transferred  onto  a  positively  charged  nylon  membrane 
(Roche)  and  analysed  by  specifically  generated  DIG-labelled  probes 
(Roche) of between 300 – 500 bp in length (Fig.3.6), generated by high-
fidelity PCR with a DIG-labelling kit (Roche). Each blot was probed with 
several  probes  as  required.  Fig.3.7  shows  examples  of  the  differently 
probed Southern blots with the PCR-selected mutant strains. All mutants 
shown in Fig.3.7 had bands of expected sizes. The 5’ UTR probe, which 
hybridised to a section of the 5’ flanking region used in the targeting for 
homologous recombination, proved particularly useful. Every construct and 
FVI contained it and with only two expected bands per mutant strain, this 
helped to distinguish quickly between correct  integration and  random or 
episomal  integration.  A  list  of  expected  band  sizes  that  the  respective 
probes  were  expected  to  detect  on the  Southern  blots  can  be found  in 
Table 3.2. The expected band sizes were based on the construct maps that 
were based on the verified L. (L.) major cDNA16 locus sequence submitted 
by the Smith lab (AJ237587). This has not been corrected on any online 
data  base,  where  the  locus  is  misassembled  due  to  the  difficulties  of 
dealing with repetitive regions of the genome during automated assembly. 
Episomes generally produce very strong bands by hybridization since they 
are  amplified  independently  from  the  genome.  Selected  mutants  were 
further analysed by qPCR for construct copy number. 
 
3.3.1.3.  qPCR screen for replacement gene copy number 
Using gDNA extracted from mutant strains and FVI, a qPCR was employed 
to  verify  the  integrated  construct  copy  number  in  the  mutant  genomes. 
Genomic DNA from FVI was used to generate a standard curve by serial 
dilution (1:10) of gDNA (10 ng → 1 ng → 0.1 ng → 0.01 ng → 0.001 ng). 
Mutant strain gDNA samples were used at 1 ng per well; initially 0.1 ng 
samples were used, too, but these were later abandoned as 1 ng amounts 
gave clearer results. Each sample was set up in 2x triplicates on 96 well 
plates (Fig.3.8). The first 48 wells were probed with HASPB (qPCR-H-F1 /128 
 
 
 
Fig.3.6 – Schematic of SacI restriction sites and DIG-probe binding sites 
The  SacI  restriction  sites  following  construct  integration  into  the  genomic  DNA  of 
mutant strains are shown. Binding sites of DIG-labelled probes (green bars) and the 
size  of  the  fragments  generated  by  SacI  digestion  are  shown.  These  correspond 
directly  with  the  expected  band  sizes  on  the  Southern  blot,  detected  with  the 
corresponding DIG-labelled probes. The schematic is not to scale. 129 
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Fig.3.7 – Southern blot verification of construct integration 
A),  B)  and  D)  show  the  Southern  blots  of  SacI  digested  genomic  DNA  samples 
probed with the relevant DIG-labelled probes for HASPA, SHERP, HASPB and the 
antibiotic resistance markers as a control for construct integration. The 5’ UTR probe 
y bound in the 5’ flanking region of the constructs and gave two signals per mutant 
line. All mutants represented here tested positive for correct integration. C) The 5’ 
UTR probe was used as quick screen in the case of the HASPA1/2  sKI mutants 
which had shown three bands in B), to verify that the third band was not due to 
trisomy of chromosome 23. Growth in Hygromycin or Puromycin showed that one 
band was lost over time and proved that an inoculation of two mutants had occurred, 
which perhaps had grown over on another on the agar plates.   
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Table 3.2 – Expected band sizes for probes per integrated construct 
Construct  DIG-labelled Probes  Nucleotides (bp) 
SHERP-NEO-KI 
5’ UTR  2220 
SHERP 
4172 
NEO 
SHERP-BSD-KI 
5’ UTR  2464 
SHERP 
3673 
BSD 
HASPB-NEO-KI 
5’ UTR 
6666  HASP 
NEO 
HASPB-BSD-KI 
5’ UTR 
6206  HASP 
BSD 
HASPA1-BSD-KI 
5’ UTR 
6062  HASP 
BSD 
HASPA2-NEO-KI 
5’ UTR 
7478  HASP 
NEO 
HASPA1/2-NEO-KI 
5’ UTR 
9253  HASP 
NEO 
S2/HB-BSD-KI 
5’ UTR  2464 
SHERP  1578 
HASP  2152 
BSD  2581 
 
 
   132 
 
Gene Copy Number
0.0 0.5 1.0 1.5 2.0 2.5 3.0
L
.
 
m
a
j
o
r
 
M
u
t
a
n
t
 
S
t
r
a
i
n
s
LmjHA2+HB sKI (5)
LmjHA2+HB sKI (4)
LmjHA1/2+HB sKI (11)
LmjHA1/2+HB sKI (2)
LmjHA1+HB sKI (30)
LmjHASPA2 sKI (18)
LmjHASPA2 sKI (8)
LmjHASPA1/2 sKI (18)
LmjHASPA1/2 sKI (16)
LmjHASPA1 sKI (8)
LmjHASPA1 sKI (3)
LmjS2+HB sKI (8-9)
LmjS2+HB sKI (1-11)
LmjS2/HB sKI (16)
LmjS2/HB sKI (4)
LmjHASPB dKI (8-7)
LmjHASPB dKI (1-13)
LmjSHERP sKI (88)
LmjSHERP sKI (34)
LmjHASPB sKI (99)
LmjHASPB sKI (98)
LmjcDNA16 dKO
HASPB 
SHERP 
HASPA 133 
 
Gene Copy Number
0.0 0.5 1.0 1.5 2.0 2.5 3.0
L
.
 
m
a
j
o
r
 
M
u
t
a
n
t
 
S
t
r
a
i
n
s
LmjHA2+S2/HB sKI (12)
LmjHA2+S2/HB sKI (11)
LmjHA1/2+S2/HB sKI (4)
LmjHA1/2+S2/HB sKI (2)
LmjHA1+S2/HB sKI (7)
LmjHA1+S2/HB sKI (5)
LmjHA2+S2 sKI (8)
LmjHA2+S2 sKI (7)
LmjHA1/2+S2 sKI (6)
LmjHA1/2+S2 sKI (4)
LmjHA1+S2 sKI (10)
LmjHA1+S2 sKI (1)
HASPB 
SHERP 
HASPA 
 
 
 
Fig.3.8 – qPCR for gene copy number verification 
Genomic DNA preps were probed in a qPCR with gene-specific primers for HASA, 
HASPB,  SHERP  and  a  control  gene  on  chromosome  23  (LmjF.23.0830).  The 
parental  line  (FVI)  was  used  to  establish  a  standard  curve.  Mean  quantities  for 
HASPA, HASPB and SHERP were divided by the mean quantities of LmjF.23.0830 
and adjusted for wild type gene copy number. With the exception of the LmjHASPB 
dKI and HASPA1/2 construct containing lines, for which the expected value was 2, 
the expected value was 1 for a single integrated gene copy. The qPCR is error prone 
due to its sensitivity to small variations in pipetted gDNA volumes and 30% deviations 
were expected from the ideal values (1 or 2). Clones within this error range were 
accepted to contain only 1 or 2 gene copies depending on the line. The graph shows 
all strains selected from the Southern blot. 
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qPCR-H-R1), HASPA (qPCR-HA-F / qPCR-HA-R) or SHERP (qPCR-S-F1 
/ qPCR-S-R1) specific qPCR primers depending on the gene probed for, 
while the second 48 wells containing the same sample array were probed 
for the LmjF.23.0830 gene (primers: qPCR-F23.0830-F1 / qPCR-F23.0830-
R1), present as two copies on chromosome 23, as control to normalise the 
data. The mean results per strain were then divided by the mean results of 
its control and multiplied by the difference in gene copy number compared 
to FVI. The expected results were a ratio of 1 for all mutants containing 
single  copy  genes  and  2  where  two  identical  ORFs  existed  as  in 
LmjHASPB dKI and all mutants containing the HASPA1/2 construct. Single 
copy mutants varying >0.4 gene copies and double copy mutants varying 
>0.55 gene copies from the expected value were discarded from further 
experiments, where possible. Two clones from each strain, each having an 
approximate  copy  number  of  1  or  2  as  appropriate,  were  picked  for 
analysis by Western blotting. 
 
3.3.1.4.  Western  blot  time  courses  to  assess  the  expression  and 
stage-regulation of the replacement genes 
Western  blot  time  courses  were  essential  to  assess  not  only  gene 
expression at the protein level, but also gene regulation at the protein level. 
To analyse protein expression patterns in culture,  10
7, 2x10
7  and 4x10
7 
parasites  were  collected  from  day  2-7  cultures,  lysed  and  the  extracts 
probed  for  HASPB,  HASPA  or  SHERP  with  the  available  anti-HASPB 
(336),  non-affinity  purified  anti-HASP  and  anti-SHERP  antibodies, 
respectively. All antibodies were polyclonal antibodies raised in rabbits and 
336 and anti-SHERP were affinity purified with an affinity column. Samples 
for HASP screening were usually run on 12% polyacrylamide gels, while 
samples  for  SHERP  detection  were  run  on  15%  polyacrylamide  gels, 
because of SHERP’s small size (6.5 KDa), which also makes this protein 
difficult to blot. The use of 0.2 µm pore membranes from Millipore on a 
semi dry electroblotter gave the best results for SHERP detection, while 
HASPB  and  HASPA  from  12%  gels  were  blotted  successfully  onto 
Immobul  membranes  (Roche).  All  blots  were  probed  first  with  the 
appropriate antibody for the respective protein of interest and then with an 
anti-rabbit immunoglobulin G (IgG) HRP antibody for signal detection by 
ECL plus or ECL prime.  
 
The Western blot time courses were designed to show re-establishment of135 
 
parental line gene regulation and expression by homologous recombination 
of the HASP and SHERP genes back into the former cDNA16 locus. This 
was a critical demand on these new mutant lines, which would distinguish 
them  from  previously  used  episomal  replacement  lines  (146,  332).  The 
results showed that in selected mutant lines, the replacement of the genes 
back into the cDNA16 locus was sufficient to re-establish the previously 
observed  parental  line  (FVI)  gene  regulation  (334,  341).  HASPB  and 
SHERP showed increased expression from day 2-7 as expected (Fig.3.9). 
HASPA2 proved difficult to detect, because HASPA2 expression from the 
integrated construct was lower than anticipated in comparison to HASPA 
expression in FVI, which may be due to having only one HASPA2 copy 
present  in the mutant  lines  compared  to  the two  copies  in  FVI.  In  FVI, 
however, HASPA1 and HASPA2 cannot be distinguished, because both 
genes have an identical ORF. This could have added to the differences 
observed  in  HASPA  expression  levels  between  FVI  and  HASPA2-
containing  mutant  lines.  In  some  replacement  mutants,  HASPA2  was 
detected only at day 6 and 7 p.i. (Fig.3.9 I & R). HASPA1 was not detected 
at  all  with  the  non-affinity  purified  anti-HASPB  antibody  in  mutant  lines 
containing only HASPA1, but not HASPA2 (Fig3.9 G, J, M & P). This could 
mean  that  HASPA1  is  amastigote  specific,  although  their  previously 
observed mRNA profiles suggested that upregulation at the transcription 
level occurs already in the metacyclic stage (329, 330). Surprisingly, the 
HASPA1/2 construct containing replacement mutant lines (Fig.3.9 H, K, N 
&  Q)  expressed  HASPA  at  higher  levels  than  in  the  single  HASPA2 
replacement  mutant  lines  (Fig.3.9  I,  L,  O,  &  R),  although  the  HASPA2 
containing DNA fragment, which had been used for construct generation, 
was the same in both constructs. All Western blots were also subsequently 
probed with an antibody against the constitutively expressed N-myristoyl 
transferase (NMT) as a loading control, to validate increased expression of 
HASP and SHERP over time. This loading control confirmed the increases 
in HASP and SHERP expression as real rather than artefactual. Selected 
mutant  lines  were  inoculated  into  BALB/c  mice  for  re-establishment  of 
parasite virulence after prolonged parasite culturing. 
 
3.3.1.5.  Assessing HASPA1 expression in amastigotes 
Total HASPA expression had previously been analysed in FVI and shown 
to be gradually upregulated from the procyclic to the metacyclic stage, with 
continued expression in amastigotes (334). However, since HASPA1 and 136 
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Fig.3.9 –Western blot time-courses of mutant lines 
The  time-course  Western  blots  were  run  for  every  mutant  line  to  verify  gene 
regulation and expression in vitro. HASPB was detected with the ab336, which was 
affinity purified on the central repeats, while HASPA was detected with a non-affinity 
purified HASP antibody, which recognized the conserved N-terminal region. SHERP 
was  detected  with  the  abSHERP.  N-myristoyl  transferase  (NMT)  was  used  as  a 
constitutive  loading  control.  The  only  inconsistencies  found  were  in  the  HASPA1 
construct, which did not express the protein at all, which could mean that HASPA1 
expression is amastigote specific, and in the HASPA1/2 construct (H, K, N & Q), 
which had a much stronger expression HASPA than the HASPA2 construct (I, L, O & 
R). This suggested differential regulation for HASPA expression from the HASPA2 
construct compared to the HASPA1/2 construct.  
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HASPA2  have  the  same  ORF,  they  are  indistinguishable  at  the  protein 
level in FVI. mRNA expression data suggested HASPA2 upregulation early 
in procyclic stage with peak expression in metacyclics, while HASPA1 was 
upregulated  only  in  metacyclic  stage  and  continued  to  be  expressed  in 
amastigotes  (329).  These  distinct  expression  patterns  for  HASPA1  and 
HASPA2 had not been previously verified at the protein level.  
 
The  generation  of  HASPA1  and  HASPA2  replacement  mutant  lines, 
expressing only one of the two genes, allowed discrimination HASPA1 and 
HASPA2  expression  individually.  In  the  Western  blot  time  courses 
described  in  section  3.3.1.4  HASPA2  was  detected  in  promastigotes  in 
HASPA2 only containing mutant lines as expected, but HASPA1 was not 
detected in mutant line promastigotes, although the mRNA analysis had 
suggested  upregulation  in  metacyclics.  It  was  possible  that  HASPA1 
mRNA might be upregulated in metacyclics, but that the protein was only 
expressed in amastigotes. To address this hypothesis, FVI,  LmjcDNA16 
dKO, LmjcDNA16 sKI, LmjHASPA1 sKI and LmjHASPA2 sKI were infected 
into BALB/c mice and amastigotes were isolated from 9 weeks old lesions. 
The Western blot run from the amastigote lysates showed that HASPA1 
was  expressed  in  LmjHASPA1  sKI  amastigotes,  which  confirmed  that  it 
was  amastigotes  specific  (Fig.3.10).  HASPA1  and  HASPA2  expression 
appears  to  alternate  with  one  another  between  life-cycle  stages  with 
HASPA2  being  promastigote-specific  and  HASPA1  amastigote-specific, 
suggesting stage specific function for both proteins. This hypothesis would 
require analysis of LmjHASPA2 sKI amastigote lysates to ensure that no 
HASPA2 is expressed in amastigotes. However, due to the lack of lesion 
development  in  LmjHASPA2  sKI,  it  was  not  possible  to  address  this 
question.  A  detailed  analysis  of  the  capacity  of  HASPA1  and  HASPA2 
mutant lines for infection/lesion development is currently still under way. 
 
3.3.1.6.  Assessing  HASPB  surface  localization  in  vitro  by 
biotinylation assay 
To confirm that the observed surface localization of HASPB in Fig.5.1 in 
culture  derived  mutant parasites was not a false positive,  since HASPB 
also localizes to the inner leaflet of the plasma membrane, a biotinylation 
assay was performed to label Leishmania surface proteins for extraction by 
streptavidin  beads.  Water  soluble  EZ-Link  Sulfo-NHS-SS-Biotin  from 
Thermo  Scientific,  which  did  not  require  any  solvents,  was  used  as  the 139 
 
 
 
Figure 3.10 – Western Blot of Amastigote Lysates 
Amastigotes isolated from 9 weeks old BALB/c mice lesions were lysed and their 
lysates  run  on  an  SDS-PAGE  for  a  Western  blot.  The  Western  blot  shows  that 
HASPA1 is expressed in the LmjHASPA1 sKI mutant line in amastigotes, although it 
was not detectable at the promastigote level (Fig.3.9). FVI and LmjcDNA16 sKI also 
show HASPA detection, but also expression of HASPB, which is absent from the 
LmjHASPA1 sKI mutant line as expected.  
* The HASPA band of FVI was exposed for a shorter time (30 sec) compared to the 
three mutant lines (1.5 min), because the HASPB signal bled into the HASPA signal 
at longer exposures, obliterating the band 
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reagent for protein labelling (335). The N-hydroxysulfosuccinimide (NHS) 
ester group on this reagent reacts stably with the ε-amine of lysine residues 
in all  accessible proteins leaving the biotin group exposed to react with 
streptavidin fixed to beads, allowing for labelled protein extraction by low 
speed centrifugation or gravity precipitation of the beads. Since HASPB is 
also present in the cytosol during its synthesis and trafficking to the cell 
surface,  it  was  necessary  to  ensure  that  intracellular  HASPB  was  not 
labelled  by  EZ-Link  Sulfo-NHS-SS-Biotin.  In  particular,  dead  and 
compromised  cells  represented  a  source  of  cytosolic  HASPB 
contamination. For this purpose, ~5x10
8 parasite derived from culture were 
stained with Sulfo-NHS-AMCA  for a live/dead cell sort by  Modular  Flow 
Cytometer (MoFlo) prior to Sulfo-NHS-SS-Biotin labelling (336). The NHS 
group on Sulfo-NHS-AMCA reacts with the ε-amine of lysine residues, like 
the NHS group of Sulfo-NHS-SS-Biotin. While intact cells are impermeable 
for  Sulfo-NHS-AMCA,  compromised  and  dead  cells  have  permeable 
plasma membranes and Sulfo-NHS-AMCA can enter these cells to label all 
the  cytosolic  protein.  This  causes  compromised  and  dead  cells  to 
fluorescent very brightly, while intact cells only fluorescent weakly from the 
Sulfo-NHS-AMCA surface staining. This difference in fluorescence intensity 
can be exploited by a MoFlo separating brightly fluorescent dead cells from 
weakly fluorescent weakly fluorescent cells. The cell suspensions highly 
enriched in intact alive parasites were used in the biotinylation assay. Since 
Sulfo-NHS-AMCA had the same mode of binding to protein as Sulfo-NHS-
SS-Biotin, there was a chance that labelling with Sulfo-NHS-SS-Biotin after 
Sulfo-NHS-AMCA  staining  would  be  inefficient.  However,  labelling  with 
Sulfo-NHS-SS-Biotin remained efficient enough to isolate surface HASPB 
by  streptavidin  beads.  Fig.3.11  shows  that  HASPB  was  detected  in  all 
sorted and Sulfo-NHS-SS-Biotin-labelled parasite sample, while detection 
of  poly(A)-binding  protein  1  (PAB1),  which  was  used  as  a  control  for 
cytosolic  contaminant,  was  almost  undetectable  in  all  sorted  parasite 
samples. Only in the parasite lysate control, PAB1 was detected strongly. 
This suggested that the detected HASPB was from the cell surface of all 
examined  parasite  lines.  This  confirmed  that  HASPB  targeting  to  the 
parasite cell surface was functioning as expected in culture derived mutant 
parasites. It is not clear, if the weaker HASPB signal in the LmjS2+HB sKI 
and LmjS2/HB sKI samples is suggestive of lower HASPB exposure on the 
cell surface of these lines or only an artefact. But it is suggestive that that 
both mutant lines containing SHERP should have a lower HASPB signal 141 
 
 
Figure 3.11 – Biotinylation Assay 
The Western blots of the lysates of MoFlo  sorted intact parasite cells confirm the 
presence of HASPB on the surface of live parasites, while the control poly(A)-binding 
protein (PAB1), which indicated cytosolic contamination, was barely detectable in the 
sorted samples. This proved that the HASPB signal was due to Sulfo-NHS-SS-Biotin-
labelled HASPB from the cell surface and not from the cytosol. The lysate control 
showed that the antibodies used against HASPB and PAB1 were working.   142 
 
compared to the HASPB only containing mutant lines, LmjHASPB sKI and 
LmjHASPB  dKI,  whose  HASPB  signal  is  comparable  to  the  FVI  one. 
However, since the antibody against GP63, which was used as a loading 
control, did not detect any protein (data not shown), it cannot be excluded 
that the difference in HASPB signal is due to differences in loaded material. 
Unfortunately, the assay could not be repeated to clarify this matter due to 
constraints  in  this  study.  However,  it  is  clear  that  HASPB  is  trafficked 
normally to the cell surface in all tested mutant lines. 
 
3.4. Parasite passage through mice 
It was observed that Leishmania parasites lose their virulence and in particular, 
lose a clear HASPB expression pattern, over the course of excessive passaging 
through culture. Usually past-passage ten, HASPB becomes difficult to detect by 
antibodies on the cell surface and is increasingly shed from the parasite’s cell 
surface (MacLean, L., personal communication). In order to restore virulence and 
controlled HASPB upregulation and expression, Leishmania parasites from day 6 
p.i. were inoculated into BALB/c mice by subcutaneous injection into the right foot 
pad. Parasites were harvested after ~8 weeks by dissection of draining lymph 
nodes, if excessive foot pad swelling did not require earlier killing. Lymph nodes 
were ground up and inoculated into fresh M199 with antibiotics as required and 
incubated at 26 °C. Promastigotes began to show as early as day 2 and usually 
cultures were dense enough by day 7 for inoculation into fresh medium and for 
the setup of cryo-samples. 
 
An  interesting  observation  was  made  with  respect  to  all  mutants  containing 
HASPA2  with  or  without  HASPB  and/or  SHERP,  but  not  with  HASPA1.  All 
mutants  containing  HASPA2  without  HASPA1  had  only  minor  lymph  node 
swelling  and  no  obvious  foot  pad  swelling  by  the  end  of  week  8  of  mouse 
infection. They were also markedly slower (3 – 5 days) to produce promastigotes 
in M199 after lymph node harvest, if they grew up at all, compared to all other 
mutant  strains.  It  had  previously  been  shown  that  the  expression  patterns  of 
HASPA1 (metacyclics and amastigotes) and HASPA2 (procyclics to metacyclics) 
are  distinct  at  the  mRNA  level  (329,  330).  This  may  suggest  a  function  for 
HASPA1  in  amastigotes  that  supports  survival  and/or  differentiation  into 
amastigotes and/or procyclics. Conversely, HASPA2 may have a negative effect 
on the transformation of metacyclics into amastigotes in the absence of HASPA1, 
impacting on the survival of amastigotes and/or their virulence in BALB/c mice, 
although  HASPA2  expression  is  down-regulated  in  amastigotes.  On  the  other 143 
 
hand this seems puzzling, since the ORFs of HASPA1 and HASPA2 are identical. 
The major difference between HASPA1 and HASPA2 is their 3’ UTR, which plays 
a role in their distinct expression patterns (Keen et al., unpublished). At this point, 
it is not clear whether HASPA1 and/or HASPA2 are post-translationally modified, 
which could explain a difference in function. However, since both ORFs have no 
known consensus motifs for protein modification and are translated in the cytosol 
never  entering  the  ER  and  Golgi,  where  commonly  protein  modifications,  like 
glycosylation, take place, it does not seem likely that HASPA1 and HASPA2 are 
post-translationally  modified.  HASPB,  which  contains  two  potential  N-linked 
glycosylation sites and which is non-classically transported to the cell surface, is 
not modified in vitro by N-glycosylation or phosphorylation (333, 336). 
 
3.5. Growth Assay 
After mouse passage, parasite viability was checked by a growth assay. Parasites 
were inoculated into 10 ml of fresh M199 to a final concentration of 10
5 parasites / 
ml.  Parasites  were  counted  every  ~24  h  on  a  haemocytometer  by  making 
appropriate dilutions of small samples of culture in 1% formaldehyde in saline 
solution. Due to the quantity of sample tested in each growth assay, cultures were 
re-inoculated twice into fresh M199 by day 3 or 4 and parasites were counted 
again, instead of preparing parallel triplicate  cultures (Fig.3.12). There was no 
obvious growth defect in culture for any of the generated mutant lines compared 
to FVI and, in general, mutant growth corresponded best to the wild type curve in 
the second and third repetition. Statistical analysis of growth rates between day 0 
– 3 p.i. by t-test revealed, however, statistically significant differences (P<0.001) 
in log phase (Table 3.3; raw data in Appendix 7), while there were no significant 
differences between replicates or in stationary phase. Differences in growth rates 
were small, however, and the parental line (FVI) was not the strongest grower in 
all  replicates.  In  general,  growth  rates  varied  for  the  individual  lines  between 
replicates, although never to statistical significance, and all lines reached similar 
parasite levels before entering into stationary phase between days 3 and 4 p.i., 
which suggested no significant fitness defect due to genetic manipulation in the 
generated mutant lines. 
 
3.6. Conclusions 
The aim of this chapter was to produce two clones for each of the 17 new mutant 
lines for sand fly infection assays that were thoroughly checked for correct gene 
integration by PCR, Southern blot and qPCR and correct expression by Western 
blot.  While  the  results  for  PCR,  Southern  blot,  qPCR  and  Western  blots  for 144 
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Figure 3.12 – Growth Assays  
10  ml  1xM199  cultures  were  inoculated  with  Leishmania  parasites  to  a  final 
concentration of 10
5 cell/10 mL and were grown at 26 °C for seven days. The growth 
assay was repeated twice by splitting at day 3 or 4 into fresh 10 mL 1x M199 to 10
5 
cell/10 mL. The results generated from the second and third round growth assays are 
shown here. FVI and LmjcDNA16 dKO were used as controls. Although there are 
significant differences (P<0.001) in growth rates (days 0-3 p.i) according to t-test, 
differences were small (Table 3.2) and all strains reached similar parasite number by 
days 3-4 p.i., which suggested no fitness defect in culture due to genetic manipulation 
in any of the mutant lines compared to the parental line (FVI). Numbers in brackets 
are the number of the respective clone. 
   146 
 
Table 3.3 – Statistics on growth rates (day 0 – 3) 
Graph  Column  Samples  Mean  Std Dev  Std. Error  Median  Max  Min  Range  Norm. test  t-test 
A) 
G.R. I (D0-3)  10  1.733  0.055  0.017  1.721  1.861  1.649  0.212  Passed  P<0.001 
G.R. II (D0-3)  10  1.695  0.046  0.015  1.703  1.770  1.619  0.151  Passed  P<0.001 
B) 
G.R. I (D0-3)  8  1.841  0.042  0.015  1.844  1.900  1.771  0.130  Passed  P<0.001 
G.R. II (D0-3)  8  1.837  0.039  0.014  1.833  1.900  1.792  0.108  Passed  P<0.001 
C) 
G.R. I (D0-3)  7  1.866  0.119  0.045  1.901  1.957  1.623  0.335  Failed  P<0.001 
G.R. II (D0-3)  7  1.943  0.058  0.022  1.918  2.025  1.872  0.153  Passed  P<0.001 
D) 
G.R. I (D0-3)  8  1.881  0.111  0.039  1.881  2.078  1.758  0.320  Passed  P<0.001 
G.R. II (D0-3)  8  1.989  0.048  0.017  1.992  2.044  1.912  0.132  Passed  P<0.001 
E) 
G.R. I (D0-3)  8  1.937  0.082  0.029  1.934  2.065  1.805  0.259  Passed  P<0.001 
G.R. II (D0-3)  8  1.974  0.057  0.020  1.981  2.047  1.896  0.152  Passed  P<0.001 
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HASPB and SHERP indicated at least two clones per strain as fulfilling these 
criteria,  Western  blots  for  HASPA1  and  HASPA2  expression  in  replacement 
mutants  raised some questions. HASPA2 expression from the single HASPA2 
construct in the replacement mutants was lower than expected as compared to 
HASPA expression in FVI as shown by McKean et al. (1997) (334). HASPA1 and 
HASPA2, however, cannot be distinguished at the protein level, because both 
genes have an identical ORF. HASPA1 was not detected at all in promastigotes 
in  the  single  replacement  mutants.  This  suggested  exclusive  amastigote 
expression for this protein and this was assessed by amastigote generation in 
BALB/c mice (Fig.3.10). The distinct 3’ UTRs of HASPA1 and HASPA2 could play 
a  role  in  HASPA2  being  promastigote  specific,  while  HASPA1  is  amastigote 
specific.  The  expression  levels  of  HASPA  in  the  HASPA1  and  HASPA2 
replacement  mutants  , however,  was  comparable  to  the  observation  made  by 
McKean et al. 1997 (334). It is not clear why the expression levels of HASPA 
were so different between the single HASPA1 or HASPA2 replacement mutant 
and  the  HASPA1  and  HASPA2  containing  mutants.  Since  HASPA1  was  not 
expressed in promastigotes from the HASPA1 construct, it can be proposed that 
HASPA expression in the HASPA1/2  construct containing mutants  is from the 
HASPA2 gene only. Since it is the same HASPA2 gene containing DNA fragment 
in  the  HASPA2  and  HASPA1/2  constructs,  this  could  mean  that  HASPA2  is 
overexpressed due to the unexpressed HASPA1 gene containing DNA fragment 
placed ahead of the HASPA2 gene in the HASPA1/2 construct, or, conversely, 
that  HASPA1  is  expressed  in  the  presence  of the  HASPA2 gene  immediately 
downstream of it, in the absence of the intervening HASPB and SHERP genes 
found in the parental line (FVI) locus. Since it is impossible to distinguish between 
HASPA1  and  HASPA2  at  the  protein  level,  mRNA  detection  by  targeting  the 
distinct 3’ UTRs would be required, which has the drawback that mRNA levels do 
not necessarily correspond to protein levels. Unfortunately, it was not possible to 
investigate this due to time constrains in this project. In culture, none of the 17 
replacement  mutants  showed  any  significant  growth  defect  compared  to  FVI, 
although significant differences were observed in the growth rates by t-test. All 
strains reached peak growth between days 3-4 p.i., however, which suggested 
that the genetic manipulations had no fitness disadvantage in vitro. Differences in 
growth rates could be attributed to inevitable variations in culture inoculations. 
With  the  exception  of  LmjHASPB  sKI,  LmjHA1+HB  sKI  and  LmjHA2+S2  sKI, 
where only one clone each survived  the mouse passage, two clones for each 
mutant  line  have  been  successfully  passaged  through  BALB/c  mice.  Parasite 
cryo-samples were sent to the Charles University in Prague for sand fly infection. 148 
 
4.  Chapter IV. – Investigating metacyclogenesis in the sand fly  
 
4.1. Introduction 
The  work  described  in  Sádlová  et  al.  (2010)  had  shown  that  the  mutant 
phenotype of LmjcDNA16 dKO was only measureable in the sand fly vector rather 
than  in  in  vitro  culture.  Therefore,  it  was  necessary  to  analyse  parasite 
metacyclogenesis  in  the  natural  context  of  the  sand  fly  midgut  (146).  As  the 
University of York did not have facilities for maintenance of appropriate sand fly 
vector colonies at that time, the mutants were taken to the laboratory of Prof. Petr 
Volf at the Charles University in Prague for analysis. This work done there was 
performed with the help of Dr. Jovana Sádlová. 
 
The aim of this part of the study was the investigation of metacyclogenesis of the 
generated mutant lines within the natural context of the sand fly midgut and the 
identification  of  the  key  elements  require  for  completion  of  this  process. 
Identifying  the  particular  contribution  of  the  HASP  and  SHERP  genes  to 
metacyclogenesis completion was considered to give new insights into the yet 
unknown  functions  of  these  genes  and  their  regulation.  For  the  investigation, 
experimentally infected natural vector species of L. (L.) major were analysed with 
respect  to  the  infection  establishment  in  the  midgut  and  the  progression  of 
parasite development over the course of 12 days post blood meal (PBM), which is 
detailed in the following section. 
 
4.2. HASP and SHERP mutant development in the sand fly midgut 
 
 Artificial sand fly infections  4.2.1.
For sand fly infections, the specific vector of L. (L.) major in the Middle-East, 
Ph. (Ph.) papatasi, was used initially. However, this was substituted by the 
more permissive sand fly vector of L. (L.) major in Western Africa, Ph. (Ph.) 
duboscqi  –  closely  related  to  Ph.  (Ph.)  papatasi  –  because  the  Ph.  (Ph.) 
papatasi  colony  became  unstable  and  was  unfit for further  use  during  this 
project. There are important differences between these two sand fly species, 
which  had  to  be  considered  in  the  comparison  of  results  between 
experiments.  Ph.  (Ph.)  papatasi  (~2  mm  in  length)  is  considerably  smaller 
than Ph. (Ph.) duboscqi (~3 mm in length), resulting in Ph. (Ph.) duboscqi 
having a larger midgut volume, known to be able to harbour more parasites 
than Ph. (Ph.) papatasi (personal communication from Petr Volf and Jovana 
Sádlová  (2012)).  This  observation  was  reflected  in  the  infection  intensity 149 
 
results of this study (see 4.2.4.). Another notable difference between these 
two sand fly species is that Ph. (Ph.) papatasi is known to be specific to L. (L.) 
major parasites with particular side chain galactosyl-modifications of the LPG, 
while Ph. (Ph.) duboscqi is permissive to all known L. (L.) major strains (375). 
As a consequence, intraspecific differences in the parasite’s ability to survive 
within  the  sand fly  were  much more  pronounced  within  Ph.  (Ph.)  papatasi 
(157).  In  general,  however,  this  did  not  make  a  significant  impact  on  the 
results in this study. In fact, our two positive controls, FVI and LmjcDNA16 
sKI, and the negative control, LmjcDNA16 dKO, behaved very similarly in both 
sand fly species with no notable differences in their development. The only 
exception was in the parasite loads, which were higher in Ph. (Ph.) duboscqi, 
as mentioned above.  
 
For artificial sand fly infections, early passage parasites were inoculated into 2 
ml M199 with the appropriate antibiotics and incubated at 23 °C until late mid- 
to late log-phase (2 – 3 days p.i.; see 2.6.2. for protocol). Parasite growth was 
checked daily by light microscopy. On the day of sand fly infection, parasites 
were recovered from culture by centrifugation, washed and suspended in 1 ml 
saline solution. Parasites were counted by removal of 10 μl from the 1 ml 
parasite suspension followed by dilution (1:100) in 1% formaldehyde in saline 
solution and applying 10 μl of that dilution onto a haemocytometer. Parasites 
were counted on a light microscope at 400x magnification. Parasite density in 
saline solution was adjusted to 10
7 parasites / 300 μl saline solution, which 
was then diluted 1:10 in heat inactivated rabbit blood to a final concentration 
of 10
6  parasites / ml  blood. 3 ml  of infected blood, kept at 37 °C in glass 
feeders, were offered to individual sand fly colonies (150 – 250 individuals) in 
net-cages for 90 – 120 min. in the dark (Fig.2.2). Blood-fed sand flies were 
separated from unfed sand flies and were allowed to live for up to 12 days 
PBM. Ph. (Ph.) duboscqi proved to be a more efficient feeder on the artificial 
blood feeding system resulting in more well fed female sand flies than had 
been  achieved  initially  with  Ph.  (Ph.)  papatasi.  This  may  have  supported 
better establishment of infection in Ph. (Ph.) duboscqi by increased parasite 
ingestion, with Ph. (Ph.) duboscqi showing less infection clearing than in Ph. 
(Ph.)  papatasi.  As  a  result,  infection  loads  were  only  compared  between 
parasite strains infected into the same sand fly species (see 4.2.3.).  
 
 Sand fly dissections  4.2.2.
Midgut  dissections  were  initially  performed  at  day  2,  5,  9  and  12  PBM  to150 
 
correlate  the  results  obtained,  in  particular  for  the  control  stains  FVI, 
LmjcDNA16  dKO  and  LmjcDNA16  sKI,  with  the  findings  of  Sádlová  et  al. 
(2010) both in Ph. (Ph.) papatasi and in Ph. (Ph.) duboscqi. After verification 
of  developmental  trends  in  the  control  strains,  dissections  were  performed 
only at day 6 and 12 PBM, because these two time points were sufficient to 
observe the previously established parasite developmental trends. 
 
Sand flies were collected for dissection by aspiration with a glass aspirator 
and were stunned by chilling in a small cups kept on ice. Whole midguts were 
dissected on glass slides in drops of sterile saline solution with needles and 
fine forceps under a magnifying glass. The sand fly midgut was divided into 
TMG and AMG and the parts placed separately in drops of saline solution on 
a glass slide  and then covered with glass cover  slips for  light  microscopic 
evaluation.  A  total  of  19  L.  (L.)  major  strains  (FVI,  LmjcDNA16  dKO, 
LmjcDNA16 sKI, LmjHASPB sKI, LmjHASPB dKI, LmjSHERP sKI, LmjS2+HB 
sKI,  LmjS2/HB  sKI,  LmjHASPA1  sKI,  LmjHASPA1/2  sKI,  LmjHASPA2  sKI, 
LmjHA1+HB  sKI,  LmjHA1/2+HB  sKI,  LmjHA2+HB  sKI,  LmjHA1+S2  sKI, 
LmjHA1/2+S2 sKI, LmjHA2+S2 sKI, LmjHA1+S2/HB sKI & LmjHA1/2+S2/HB 
sKI) have been analysed in this fashion and a total of 2736 sand fly midguts 
have  been  dissected  for  this  study.  Only  LmjHA2+S2/HB  sKI  was  not 
passaged  through  sand  flies,  because  the  cryo-samples  did  not  survive 
transportation to Prague and no substitutes could be arranged in time. 
 
 Assessing Leishmania forward migration in the sand fly vector  4.2.3.
Under the light microscope, parasite localization was firstly estimated by eye. 
Since the sand fly midgut was translucent, assessment of parasite localization 
was easily done at 400x magnification using a light polarizer in the set up for 
better  contrast  and  resolution.  Parasite  localization  was  distinguished 
between localization in the EnS, the midgut lumen without stomodeal valve 
(SV) colonization (AMG – Cardia), weak SV colonization (weak SV col.) and 
heavy SV colonization (SV col.) (see Fig.1.9 for midgut anatomy). Parasites 
were  mostly  observed  within  the  EnS  at  day  2  PBM  before  blood  meal 
excretion and rarely at day 5 PBM, when blood meals were not completely 
defecated. In general, parasites were observed in the midgut lumen up to the 
cardia  at  day  5  PBM,  but  infrequently  with  SV  involvement  even  for  the 
positive controls, FVI and LmjcDNA16 sKI. At day 6 PBM, SV colonization by 
FVI and LmjcDNA16 sKI were significantly higher and by days 9 and 12 PBM 
it  became  clear  that  all  mutant  strains  were  not  able  to  colonize  the  SV 151 
 
efficiently, as observed for FVI, with the exception of LmjcDNA16 sKI (Fig.4.1; 
raw data in Appendix 8). Occasionally, a few parasites appeared attached to 
the  SV  for  some  mutant  strains,  which  was  then  classified  as  weak  SV 
colonization. However, in general, parasites only migrated as far as the cardia 
(AMG – Cardia). Another observation was that in almost all mutant strains, 
parasites were found in the entire AMG up to the HG and very rarely even 
within the HG, which was distinct from the observation in FVI, where parasites 
accumulated at the anterior of the AMG. Conversely, TMG infections were 
visibly weaker for all mutant strains even at day 12 PBM, than in FVI and 
LmjcDNA16  sKI,  where  TMGs  appeared  enlarged  by  day  12  PBM.  It  was 
further observed that when the TMGs of FVI and LmjcDNA16 sKI infected 
midguts were analysed by day 12 PBM, using a cover slip to squeeze out the 
contents, the immobilized parasites were fanning out from the TMG in what 
was assumed to be the promastigote secretory gel (PSG) (Fig.4.2). This was 
never observed with any other mutant strain tested. 
 
Leishmania leptomonads secrete filamentous proteophosphoglycans (fPPG) 
within  the  TMG  (161).  At  sufficient  fPPG  concentration,  the  PSG  gel  is 
spontaneously formed to which nectomonads and leptomonads adhere (255). 
Since most mutant strains did not show TMG enlargement and did not show 
gel-immobilized parasites after squeezing on the TMG, it was reasonable to 
question whether the tested mutant lines were efficiently  secreting  PSG. It 
had previously been shown that LmjcDNA16 dKO secreted PSG in culture 
(146), but it was not clear, if the same was true in the sand fly midgut. Since 
the PSG is considered to be required for transmission, it was important to test 
for PSG secretion in the midgut. Data addressing this question are presented 
in section 5.5. 
 
 Assessing Leishmania infection loads in the sand fly vector  4.2.4.
Parasite  infection  loads  were  assessed  for  all  dissection  time  points  by 
estimating parasite loads under the light microscope; day 12 PBM samples 
were also quantitated by qPCR targeting kinetoplastid minicircle DNA to verify 
light  microscopic  estimates  (Fig.4.3).  Infection  loads  were  scored  as  either 
uninfected,  light  (<100  parasites/gut),  moderate  (100-1000  parasites/gut), 
heavy (>1000 parasites/gut)  or  very heavy (>>1000 parasites/gut)  infection 
(see 2.6.3 for details). 
 
By  light  microscopy,  significant  differences  were  observed  between  strains152 
 
 
 
Fig.4.1 – Parasite localization in the sand fly midgut 
The graphs show a steady increase of SV colonization (blue) for the positive controls, 
FVI and LmjcDNA16 sKI, from day 5/6 to 12 PBM, while all other mutant stains show 
a significant incapacity (P<0.001) for efficient SV colonization by day 12 PBM in both, 
Ph. (Ph.) papatasi and Ph. (Ph.) duboscqi. 
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Fig.4.2 – Apparent presence and absence of PSG in the TMG in different L. (L.) 
major strains 
Wet mounts of FVI and LmjcDNA16 dKO showed that there was an apparent lack of 
PSG secretion in the null mutant. While immobilized parasites fanned out from a day 
12  PBM  FVI  midgut,  parasites  from  LmjcDNA16  dKO  were  immediately  free 
swimming  and  the  fan  shape  of  immobilized  parasites  was  never  observed. 
LmjcDNA16 dKO is representative for all tested mutant strain with the exception of 
LmjcDNA16 sKI (data not shown). 
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Fig.4.3 – Comparing light microscopic infection load results with qPCR results for day 12 PBM 
With a few exceptions (in particular, LmjcDNA16 dKO & LmjSHERP sKI) there was a good correlation of trends in infection intensity between light 
microscopic and qPCR analysis. In general, light microscopic analysis underestimated true parasite loads with the exception in LmjHASPB sKI. The 
qPCRs to assess infection loads were performed by Jan Votýpka at the Charles University, Prague, CZ. (note: the nine mutants are still missing 
from the qPCR analysis) 155 
 
tested  in  Ph.  (Ph.)  papatasi  and  Ph.  (Ph.)  duboscqi  (Fig.4.4).  FVI  and 
LmjcDNA16 dKO both survived better and achieved higher infection loads in 
Ph. (Ph.) duboscqi compared to Ph. (Ph.) papatasi (P<0.001 for both), which 
was  expected  from  previous  observations  in  the  Volf  lab.  Therefore, 
experiments  done  in  Ph.  (Ph.)  papatasi  were  considered  separately  from 
those done in Ph. (Ph.) duboscqi for statistical analysis of infection intensity. 
 
All tested parasite strains showed efficient survival in both vectors. For most 
strains, there were steady increases on average in parasite load from day 5/6 
PBM  to  day  12  PBM,  of  which  some  reached  statistical  significance  (FVI 
[P=0.022]; LmjHASPB dKI [P=0.011] & LmjHASPB sKI [P=0.016] in Ph. (Ph.) 
papatasi  and  FVI  [P<0.001];  LmjcDNA16  sKI  [P=0.038];  LmjHASPA1  sKI 
[P<0.001]; LmjHASPA1/2 sKI [P=0.001] & LmjHASPA2 sKI [P=0.007] in Ph. 
(Ph.) duboscqi). A few exceptions (LmjcDNA16 dKO in Ph. (Ph.) papatasi and 
LmjHA1/2+S2  sKI,  LmjHA2+S2  sKI  and  LmjHA1+S2/HB  sKI  in  Ph.  (Ph.) 
duboscqi)  showed  non-significant  decreases  from  day  5/6  PBM  to  day  12 
PBM  These  never  reached  statistical  significance  with  the  exception  of 
LmjHA1+S2/HB sKI (P=0.033) (raw data in Appendix 9). These decreases in 
parasite  numbers  are  not  considered  to  confer  true  fitness  disadvantage, 
however, since these experiments are prone to strong variations and the data 
are  cumulative  of  three  repeats  that  were  initiated  at  weekly  intervals 
(Fig.4.5). 
 
The only mutant strain which survived poorly in Ph. (Ph.) papatasi by light 
microscopic  analysis  was  LmjSHERP  sKI.  This  line  was  observed  in  only 
~40% of all dissected midguts by day 12 PBM in Ph. (Ph.) papatasi, while in 
Ph. (Ph.) duboscqi, LmjSHERP sKI did not show any lack of survival (>80% 
by day 12 PBM) compared to other mutant strains. Whether this is a vector 
species-specific phenotype, or an artefact caused by the Ph. (Ph.) papatasi 
colony  becoming  unreliable,  is  not  clear,  but  the  qPCR  data  in  contrast 
showed  a  ~70%  survival  rate  for  LmjSHERP  sKI  in  Ph.  (Ph.)  papatasi 
(Fig4.3). Although the light microscopic approach was shown to be prone to 
underestimation compared to qPCR, which is reflected in the data in Fig.4.3, it 
is not likely that parasites were completely missed in the light microscopic 
analysis in ~30% of dissected midguts for  LmjSHERP sKI. A re-run in Ph. 
(Ph.) papatasi would be required to address this issue, but due to the lack of 
an available colony this could not be done in this study. 
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Fig.4.4 – Parasite infection load by light microscopy in the sand fly midgut  
In most cases, parasite loads increased over time as expected, which was more obvious in Ph. (Ph.) duboscqi than in Ph. (Ph.) papatasi, although 
infection load increases were strongest in the two positive controls, FVI and LmjcDNA16 sKI (P<0.001). The few cases where in particular very 
heavy infections (blue) cases reduced over time usually did not show a significant reduction with the exception in LmjHA1+S2/HB sKI. The dramatic 
difference of LmjSHERP sKI survival in Ph. (Ph.) papatasi compared to Ph. (Ph.) duboscqi was not supported by the qPCR analysis. 157 
 
 
Fig.4.5 – Variability of observed infection intensity 
The graphs show, exemplified on FVI, how infection intensity in midguts can vary 
from infection round to infection round impacting on the cumulative data set for each 
day  PBM.  For  example,  at  day  12  PBM  in  FVI*  the  infection  round  1  is  poor 
compared to 2 & 3 and significantly different (P<0.001). 158 
 
In general, the statistical comparison of the infection intensity data based on 
light microscopy and qPCR showed relatively good correlation of the two data 
sets, although in most cases the light microscopic approach underestimated 
the  qPCR  results  (Fig.4.3).  In  some  case  there  were  significant  difference 
between strains checked at day 12 PBM by light microscopy and qPCR (FVI 
[P=0.006];  LmjcDNA16  dKO  [P<0.001];  LmjSHERP  sKI  [P<0.001]; 
LmjcDNA16  dKO*  [P<0.001];  LmjHASPB  sKI  [P=0.002];  LmjcDNA16  sKI 
[P<0.001], LmjHASPA1/2 sKI [P=0.001] & LmjHASPA2 sKI [P=0.022]), yet the 
observed trends by both methods were for most checked strains similar with 
only  a  few  exceptions  (LmjcDNA16  dKO,  LmjSHERP  sKI  and  LmjcDNA16 
dKO*), where significant differences were observed (P<0.001 for each) (raw 
data in Appendix 10). 
 
With a few exceptions, there was a varying degree of significant difference 
between the positive controls, FVI and LmjcDNA16 sKI, and the other mutant 
strains  in  the  light  microscopic  data,  which  suggested  that  FVI  and 
LmjcDNA16 sKI proliferated and survived better in the sand fly midgut than all 
other replacement mutant lines. This trend, however, was not so clear cut in 
the qPCR data, where, for example, LmjcDNA16 dKO produced more very 
heavy infections in the second infection experiment than FVI by day 12 PBM 
(Fig.4.3). Despite the huge variation in the infection intensity data, it can be 
said that parasite survival is generally not impaired in the mutant lines. 
 
 Analysing Leishmania parasite morphology and metacyclogenesis  4.2.5.
in the sand fly vector  
AMGs and TMGs in drops of saline solution were smeared individually onto 
glass  slides  by  pressing  cover  slips  onto  them.  The  samples  were  then 
allowed to dry before fixing the parasites together with the midgut material by 
applying 100% methanol at room temperature to the slides, which were then 
left  to  dry  again.  For  analysis  of  parasite  morphology,  fixed  slides  were 
stained with Giemsa’s stain for 20 min. and imaged under the light microscopy 
with a 100x oil-immersion lens. The flagellar length, cell body length and cell 
body width were measured on the parasite images and they were classified 
either  as  procyclic,  nectomonad,  leptomonad  or  metacyclic  promastigotes 
according to established criteria (157, 365), which had been used previously 
by Sádlová et al. (2010). 
 
Fig.4.6 shows the complete, unaveraged data set for day 5/6, 9 and 12 PBM159 
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Fig.4.6 – Complete morphology data set of sand fly midgut derived parasites 
60  parasites  per  AMG  and  TMG,  respectively,  were  measured  per  midgut  smear 
slides per dissection day per strain. Three midgut smear slides were analysed per 
strain per dissection day, which amounts to 180 measured parasites per 100% bar in 
the graph. A total of 24120 individually measured parasites are represented in the 
data. Clear increases of metacyclics (blue) are observed in the positive controls, FVI 
and LmjcDNA16 sKI, while this was not the case in all other mutant strains. Merely 
leptomonad  generation  was  observed  to  varying  degree  among  the  mutants 
suggesting a lack of metacyclogenesis completion in the all mutant strains. 
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for the morphological analysis of all strains (raw data in Appendix 11). The 
data show that parasite differentiation took place in all tested strains from day 
5/6 PBM towards day 12 PBM, but the numbers of generated leptomonads 
and  metacyclics  over  time  varied  strongly  between  the  different  lines 
(Fig.4.7B). With the exception of LmjHASPA1 sKI and LmjHA1+HB sKI, all 
tested strains showed a significant increase in leptomonads and metacyclics 
over time. However, with the exception of FVI and LmjcDNA16 sKI, none of 
the  mutant  strains  had  generated  metacyclics  efficiently  by  day  12  PBM 
(Fig.4.7). Not even the LmjHA1/2+S2/HB sKI mutant, which technically had all 
the  cDNA16 genes replaced  back  into  the  original  cDNA16  locus  with  the 
exception  of  SHERP1  (98.8%  gene  and  100%  ORF  identity  to  SHERP2), 
generated  metacyclics  efficiently  suggesting  that  it  takes  more  than  just 
replacing  genes  back  into  the  former  cDNA16  locus  to  rescue  metacyclic 
generation.  Looking  at  FVI  and  LmjcDNA16  sKI,  it  was  observed  that  a 
gradient of metacyclics was clearly established by day 12 PBM from AMG 
towards TMG with a significantly larger amount of metacyclics in the TMG 
compared to the AMG (P<0.001) (Fig.4.7A). Considering that metacyclics are 
the mammalian infective forms, which need to localize as far forward in the 
digestive system as possible, it made sense that such a metacyclic gradient 
towards the SV should exist. The fact that none of the mutant strains tested 
was able to establish this gradient may be a direct consequence of the lack of 
efficient  metacyclogenesis.  Leptomonad  generation,  however,  seems  to 
improve with the increase in the number of replaced genes (Fig.4.8), although 
the  data  do  not  clearly  indicate  which  specific  gene(s)  were  beneficial  to 
improved leptomonad generation. It could be the HASPA1 and HASPA2 may 
be required, because the data from the individual infection rounds showed 
better  leptomonad  generation  in  all  three  infection  compared  to  mutants 
containing  only  HASPA1  or  HASPA2  (Fig.4.9).  This  may  be  due  to  the 
increase  HASPA2  expression  in  mutant  lines  containing  HASPA1  and 
HASPA2  in  a  single  construct  (Fig.3.9).  However,  improved  leptomonad 
generation could be an artefact related to infected sand fly species too. Unlike 
metacyclics, leptomonads did not form a gradient towards the TMG, although 
one of the leptomonads' main functions is the secretion of the PSG plug in the 
TMG,  potentially,  helping  the  parasites  to  colonize  the  TMG  strongly.  In 
particular, LmjHA1/2+S2 sKI, LmjHA1+S2/HB sKI and LmjHA1/2+S2/HB sKI 
showed  high  levels  of  leptomonads  in  both  AMG  and  TMG.  Perhaps  the 
accumulation  of  leptomonads  was  due  to  the  lack  of  conversion  of 
leptomonads into metacyclics, as observed in FVI and LmjcDNA16 sKI.   162 
 
 
 
Fig.4.7 – Representation of statistically significant difference in parasite form 
distribution of summarized data 
A) Differences in parasite form distribution between AMG and TMG. Only FVI and 
LmjcDNA16 sKI showed a significantly different load of metacyclics between AMG 
and  TMG  (P<0.001).  B)  Parasite  differentiation  over  time.  Most  strains  showed  a 
significant increase (P<0.001) in parasite differentiation from day 5/6 PBM towards 
day 12 PBM.  
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Fig.4.8 – Parasite morphology at day 12 PBM in the sand fly midgut 
The boxes group strains, which showed no statistical significant difference in parasite 
differentiation capacity between on another. Parasites in the red and black boxes at 
the extremes of the spectrum always showed significant differences to those in the 
other boxes (P=0.006 to P<0.001), while the parasites in the orange and purple box 
did  not  show  an  statistically  relevant  difference  between  one  another.  Although 
individual  replacement  of  HASP  and/or  SHERP  genes  did  not  recover  efficient 
metacyclic generation a significant increase in leptomonad generation was observed, 
which correlated with the increased number of replaced HASP and SHERP genes. 
However,  it  remains  unclear,  which  HASP  and/or  SHERP  genes  in  particular 
contributed to the increased leptomonad generation. 
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Fig.4.9 – Variability of observed parasite morphology between infection rounds 
The graphs show the entire morphology data split into the individual infection rounds. In particular, at day 12 PBM strong variations in the ratio of 
observed morphological forms can be seen between the samples from individual infection rounds. Mutant lines with multiple HASP and/or SHERP 
genes replaced into the cDNA16 locus were able to produce leptomonads more efficiently. 
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 Effects of parasite morphological plasticity on morphological data  4.2.6.
There is a lack of stage-specific parasite protein markers that allow parasite 
stage distinction from one another, with the exception of HASPB and SHERP, 
which are considered specific for the metacyclic promastigote stage. HASPB 
and SHERP, however, could not be used as stage specific markers in this 
study,  since  they  are the  proteins  of  interest  and  are  not  expressed  in  all 
mutant stains tested. This left only cell body and flagellum measurement to 
distinguish  the  parasite  stages.  The  criteria  for  parasite  form  distinction 
established by Walters et al. (1993) (365) and Cihakova & Volf (1997) (157), 
which had also been applied by Sádlová et al. (2010) (146), were used in this 
study  (see  2.2.7.).  Using  only  cell  body  and  flagellum  measurements  for 
classification  of  parasite  forms,  however,  bears  an  inherent  problem.  The 
change  from  one  parasite  form  to  another  is  gradual,  which  causes  an 
unbroken  gradient  of  measurements  to  appear  with  no  clear  distinction 
between parasite forms (Fig.4.10). For example, nectomonads are primarily 
distinguished  from  all  other  forms  by  having  a  cell  body  length  ≥14  µm, 
however, cell body length measurements clustered strongly around the 14 µm 
mark putting into question if a parasite that measured 13.99 µm was indeed 
different from one that measures 14.00 µm (Fig.4.10A). The same applies for 
the distinction between leptomonads and metacyclics by measurement, where 
the main criterion for metacyclics is a coefficient >2, when flagellum length is 
divided by cell body length (Fig.4.10B). Kinetoplastids in general have a very 
flexible cell morphology and it is debatable whether measurements as the sole 
tool  are  sufficient  for  the  distinction  of  parasite  developmental  stages 
(personal  communication.  J.  Lukeš,  Kinetoplastid  Molecular  Cell  Biology 
Meeting V, April 2013).  
 
To address this uncertainty in the morphology data, parasites falling close to 
break-off points  were transiently  excluded  from  consideration  or thresholds 
were moved up or down the scale to see, whether these changes would affect 
the overall results. The data shown in Fig.4.11A-F indicated that overall there 
was little variation in the ratios of the different morphological parasite forms in 
the  data  by  moving  thresholds  slightly  up  and  down  the  scale  or  even 
excluding data points close to the artificial thresholds. Statistical re-analysis of 
the altered data set did not show any significant changes from the original 
data  set.  This  showed  robustness  in  the  morphology  data,  increasing  the 
confidence in the conclusions made. 
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Fig.4.10 – Limitations of measurements to determine parasite form 
A) shows gradient of cell body length in particular from leptomonads to nectomonads, 
where  many  parasite  measurements  cluster  around  the  14  μm  threshold  and  not 
clear  distinction  is  truly  possible  between  the  two.  B)  shows  the  gradient  for  the 
coefficient of flagellum length (F.L.) divided by the cell body length (C.B.L.), which 
marks the difference between leptomonads and metacyclics, if the threshold is ≥2. 
Also here is no clear distinction between the majority of parasites the cluster around 
this mark. Each circle is a single measurement. 
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Fig.4.11 – Parasite morphology data with adjusted threshold 
A) shows the unsummarized, unaltered morphology dataset. B) shows the data when 
parasites  with  a  cell  body  length  between  13  –  15  μm  were  excluded  from 
consideration  to  achieve  a  clearer  the  threshold  between  leptomonads  and 
nectomonads. C) – F) address the distinction between leptomonads and metacyclics 
by the ≥2 coefficient. In C) the data is shown for when the threshold was decreased 
to  1.9  and  in  D)  when  it  was  increased  to  2.1.  In  E)  parasites  with  a  coefficient 
between 1.9 – 2.1 were excluded from consideration and F) combined the statistical 
aspects of B) and E). In F) this statistical exclusions deleted as little as 4.73% (FVI^) 
of all parasites up to 27% of parasites (HASPA2 sKI). However, all these modification 
did  not  change  anything  about  the  statistical  relations  as  shown  in  the  graphs 
between the different strains analysed, which showed robustness of the dataset with 
the chosen thresholds. 
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 Discriminating between FVI metacyclics and mutant metacyclics  4.2.7.
One  point  of  concern  that  remained  was  the  classification  of  metacyclics 
based solely on the coefficient between flagellum and cell body length. By day 
12 PBM, parasites from sand fly midguts classified as metacyclics of FVI and 
LmjcDNA16  sKI  showed  a  very  narrow  cell  body  with  a  pointed  posterior, 
while  those  of  LmjcDNA16  dKO,  LmjHASPB  sKI,  LmjSHERP  sKI, 
LmjHASPA2 sKI and others showed a visibly broader cell body with a rounded 
posterior  (Fig.4.12B),  which  gave  the  cell  body  a  more  leptomonad-like 
appearance. Looking at the average cell body width of classified metacyclics 
by day 12 PBM, it became apparent that classified metacyclics of FVI were 
significantly narrower (P<0.001) than those of LmjcDNA16 dKO, LmjHASPA2 
sKI  and  LmjS2/HB  sKI,  while  difference  of  metacyclic  cell  body  width 
compared to LmjHASPB sKI (P=0.057) and LmjHASPA1 sKI (P=0.054) were 
not  significant,  which  could  be  due  to  the  low  number  of  measured 
metacyclics  for  these  two  strains  (28  and  5  metacyclics,  respectively, 
compared to 491 in FVI). Although LmjSHERP sKI did not show a significant 
difference in the Kruskal-Wallis test, its position in the bar chart in Fig.4.12A 
showed that its metacyclics were visibly broader. This is underlined by the 
Giemsa  stained  parasites  shown  in  Fig.4.12B.  Although  the  majority  of 
classified metacyclics in LmjS2+HB sKI were significantly broader than FVI 
metacyclics, a few were equally narrow as in FVI. Due to the low efficiency of 
metacyclic  generation  in  LmjS2+HB  sKI,  however,  it  was  not  possible  to 
establish whether HASPB and SHERP were sufficient to recover the narrow 
metacyclic  cell  body  phenotype  of  FVI.  The  replacement  of  all  HASP  and 
SHERP  genes  back  into  the  null  background  was  sufficient  in 
LmjHA1/2+S2/HB sKI and LmjcDNA16 sKI to re-establish the narrow cell body 
phenotype  with  the  pointed  posterior typical  for  FVI metacyclics  at  day  12 
PBM.  Interestingly,  it  was  not  sufficient  to  rescue  the  efficient  metacyclic 
generation in LmjHA1/2+S2/HB sKI, which was observed in LmjcDNA16 sKI. 
In  LmjcDNA16  sKI,  all  HASP  and  SHERP  genes  had  been  replaced  in  a 
single  construct  which  contained  the  native  cDNA16  locus,  while  in 
LmjHA1/2+/S2/HB  sKI  the  genes  had  been  replaced  as  two  separate 
construct into the alleles. This suggested that gene organization  within the 
locus may be important for parasite metacyclogenesis in vivo. It needs to be 
emphasised that, with the exception of LmjcDNA16 sKI, none of the mutants 
recovered efficient metacyclic generation. 
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Fig.4.12 – Differences in cell shape among metacyclics from different strains 
The stringency of the measurement threshold had a draw back when metacyclics 
were being identified. Cell bodies of metacyclics in many mutant lines were visibly 
different among strains. While FVI had metacyclics with narrow cell bodies and pointy 
posterior, metacyclics of some mutant strains (LmjcDNA16 dKO, LmjS2+HB sKI & 
LmjHASPA2  sKI)  were  significantly  broader  (P<0.001),  while  LmjHASPB  sKI 
(P=0.057)  and  LmjHASPA1  sKI  (P=0.054)  border  on  significance.  Other  mutant 
strains like LmjcDNA16 sKI and LmjHA1/2+S2/HB sKI showed the same narrow cell 
body as FVI. Also LmjS2+HB sKI showed some of these narrow metacyclics, but the 
majority of classified metacyclics had the broad leptomonad like cell body.  171 
 
4.3. Conclusions 
The data described in this chapter show that simply replacing correctly-regulated 
genes  back  into  the  former  cDNA16  locus  did  not  rescue  restoration  of 
metacyclogenesis. This was unexpected, since all mutants had been meticulously 
tested  in  in  vitro  cultures  and  had  been  verified  for  correct  expression  and 
regulation  of  the  HASPs  and  SHERP  genes.  Not  even  LmjHA1/2+S2/HB  sKI, 
which contained one gene of each of the four gene types found in the cDNA16 
locus (HASPA1, SHERP, HASPB and HASPA2), rescued the parental line (FVI) 
phenotype; only LmjcDNA16 sKI did. LmjcDNA16 sKI contained a single copy of 
the  whole  cDNA16  locus  in  its  native  form  in  a  single  replacement  construct, 
which distinguishes it from all other mutant lines. All HASP and SHERP gene 
replacement constructs contained one or two genes with their native 5’ and 3’ 
UTRs, but out of the native context of the cDNA16 locus. This could impact on the 
regulation and expression of the genes. For example, during mRNA maturation in 
Leishmania,  the  polycistronic  transcripts  are  5’  trans-spliced  and  3’ 
polyadenylated in a coupled process (reviewed in (308, 309)). 5’ trans-splicing 
sites are generally 100 – 300 nt downstream of the 3’ poly(A)site of upstream 
genes and it has been proposed that the 5’ trans-splicing sites help to determine 
the poly(A)-sites of the upstream gene (313, 314). Since the HASP and SHERP 
genes  are  out  of  their  native  context  within  the  constructs,  it  could  be  that 
changes to their poly(A)-sites occur, which causes mRNA instability. This could 
be selective for the environmental conditions these mutant lines find themselves 
in, because within the rich M199 in vitro culture medium, gene regulation and 
expression  worked  as  expected  (Fig.3.9).  Yet  unidentified  regulatory  elements 
may  exist  up-  and  downstream  of  the  HASP  and  SHERP  genes  that  were 
excluded  in  the  gene  fragments,  when  they  were  amplified.  These  regulatory 
elements may be important for gene regulation within the sand fly vector rather 
than a rich medium like M199, where the parasite may be taking cues from sand 
fly-derived molecules to time their development. Further investigation is required 
to address these questions. 
 
While  the  study  of  Sádlová  et  al.  (2010)  suggested  that  parasite 
metacyclogenesis  was  primarily  stalled  in  the  nectomonad  stage,  the  data 
presented here suggest that the critical step stalled in parasite metacyclogenesis 
is the differentiation of parasites past the leptomonad stage into metacyclics and 
haptomonads. This conclusion is based on the morphology and localization study, 
respectively. The morphology data showed clearly that no mutant line, with the 
exception of LmjcDNA16 sKI, was able to generate metacyclics in high numbers 172 
 
by day 12 PBM, like FVI and LmjcDNA16 sKI. The localization data suggested 
that  haptomonads  were  not  being  produced,  because  the  SV  was  never 
colonized  in  the  mutant  lines,  with  the  exception  of  FVI  and  LmjcDNA16  sKI. 
Gene  replacement  of  combinations  of  HASP  and  SHERP  genes  does  aid 
leptomonad generation in the sand fly midgut, however. The data show a trend of 
increased leptomonad generation with the number of HASP and SHERP genes 
replaced, although it is not clear which HASP and/or SHERP genes were most 
prominent in promoting leptomonad generation.  
 
Sádlová et al. (2010) suggested a key role for HASPB during metacyclogenesis 
restoration.  They  tested  an  episomal  HASPB  replacement  mutant  in  the  null 
background. The data in this study, however, did not confirm this observation. In 
all  replacement  mutants,  with  the  exception  of  LmjcDNA16  sKI,  HASPB 
replacement by homologous recombination did not restore metacyclogenesis. In 
fact,  replacement  mutants  had  similar  phenotypes  to  the  cDNA16  locus  null 
mutant, LmjcDNA16 dKO, confirming that replacing all single component genes 
back into the cDNA16 locus was insufficient to restore metacyclogenesis. This 
could mean that increased HASPB expression is the key for metacyclogenesis 
completion. 
 
In summary, FVI and LmjcDNA16 sKI parasites were able to establish stronger 
infections in both Ph. (Ph.) papatasi and Ph. (Ph.) duboscqi than all other mutant 
lines.  FVI  and  LmjcDNA16  sKI  were  also  the  only  strains  to  colonize  the  SV 
efficiently,  suggesting  efficient  haptomonad  generation,  and  to  produce  high 
numbers of narrow bodied metacyclics. Further analysis of mutant parasites in the 
sand fly vector will be necessary to explain the failure of single component HASP 
and SHERP gene replacement to rescue the parental line phenotype. 
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5.  Chapter V. – Further investigation into the cDNA16 locus in vitro and in vivo 
 
5.1. Introduction 
The  results  from  the  sand  fly  infection  studies  (Chapter  IV)  required  further 
investigation into the mutants’ behaviour within the sand fly midgut, to explain why 
none  of  the  17  replacement  mutants  had  rescued  full  completion  of 
metacyclogenesis. Most importantly, the expression and regulation patterns of the 
HASPs and SHERP from the replacement constructs had to be assessed within 
the sand fly midgut. The question as to whether in vitro growth in the rich M199 
did  alter  parasite  behaviour  and/or  HASP  and  SHERP  regulation  markedly 
compared to in vivo growth in the sand fly midgut also needed to be addressed, 
since  it  has  been  found  that  parasite  differentiation  has  different  kinetics  in 
minimal  conditions,  such  as  5%  sucrose/PBS,  compared  to  rich  medium  like 
M199 (personal communication, S. Kamhawi and D. Sacks, WorldLeish5, May 
2013). The observed lack of strong TMG colonization in all mutant lines with the 
exception of LmjcDNA16 sKI needed further investigation, too. Another important 
question was, whether the mutant lines could actually be transmitted from the 
sand fly to a new mammalian host, since neither the SV was colonized efficiently, 
which  suggested  no  SV  degradation,  nor  the  PSG  seemed  to  be  secreted 
efficiently, which had been suggested by the lack of gel-immobilized parasites in 
dissected TMGs at days 9 and 12 PBM. 
 
5.2. Confocal  microscopic  analysis  of  HASP  and  SHERP  localization  in 
Leishmania parasites derived from culture and sand fly midguts 
Confocal microscopy had been used previously as a method for  HASPB and 
SHERP detection and localization in the FVI, LmjcDNA16 dKO and LmjcDNA16 
sKI lines (146, 336). The same approach was used to investigate HASPB and 
SHERP expression and localization in the new mutant lines derived from M199 
cultures and in midgut derived mutant lines. Parasites were fixed on glass slides 
and  probed  with  specific  antibodies  (anti-336  for  HASPB  and  anti-SHERP  for 
SHERP) for the individual proteins. Alexa Fluor
® secondary antibodies – usually 
488 anti-rabbit – were used for the fluorescent signal required for visualization 
under a confocal microscope. DAPI was used to stain the DNA of the nucleus and 
kinetoplast  of  permeabilized  parasite  cells  and  was  visualised  with  a  405  nm 
laser.  LmjcDNA16  dKO  parasites  served  as  a  negative  control,  while  FVI  not 
probed with the primary antibody was used as an antibody control to check for 
non-specific binding of secondary 488 anti-rabbit antibodies. 
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HASPB was probed for in cultured and midgut derived FVI,  LmjcDNA16 dKO, 
LmjHASPB sKI, LmjHASPB dKI, LmjS2+HB sKI and LmjS2/HB sKI. The results 
for  cultured  parasites  showed  that  HASPB  was  present  on  the  cell  body  and 
flagellum  of  all  tested  mutant  lines  except  for  LmjcDNA16  dKO  as  expected 
(Fig.5.1). All parasites positive for HASPB detection were measured and verified 
to be metacyclic (Table 5.1). These data demonstrated that HASPB expression 
and  regulation  in  these  mutants  occurred  as  in  the  parental  line  (FVI).  The 
strongly  positive  signal  obtained from the  LmjHASPB  sKI  and  LmjHASPB  dKI 
strains  suggested  that  the  other  cDNA16  locus  genes  were  not  required  for 
HASPB  expression  in  the  new  mutants  in  culture.  This  was  an  interesting 
observation, because it had been debated whether SHERP, which locates to the 
cytosolic face of the ER and mitochondrial outer membrane, might interact with an 
ATPase-pump on vesicles and play a role in HASPB stable expression and/or 
trafficking (348). Also, SHERP was detected in all SHERP-containing mutant lines 
tested from culture (Fig.5.2), although the signal was not as compartmentalized in 
the cell body as previously observed (341). Thus, the confocal data confirmed the 
expression  and  regulation  of  HASPB  and  SHERP  within  mutant  lines  shown 
already on Western blots (see 3.3.1.4). 
 
Since Western blots are inapplicable for sand fly derived parasites due to the 
great limitation of parasite material that can be generated from a sand fly midgut 
(about 5x10
3 – 2x10
4 parasites per midgut), HASP and SHERP expression and 
regulation  were  tested by  confocal microscopy  on  midgut  derived  parasites  in 
methanol-fixed midgut smears. The antibody probing, imaging and analysis was 
done using the same protocol as for the cultured parasites. A significant problem 
for  HASPB  and  SHERP  detection  in  midgut  smears  was  the  high  level  of 
background staining. Although a positive signal was detected for HASPB in the 
positive control (FVI), surprisingly, HASPB was not detected in LmjHASPB sKI, 
LmjHASPB dKI, LmjS2+HB sKI and LmjS2/HB sKI, while a clear positive signal 
had been observed in the same mutant lines in cells derived from M199 cultures 
(Fig.5.3). The same applied for SHERP, which was detected in midgut-derived 
FVI, but not in LmjSHERP sKI, although a positive signal had been observed in 
the  same  strain  derived  from  culture  (Fig.5.4).  Potentially,  the  rich  culture 
condition  in  M199  could  have  a  positive  feedback  on  HASPB  and  SHERP 
expression. Alternatively, a sand fly derived signal or midgut metabolite could be 
involved, via a yet-to-be-identified signalling cascade, in the regulation of HASP 
and  SHERP  expression.  Potentially,  mRNA  stability,  translational  or  post-
translational  mechanisms might  be  active  in the  sand fly midgut  only,  thereby175 
 
 
Fig.5.1 – Confocal images detecting HASPB in culture derived parasites 
All parasites were probed with the primary ab336 and the secondary Alexa Fluor
® 
ab488 with the exception of FVI (no 1
y) (e, f, g, h), which served as a non-specific-
binding  control for the secondary. Only  LmjcDNA16  dKO did  not  show  a  positive 
signal for HASPB probing (j), which was expected. HASPB was detected on the cell 
body and the flagellum in all positive samples as expected.   176 
 
Table 5.1 – Measurements of Parasites on Confocal Images 
Strains  Flagellum  Cell length  Cell width  Form 
Fig.5.1 
FVI  20.66 μm  10.13 μm  1.11 μm  Metacyclic 
FVI (No 1
o)  19.21 μm  9.57 μm  1.33 μm  Metacyclic 
KO  18.69 μm  9.65 μm  1.55 μm  Leptomonad 
HASPB sKI  16.06 μm  6.89 μm  1.05 μm  Metacyclic 
HASPB dKI  19.74 μm  9.36 μm  1.38 μm  Metacyclic 
S2+HB sKI  22.02 μm  8.89 μm  1.61 μm  Metacyclic 
S2/HB sKI  21.37 μm  8.30 μm  1.51 μm  Metacyclic 
Fig.5.2 
FVI  18.92 μm  8.22 μm  1.08μm  Metacyclic 
FVI (No 1
o)  21.09 μm  6.34 μm  1.96 μm  Metacyclic 
KO  17.49 μm  6.47 μm  1.08 μm  Metacyclic 
SHERP sKI  19.71 μm  8.38 μm  1.81 μm  Metacyclic 
S2+HB sKI  19.09 μm  7.95 μm  1.93 μm  Metacyclic 
S2/HB sKI  16.50μm  8.98μm  1.42μm  Metacyclic 
Fig.5.3 
FVI  24.07 μm  8.47 μm  1.32 μm  Metacyclic 
FVI (No 1
o)  16. 56 μm  7.42 μm  1.76 μm  Metacyclic 
KO  18.88 μm  9.18 μm  2.18 μm  Metacyclic 
HASPB sKI  12.80 μm  8.54 μm  1.43 μm  Leptomonad 
HASPB dKI  19.50 μm  9.76 μm  2.37 μm  Metacyclic 
S2+HB sKI  23.07 μm  11.89 μm  1.78 μm  Leptomonad 
S2/HB sKI  23.69 μm  9.78 μm  1.87 μm  Metacyclic 
Fig.5.4 
FVI  22.31 μm  7.84 μm  1.81 μm  Metacyclic 
FVI (No 1
o)  16.16 μm  7.95 μm  1.34 μm  Metacyclic 
KO  19.19 μm  9.58 μm  1.48 μm  Metacyclic 
SHERP sKI  22.31 μm  11.05 μm  2.23 μm  Metacyclic 
S2+HB sKI  19.49 μm  11.63 μm  1.58 μm  Leptomonad 
S2/HB sKI  21.96 μm  10.64 μm  1.68 μm  Metacyclic 
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Fig.5.2 – Confocal images detecting SHERP in culture derived parasites 
All parasites were probed with the primary abSHERP and the secondary Alexa Fluor
® 
ab488 with the exception of FVI (no 1
y) (e, f, g, h), which served as a non-specific-
binding control for the secondary. Only LmjcDNA16 dKO did not give a positive signal 
as expected, while all other tested lines had a strong positive signal in the cell body. 
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Fig.5.3 – Confocal images detecting HASPB in midgut derived parasites 
For the confocal analysis, fixed parasites on midgut smear slides were treated as 
previously for the culture-derived parasites (Fig.5.1 & 2). Only FVI showed a positive 
signal  for  HASPB,  while  all  tested  mutant  lines  were  negative  together  with  the 
negative control LmjcDNA16 dKO (in contrast to the data generated from cultured 
parasites). 179 
 
 
Fig.5.4 – Confocal images detecting SHERP in midgut derived parasites 
Parasites  derived  from  midguts  were  also  probed  for  SHERP  on  midgut  smears. 
While FVI had a positive signal for SHERP, the single SHERP replacement mutant 
did not show a positive signal. Interestingly, SHERP was detected in the SHERP and 
HASPB containing mutant line, LmjS2+HB sKI. 180 
 
preventing the stable expression of HASPB and SHERP. 
 
Interestingly, SHERP expression seemed to be rescued in the LmjS2+HB sKI and 
LmjS2/HB sKI mutant lines in vivo, which showed a compartmentalized signal in 
the cell body. This suggested that the presence of the HASPB gene promoted 
stable  SHERP  up-regulation,  although  HASPB  itself  was  not  up-regulated  in 
these mutant lines in vivo. This was confusing, because SHERP has been shown 
to be up-regulated ahead of HASPB in culture (341). Due to a lack of a specific 
HASPA  antibody,  it  was  not  possible  to  investigate  HASPA1  and  HASPA2 
expression in these experiments. The non-affinity purified HASP antibody, used 
successfully for HASPA detection on the Western blots, was used to probe for 
HASPA in mutant lines not containing HASPB, but no detectable signals were 
observed in all tested lines from culture. The non-affinity purified HASP antibody 
produced a signal only in FVI, which, however, was likely to be due to HASPB 
which cannot be distinguished from HASPA with this antibody on a confocal slide. 
Attempts to raise a specific HASPA antibody in rabbits via two different protocols 
failed  for  unknown  reasons  and,  therefore,  HASPA  expression  could  not  be 
investigated by confocal microscopy. 
 
Further investigations are required to explain the distinct differences in HASPB 
and SHERP detection in mutant lines in culture and in the sand fly midgut.  
 
5.3. Parasite in vitro differentiation in 5% sucrose/PBS compared to M199 
medium 
One  possibility  for  the  differences  in  HASPB  and  SHERP  expression  in  vivo 
compared to in vitro was that the relatively stable and nutrient rich conditions in 
M199 interfered with the proper regulation of the cDNA16 locus. In contrast, the 
conditions  the  parasites  normally  encounter  in  the  sand  fly  midgut  are  highly 
dynamic,  with  nutrients  depleted  once  the  blood  meal  has  been  excreted.  In 
nature, the sand fly’s primary food sources are nectar and plant saps, which are 
essentially high concentration sugar solutions that are channelled into the midgut 
in regular intervals from the sand fly’s crop. Observations indicated that there are 
distinct  differences  in  the  outcome  of  Leishmania  metacyclogenesis  between 
parasites  grown  in  M199  and  5%  sucrose/PBS,  which  mimicked  the  minimal 
conditions  in  the  midgut  after  blood  excretion  (personal  communication,  S. 
Kamhawi and D. Sacks, 2013). In particular, metacyclics were distinct between 
parasites grown in M199 and 5% sucrose/PBS and in the latter case, two different 
types of metacyclics have been found, something never observed in M199. To 181 
 
verify that M199 conditions did not influence HASP and SHERP gene expression 
from the constructs, HASPB and SHERP expression were tested in both M199 
and  5%  sucrose/PBS.  Since  starvation  is  a  trigger  for  metacyclogenesis, 
parasites  were  grown  until  late  log  phase  (day  2-3  p.i.)  in  M199  before 
transferring them into 5% sucrose/PBS after several washes. A time course of 
protein samples (day 3-6 p.i.) was taken from FVI, LmjcDNA16 dKO, LmjcDNA16 
sKI,  LmjHASPB  sKI  and  LmjSHERP  sKI  for  both  culture  conditions,  and  the 
lysates  from  these  parasites  were  then  analysed  by  Western  blots.  It  was 
expected that if the minimal conditions of 5% sucrose/PBS interfered with the 
expression of HASPB and SHERP from the constructs in  LmjHASPB sKI and 
LmjSHERP sKI, respectively, then no increase of HASPB and SHERP would be 
seen in 5% sucrose/PBS compared to M199. The results showed that no distinct 
difference in expression of HASPB and SHERP was detected in LmjHASPB sKI 
and  LmjSHERP  sKI,  respectively,  between  the  two  conditions  (Fig.5.5).  The 
differences observed in FVI and LmjcDNA16 sKI HASP and SHERP expression 
were  unexpected  and  may  be  artefacts.  These  results  were  interpreted  as 
indicative of another factor (other than nutrient depletion) interfering with HASP 
and SHERP expression in vivo. Potentially, sand fly derived molecules or midgut 
metabolites were responsible for the differences in expression, acting through a 
yet unknown signalling pathway. 
 
5.4. Assessing the potential effect of sand fly midgut molecules on parasite 
growth in liquid medium 
To investigate the possibility that HASP and SHERP gene expression might be 
regulated by sand fly derived molecules or midgut metabolites, sand flies were 
fed on uninfected heat inactivated rabbit blood to stimulate changes in midgut 
enzyme content and simulate the conditions normally experienced by parasites 
during their development in the midgut. 50 midguts were dissected at days 6 and 
12 PBM, respectively, into 100 μl M199. The midguts were homogenized, briefly 
spun  down  and  the  supernatant  filtered  through  a  0.2  μm  pore  membrane  to 
eliminate bacterial and fungal contaminants. This meant that only soluble midgut 
components  were  in the  supernatant. The  M199  medium  contained  antibiotics 
against bacteria and fungi, too, as a precaution. The filtered midgut extracts were 
diluted in 4 ml M199 (1 midgut / 80 μl) and four 1 ml culture were set up with FVI, 
LmjcDNA16 dKO, LmjcDNA16 sKI and LmjHASPB sKI. Another four 1 ml cultures 
were set up without the midgut extracts of the same lines as negative controls. 
Since  M199  is  a  very  protein  rich  medium  due  to  FCS  supplementation,  the 
change in protein content of the medium by the addition of the midgut extracts182 
 
 
 
 
Fig.5.5 – HASP and SHERP expression in parasites grown in M199 versus 5% Sucrose/PBS 
Whole lysate samples of parasites grown in rich (M199) and limited (5% sucrose / PBS) media were compared throughout metacyclogenesis in 
culture, over a time course from day 3-6 p.i. for HASP and SHERP expression. NMT served as a loading control. 
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was negligible. Cultures were incubated at 23 °C for 7 days before harvesting 
cells for lysate generation. 
 
The hypothesis tested was that LmjHASPB sKI would show suppressed HASPB 
expression in the presence of midgut extract if any soluble midgut molecules were 
present  and  at  sufficient  concentrations  to  affect  HASPB  expression  from  the 
constructs.  Analysis  of  the  parasite  lysates  is  shown  in  Fig.5.6.  The  results 
showed  that  LmjHASPB  sKI  did  not  show  a  marked  difference  in  HASPB 
expression between growth in M199 with day 6 or 12 PBM midgut extract and the 
negative  controls.  This  suggested  that  it  was  not  necessarily  the  presence  of 
midgut  molecules  that  regulated  HASPB  expression  in  the  sand  fly  midgut 
differently from culture. However, it could also be that the concentration of midgut 
extracts was too low to make an impact in these experiments. Potentially, relevant 
molecules  may  have  decomposed  over  time  or  the  key  factors  were  in  the 
insoluble fraction; perhaps a membrane protein of the midgut epithelia microvilli. 
Refinement of the method and testing of unfiltered homogenates containing the 
insoluble fraction would be required to confirm that HASPB construct regulation is 
not subject to regulation control via a midgut molecule-dependent mechanism. 
Interestingly,  LmjcDNA16  sKI  showed  comparably  low  expression  of  HASPB, 
which may be due to slower growth in the antibiotics, resulting in the entry into 
metacyclogenesis  at  a  later  day  then  the  other  strains  tested.  In  addition,  it 
appeared that LmjcDNA16 sKI produced less HASPB grown in day 6 PBM midgut 
extracts than without, but this was not observed for growth in day 12 PBM midgut 
extracts.  A  repeat  of  the  assay  would  be  required  to  confirm  the  observed 
differences, which was not possible due to time constraints and limitations of sand 
fly  material  availability  in  this  project.  The  difference  in  HASPB  expression 
observed in FVI grown in day 12 PBM midgut extract could also be due to lower 
protein  loading,  looking  at  the  NMT  band  compared  to  the  negative  control. 
However, a difference was observed in HASPA expression in FVI grown in day 6 
PBM  midgut  extracts,  which  could  not  be  explained  by  differences  in  protein 
loading. Repeated experiments and perhaps the use of earlier lysates would be 
required to confirm these findings. However, it is clear that the addition of the 
midgut extract had no impact on LmjHASPB sKI. 
 
5.5. Looking at HASP and SHERP mRNA levels within the sand fly vector 
Since in vitro approaches did not offer an explanation for the difference in HASPB 
and SHERP signal in the confocal microscopy, gene expression was investigated 
at the mRNA level while the parasites were within the sand fly midgut. Parasite184 
 
 
 
Fig.5.6  –  Western  blot  to  assess  potential  changes  in  HASPB  expression 
profiles in the presence of midgut extracts 
Four strains were grown in M199 for 7 days with (+) and without (-) the addition of 
extracts of blood fed sand fly midguts from days 6 and 12 PBM.  The Western blot 
does not show a significant reduction in HASPB expression in the LmjHASPB sKI line 
as anticipated, if midgut molecules would have impacted on the HASPB expression 
from the construct as observed by confocal microscopy. NMT served as a loading 
control to exclude that differences in HASPA and HASPB expression were due to 
uneven loading.  
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protein analysis by Western blot was difficult due to the limitations of recoverable 
parasite protein material due to the relatively low parasite numbers present in 
sand  fly  midguts  (on  average  5x10
3  –  2x10
4  parasites  /  midgut).  HASP  and 
SHERP mRNA from midgut derived parasites was extracted with magnetic oligo-
dT  beads  from  FVI,  LmjcDNA16  dKO,  LmjcDNA16  sKI,  LmjHASPB  sKI, 
LmjHASPA2 sKI and LmjSHERP sKI at days 6, 9 and 12 PBM. 20 midguts were 
collected per strain per day PBM, homogenized and lysed by flash freezing in 
liquid  nitrogen  and  lysis  buffer  for  mRNA  extraction.  In  addition,  RNA  was 
extracted from the same six lines grown in M199 culture on day 3, 5 and 7 p.i. by 
Trizol  extraction  to  compare  the  profiles  of  HASP  and  SHERP  mRNA  level 
changes  over  time.  The  extracted  mRNA  samples  were  treated  with  reverse 
transcriptase for cDNA generation. These samples were analysed by qPCR for 
mRNA levels and PCR for mRNA length. 
 
qPCR analysis of the mRNA samples was used to assess HASP and SHERP 
mRNA  levels  relative  to  NMT  mRNA  levels.  NMT  mRNA  levels  are  stable 
throughout the promastigote stages and served as a sample control to normalize 
the  HASP  and  SHERP  mRNA  level  data.  Since  the  HASPs  and  SHERP  are 
regulated genes, changes in the mRNA levels over time relative to NMT mRNA 
levels were expected. Differences in these profiles between parasite lines and 
growth conditions might explain the difference in HASP and SHERP expression 
between in vivo and in vitro and the difference in metacyclogenesis rescue in 
LmjcDNA16 sKI compared to all other replacement mutants. 
 
The  qPCR  results  are  shown  in  Fig.5.7.  The  two  repeats  of  midgut  derived 
parasite samples showed that relative HASPB mRNA levels are increased 2.5 – 
5-fold at day 6 PBM in FVI and LmjcDNA16 sKI compared to the following time 
points (Fig.5.7A). They decrease as the midgut infection continues until day 12 
PBM in both repeats of the assay. LmjHASPB sKI also showed its highest levels 
at day 6 PBM, but in LmjHASPB sKI relative HASPB mRNA levels were 2 – 4.5-
fold lower than in FVI and LmjcDNA16 sKI on day 6 PBM after normalizing the 
data. This reduction in HASPB mRNA levels in LmjHASPB sKI could explain the 
lack  of  detectable  HASPB  levels  in  vivo.  This  hypothesis  is  supported  by  the 
observation that LmjHASPB sKI expressed HASPB mRNA at similar levels and 
with a similar pattern compared to FVI and LmjcDNA16 sKI in vitro in the first 
qPCR repeat of the culture derived parasite mRNA samples. Unfortunately, the 
second qPCR repeat did not confirm the results from the first run. A significant 
reduction of mRNA material in particular in the samples from day 5 p.i. may have186 
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Fig.5.7 – HASP and SHERP mRNA levels relative to NMT mRNA levels 
Relative HASP and SHERP mRNA levels of FVI, LmjcDNA16 dKO, LmjcDNA16 sKI, 
LmjHASPB  sKI,  LmjSHERP  sKI  and  LmjHASPA2  sKI  were  assessed  by  qPCR. 
Average HASP and SHERP mRNA quantities were normalized against NMT mRNA 
quantities  in  the  respective  samples.  Two  qPCR  repeats  of  midgut  and  culture 
derived  parasite  HASP  and  SHERP  mRNA  are  shown.  Each  sample  was  run  in 
triplicate repeats per qPCR. Although variations in relative mRNA coefficient were 
observed between repeats, in general, the patterns of HASP and SHERP up- and 
down-regulation stayed the same for the different parasite lines tested. Error bars are 
based on the standard error calculated from the standard deviation from the triplicate 
repeats per sample. A) shows graphs for relative HASPB mRNA levels, B) for relative 
SHERP mRNA levels and C)  for relative HASPA mRNA levels for midgut and culture 
derived parasite samples.   188 
 
been the cause of the changed results in the second run.  
 
Variations in the detected relative mRNA content were also observed in mRNA 
samples probed for relative SHERP mRNA abundance (Fig.5.7B). For SHERP 
these  variations  were  comparatively  small,  however,  and  did  not  change  the 
overall  SHERP  mRNA  expression  pattern  both  in  midgut  and  culture  derived 
parasite mRNA samples. Interestingly, the SHERP mRNA expression pattern of 
LmjcDNA16 sKI matched that of LmjSHERP sKI rather than FVI both in vivo and 
in vitro. FVI showed a 2 – 3-fold increase in relative SHERP mRNA levels from 
day 6 PBM to day 9 PBM followed by a 3 – 3.5-fold decrease at day 12 PBM. 
LmjcDNA16  sKI  and  LmjSHERP  sKI  lag  behind  in  their  SHERP  mRNA 
upregulation and an increase is only observed by day 12 PBM. In vitro SHERP 
mRNA levels increase 3 – 4-fold from day 3 p.i. until day 7 p.i. in FVI. In contrast, 
LmjcDNA16 sKI and LmjSHERP sKI only showed a slight increase in SHERP 
mRNA levels from day 3 p.i. to day 5 p.i., but then a decrease again towards day 
7 p.i. 
 
A  stark  difference  in  HASPA  expression  was  observed  in  the  midgut  derived 
parasite mRNA samples between tested strains (Fig.5.7C). FVI showed similar 
high HASPA mRNA level on day 3 and 5 p.i. and then a drop at day 7 p.i. in both 
assay repeats. In contrast, LmjcDNA16 sKI and LmjHASPA2 sKI did not increase 
their HASPA mRNA levels until day 7 p.i.  Conversely, the  HASPA  expression 
profiles of culture-derived FVI, cDNA16 sKI and HASPA2 sKI parasites are very 
similar to one another. 
 
The results suggest that mutant HASPA and SHERP mRNA expression patterns, 
including that of LmjcDNA16 sKI, are distinct from FVI both in vivo and in vitro. 
The only mRNA expression patterns in LmjcDNA16 sKI that matched the one of 
FVI both in vivo and in vitro were the ones for HASPB mRNA, suggesting that 
HASPB expression at the right time and the right level is key for LmjcDNA16 sKI’s 
capacity to complete metacyclogenesis. This is supported by the observation that 
LmjHASPB sKI does not increase its HASPB mRNA levels to similar levels as FVI 
and  LmjcDNA16  sKI  in  vivo  and  does  not  complete  metacyclogenesis.  The 
importance of HASPB in metacyclogenesis completion was previously suggested 
by  observations  made  in  an  episomal  HASPB  replacement  mutant  line  by 
Sádlová et al. (2010) (146).  
 
Since it has been proposed that poly(A)-sites could be influenced by downstream189 
 
splice  acceptor  sites  due  to the coupling  of  5’ splicing  and  3’  polyadenylation 
(313, 314), it was possible that HASP and SHERP mRNA lengths expressed from 
some of the constructs might be different from the parental line (FVI), because of 
the foreign 5’ splice acceptor sites downstream of the single HASP and SHERP 
genes in the constructs. These 5’ splice acceptor sites were further downstream 
than the native ones in the cDNA16 locus (Fig.5.8A & B). If the 3’ UTR of an 
mRNA was artificially extended in this fashion, it could destabilize the mRNA and 
target it for degradation. However, why this effect should be restricted to midgut 
conditions and does not reduce mRNA levels in cultured parasites is not known. 
To check whether HASPB and SHERP mRNA lengths were changed compare to 
the parental line (FVI), two fragments were generating, using a spliced leader 
forward primer and an internal reverse primer for one fragment and an internal 
forward primer and an oligo-dT reverse primer for the second fragment (Fig.5.8C).   
 
Unfortunately, no conclusive results are available yet as the investigation is still 
underway after encountering a technical problem with the PCR amplification. 
 
5.6. Assessing osmotaxis capacity in cDNA16 mutant strains  
It was observed during this study that parasites spread relatively evenly through 
the AMG and TMG in all tested lines, except for FVI and LmjcDNA16 sKI. To 
investigate  the reasons for  this,  the  osmotactic  capacity  of  some mutant  lines 
(LmjcDNA16 dKO, LmjcDNA16 sKI, LmjHASPB sKI and LmjSHERP sKI) were 
assessed and compared to FVI. To do this, an osmotaxis assay was adapted 
from Oliveira  et  al. (2000) (366)  and  Leslie  et al. (2002) (367)  using 100 mM 
sucrose as an attractant (see 2.2.9.). Initially, the assay was performed in three 
repeats on FVI,  LmjcDNA16 dKO and  LmjcDNA16 sKI only; during the re-run 
LmjHASPB sKI and LmjSHERP sKI were also analysed. The attraction coefficient 
(A.C.) was calculated by dividing the number of parasite counted in the sample 
collected  from  capillaries  containing  the  attractant  (100  mM  sucrose)  by  the 
number of parasites counted in the samples taken from the capillaries without 
attractant. An A.C. of ~1 is indicative of zero attraction of the parasites for the 
sucrose.  Since  there  were  six  attractant  positive  and  six  attractant  negative 
capillaries per sample per run and six (FVI, LmjcDNA16 dKO and LmjcDNA16 
sKI) or three (LmjHASPB sKI and LmjSHERP sKI) repeats of the assay per tested 
strain, the A.C. could have been calculated using two distinct methods, which on 
occasion gave significantly different results. Firstly, the largest parasite count of 
the positive capillary samples was divided by the largest parasite count of the 
negative control capillaries for all six samples. Then the individual A.C.s were190 
 
 
 
Fig.5.8 – PCR amplification to determine mRNA length 
A) shows a schematic of the cDNA16 locus and the location and distance between 3’ 
poly(A)sites  and  downstream  5’  splice  acceptor  sites  (not  to  scale).  B)  shows  a 
schematic of the HASP and SHERP gene constructs (not to scale). The left side 
shows the native 3’ poly(A)-sites and downstream 5’ spliced leader acceptor site of 
the  antibiotic  resistance  gene;  the  right  side  shows  the  3’  poly(A)-sites  shifted 
downstream  to  be  at  the  same  distance  from  the  downstream  5’  spliced  leader 
acceptor site as the genes are within the cDNA16 locus (see A). C) Schematic of the 
PCR approach chosen to investigate mRNA lengths. Two primer pairs (SL-primer 
(orange/green) / internal reverse primer (red) and internal forward primer (green) / 
oligo(dT) primer (red/orange)) were chosen to amplify the mRNA in all tested lines. 
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summed and divided by the number of paired samples to get the mean A.C.  
 
Method 1:           
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)
   
 
Secondly, parasite counts were first summed in total and then, total parasites 
counts of the positive samples were divided by the total parasite counts of the 
negative samples to get the mean A.C.  
 
Method 2:           
                 
                 
 
 
The second method generally rendered a mean A.C. that was slightly smaller 
than the ones calculated using the first method; however, the trend pattern was 
always the same (Fig.5.10A). The assay is prone to strong variations between 
capillaries  and  test  rounds,  but  any  osmotaxis  deficiency  should  have  been 
readily detected according to literature (366, 367). A Kruskal-Wallis test was used 
to establish any significant difference in the overall results, but none was found 
between the five tested strains whose mean A.C.s were all within each other’s 
error range (Table 5.2). However, all five strains showed significant difference in 
their A.C.s compared to their negative controls (P<0.001 for all), which showed 
that all strains were osmotactically active (Fig.5.10B). Thus, all parasite mutant 
lines had the capacity to sense the posterior of the midgut and the reason why the 
mutant lines did not preferentially accumulate in TMG in late stage of sand fly 
infections, as in the case of FVI and LmjcDNA16 sKI, was not due to parasite 
osmotactic deficiencies. 
 
5.7. Looking for promastigote secretory gel secretion in vivo 
The PSG is secreted by leptomonads in the TMG and both leptomonads and 
nectomonads  attach  to  the  gel  with  high  affinity.  It  is  possible  that  the  PSG 
facilitates strong parasite colonization of the TMG by retaining parasites in the 
PSG  matrix  against  peristalsis  and  the  intake-flow  of  sucrose.  A  lack  of  PSG 
secretion had been suggested previously in LmjcDNA16 dKO by Sádlová in her 
analysis of infected midgut wet mounts (unpublished) (Fig.4.2). This observation 
was supported in this study by the fact that mutant parasites swam immediately 
freely after releasing them from an infected TMG at day 12 PBM, while FVI and 
LmjcDNA16  sKI  parasites  were  immobilized  initially  after  release.  To  confirm 
conclusively that a lack of PSG secretion occurred in the LmjcDNA16 dKO, PSG 
extracts from day 12 PBM infected TMGs were prepared by collecting 10 infected192 
 
 
Fig.5.10 – Osmotaxis assay 
A) The graph shows the A.C.s for the two calculation methods:  
 
Method one (green):         
(
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Method two (blue):         
                 
                 
 
 
The mean A.C.s are listed in Table 5.2. Neither approach showed any statistically 
significant differences between samples suggesting that osmotaxis is unimpaired in 
the mutants. B) The graph shows the A.C.s calculated by method 1 (green) and the 
A.C.s for the control experiment (blue), where no attractant was used. The results 
show a significant difference (P<0.001) in mean A.C.s in the presence of 100 mM 
sucrose compared to its absence, suggesting that parasites migrate ~4 times more 
often into capillaries with 100 mM sucrose than into sucrose negative capillaries. 
 
Table 5.2 – Attraction Coefficient, Means and Standard Deviations 
  Method 1  Method 2  Method 1 
Strains  Mean A.C. 
(Div./Sum) 
S.D.  Mean A.C. 
(Sum/Div.) 
S.D.  Mean A.C. 
(-ve Con.) 
FVI  4.09  ± 1.92  3.63  ± 1.12  1.19 
cDNA16 dKO  3.81  ± 1.73  3.31  ± 1.22  1.17 
cDNA16 sKI  4.52  ± 1.92  3.93  ± 0.91  1.11 
HASPB sKI  3.84  ± 1.43  3.44  ± 0.58  1.16 
SHERP sKI  4.92  ± 2.33  4.20  ± 0.88  1.20 
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TMGs  into  50  μl  PBS  (see  2.5.4).  Samples  were  spun  6  times,  with  the 
supernatant transferred to a fresh tube after every spin to remove contaminating 
debris.  2-4  µl  of  supernatant  were  blotted  onto  an  activated  nitrocellulose 
membrane, which was blocked and probed with the LT15 antibody specific for the 
phosphoglycan  disaccharide  repeats  [PO4-6Gal(β1-4)Man(α1)]  on  LPG  and 
selected PPGs, including fPPG (54).  
 
The  results  showed  that  LmjcDNA16  dKO  had  no  positive  signal  for  abLT15 
binding suggesting that no soluble fPPG  was present in the  LmjcDNA16 dKO 
supernatant, while FVI and LmcDNA16 sKI had clear signals (Fig.5.11). The faint 
signal  for  LmjcDNA16  dKO  after  only  one  round  of  spinning  away  debris 
suggested that parasite surface LPG and PPG contaminants were still present in 
the  supernatant.  Also,  the  LmjHA1/2+S2/HB  sKI  supernatant  lacked  PSG, 
suggesting that all mutant lines did not produce PSG, except for LmjcDNA16 sKI. 
In a repeat of the assay, debris pellets were also collected, lysed and blotted onto 
activated  nitrocellulose  membrane.  FVI  and  LmjcDNA16  sKI  showed  positive 
signals on abLT15 probing, while LmjcDNA16 dKO did not (Fig.5.12A). This was 
surprising, because Fig.5.11 suggested the abLT15 would detect something in 
the LmjcDNA16 dKO debris pellet, because the abLT15 had given a weak signal 
in the 1x spun LmjcDNA16 dKO sample. LmjHASPB sKI and LmjHASPA2 sKI 
extracts were also analysed and did not show a positive signal either for pellet 
and supernatant. This confirmed the observations that L. (L.) major mutant lines 
without the complete cDNA16 locus do not produce PSG in the sand fly midgut. 
Interestingly, the abLT15 also did not detect anything in whole lysates of cultured 
parasites, including the FVI and LmjcDNA16 sKI, although it was anticipated that 
parasite surface LPG and PPG would be detected by abLT15. This, however, 
does not suggest that mutant parasite lines grown in culture do not produce PSG, 
because the fPPG is secreted into the culture medium and removed with it, when 
isolating parasite cells for lysate production. 
 
The PSG extracts and debris pellets were also probed for HASPB. It had been 
previously  suggested  that  HASPB  may  be  shedded  within  the  midgut  by 
metacyclics  (336).  Fig.5.12B  shows  that  HASPB  was  readily  detected  in  the 
parasite lysate samples of FVI, LmjcDNA16 sKI and LmjHASPB sKI as expected. 
Surprisingly,  the  LmjcDNA16  dKO  lysate  sample  also  had  a  positive  signal, 
although the mutant line does not contain a HASPB gene. This suggest unspecific 
antibody binding on the membrane. The only sample showing a positive signal for 
HASPB was the FVI PSG extract sample, while the debris pellet sample showed194 
 
 
 
Fig.5.11 – Dot blot of PSG containing supernatants from midgut extracts 
The dot blot was probed with the LT15 antibody for fPPG detection. Two sets of 
samples were blotted at two different volumes per parasite strain, with the exception 
of  LmjHA1/2+S2/HB  sKI.  The  samples  showed  PSG  extracts  after  6  rounds  of 
spinning them down and transferring them (I) and samples that had been spun down 
only once to clear away cell debris (II). After 6x spins (I) there is not more positive 
signal in LmjcDNA16 dKO and LmjHA1/2+S2/HB sKI samples, suggesting a severe 
lack of fPPG secretion at day 12 PBM resulting in the absence of PSG. The weak 
positive signal in the 1x spun down sample suggests the presence of contaminating 
parasite surface PPGs and LPG, which are also detected by the abLT15 according to 
M. E. Rogers, who kindly supplied the antibody. 1 µl of abLT15 had also been blotted 
as a secondary antibody control. 
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Fig.5.12 – Dot blot of PSG extracts from midgut 
A repeat of the Dot blot with new extracts derived from thoracic sand fly midguts is 
shown. Whole lysates of cultured parasites were used as a control. A) Only FVI and 
LmjcDNA16  sKI  showed  presence  of  PSG  in  pellet  and  supernatant,  while 
LmjcDNA16 dKO, LmjHASPB sKI and LmjHASPA2 sKI did not show any PSG signal 
when probed with the abLT15. The lysate samples were negative, although it had 
been expected that the abLT15 would detect parasite LPG and surface PPG too. B) 
The PSG extract were also probed with the non-affinity purified anti-HASP antibody 
to  detect  HASPB.  The  dot  blot  showed  HASP  staining  in  the  lysates  of  FVI, 
LmjcDNA16  sKI  and  LmjHASPB  sKI  as  expected,  but  unexpectedly  also  in 
LmjcDNA16 dKO. Only the PSG extract from FVI was positive for HASPB, but not 
debris pellets. C) The dot blot results for HASPB staining were verified by Western 
blot. Here, no positive signal was observed in any the debris pellet lysates or PSG 
extracts,  while  HASPB  was  detected  in  the  whole  lysate  samples  from  cultured 
parasites, as expected. 
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only a bleached out circle. LmjcDNA16 sKI was also expected to show a positive 
signal for HASPB in the PSG extract and debris sample, but none was observed. 
However, since the LmjcDNA16 dKO lysate did show a positive signal, it was put 
into  question  whether  the  positive  HASPB  signal  in  the  FVI  PSG  extract  was 
specific.  A  Western  blot  was  produced  of  the  same  samples  at  the  same 
quantities as had been used in the dot blot for verification. Fig.5.12C shows that 
only  the  parasite  lysates  of  FVI,  LmjcDNA16  sKI  and  LmjHASPB  sKI  were 
positive for HASPB. No PSG extract sample or debris pellet sample gave any 
positive signal even on longer exposure of the probed Western blot to film. Since 
HASPB expressing parasites had been present in the debris pellets of FVI and 
LmjcDNA16 sKI before lysis, this could mean that the HASPB concentration was 
too low to be detected clearly on a Western blot. 
 
5.8. Conclusions 
The  analysis  of  midgut  derived  parasites  by  confocal  microscopy  provided  a 
method to look at HASP and SHERP expression without being limited by parasite 
numbers  per  midgut.  Although  midgut  smears  can  be  difficult  to  image  by 
immunofluorescence  due  to  high  level  background  fluorescence,  the  analysis 
showed that there were marked differences for HASP and SHERP expression in 
vitro and in vivo for all mutant lines tested. Only FVI showed a positive signal for 
HASPB under both conditions, while SHERP could be detected in the LmjS2+HB 
sKI mutant line, although HASPB was not detected in this line either. The lack of 
a positive signal in all mutant lines tested offered an explanation why no mutant 
line had managed to recover the parental line phenotype, but appeared in most 
aspects similar to the cDNA16 locus null phenotype.  
 
Different possible explanations for the HASP and SHERP expression differences 
were explored in this part of the study. The rich M199 medium could be excluded 
from having an effect on construct regulation and the addition of blood fed sand 
fly midgut extracts from days 6 and 12 PBM to M199 cultures did not make a 
difference to HASPB expression in LmjHASPB sKI either. This could mean that 
HASPB expression from the replacement constructs was not influenced by culture 
conditions  or  midgut  derived  molecules  However,  I  cannot  exclude  that  high 
dilution of midgut material or loss of molecules due to their size or insolubility. The 
methods would need to be refined for further analysis.  
 
Further investigation into mRNA expression patterns showed that LmjHASPB sKI 
had no mRNA peak at day 6 PBM, like FVI and LmjcDNA16 sKI, which could 197 
 
explain  the  lack  of  up-regulation  of  HASPB  expression  in  that  mutant  line. 
Differences  in  the  expression  patterns  of  HASPA  and  SHERP  between  the 
parental line (FVI) and all mutant lines, including LmjcDNA16 sKI, both in vivo and 
in vitro, suggest that regulation of HASPB at parental line levels and timing in 
LmjcDNA16  sKI  may  be  the  key  element  for  metacyclogenesis  completion  in 
LmjcDNA16 sKI compared to all other mutant lines. 
 
Investigations into the parasite’s osmotaxis capacity to explain the even spread of 
all mutant lines in AMG and TMG, instead of accumulation in the TMG like FVI 
and LmjcDNA16 sKI, showed that all mutant lines tested were attracted efficiently 
towards an independent sucrose source. This excluded osmotaxis as a potential 
mechanism requiring the HASP and SHERP function. However, the investigation 
into PSG secretion in vivo showed that all mutant lines tested had a clear lack of 
PSG secretion. This could be hypothesised to prevent parasite accumulation in 
the  TMG,  because  nectomonads  and  leptomonads  can  bind  to  the  PSG 
maintaining them in the TMG against peristalsis and intake-flow of sugar meals. 
Metacyclics can swim freely through the PSG and tend to accumulate at the poles 
of the PSG, which could mean that the fPPG matrix provides metacyclics with 
hold  and  orientation  in  the  TMG.  Further  investigations  would  be  required  to 
determine  if  the  HASPs  and  SHERP  are  directly  involved  in  the  pathways 
essential for fPPG synthesis and secretion or if this is only an indirect effect.  
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6.  Chapter VI. – L. (V.) braziliensis orthologous HASP locus 
 
6.1. Introduction 
The  broad  aim  of  this  part  of  the  study  was  to  investigate  whether  the  locus 
equivalent  to  the  L.  (L.)  major  cDNA16  locus  is  also  required  for 
metacyclogenesis  in  the  L.  (Viannia)  spp.,  L.  (V.)  braziliensis.  This  required 
comparison of the phenotypes of L. (V.) braziliensis full orthologous HASP locus 
(OHL) deletion and replacement mutants in vitro and in vivo to the L. (L.) major 
full cDNA16 deletion (LmjcDNA16 dKO) and replacement mutants (LmjcDNA16 
sKI).  The  OHL,  which  localizes  in  L.  (Viannia)  spp.  to  the  same  region  on 
chromosome  23  as  the  cDNA16  locus  in  the  L.  (Leishmania)  subgenus,  was 
previously investigated by Depledge et al. (2010) (294). This study showed that 
the two annotated genes (LbrM.23.1110 and LbrM.23.1120), although distinct in 
sequence at the genomic level, expressed proteins with similar biochemical and 
structural  properties  to  the  HASPs.  Due  to  these  similarities  and  because 
frequently  genes  occurring  in  the  same  chromosomal  context  in  different 
Leishmania spp. are functional homologues, it was hypothesised that the genes 
of the OHL in L. (Viannia) spp. may be functionally similar to those encoded by 
the cDNA16 locus in L. (Leishmania) spp. Based on these observations, it was 
hypothesised that the full deletion of the OHL may cause the same phenotype in 
L. (V.) braziliensis as the deletion of cDNA16 locus in L. (L.) major. 
 
The available genomic sequence of OHL was recently assembled with reference 
to  the  cDNA16  locus  in  L.  (L.)  major  which  is  known,  however,  to  be 
misassembled due to the extensive repetitive sequence within the locus (see 1.7). 
Due to the similar high levels of sequence repetitiveness in the OHL, a repeat 
collapse had occurred in the assembly making the OHL appear smaller (~7 Kb) 
and with fewer genes than present in this segment of the genome (Fig.6.1). This 
was supported by the observation that the reanalysis of the automated genome 
assembly of the Lbr2904 genome (done by M. B. Rogers at the Sanger Institute) 
had a 4-5 fold increase in read depth compared to the surrounding sequence 
(Fig.6.2). The first step in this part of the study was to resolve the map of the OHL 
to be able to generate full OHL deletion and single OHL replacement mutants in 
L. (V.) braziliensis 2904 (reference strain). 
 
6.2. Variation in the orthologous HASP locus between clinical Leishmania 
(Viannia) braziliensis  
In order to address this repeat collapse, three genomic digests (PstI – HindIII,199 
 
 
 
 
 
 
 
Fig.6.1 – Repeat collapse in OHL 
The OHL consists of highly similar A’B’ tandem repeats. A’ contains the ORF and all 
single-nucleotide polymorphisms observed in the repeats. B’ contains part of the 3’ 
UTRs  and  the  intergenic  region,  which  are  highly  conserved.  During  automated 
sequence  assembly,  the  A’B’  motives  were  collapsed  into  a  single  A’B’  unit, 
explaining the increased read depth for this region. Adapted from D. P. Depledge 
(PhD Thesis, 2009).   200 
 
 
 
Fig.6.2 – Screen shot of Artemis software showing the reading depth for the 
OHL genes LbrM.23.1110 and LbrM.23.1120 
The red and black boxes mark the areas of increased read depth compared to the 
neighbouring sequence, as represented in the elevated peaks of the graph in the 
second  row  (boxed).  The  ORFs  of  the  two  OHL  genes  are  shown  in  pink.  In 
particular, the area around the LbrM.23.1110 (1110) gene and the intergenic region 
between 1110 and LbrM.23.1120 (1120) show a 4-5 fold increase in read depth (red 
box), indicating the repeat collapse observed previously by Depledge et al. (2010). 
This analysis suggested that 1110 may occur as 4 – 5 copies in the OHL. Another 
smaller  peak  within  the  ORF  of  1120  (black  box)  also  suggested  some  sort  of 
collapse, but one at a 2-fold level. As subcloning and sequencing showed later, there 
are two distinct ORFs for 1120. (The image was kindly provided by M. B. Rogers, 
Wellcome Trust Sanger Insitute) 
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XhoI or NotI – HindIII) were designed based on the available genomic sequence 
of  L.  (V.)  braziliensis  2904  (Lbr2904)  and  performed  individually.  The  digests 
were analysed on a Southern blot to determine the wild type OHL size. Together 
with Lbr2904, genomic digests of another available L. (V.) braziliensis strain (LTB 
300)  were  run  in  parallel.  The  Southern  blot  (Fig.6.3)  was  probed  with  three 
different DIG-labelled probes (OHL I = binding to the intergenic region attached to 
1110, OHL II = binding to the 5’flanking region, OHL III = binding to the 3’flanking 
region – Fig.6.4). Unfortunately, the first lane with LBT 300 gDNA was empty, 
because the gDNA digest was lost. Its size was later calculated based on the ratio 
of the other two pairs of Lbr2904 and LTB 300 measured bands observed. The 
resulting Southern blot (Fig.6.3) clarified the following points: (i) according to the 
available OHL sequence from GeneDB a genomic digest with either PstI – HindIII, 
XhoI or NotI – HindIII should have a single fragment of the size  5.2 Kb, 5.6 Kb 
and 6.5 Kb, respectively (Fig.6.4A). Instead, bands were observed with 13.5 Kb 
(LTB300) and 14.9 Kb (Lbr2904) for PstI – HindIII, 13.65 Kb (LTB 300) and 15 Kb 
(Lbr2904) for XhoI and 15 Kb (LTB 300) and 16.65 Kb (Lbr2904) for NotI – HindIII 
digests (Table 6.1). (ii) Comparing the digestion results for Lbr2904 and LTB 300, 
it  was  obvious  that  the  locus  size  is  not  equivalent  for  these  two  L.  (V.) 
braziliensis strains. The Lbr2904 OHL appeared larger for all three digests than 
the equivalent detected for LTB 300. These results confirmed that the data base 
sequence for the OHL was incomplete. 
 
To investigate this variation of OHL size between Lbr2904 and LTB 300 further, a 
SacI digest of gDNA was performed, which was designed to break the locus apart 
and  generate  individual  fragments  with  LbrM.23.1110  and  LbrM.23.1120, 
respectively (Fig.6.4). It was expected that each probe would only detect a single 
band on a Southern blot with the OHL I and OHL III probes detecting the same 
band. However, the OHL I probe was able to detect at least four distinct bands for 
Lbr2904 and three for LTB 300, of which two and one band was also detected by 
OHL  III,  respectively  (Fig.6.5).  Finding  multiple  bands  with  the  OHL  I  probed 
suggested that the intergenic region was present several times rather than only 
once, underlining the observation made during the reanalysis of the automated 
re-assembly of the  Lbr2904 genome, which had shown a 4-5 fold  increase in 
reading depth for the region containing the 1110 gene (Fig.6.2). 
 
To  further  analyse  the  L.  (V.)  braziliensis  intraspecific  OHL  variability,  gDNA 
samples  from  clinical  L.  (V.)  braziliensis  isolates  taken  from  patients  in  Brazil 
(supplied by S. R. B. Uliana, Universidade de São Paulo, Brazil; investigated in202 
 
 
 
Fig.6.3 – Southern blot of three gDNA digests for two L. (V.) braziliensis strains 
Genomic DNA from L. (V.) braziliensis 2904 and LTB 300 were restricted with three 
combinations of enzymes as shown, size separated and probed with three distinct 
DIG labelled probes (OHL I – III; Fig.6.4). All three DIG-labelled probes detected the 
same fragment for all three digests that were designed to cut out the entire OHL, 
confirming  that  the  whole  locus  was  isolated  by  the  digest.  Bands  differ  in  size 
between  LTB  300  and  Lbr2904  for  each  digest,  suggesting  variation  in  the  OHL 
content with the LTB 300 OHL smaller than the Lbr2904 OHL. The bands are also 
~2.5x larger in size than the expected bands according to the available sequence for 
the OHL from GeneDB. (The gDNA HindIII - PstI digest of the LTB 300 in the first 
lane was largely lost during precipitation, but a weak band, not visible on these blots, 
was visible against the light, which permitted determination of the migrated distance 
and band size). 
 
Table 6.1 – Fragment size calculated by Fragment Size Calculator* 
Restriction Enzymes  LTB300 (Kb)  Lbr2904 (Kb) 
HindIII - PstI  ~13.5  ~14.9 
XhoI  ~13.65  ~15 
HindIII - NotI  ~15  ~16.65 
*Source: http://www.basic.northwestern.edu/biotools/SizeCalc.html   203 
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Fig.6.4 – Expected and measured sizes for the gDNA digests of LTB 300 and 
Lbr2904, respectively 
A) The gDNA digests were planned using the available sequence of the OHL from 
GeneDB  and  the  expected  fragment  sizes  for  each  digest  were  calculated 
accordingly.  B)  The  band  sizes  observed  on  the  Southern  blot  (Fig.6.3)  were 
estimated by measuring the distance travelled for each band against the distances 
travelled for the marker bands and applying those figures to the open source program 
“Fragment  Size  Calculator”.  (http://www.basic.northwestern.edu/biotools/ 
SizeCalc.html). The calculated band sizes were on 2.3 – 2.6 times larger than the 
expected  once.  Notably,  multiple  bands  were  also  detected  after  the  SacI  digest 
containing the intergenic region and 1110 of varying sizes (Fig.6.5), suggesting that 
1110 may occur as multiple gene copies in the OHL. This underlined the observed 
repeat collapse for this region, which was expect to have an at least 4-fold increase in 
reading depth during automated genome reassembly. 204 
 
 
 
 
Fig.6.5 – Southern blot of SacI digested gDNA of LTB 300 and Lbr2904 
The SacI digest was designed on the available sequence of the OHL to separate the 
1110 and 1120 genes. For each DIG-labelled probe (OHL I – III; Fig.6.3B) a single 
band was expected, but for the OHL I probe binding to the intergenic region unique to 
the OHL 3 – 4 bands were detected, suggesting that the intergenic region occurs 
multiple times within the L. (V.) braziliensis genome. The 1120 fragment, which was 
not detected by the intergenic OHL I probe, was detected by probe OHL II and only a 
single band was detected as expected. Also the ~3.5 Kb fragment containing 1110, 
the  3’  flanking  region  and  the  intergenic  region  up-stream  of  1110  was  detected. 
However, Lbr2904 also showed an unexpected band of ~5.9 Kb, which may be a 
fragment fused to one of the smaller unexpected fragments due to a mutation in the 
SacI site. 
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Depledge  et  al.  (2010))  were  amplified  using  the  GenomiPhi  kit  to  generate 
enough material for a Southern blot. The efficacy of the kit was moderate, but 
enough  gDNA  was  still  available  to  perform  a  SacI  digest  and  run  the  gDNA 
digest on a gel for a Southern blot. Probing the blot with the OHL I probe, which 
hybridized to the intergenic region between the genes 1110 and 1120, a series of 
bands  of  variable  size  between  the  different  clinical  isolates  were  detected 
(Fig.6.6).  This  confirmed  that  the  OHL  was  variable  in  size  between  L.  (V.) 
braziliensis strains.  
 
6.3. Addressing  the  Leishmania  (Viannia)  braziliensis  orthologous  HASP 
locus repeat collapse 
In an attempt to resolve the full sequence and organisation of the OHL, different 
approaches  were  considered  to  overcome  the  problem  of  the  high  levels  of 
sequence repetitiveness, which had caused the repeat collapse in the automated 
sequence assembly. Looking at the multiple bands detected by the OHL I probe, 
it was decided to focus on individual fragments of the OHL and determine their 
sequence. Several high fidelity PCR reactions with different sets of primers were 
set up including a reaction with a set of divergent primers in the intergenic region. 
Based  on  the  available  sequence,  these  divergent  primers  should  not  allow 
amplification of any fragments (Fig.6.7). However, all PCR reactions did generate 
fragments (Fig.6.8) and these were subcloned into the pCR-2.1 TOPO vector and 
transformed into chemically competent E. coli XL-1 cells. Clones were picked, 
screen and amplified. The plasmids were extracted and submitted for sequencing 
with appropriate primers.  
 
The sequencing results for the different clones and fragments were assembled 
into contigs using the open source CAP3 Sequence Assembly Program and were 
analysed by sequence alignments using the open source ClustalW2 - Multiple 
Sequence  Alignment  software.  The  results  showed  two  distinct  ORF  for  1120 
(1120_v1  and  1120_v2),  both  with  the  same  5’  and  3’  UTRs  and  up-  and 
downstream  flanking  regions  (Fig.6.9).  Nine  distinct  single-nucleotide 
polymorphisms  (SNPs)  were  identified  within  these  two  sequences,  which 
correlated  with  the  expected  number  of  8  SNPs  suggested  by  previous,  yet 
unconfirmed,  analysis  (M.  B.  Rogers,  unpublished).  In  addition,  1120_v2 
contained one amino acid triplet and three repeat sequences more between its 
central  section  than  1120_v1.  Interestingly,  due  to  a  premature  stop-codon  in 
1120_v2, however, both ORF are 554 bp long. The upstream flanking region of 
both 1120 gene versions is also the upstream flanking region of the OHL and206 
 
 
 
 
Fig.6.6  –  Southern  blot  of  SacI  digested  GenomiPhi  amplified  gDNA  from 
clinical L. (V.) braziliensis isolates to assess intra OHL variablilty 
To assess OHL variability further between L. (V.) braziliensis strains, gDNA samples 
from  clinical  L.  (V.)  braziliensis  isolates  (*;  supplied  by  Silvia  R.  B.  Uliana, 
Universidade de São Paulo, Brazil; (294)) were amplified by the GenomiPhi kit (GE 
Healthcare)  according  to  the  supplier’s  protocol,  SacI  digested  and  then  size 
separated. Probing with the OHL I DIG-labelled probe in the intergenic region showed 
a variety of band patterns, supporting the hypothesis of OHL variability and multiple 
repeats of intergenic regions and LbrM.23.1110 genes. The OHL II probe detected 
only one band in all samples as expected (bands are not all visible in printed image, 
but are visible on the original blot), which suggested single copies of LbrM.23.1120 
for all strains. 
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Fig.6.7 – Schematic for placement of primer in OHL used to amplify fragments 
for subcloning 
Primer and amplification strategy was based on the available sequence for the OHL 
on GeneDB. Taking the findings from the SacI digested gDNA Southern blots into 
account, which suggested multiple occurrences of the intergenic region, a primer pair 
(red box) was also picked facing away from one another in the intergenic region to 
test  whether  fragments  could  be  amplified,  confirming  the  presence  of  multiple 
intergenic region in the OHL. 
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Fig.6.8 – PCR amplification of parts of the OHL for subcloning 
To assess the OHL gene content four PCR reactions were set up with distinct primers 
to amplify fragments of the OHL for subcloning and sequencing (Fig.6.7). Three of 
these  reaction  were  expected  to  generate  single  bands  of  expected  sizes  (1110 
genes  =  ~1.8  Kb;  Intergenic  region  =  ~750  kb;  1120  genes  =  ~1.8  kb).  These 
reactions  always  rendered  the  same  band  of  the  same  size  suggesting  no  size 
variation between alleles as suggested by Southern blots (Fig.6.5 & 6.6). 
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1120_v2_ CTCTCATACCAGCCCTCTGCGTTGTCGCTCGCTCACCGCCCCACCCCACTCCGTGTATCC 60 
Lbr.1120 CTCTCATACCAGCCCTCTGCGTTGTCGCTCGCTCACCGCCCCACCCCACTCCGTGTATCC 60 
1120_v1_ CTCTCATACCAGCCCTCTGCGTTGTCGCTCGCTCACCGCCCCACCCCACTCCGTGTATCC 60 
         ************************************************************ 
 
1120_v2_ ACACCTTTCGCACCTCAACGCTTCTCTCCCTCAGCAGTTATCGCGCTATATTGGTGTGGC 120 
Lbr.1120 ACACCTTTCGCACCTCAACGCTTCTCTCCCTCAGCAGTTATCGCGCTATATTGGTGTGGC 120 
1120_v1_ ACACCTTTCGCACCTCAACGCTTCTCTCCCTCAGCAGTTACCGCGCTATATTGGTGTGGC 120 
         **************************************** ******************* 
 
1120_v2_ TCTAAACCTACACTTACATCTGCTCCTCCTCTCTTCTTTCTCTCTCCCTTGACGCATACT 180 
Lbr.1120 TCTAAACCTACACTTACATCTGCTCCTCCTCTCTTCTTTCTCTCTCCCTTGACGCATACT 180 
1120_v1_ TCTAAACCTACACTTACATCTGCTCCTCCTCTCTTCTTTCTCTCTCCCTTGACGCATACT 180 
         ************************************************************ 
 
1120_v2_ CTTCGCTGACGTGCGCCGTCGCAGGCTTTCCCCTTTACAGGCTCACCTACACGTCCCCCT 240 
Lbr.1120 CTTCGCTGACGTGCGCCGTCGCAGGCTTTCCCCTTTACAGGCTCACCTACACGTCCCCCT 240 
1120_v1_ CTTCGCTGACGTGCGCCGTCGCAGGCTTTCCCCTTTACAGGCTCACCTACACGTCCCCCT 240 
         ************************************************************ 
 
1120_v2_ ACAGCGCAGTCTCCCAGTATTGTCACTTTCTAGTCTGGAATCCGCCAGCCTCAGCCCCTG 300 
Lbr.1120 ACAGCGCAGTCTCCCAGTATTGTCACTTTCTAGTCTGGAATCCGCCAGCCTCAGCCCCTG 300 
1120_v1_ ACAGCGCAGTCTCCCAGTATTGTCACTTTCTAGTCTGGAATCCGCCAGCCTCAGCCCCTG 300 
         ************************************************************ 
 
1120_v2_ CGCACACTACACTCGATTCACTTATCCCCGTAGTAGCGCTTCACTCACCCTTAGCCGCTG 360 
Lbr.1120 CGCACACTACACTCGATTCACTTATCCCCGTAGTAGCACTTCACTCACCCTTAGCCGCTG 360 
1120_v1_ CGCACACTACACTCGATTCACTTATCCCCGTAGTAGCACTTCACTCACCCTTAGCCGCTG 360 
         ************************************* ********************** 
 
1120_v2_ CCTTTCTTCCTCTACCCACTACTCTCTCACCCCACCTATAAGCAATGGGGACCATCTGTG 420 
Lbr.1120 CCTTTCTTCCTCTACCCACTACTCTCTCACCCCACCTATAAGCAATGGGGACCATCTGTG 420 
1120_v1_ CCTTTCTTCCTCTACCCACTACTCTCTCACCCCACCTATAAGCAATGGGGACCATCTGTG 420 
         ************************************************************ 
 
1120_v2_ CGAAGCTGTCGCCGATGCCGCGCGGGACCAACCGTCCGACGAACCAGAAGGGCCGTGGCA 480 
Lbr.1120 CGAAGCTGTCGCCGATGCCGCGCGGGACCAACCGTCCGACGAACCAGAAGGGCCGTGGCA 480 
1120_v1_ CGAAGCTGTCGCCGATGCCGCGCGGGACCAACCGTCCGACGAACCAGAAGGGCCGTGGCA 480 
         ************************************************************ 
 
1120_v2_ AAGGGAATAAGAAGAAGGGTGGTGGCCATCATAGACATGGGAAGAAGGATGGTGGCGACC 540 
Lbr.1120 AAGGGAATAAGAAGAAGGGTGGTGGCCATCATAGACATGGGAAGAAGGATGGTGGCGACC 540 
1120_v1_ AAGGGAATAAGA---AGGGTGGTGGCCATCATAGACATGGGAAGAAGGATGGCGGCGACC 537 
         ************   ************************************* ******* 
 
1120_v2_ ATGGACATGAGAAGGTGAACGGCGGCGACCATGGACATGAACATATGGACGGCGGCCATC 600 
Lbr.1120 ATGGACATGAGAAGGTGAACGGCGGCGACCATGGACATGAACATATGGACGGCGGCCATC 600 
1120_v1_ ATGGACATGAGAAGGTGAACGGCGGCGACCATGGACATGAACATATGGACGGCGGCCATC 597 
         ************************************************************ 
 
1120_v2_ ATGGACATGAGCATATGAACGGTGGCGACCATGGACATGAACATATGGACGGCGGCCAGC 660 
Lbr.1120 ATGGACATGAGCATATGAACGGTGGCGACCATGGACATGAACATATGGACGGCGGCCAGC 660 
1120_v1_ ATGGACATGAGCATATGAACGGTGGCGACCATGGACATGAACATATGGACGGCGGCCAGC 657 
         ************************************************************ 
 
1120_v2_ ATGGACATGAACATATGGACGGTGGCGACCATGGACATGAACATATGGACGGTGGCGACC 720 
Lbr.1120 ATGGACATGAACATATGGACGGTGGCGACCATGGACATGAACATATGGACGGTGGCGACC 720 
1120_v1_ ATGGACATGAACATATGGACGGTGGCGACCATGGACATGAACATATGGACGGTGGCGACC 717 
         ************************************************************ 
 
1120_v2_ ATGGACATGGGAATATGGACGGTGGCGACCATGGACATGAACATATGGACGGTGGCGACC 780 
Lbr.1120 ATGGACATGGGAATATGGACGGTGGCGACCATGGACATGAACATATGGACGGTGGCGACC 780 
1120_v1_ ATGGACATGGGAATATGGACGGTGGCGACCATGGACATGAACATATGGACGGTGGCGACC 777 
         ************************************************************ 
 
1120_v2_ ATGGACATGAACATATGGACGGCGGCGACCATGGACATGAACATATGGACGGCGGCGACC 840 
Lbr.1120 ATGGACATGAACATATGGACGGCGGCGACCATGGACATGAACATATGGACGGCGGCGACC 840 
1120_v1_ ATGGACATGAACATATGGACGGTGGCGACCATGGACATGAACATATGAACGGTGGCGACC 837 
         ********************** ************************ **** ******* 
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1120_v2_ ATGGACATGAACATATGGACGGTGGCGACCATGGACATGAACATATGAACGGTGGCGACC 900 
Lbr.1120 ATGGACATGAACATATGGACGGTGGCGACCATGGACATGAACATATGAACGGTGGCGACC 900 
1120_v1_ ATGGACATGAACATATGGACGGTGGCG--------------CACCT-AACGGTA------ 876 
         ***************************              **  * ******        
 
1120_v2_ ATGGACATGAGCACATGGGCGATGGCGCACCTAACGGGGATTGAAATATGGGGAACGATA 960 
Lbr.1120 ATGGACATGAGAACATGGGCGATGGCGCACCTAACGGGGATTGAAATATGGGGAACGATA 960 
1120_v1_ --------------ATGGG----------------AAGGATGAAAATATGGGGAACGATA 906 
                       *****                  ****  ***************** 
 
1120_v2_ ACGAGCATAATGGGATGGGTGATGATGCCAACCCCTGATGTGCTGCGTGCCGGCTTGTGC 1020 
Lbr.1120 ACGAGCATAATGGGATGGGTGATGATGCCAACCCCTGATGTGCTGCGTGCCGGCTTGTGC 1020 
1120_v1_ ACGAGCATAATGGGATGGGTGATGATGCCAACCCCTGATGTGCTGCGTGCCGGCTTGTGC 966 
         ************************************************************ 
 
1120_v2_ TTGTGGGCCGAGCCCTTCGTCGGGCCTCTTGTGCCTCGTGCGCAGACTGCGTGTGTTGCT 1080 
Lbr.1120 TTGTGGGCCGAGCCCTTCGTCGGGCCTCTTGTGCCTCGTGCGCAGACTGCGTGTGTTGCT 1080 
1120_v1_ TTGTGGGCCGAGCCCTTCGTCGGGCCTCTTGTGCCTCGTGCGCAGACTGCGTGTGTTGCT 1026 
         ************************************************************ 
 
1120_v2_ CGCGGTTCGTGTCTCTCCGCACACAGTGGCTAATGCCTGCCTGGGGTCGTTGTGATTGTA 1140 
Lbr.1120 CGCGGTTCGTGTCTCTCCGCACACAGTGGCTAATGCCTGCCTGGGGTCGTTGTGATTGTA 1140 
1120_v1_ CGCGGTTCGTGTCTCTCCGCACACAGTGGCTAATGCCTGCCTGGGGTCGTTGTGATTGTA 1086 
         ************************************************************ 
 
1120_v2_ CCTCATGGGCACCCCCGGCTTTCCCCGACTCGACTTCCCCTCTCCGCTTCCGAGTGTGTG 1200 
Lbr.1120 CCTCATGGGCACCCCCGGCTTTCCCCGACTCGACTTCCCCTCTCCGCTTCCGAGTGTGTG 1200 
1120_v1_ CCTCATGGGCACCCCCGGCTTTCCCCGACTCGACTTCCCCTCTCCGCTTCCGAGTGTGTG 1146 
         ************************************************************ 
 
1120_v2_ GTGGGTGTGGGGTTGGGCGCATAATGGACATTGTCGGTGGATGCGCGACGACTGCCGCTA 1260 
Lbr.1120 GTGGGTGTGGGGTTGGGCGCATAATGGACATTGTCGGTGGATGCGCGACGACTGCCGCTA 1260 
1120_v1_ GTGGGTGTGGGGTTGGGCGCATAATGGACATTGTCGGTGGATGCGCGACGACTGCCGCTA 1206 
         ************************************************************ 
 
1120_v2_ CACAACTGTGGCCACGCCGAGTCCTGTGTGTGTATGCTTAGATCACCGGTGCTAGCAGCT 1320 
Lbr.1120 CACAACTGTGGCCACGCCGAGTCCTGTGTGTGTATGCTTAGATCACCGGTGCTAGCAGCT 1320 
1120_v1_ CACAACTGTGGCCACGCCGAGTCCTGTGTGTGTATGCTTAGATCACCGGTGCTAGCAGCT 1266 
         ************************************************************ 
 
1120_v2_ CTCTTGCTGCCTCTGCGTGGACTCTCTTTGTTTCTTGTGTCTTTTCTGTTCGGGTACCTC 1380 
Lbr.1120 CTCTTGCTGCCTCTGCGTGGACTCTCTTTGTTTCTTGTGTCTTTTCTGTTCGGGTACCTC 1380 
1120_v1_ CTCTTGCTGCCTCTGCGTGGACTCTCTTTGTTTCTTGTGTCTTTTCTGTTCGGGTACCTC 1326 
         ************************************************************ 
 
 
Fig.6.9 – Two heterozygous copies of LbrM.23.1120 
Only  two  distinct  sequences  have  been  identified  by  subcloning  and  sequencing 
among several sequenced clones (shown here). Two distinct LbrM.23.1120 ORFs 
have been identified. The 5’ flanking region of both LbrM.23.1120 copies is distinct 
from the intergenic region found between LbrM.23.1110 and LbrM.23.1120, which 
suggests that these two genes do not occur in a tandem repeat, but only once per 
allele and are heterozygous copies. The SNPs are marked in green and are restricted 
almost exclusively to the ORF (in red). Both ORFs have exactly the same length of 
540 bp, although 1120_v2 copy contains three extra repeats and is also truncated 
due to a premature stop codon (in purple), reducing its size to 540 bp. The protein 
products are very similar at N-terminus and central repeat region, but have distinct C-
termini (Fig.6.10). 
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distinct from the intergenic region between 1120 and 1110, which is flanking both 
1120 gene versions downstream. Since the OHL upstream flank had not been 
detected anywhere else in the locus, this suggested that both 1120 gene version 
localized to the beginning of the OHL and were not tandemly repeated – that is, 
the two 1120 genes are heterozygous. At the protein level both products comprise 
of 179 aa and have a conserved N-terminus and internal repeat region, while the 
C-terminal regions are distinct (Fig.6.10A). A total of seven distinct 10 aa repeats 
were  identified,  which  are  all  very  similar  (Fig.6.10B).  Whether  both  protein 
products are functionally distinct remains to be determined. 
 
The intergenic region showed the greatest level of sequence conservation, which 
was unexpected, because usually it is the non-functional intergenic regions which 
are  prone  to  variations  between  species  or  even  strains  (Fig.6.11).  This 
suggested  that  there  is  pressure  for  sequence  conservation  in  this  region, 
perhaps correlating with the presence of a SHERP homologue, which has a very 
short ORF (174 bp = 57 aa), within this region. Sequence analysis identified four 
potential  ORFs  within  the  ~1  Kb  intergenic  region  (Appendix  12).  The  largest 
potential ORF contained two methionines, which could both serve as a translation 
initiation site resulting in a 363 and 405 bp ORF coding for a 120 and 134 amino 
acid long hypothetical protein, respectively. The other potential ORFs contained 
219 bp, 192 bp and 177 bp and corresponded to 72, 63 and 58 amino acids long 
hypothetical proteins, respectively. However, BLAST searches against the amino 
acid sequences did not find any matches. 
 
In the LbrM.23.1110 gene flanked downstream by the 3’ OHL flanking region only 
two  distinct  sequences  were  observed  among  all  the  sequenced  clones 
(Fig.6.12).  These  were  distinct  by  a  single  synonymous  SNP  in  position  147 
(C→T) of the ORF. However, at least 5 distinct sequences were found for the 
LbrM.23.1110 ORFs flanked on both sides by the intergenic region with 7 SNPs in 
the ORF and three in the 3’ UTR, ranging between 1 – 7 SNPs per sequence 
compared to the available sequence of Lbr.23.1110 on GeneDB (Fig.6.13). A total 
of  9  distinct  SNPs  were  identified  by  comparison  of  all  LbrM.23.1110  ORFs 
(Fig.6.14; Table 6.2); 6 matched SNP locations identified previously by comparing 
sequences of L. (V.) braziliensis 2904 and 2903 (available on TriTrypDB). 3 SNPs 
were synonymous changes, while 6 were non-synonymous. However, 5 of the six 
amino  acid  changes  occurred  within  amino  acid  groups  of  strongly  similar 
properties (Table 6.2); only one at amino acid position 7 was random (R→G). 
This suggested that all 1110 proteins are closely related and may have the same212 
 
A) 
 
1120_v1  MGTICAKLSPMPRGTNRPTNQKGRGKGNKK-GGGHHRHGKKDGGDHGHEKVNGGDHGHE 
1120_v2  MGTICAKLSPMPRGTNRPTNQKGRGKGNKKKGGGHHRHGKKDGGDHGHEKVNGGDHGHE 
         ****************************** **************************** 
 
1120_v1  HMDGGHHGHEHMNGGDHGHEHMDGGQHGHEHMDGGDHGHEHMDGGDHGHGNMDGGDHGH 
1120_v2  HMDGGHHGHEHMNGGDHGHEHMDGGQHGHEHMDGGDHGHEHMDGGDHGHGNMDGGDHGH 
         *********************************************************** 
 
1120_v1  EHMDGGDHGHEHMDGGDHGHEHMNGGDHGHEHMDGGAPNGNGKDENMGNDNEHNGMGDD 
1120_v2  EHMDGGDHGHEHMDGGDHGHEHMDGGDHGHEHMDGGDHGHE---HMNGGDHGHEHMGDG 
         ***********************:************    :   .  * *. *: ***     
 
1120_v1  ANP-- 
1120_v2  APNGD 
         * 
 
B) 
 
Rep-blue        GGDHGHGNMD 
Rep-green       GGDHGHEKVN 
Rep-red         GGHHGHEHMN 
Rep-pink        GGDHGHEHMN 
Rep-purple      GGDHGHEHMG 
Rep-yellow      GGDHGHEHMD 
Rep-grey        GGQHGHEHMD 
                **.*** .:  
 
Fig.6.10 – Amino acid alignment of 1120_v1 and 1120_v2 
A) Amino acid alignment of 1120_v1 and 1120_v2 proteins based on their ORFs. The 
alignment shows high levels of sequence identity in the N-terminal and central repeat 
region  (coloured).  1120_v2  has  an  extra  lysine  at  position  31  due  to  an  inserted 
amino acid triplet (AAG). The change of T in the GTG codon to C (GCG) changes 
asparagine
141 to aspartic acid
141. The three central repeat insertions in 1120_v2 and 
most  polymorphisms  were  identified  towards  the  C-terminus,  which  is  distinct 
between  1120_v1  and  1120_v2.  Both  proteins  consist  of  179  aa,  however.  B) 
Alignment of distinct internal 10 aa repeats. Seven distinct repeat sequence of 10 aa 
were identified, with similarity to one another. The GGDHGHEHMD (yellow) is the 
most  frequently  occurring,  either  following  itself  or  alternating  with  the  other  six 
sequences, which occur only once per protein version. The GGDHGHEHMG (purple) 
is distinct for 1120_v2, although it is only the C-terminal glycine, which distinguishes 
it. 
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Inter-reg-1 TCCCTTTGCTTCTGTGTGTGTGTGTGCGTGTGTGGTCTCGTTGGCCTCATGCCAGACTAG 60 
Inter-reg-3 TCCCTTTGCTTCTGTGTGTGTGTGTGCGTGTGTGGTCTCGTTGGCCTCATGCCAGACTAG 60 
Inter-reg-4 TCCCTTTGCTTCTGTGTGTGTGTGTGCGTGTGTGGTCTCGTTGGCCTCATGCCAGACTAG 60 
Lbr2904     TCCCTTTGCTTCTGTGTGTGTGTGTGCGTGTGTGGTCTCGTTGGCCTCATGCCAGACTAG 60 
Inter-reg-5 TCCCTTTGCTTCTGTGTGTGTGTGTGCGTGTGTGGTCTCGTTGGCCTCATGCCAGACTAG 60 
            ************************************************************ 
 
Inter-reg-1 TACAGGATGCACATCCGCCCTTTCGCTGCCCCTGTCTTCTTTTCCTCGTCTGCTCTCTCT 120 
Inter-reg-3 TACAGGATGCACATCCGCCCTTTCGCTGCCCCTGTCTTCTTTTCCTCGTCTGCTCTCTCT 120 
Inter-reg-4 TACAGGATGCACATCCGCCCTTTCGCTGCCCCTGTCTTCTTTTCCTCGTCTGCTCTCTCT 120 
Lbr2904     TACAGGATGCACATCCGCCCTTTCGCTGCCCCTGTCTTCTTTTCCTCGTCTGCTCTCTCT 120 
Inter-reg-5 TACAGGATGCACATCCGCCCTTTCGCTGCCCCTGTCTTCTTTTCCTCGTCTGCTCTCTCT 120 
            ************************************************************ 
 
Inter-reg-1 CTCTCTTCTCCTTGAGGGGCTTTTTCTTTCCTTCATCATTCCGTCTATCTCTTTGTGTAC 180 
Inter-reg-3 CTCTCTTCTCCTTGAGGGGCTTTTTCTTTCCTTCATCATTCCGTCTATCTCTTTGTGTAC 180 
Inter-reg-4 CTCTCTTCTCCTTGAGGGGCTTTTTCTTTCCTTCATCATTCCGTCTATCTCTTTGTGTAC 180 
Lbr2904     CTCTCTTCTCCTTGAGGGGCTTTTTCTTTCCTTCATCATTCCGTCTATCTCTTTGTGTAC 180 
Inter-reg-5 CTCTCTTCTCCTTGAGGGGCTTTTTCTTTCCTTCATCATTCCGTCTATCTCTTTGTGTAC 180 
            ************************************************************ 
 
Inter-reg-1 GAGCTTGCGGTGCCTCTGTTTTCGAACATTTTCTCCTCTTTGGGGGGAGCCCTTCCCCCT 240 
Inter-reg-3 GAGCTTGCGGTGCCTCTGTTTTCGAACATTTTCTCCTCTTTGGGGGGAGCCCTTCCCCCT 240 
Inter-reg-4 GAGCTTGCGGTGCCTCTGTTTTCGAACATTTTCTCCTCTTTGGGGGGAGCCCTTCCCCCT 240 
Lbr2904     GAGCTTGCGGTGCCTCTGTTTTCGAACATTTTCTCCTCTTTGGGGGGAGCCCTTCCCCCT 240 
Inter-reg-5 GAGCTTGCGGTGCCTCTGTTTTCGAACATTTTCTCCTCTTTGGGGGGAGCCCTTCCCCCT 240 
            ************************************************************ 
 
Inter-reg-1 CTTTCCCCGTCCGGTGCACGTGTTTGCCACTCTTTTTCGTTTCGTTCTTCTGATGGCAGC 300 
Inter-reg-3 CTTTCCCCGTCCGGTGCACGTGTTTGCCACTCTTTTTCGTTTCGTTCTTCTGATGGCAGC 300 
Inter-reg-4 CTTTCCCCGTCCGGTGCACGTGTTTGCCACTCTTTTTCGTTTCGTTCTTCTGATGGCAGC 300 
Lbr2904     CTTTCCCCGTCCGGTGCACGTGTTTGCCACTCTTTTTCGTTTCGTTCTTCTGATGGCAGC 300 
Inter-reg-5 CTTTCCCCGTCCGGTGCACGTGTTTGCCACTCTTTTTCGTTTCGTTCTTCTGATGGCAGC 300 
            ************************************************************ 
 
Inter-reg-1 GAGCGGCGGCTGTGGCCTGCTGGGATGAGGTGTGGAGTGTGCCTGTCTGCGCACCGCTCT 360 
Inter-reg-3 GAGCGGCGGCTGTGGCCTGCTGGGATGAGGTGTGGAGTGTGCCTGTCTGCGCACCGCTCT 360 
Inter-reg-4 GAGCGGCGGCTGTGGCCTGCTGGGATGAGGTGTGGAGTGTGCCTGTCTGCGCACCGCTCT 360 
Lbr2904     GAGCGGCGGCTGTGGCCTGCTGGGATGAGGTGTGGAGTGTGCCTGTCTGCGCACCGCTCT 360 
Inter-reg-5 GAGCGGCGGCTGTGGCCTGCTGGGATGAGGTGTGGAGTGTGCCTGTCTGCGCACCGCTCT 360 
            ************************************************************ 
 
Inter-reg-1 ATTTCCGTGTCTCCACCCTCCCAAGCTGCCCACGTCCCCGCACGCGAGTCTGCCGGGGCA 420 
Inter-reg-3 ATTTCCGTGTCTCCACCCTCCCAAGCTGCCCACGTCCCCGCACGCGAGTCTGCCGGGGCA 420 
Inter-reg-4 ATTTCCGTGTCTCCACCCTCCCAAGCTGCCCACGTCCCCGCACGCGAGTCTGCCGGGGCA 420 
Lbr2904     ATTTCCGTGTCTCCACCCTCCCAAGCTGCCCACGTCCCCGCACGCGAGTCTGCCGGGGCA 420 
Inter-reg-5 ATTTCCGTGTCTCCACCCTCCCAAGCTGCCCACGTCCCCGCACGCGAGTCTGCCGGGGCA 420 
            ************************************************************ 
 
Inter-reg-1 GAAATGCTGTACTGCGCCGTAATAAAGGAAAACACGGAGACGAAGTGCGCCGGCGCCAGA 480 
Inter-reg-3 GAAATGCTGTACTGCGCCGTAATAAAGGAAAACACGGAGACGAAGTGCGCCGGCGCCAGA 480 
Inter-reg-4 GAAATGCTGTACTGCGCCGTAATAAAGGAAAACACGGAGACGAAGTGCGCCGGCGCCAGA 480 
Lbr2904     GAAATGCTGTACTGCGCCGTAATAAAGGAAAACACGGAGACGAAGTGCGCCGGCGCCAGA 480 
Inter-reg-5 GAAATGCTGTACTGCGCCGTAATAAAGGAAAACACGGAGACGAAGTGCGCCGGCGCCAGA 480 
            ************************************************************ 
 
Inter-reg-1 GCACACGCTCACGCACACGTACACGGGCGCTGCGTGGTACGGTTTAGTGGATGGCACGCC 540 
Inter-reg-3 GCACACGCTCACGCACACGTACACGGGCGCTGCGTGGTACGGTTTAGTGGATGGCACGCC 540 
Inter-reg-4 GCACACGCTCACGCACACGTACACGGGCGCTGCGTGGTACGGTTTAGTGGATGGCACGCC 540 
Lbr2904     GCACACGCTCACGCACACGTACACGGGCGCTGCGTGGTACGGTTTAGTGGATGGCACGCC 540 
Inter-reg-5 GCACACGCTCACGCACACGTACACGGGCGCTGCGTGGTACGGTTTAGTGGATGGCACGCC 540 
            ************************************************************ 
 
Inter-reg-1 TAAGCACTGTGAGAAAGCGGCGCGCTCTCTCTCCAAAAAGGCACACTCGCCATGGTGGTG 600 
Inter-reg-3 TAAGCACTGTGAGAAAGCGGCGCGCTCTCTCTCCAAAAAGGCACACTCGCCATGGTGGTG 600 
Inter-reg-4 TAAGCACTGTGAGAAAGCGGCGCGCTCTCTCTCCAAAAAGGCACACTCGCCATGGTGGTG 600 
Lbr2904     TAAGCACTGTGAGAAAGCGGCGCGCTCTCTCTCCAAAAAGGCACACTCGCCATGGTGGTG 600 
Inter-reg-5 TAAGCACTGTGAGAAAGCGGCGCGCTCTCTCTCCAAAAAGGCACACTCGCCATGGTGGTG 600 
            ************************************************************ 
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Inter-reg-1 AGCCCCTTTCGTCGCTTGCTTTTCTGTTTCAGCCCCCAGTGCGAATGCACATGTGTACTT 660 
Inter-reg-3 AGCCCCTTTCGTCGCTTGCTTTTCTGTTTCAGCCCCCAGTGCGAATGCACATGTGTACTT 660 
Inter-reg-4 AGCCCCTTTCGTCGCTTGCTTTTCTGTTTCAGCCCCCAGTGCGAATGCACATGTGTACTT 660 
Lbr2904     AGCCCCTTTCGTCGCTTGCTTTTCTGTTTCAGCCCCCAGTGCGAATGCACATGTGTACTT 660 
Inter-reg-5 AGCCCCTTTCGTCGCTTGCTTTTCTGTTTCAGCCCCCAGTGCGAATGCACATGTGTACTT 660 
            ************************************************************ 
 
Inter-reg-1 ACGGGCTGCGGTTGCTGCGAAAGGAACAAGCTAACATGCCCGGGGCACCGCATTTCTGTT 720 
Inter-reg-3 ACGGGCTGCGGTTGCTGCGAAAGGAACAAGCTAACATGCCCGGGGCACCGCATTTCTGTT 720 
Inter-reg-4 ACGGGCTGCGGTTGCTGCGAAAGGAACAAGCTAACATGCCCGGGGCACCGCATTTCTGTT 720 
Lbr2904     ACGGGCTGCGGTTGCTGCGAAAGGAACAAGCTAACATGCCCGGGGCACCGCATTTCTGTT 720 
Inter-reg-5 ACGGGCTGCGGTTGCTGCGAAAGGAACAAGCTAACATGCCCGGGGCACCGCATTTCTGTT 720 
            ************************************************************ 
 
Inter-reg-1 AAAGAACCTTCGATCCTGCTGCGTGTTTCTCT 752 
Inter-reg-3 AAAGAACCTTCGATCCTGCTGCGTGTTTCTCT 752 
Inter-reg-4 AAAGAACCTTCGATCCTGCTGCGTGTTTCTCT 752 
Lbr2904     AAAGAACCTTCGATCCTGCTGCGTGTTTCTCT 752 
Inter-reg-5 AAAGAACCTTCGATCCTGCTGCGTGTTTCTCT 752 
            ******************************** 
 
Fig.6.11 – Conserved intergenic region between OHL genes 
The  intergenic  region  between  LbrM.23.1110  and  LbrM.23.1120  shown  is  highly 
conserved (100% identity) between all sequenced clones. No SNPs were found.  215 
 
1110+3'f-2  CACTGCTCTCTCTCCCCCACCTATAAGCAATGGGGACCGCCTGTATGAGGGAGTTGACGA 717 
1110+3'f-1  CACTGCTCTCTCTCCCCCACCTATAAGCAATGGGGACCGCCTGTATGAGGGAGTTGACGA 720 
Lbr1110+3'f CACTGCTCTCTCTCCCCCACCTATAAGCAATGGGGACCGCCTGTATGAGGGAGTTGACGA 717 
            ************************************************************ 
 
1110+3'f-2  GGCCGCGCACGTTCGACCTTAAGGCTCACGGGATGGGCGGTGGCAAAGGGGATAGGGCGA 777 
1110+3'f-1  GGCCGCGCACGTTCGACCTTAAGGCTCACGGGATGGGCGGTGGCAAAGGGGATAGGGCGA 780 
Lbr1110+3'f GGCCGCGCACGTTCGACCTTAAGGCTCACGGGATGGGCGGTGGCAAAGGGGATAGGGCGA 777 
            ************************************************************ 
 
1110+3'f-2  ACGGCGGCGAGCATGGACATGAACATATGAACGGCGGCGACCATGGACATGAACACATGG 837 
1110+3'f-1  ACGGCGGCGAGCATGGACATGAACATATGAACGGCGGCGACCATGGACATGAACATATGG 840 
Lbr1110+3'f ACGGCGGCGAGCATGGACATGAACATATGAACGGCGGCGACCATGGACATGAACATATGG 837 
            ******************************************************* **** 
 
 
1110+3'f-2  ACGGTGGCGACCATGGACATGAACATATGGACGGTGGCGCACCTAACGGGAATGGGAAGG 897 
1110+3'f-1  ACGGTGGCGACCATGGACATGAACATATGGACGGTGGCGCACCTAACGGGAATGGGAAGG 900 
Lbr1110+3'f ACGGTGGCGACCATGGACATGAACATATGGACGGTGGCGCACCTAACGGGAATGGGAAGG 897 
            ************************************************************ 
 
1110+3'f-2  ATGAAAATATGGGGAACGATAACGAGCATAATGGGATGGGTGATGATGCCAACCCCTGAT 957 
1110+3'f-1  ATGAAAATATGGGGAACGATAACGAGCATAATGGGATGGGTGATGATGCCAACCCCTGAT 960 
Lbr1110+3'f ATGAAAATATGGGGAACGATAACGAGCATAATGGGATGGGTGATGATGCCAACCCCTGAT 957 
            ************************************************************ 
 
1110+3'f-2  GTGCTGCGTGCCGGCTTGTGCTTGTGGGCCGAGCCCTTCGTCGGGCCTCTTGTGCCTCGT 1017 
1110+3'f-1  GTGCTGCGTGCCGGCTTGTGCTTGTGGGCCGAGCCCTTCGTCGGGCCTCTTGTGCCTCGT 1020 
Lbr1110+3'f GTGCTGCGTGCCGGCTTGTGCTTGTGGGCCGAGCCCTTCGTCGGGCCTCTTGTGCCTCGT 1017 
            ************************************************************ 
----------------------------------------------------------------------------- 
 
1110+3'f-2  AAAGAAAAGCATAGTAGCGCAGCGCTCTCGTTCGTGCTGGTCCCTCGCTCTCGCCCCCCT 2637 
1110+3'f-1  AAAGAAAAGCATAGTAGCGCAGCGCTCTCGTTCGTGCTGGTCCCTCGCTCTCGCCCCCCT 2640 
Lbr1110+3'f AGAGAAAAGCATAGTAGCGCAGCGCTCTCGTTCGTGCTGGTCCCTCGCTCTCGCCCCCCT 2637 
            *.********************************************************** 
 
1110+3'f-2  TTTTATTGTTTACTGAGTCTGCATGCGCTTGTGGAGGTTGCTCTCGCACCACGCCATCGA 2697 
1110+3'f-1  TTTTATTGTTTACTGAGTCTGCATGCGCTTGTGGAGGTTGCTCTCGCACCACGCCATCGA 2700 
Lbr1110+3'f TTTTATTGTTTACTGAGTCTGCATGCGCTTGTGGAGGTTGCTCTCGCACCACGCCATCGA 2697 
            ************************************************************ 
 
1110+3'f-2  TGAGGAAAGGGCGAGATAAAAACAACCCATCAGGTAACTTTCATGATATCAGCCTCTCTC 2757 
1110+3'f-1  TGAGGAAAGGGCGAGATAAAAACAACCCATCAGGTAACTTTCATGATATCAGCCTCTCTC 2760 
Lbr1110+3'f TGAGGAAAGGGCGAGATAAAAACAACCCATCAGGTAACTTTCATGATATCAGCCTCTCTC 2757 
            ************************************************************ 
 
1110+3'f-2  TGCCTGTCTCTGTCTGTCTCTCCGCGTCTGTGTCTGTGTGTGTGTGTGTGTTGTGCTATG 2817 
1110+3'f-1  TGCCTGTCTCTGTCTGTCTCTCCGCGTCTGTGTCTGTGTGTGTGTGTGTGTTGTGCTATG 2820 
Lbr1110+3'f TGCCTGTCTCTGTCTGTCTCTCCGCGTCTGTGTCTGTGTGTGTGTGTGTGTTGTGCTATG 2817 
            ************************************************************ 
 
1110+3'f-2  GGGGTCTGCATGCGAAGCTTTGTGGCACTAACACCCCTCGCTTTGAAGGTAGCTCGAGAA 2877 
1110+3'f-1  GGGGTCTGCATGCGAAGCTTTGTGGCACTAACACCCCTCGCTTTGAAGGTAGCTCGAGAA 2880 
Lbr1110+3'f GGGGTCTGCATGCGAAGCTTTGTGGCACTAACACCCCTCGCTTTGAAGGTAGCTCGAGAA 2877 
            ************************************************************ 
 
1110+3'f-2  AAGAATTGCTATAGTGAGTCACGTTAAACAGCGAACTTAGGGAAGGCGGAAAGGGTTGAT 2937 
1110+3'f-1  AAGAAATGCTATAGTGAGTCACGTTAAACAGCGAACTTAGGGAAGGCGGAAAGGGTTGAT 2940 
Lbr1110+3'f AAGAATTGCTATAGTGAGTCACGTTAAACAGCGAACTTAGG-AAGGCGGAAAGGTTTGAT 2936 
            *****:*********************************** ************ ***** 
 
1110+3'f-2  ACATGTCGCAAGGTGAGCTCTAATGCCCGTACCCCCTGCGCTACCCAACCTTCTCCCTCT 2997 
1110+3'f-1  ACATGTCGCAAGGTGAGCTCTAATGCCCGTACCCCCTGCGCTACCCAACCTTCTCCCTCT 3000 
Lbr1110+3'f ACATGTCGCAAGGTGAGCTCTAATGCCCGTACCCCCTGCGCTACCCAACCTTCTCCCTCT 2996 
            ************************************************************ 
 
1110+3'f-2  CCGCCGCCACGCAGAGAGAGAGAGAGAGAGAGCAGCTGTTTTACCCAAAAGAAAAAGAGC 3057 
1110+3'f-1  CCGCCGCCACGCAGAGAGAGAGAGAGAGAGAGCAGCTGTTTTACCCAAAAGAAAAAGAGC 3060 
Lbr1110+3'f CCGCCGCCACGCAGAGAGAGAGAGAGAGAGAGCAGCTGTTTTACCCAAAAGAAAAAGAGC 3056 
            ************************************************************ 216 
 
1110+3'f-2  ACACTTGCCCGGGAAATGAAGCGGGACAATCAAAGTACACGTGGGTTTCACCTGTGGAAA 3117 
1110+3'f-1  ACACTTGCCCGGGAAATGAAGCGGGACAATCAAAGTACACGTGGGTTTCACCTGTGGAAA 3120 
Lbr1110+3'f ACACTCGCACGCGAACTGAAGCGCGACAATCAACGTACACGTGCGTTTCACCTGTGGAAA 3116 
            ***** **.** ***.******* *********.********* **************** 
 
1110+3'f-2  GTGAACATTTGCTGATCACCTCGACAGGGGGGGGGGGACGCTTTCGAGATGATTTGTGAA 3177 
1110+3'f-1  GTGAACATTTGCTGATCACCTCGACAGGGGGGGGGGGACGCTTTCGAGATGATTTGTGAA 3180 
Lbr1110+3'f GTGAACATTCGCTGATCACCTCGACAGGGGGGGGGTGACGCTTCCGAGATGATTCGTGAA 3176 
            ********* ************************* ******* ********** ***** 
 
1110+3'f-2  CGGATGGTGATGGGAGTTGGGGGGAAGGAGAATGGAGAAAGAGAGAGCCTAATTGTGTGT 3237 
1110+3'f-1  CGGATGGTGATGGGAGTTGGGGGGAAGGAGAATGGAGAAAGAGAGAGCCTAATTGTGTGT 3240 
Lbr1110+3'f CGGATGGTGATGGGAGTTGGTGGGAAGGAGAATGGAGAACGAGAGAGCCTACTTGTGTGT 3236 
            ******************** ******************.***********.******** 
 
1110+3'f-2  AGCCATTTTTGAGTGTTTGTTGTTTGTTTCCCCGTCGCCCGCCCCCTTCACTTACGTTTT 3297 
1110+3'f-1  AGCCATTTTTGAGTGTTTGTTGTTTGTTTCCCCGTCGCCCGCCCCCTTCACTTACGTTTT 3300 
Lbr1110+3'f AGCCATCTCTGAGTGTCTGTCGTCTGTCTCCCCGTCGCCCGCCACCTTCACTTACGTTTT 3296 
            ****** * ******* *** ** *** ***************.**************** 
 
1110+3'f-2  TTTCCCTTGCTTTGTGAATTGCTAACCTGCTTGGTGGTGTTGGGCATTGTTGCTACCCCC 3357 
1110+3'f-1  TTTCCCTTGCTTTGTGAATTGCTAACCTGCTTGGTGGTGTTGGGCATTGTTGCTACCCCC 3360 
Lbr1110+3'f TCTCCCTTGCTCTGTGAATTGCTAACCTGCTTGCTGGTGTTGCGCATCGTTGCTACCCCC 3356 
            * ********* ********************* ******** **** ************ 
 
 
1110+3'f-2  CCCCCCCCC-------CCCCGTCCATCTTGTACACCTGCTTCTCACCATCTCTCTTTTTG 3410 
1110+3'f-1  CCCCCCCCC-------CCCCGTCCATCTTGTACACCTGCTTCTCACCATCTCTCTTTTTG 3413 
Lbr1110+3'f CTCCCCCCCACCACCCCCCCGTCCATCTTGTACACCTGCTTCTCACCATCTCTCTTTTTG 3416 
            * *******       ******************************************** 
 
1110+3'f-2  CGGATCATCCTCTTTCATGTTCGCTGCACAGTTTGGTGCACATTCATCTGTCCTCCTTTT 3470 
1110+3'f-1  CGGATCATCCTCTTTCATGTTCGCTGCACAGTTTGGTGCACATTCATCTGTCCTCCTTTT 3473 
Lbr1110+3'f CGGATCATCCTCTTTCATGTTCGCTGCACAGTTTGGTGCACATTCATCTGTCCTCCTTTT 3476 
            ************************************************************ 
 
1110+3'f-2  ACCCCATTAAAGCCCACTCGCCCACACCCATTCATACACACTAAAAACGTGAAGTGG 3527 
1110+3'f-1  ACCCCATTAAAGCCCACTCGCCCACACCCATTCATACACACTAAAAACGTGAAGTGG 3530 
Lbr1110+3'f ACCCCATTAAAGCCCACTCGCCCACACCCATTCATACACACTAAAAACGTGAAGTGG 3533 
            ********************************************************* 
 
Fig.6.12 – Sequence alignment of down-stream LbrM.23.1110 gene copy with 
3’flanking region of OHL 
The most downstream copy of LbrM.23.1110 has a 3’ flanking region distinct of the 
intergenic region, which separated the OHL from the downstream Lbr.23.1100 gene. 
Only  two  distinct  fragment  sequences  were  identified  among  several  sequence 
clones.  Here  only  a  part  of  the  sequenced  fragment  is  shown  (full  sequence  in 
Appendix 13). The first cut out shows the ORF of LbrM.23.1110 (red), where only one 
SNP (green) was identified. No SNPs were found in the UTRs. However, in second 
sequence cut out of the 3’ flanking region of the OHL, many SNPs were identified 
compared to the available sequence on GeneDB (green).   217 
 
1110+int-3 TGCTCTCTCTCCCCCACCTATAAGCAATGGGGACCGCCTGTATGAGGGAGTTGACGAGGC 720 
1110+int-5 TGCTCTCTCTCCCCCACCTATAAGCAATGGGGACCGCCTGTATGAGGGAGTTGACGAGGC 720 
1110+int-1 TGCTCTCTCTCCCCCACCTATAAGCAATGGGGACCGCCTGTATGAGGGAGTTGACGAGGC 720 
1110+int-2 TGCTCTCTCTCCCCCACCTATAAGCAATGGGGTCCGCCTGTATGGGGGAGTTCACGAGGC 720 
Lbr2904    TGCTCTCTCTCCCCCACCTATAAGCAATGGGGACCGCCTGTATGAGGGAGTTGACGAGGC 720 
1110+int-4 TGCTCTCTCTCCCCCACCTATAAGCAATGGGGTCCGCCTGTATGGGGGAGTTGACGAGGC 720 
           ******************************** *********** ******* ******* 
 
1110+int-3 CGCGCACGTTCGACCTTAAGGCTCACGGGATGGGCGGTGGCAAAGGGGATAGGGCGAACG 780 
1110+int-5 CGCGCACGTTCGACCTTAAGGCTCACGGGATGGGCGGTGGCAAAGGGGATAGGGCGAACG 780 
1110+int-1 CGCGCACGTTCGACCTTAAGGCTCACGGGATGGGCGGTGGCAAAGGGGATAGGGCGAACG 780 
1110+int-2 CGCGCACGTTCGACCTTAAGGCTCACGGGATGGGCGGTGGCAAAGGGGATAGGGCGAACG 780 
Lbr2904    CGCGCACGTTCGACCTTAAGGCTCACGGGATGGGCGGTGGCAAAGGGGATAGGGCGAACG 780 
1110+int-4 CGCGCACGTTCGACCTTAAGGCTCACGGGATGGGCGGTGGCAAAGGGGATAGGGCGAACG 780 
           ************************************************************ 
 
1110+int-3 GCGGCGAGCATGGACATGAACATATGAACGGCGGCGACCATGGACATGAACATATGGACG 840 
1110+int-5 GCGGCGAGCATGGACATGAACATATGAACGGT---------------------------- 811 
1110+int-1 GCGGCGAGCATGGACATGAACATATGGACGGTGGCGACCATGGACATGAACATATGAACG 840 
1110+int-2 GCGGCGAGCATGGACATGAACATATGGACGGTGGCGACCATGGACATGAACATATGAACG 840 
Lbr2904    GCGGCGAGCATGGACATGAACATATGAACGGCGGCGACCATGGACATGAACATATGGACG 840 
1110+int-4 GCGGCGAGCATGGACATGAACATATGGACGGTGGCGACCATGGACATGAACATATGAACG 840 
           ************************** ****                              
 
1110+int-3 GTGGCGACCATGGACATGAACATATGGACGGTGGCGCACCTAACGGGAATGGGAAGGATG 900 
1110+int-5 --GGCGACCATGGACATGAACATATGGACGGTGGCGCACCTAACGGGAATGGGAAGGATG 870 
1110+int-1 GTGGCGACCATGGACATGAACATATGGACGGTGGCGCACCTAACGGGAATGGGAAGGATG 900 
1110+int-2 GTGGCGACCATGGACATGAACATATGGACGGTGGCGCACCTAACGGGAATGGGAAGGATG 900 
Lbr2904    GTGGCGACCATGGACATGAACATATGGACGGTGGCGCACCTAACGGGAATGGGAAGGATG 900 
1110+int-4 GTGGCGACCATGGACATGAACATATGGACGGTGGCGCACCTAACGGGAATGGGAAGGATG 900 
             ********************************************************** 
 
1110+int-3 AAAATATGGGGAACGATAACGAGCATAATGGGATGGGTGATGATGCCAACCCCTGATGTG 960 
1110+int-5 AAAATATGGGGAACGATAACGAGCATAATGGGATGGGTGATGATGCCAACCCCTGATGTG 930 
1110+int-1 AAAATATGGGGAACGATAACGAGCATAATGGGATGGGTGATGATGCCAACCCCTGATGTG 960 
1110+int-2 AAAATATGGGGAACGATAACGAACATAATGGGATAGGTGATGATGCCAACCCCTGATGTG 960 
Lbr2904    AAAATATGGGGAACGATAACGAGCATAATGGGATGGGTGATGATGCCAACCCCTGATGTG 960 
1110+int-4 AAAATATGGGGAACGATAACGAGCATAATGGGATGGGTGATGATGCCAACCCCTGATGTG 960 
           ********************** *********** ************************* 
 
1110+int-3 CTGCGTGCCGGCTTGTGCTTGTGGGCCGAGCCCTTCGTCGGGCCTCTTGTGCCTCGTGCG 1020 
1110+int-5 CTGCGTGCCGGCTTGTGCTTGTGGGCCGAGCCCTTCGTCGGGCCTCTTGTGCCTCGTGCG 990 
1110+int-1 CTGCGTGCCGGCTTGTGCTTGTGGGCCGAGCCCTTCGTCGGGCCTCTTGTGCCTCGTGCG 1020 
1110+int-2 CTGCGTGCCGGCTTGTGCTTGTGGGCCGAGCCCTTCGTCGGGCCTCTTGTGCCTCGTGCG 1020 
Lbr2904    CTGCGTGCCGGCTTGTGCTTGTGGGCCGAGCCCTTCGTCGGGCCTCTTGTGCCTCGTGCG 1020 
1110+int-4 CTGCATGCCGGCTTGTGCTTGTGGGCCGAGCCCTTCGTCGGGCCTCTTGTGCCTCGTGCG 1020 
           **** ******************************************************* 
 
1110+int-3 CAGACTGCGTGTGTTGCTCGCGGTTCGTGTCTCTCCGCACACAGTGGCTAATGCCTGCCT 1080 
1110+int-5 CAGACTGCGTGTGTTGCTCGCGGTTCGTGTCTCTCCGCACACAGTGGCTAATGCCTGCCT 1050 
1110+int-1 CAGACTGCGTGTGTTGCTCGCGGTTCGTGTCTCTCCGCACACAGTGGCTAATGCCTGCCT 1080 
1110+int-2 CAGACTGCGTGTGTTGCTCGCGGTTCGTGTCTCTCCGCACACAGTGGCTAATGCCTGCCT 1080 
Lbr2904    CAGACTGCGTGTGTTGCTCGCGGTTCGTGTCTCTCCGCACACAGTGGCTAATGCCTGCCT 1080 
1110+int-4 CAGACTGCGTGTGTTGCTCGCGGTTCGTGTCTCTCCGCACACAGTGGCTAATGCCTGCCT 1080 
           ************************************************************ 
1110+int-3 GGGGTCGTTGTGATTGTACCTCATGGGCACCCCCGGCTTTCCCCGACTCGACTTCCCCTC 1140 
1110+int-5 GGGGTCGTTGTGATTGTACCTCATGGGCACCCCCGGCTTTCCCCGACTCGACTTCCCCTC 1110 
1110+int-1 GGGGTCGTTGTGATTGTACCTCATGGGCACCCCCGGCTTTCCCCGACTCGACTTCCCCTC 1140 
1110+int-2 GGGGTCGTTGTGATTGTACCTCATGGGCACCCCCGGCTTTCCCCGACTCGACTTCCCCTC 1140 
Lbr2904    GGGGTCGTTGTGATTGTACCTCATGGGCACCCCCGGCTTTCCCCGACTCGACTTCCCCTC 1140 
1110+int-4 GGGGTCGTTGTGATTGTACCTCATGGGCACCCCCGGCTTTCCCCGACTCGACTTCCCCTC 1140 
           ************************************************************ 
 
1110+int-3 TCCGCTTCCGAGTGTGTGGTGGGTGTGGGGTTGGGCGCATAATGGACATTGTCGGTGGAT 1200 
1110+int-5 TCCGCTTCCGAGTGTGTGGTGGGTGTGGGGTTGGGCGCATAATGGACATTGTCGGTGGAT 1170 
1110+int-1 TCCGCTTCCGAGTGTGTGGTGGGTGTGGGGTTGGGCGCATAATGGACATTGTCGGTGGAT 1200 
1110+int-2 TCCGCTTCCGAGTGTGTGGTGGGTGTGGGGTTGGGCGCATAATGGACATTGTCGGTGGAT 1200 
Lbr2904    TCCGCTTCCGAGTGTGTGGTGGGTGTGGGGTTGGGCGCATAATGGACATTGTCGGTGGAT 1200 
1110+int-4 TCCGCTTCCGAGTGTGTGGTGGGTGTGGGGTTGGGCGCATAATGGACATTGTCGGTGGAT 1200 
           ************************************************************ 
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1110+int-3 GCGCGACGACTGCCGCTACACAACTGTGGCCACGCCGAGTCCTGTGTGTGTATGCTTAGA 1260 
1110+int-5 GCGCGACGACTGCCGCTACACAACTGTGGCCACGCCGAGTCCTGTGTGTGTATGCTTAGA 1230 
1110+int-1 GCGCGACGACTGCCGCTACACAACTGTGGCCACGCCGAGTCCTGTGTGTGTATGCTTAGA 1260 
1110+int-2 GCGCGACGACTGCCGCTACACAACTGTGGCCACGCCGAGTCCTGTGTGTGTATGCTTAGA 1260 
Lbr2904    GCGCGACGACTGCCGCTACACAACTGTGGCCACGCCGAGTCCTGTGTGTGTATGCTTAGA 1260 
1110+int-4 GCGCGACGACTGCCGCTACACAACTGTGGCCACGCCGAGTCCTGTGTGTGTATGCTTAGA 1260 
           ************************************************************ 
 
1110+int-3 TCACCGGTGCTAGCAGCTCTCTTGCTGCCTCTGCGTGGACTCTCTTTGTTTCTTGTGTCT 1320 
1110+int-5 TCACCGGTGCTAGCAGCTCTCTTGCTGCCTCTGCGCGGACTCTCTTTGTTTCTTGTGTCT 1290 
1110+int-1 TCACCGGTGCTAGCAGCTCTCTTGCTGCCTCTGCGCGGACTCTCTTTGTTTCTTGTGTCT 1320 
1110+int-2 TCACCGGTGCTAGCAGCTCTCTTGCTGCCTCTGCGCGGACTCTCTTTGTTTCTTGTGTCT 1320 
Lbr2904    TCACCGGTGCTAGCAGCTCTCTTGCTGCCTCTGCGCGGACTCTCTTTGTTTCTTGTGTCT 1320 
1110+int-4 TCACCGGTGCCAGCAGCTCTCTTGCTGCCTCTGCGCGGACTCTCTTTGTTTCTTGTGTCT 1320 
           ********** ************************ ************************ 
 
1110+int-3 TTTCTGTTCGGGTACCTCTACGCATGCGCATACCCCCTCCCTGCCTCTTCCCCTCTTTAC 1380 
1110+int-5 TTTCTGTTCGGGTACCTCTACGCATGCGCATACCCCCTCCCTGCCTCTTCCCCTCTTTAC 1350 
1110+int-1 TTTCTGTTCGGGTACCTCTACGCATGCGCATACCCCCTCCCTGCCTCTTCCCCTCTTTAC 1380 
1110+int-2 TTTCTGTTCGGGTACCTCTACGCATGCGCATACCCCCTCCCTGCCTCTTCCCCTCTTTAC 1380 
Lbr2904    TTTCTGTTCGGGTACCTCTACGCATGCGCATACCCCCTCCCTGCCTCTTCCCCTCTTTAC 1380 
1110+int-4 TTTCTGTTCGGGTACCTCTACGCATGCGCATACCCCCTCCCTGCCTCTTCCCCTCTTTAC 1380 
           ************************************************************ 
 
1110+int-3 CTCAGTGCGTCACACAGTGAGCTCCCTTCCCTCGACCTTATTTTGCTGCCTCTGGCGCCT 1440 
1110+int-5 CTCAGTGCGTCACACAGTGAGCTCCCTTCCCTCGACCTTATTTTGCTGCCTCTGGCGCCT 1410 
1110+int-1 CTCAGTGCGTCACACAGTGAGCTCCCTTCCCTCGACCTTATTTTGCTGCCTCTGGCGCCT 1440 
1110+int-2 CTCAGTGCGTCACACAGTGAGCTCCCTTCCCTCGACCTTATTTTGCTGCCTCTGGCGCCT 1440 
Lbr2904    CTCAGTGCGTCACACAGTGAGCTCCCTTCCCTCGACCTTATTTTGCTGCCTCTGGCGCCT 1440 
1110+int-4 CTCAGTGCGTCACACAGTGAGCTCCCTTCCCTCGACCTTATTTTGCTGCCTCTGGCGCCT 1440 
           ************************************************************ 
 
 
Fig.6.13 – Multiple copies and polymorphisms in LbrM.23.1110 
A part of the sequences of the fragments amplified by divergent primers from the 
intergenic region, which contain SNPs, are shown (full sequence in Appendix 14). A 
set  of  fragments  containing  a  single  copy  of  LbrM.23.1110  flanked  up-  and 
downstream by the same intergenic region were generated with the divergent primers 
unexpectedly (Fig.6.7). Seven SNPs (green) were identified within the ORF (marked 
in red for the Lbr2904) and three in the 3’ UTR of the gene. In one case (1110+int-5) 
a sequence repeat was deleted from the central region (blue).  
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1110+int-2    MGSACMGEFTRPRTFDLKAHGMGGGKGDRANGGEHGHEHMDGGDHGHEHMNGGDHGHEHM 
1110+int-4    MGSACMGELTRPRTFDLKAHGMGGGKGDRANGGEHGHEHMDGGDHGHEHMNGGDHGHEHM 
1110+int-1    MGTACMRELTRPRTFDLKAHGMGGGKGDRANGGEHGHEHMDGGDHGHEHMNGGDHGHEHM 
1110+int-5    MGTACMRELTRPRTFDLKAHGMGGGKGDRANGGEHGHEHMNGGDHGHEHMDGG------- 
1110+int-3    MGTACMRELTRPRTFDLKAHGMGGGKGDRANGGEHGHEHMNGGDHGHEHMDGGDHGHEHM 
1110+3'f-1    MGTACMRELTRPRTFDLKAHGMGGGKGDRANGGEHGHEHMNGGDHGHEHMDGGDHGHEHM 
1110+3'f-2    MGTACMRELTRPRTFDLKAHGMGGGKGDRANGGEHGHEHMNGGDHGHEHMDGGDHGHEHM 
Lbr2904       MGTACMRELTRPRTFDLKAHGMGGGKGDRANGGEHGHEHMNGGDHGHEHMDGGDHGHEHM 
              **:*** *:*******************************:*********:**        
 
1110+int-2    DGGAPNGNGKDENMGNDNEHNGIGDDANP 
1110+int-4    DGGAPNGNGKDENMGNDNEHNGMGDDANP 
1110+int-1    DGGAPNGNGKDENMGNDNEHNGMGDDANP 
1110+int-5    ---APNGNGKDENMGNDNEHNGMGDDANP 
1110+int-3    DGGAPNGNGKDENMGNDNEHNGMGDDANP 
1110+3'f-1    DGGAPNGNGKDENMGNDNEHNGMGDDANP 
1110+3'f-2    DGGAPNGNGKDENMGNDNEHNGMGDDANP 
Lbr2904       DGGAPNGNGKDENMGNDNEHNGMGDDANP 
                 *******************:****** 
 
Fig.6.14 – Alignment of distinct 1110 amino acid sequences 
The DNA sequence obtained by subcloning and sequencing of LbrM.23.1110 were 
translated and aligned. SNPs in the ORF location 7, 19, 27, 121, 126 and 151 had 
been previously identified by comparing sequences from L. (V.) braziliensis 2904 and 
2903 for  this  ORF  and are  available  on TriTryp.  Five  of six  the  non-synonymous 
amino acid changes occurred within groups of strongly similar properties and only 
one was random (position 7 in the amino acid sequence). 
 
Table 6.2 – SNPs with the LbrM.23.1110 and Lbr.23.1120 ORFs 
Gene in OHL  Position in 
ORF 
Base 
Change  Non-/Syn.  Position in 
AA seq. 
AA 
Change 
LbrM.23.1110  7  A→T  Non-syn.  3  T→S 
LbrM.23.1110  19  A→G  Non-syn.  7  R→G 
LbrM.23.1110  27  G→C  Non-syn.  9  L→F 
LbrM.23.1110  121  A→G  Non-syn.  41  N→D 
LbrM.23.1110  126  C→T  Syn.  42   
LbrM.23.1110  147  T→C  Syn.  49   
LbrM.23.1110  151  G→A  Non-syn.  51  D→N 
LbrM.23.1110  237  G→A  Syn.  79   
LbrM.23.1110  249  G→A  Non-syn.  83  M→I 
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function. In one case, the deletion of an entire sequence repeat (30 nt or 10 aa) 
within  the  ORF  was  observed,  too,  which  changed  the  ORF  size  (Fig.6.13). 
However,  all  sequenced  clones  of  LbrM.23.1110  flanked  up-  and  downstream 
with the intergenic region were of very similar size and did  not account for all 
bands detected by OHL I on the southern blot (Fig.6.15). 
 
In  summary,  the  OHL  shows  intra-species  size  variation.  Two  distinct 
heterozygous  copies  of  LbrM.23.1120  and  a  single  polymorphism  in 
LbrM.23.1110 were found in the L. (V.) braziliensis 2904 gDNA. In addition, it was 
shown that multiple LbrM.23.1110 copies occur within the OHL flanked by the 
intergenic region as a tandem repeat array of 3-4 copies. It was also found that 
the intergenic region is unusually well preserved, which suggests the presence of 
a  yet  to  be  identified  SHERP  homologue  within  the  intergenic  region.  Four 
hypothetical ORFs were found within the intergenic region, but no homologues 
were  found  for  the  hypothetical  proteins.  However,  since  SHERP  is  a  unique 
protein to L. (Leishmania) spp., it could be that this hypothetical gene within the 
OHL intergenic region is unique to L. (Viannia) spp. 
 
6.4. Generating L. (V.) braziliensis OHL double deletion mutants 
Rogers et al. (2011) had suggested that L. (V.) braziliensis 2409 was generally 
triploid. For phenotypic comparison between L. (L.) major cDNA16 locus and L. 
(V.) braziliensis OHL fill deletion mutants, it was, therefore, necessary to generate 
an  L.  (V.)  braziliensis  OHL  triple  deletion  mutant  by  sequential  homologous 
recombination.  Three  OHL  deletion  constructs  were  generated  by  the  same 
method employed for the HASP and SHERP replacement constructs (see 3.2) 
using the OHL 5’ and 3’ flanking regions available on TriTrypDB and a cassette 
containing the antibiotic resistance gene (SAT, NEO or BSD) flanked by DHFR 
flanking regions (Fig.6.16). The minimal concentrations of SAT, NEO and BSD 
required  for  killing  the  L.  (V.)  braziliensis  parental  strain  (Lbr2904)  were 
determined by Lbr2904 growth in M199 with different antibiotic concentration. 
  
The first OHL allele deleted was performed with a BSD-deletion construct. Initially 
positive/negative screening was done by PCR (Fig.6.15). Using a forward primer 
upstream of the integration within Lbr2904 genomic DNA and a reverse primer 
within the construct’s 5’ DHFR flanking region, a ~2.1 Kb band was expected to 
confirm construct integration. A Southern blot of SacI digested gDNA samples of 
all  PCR  positive  single  OHL  deletion  mutants  was  used  to  determine  correct 
integration of a single BSD-deletion construct copy (Fig.6.17). Out of 12 tested221 
 
 
 
Fig.6.15 – PCR screen for verification of OHL single deletion 
The gel images shows examples of LbrOHL sKO clones, which checked positive. A 
~2 Kb band was expected according to sequence map. 
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Fig.6.16 – Orthologous HASP locus deletion constructs in plasmid vectors 
All vectors were generated within the pCR
®2.1-TOPO
® with identical 5’ and 3’ OHL 
flanks  based  on  the  available  OHL  sequence  on  GeneDB  and  TriTrypDB  for 
homologous recombination. OHL-KO1 contains a blasticidin (BSD) resistance gene, 
OHL-KO2 a streptophricin (SAT) resistance gene and OHL-KO3 a neomycin (NEO) 
resistance gene. 
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Fig.6.17 – Southern blot to verify successful single OHL deletion 
The Southern blots showed that LbrOHL sKO clones 8 and 10 did not have the expected ~3.95 Kb band when probed with the BSD DIG-labelled 
probe and were, therefore, excluded from further analysis. LbrOHL sKO clones 3 and 9 were questionable, because the OHL III probe found two 
instead of only one expected band. Probing with the OHL I probe showed two distinct band patterns for LbrOHL sKO clones 1, 6, 7, 11, & 12 and 2, 
4 & 5, respectively. This suggested that both alleles are heterozygous and were both targeted with the deletion construct. 224 
 
clones, two (LbrOHL sKO 8 and 10) were shown to have incorrect BSD construct 
integration and in two others (LbrOHL sKO 3 and 9), the OHL III probe detected 
two  bands,  although  only  one  was  expect  (Fig.6.17).  The  remaining  8  clones 
showed correct deletion construct integration. 10 clones were tested in a qPCR 
for locus copy number (Fig.6.18). The single copy gene LbrM.23.1040 served as 
a control gene and the coefficient of average OHL abundance was calculated by 
dividing  the  mean  quantities  of  the  OHL  with  those  from  the  control  gene. 
Although the results showed some variation, 5 clones (LbrOHL sKO 1, 4, 6, 7 & 
11) had values close to 1 for one OHL copy compared to Lbr2904, which had a 
value close to 2. This indicated that one OHL copy had been successfully deleted 
in these 5 clones. LbrOHL sKO 7 was picked for a second round of OHL deletion. 
 
The  generation  of  the  OHL  double  deletion  mutant  was  attempted  4  times 
targeting the second allele of this locus with two different deletion constructs (one 
containing SAT, the other NEO) 2 times each, but no colonies were obtained on 
the antibiotic agar plates, although colonies grew on antibiotic free control plates. 
This  may  suggest  that  the  OHL  in  L.  (V.)  braziliensis  is  diploid  against 
expectations and – unlike the cDNA16 locus in L. (Leishmania) spp. – is essential 
for parasite survival. Conversely, it could mean that the antibiotic concentration 
was  still  too  high,  although  the  previously  determined  minimal  antibiotic 
concentration for Lbr2904 killing had been used. Potentially, the constructs for 
OHL deletion were unfit to delete the second locus copy due to yet unrecognized 
heterogeneity  in  the  OHL  flanking  regions.  This,  however,  seems  unlikely 
considering the Southern blot results from the OHL single deletion mutant. When 
probing with the OHL I probe in the intergenic region between 1110 and 1120 
three distinct band patterns were observed (one pattern for clones LbrOHL sKO 
1, 6, 7, 11, & 12; the second for clones LbrOHL sKO 2, 4 & 5 and the third for 
LbrOHL sKO 3 & 9), which suggested that all alleles had been targeted in the first 
deletion round with the flanking regions used. These data suggested that the OHL 
might be essential for viability in L. (V.) braziliensis. 
 
To determine whether OHL is  indeed  essential for  L. (V.) braziliensis  viability, 
more work was required. For example, the full locus could be integrated into one 
of the ribosomal SSU loci prior to another deletion attempt of the second OHL 
copy. In this situation, if integrated colonies with both original OHL copies deleted 
grew, that would suggest that the OHL is essential for L. (V.) braziliensis survival 
and would mark an important difference to the cDNA16 locus. To test whether the 
SAT and NEO-containing constructs were fit for gene deletion, Lbr2904 could be225 
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Fig.6.18 – qPCR verification of OHL copy number in single deletion mutants 
A qPCR was used to determine OHL copy number within the LbrOHL sKO clones. A 
coefficient of 1 was expected compared to two for the parental line Lbr2904. Clones 
1, 4, 6, 7 and 11 had the closest coefficients to 1. 
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subjected  to  first  round  OHL  deletion  and  any  clones  generated  analysed  as 
above. Further in-detail analysis of the OHL  DNA sequences may also reveal 
further  heterogeneity  between  the  alleles,  potentially  explaining  the  failure  to 
generate a full OHL deletion mutant with the available constructs. 
 
Unfortunately, it was not possible to investigate the OHL any further during this 
project due to time constraints.  
 
6.5. Conclusions 
Regarding the map of the L. (V.) braziliensis orthologous HASP locus, the data 
generated in this study have confirmed that the currently available sequence of 
the OHL on GeneDB and TriTrypDB is incorrect and suffers from repeat collapses 
as previously suggested by Depledge et al. (2010) (294). Considering that the 
fragment  containing  the  LbrM.23.1110  gene  could  be  amplified  with  divergent 
primers from the intergenic region, this suggested that there are repeat copies of 
LbrM.23.1110  present  within  the  OHL.  These  copies  were  distinct  from  one 
another by SNPs occurring in their ORFs, although most of the SNPs were either 
synonymous or only cause an amino acid change within groups of highly similar 
properties.  This  suggested  that  the  1110  proteins  have  the  same  function. 
Considering  that  seven  of  the  nine  identified  SNPs  in  LbrM.23.1110  were 
previously identified comparing the sequences of two different L. (V.) braziliensis 
strains  (2904  and  2903),  this  would  suggest  that  these  SNPs  are  not  strain 
specific, but conserved in the multiply repeated LbrM.23.1110 gene between L. 
(V.) braziliensis strains. To prove this, higher resolution of the OHL map would be 
required. It was not possible to determine how many LbrM.23.1110 copies were 
present in the analysed OHL of Lbr2904, but considering a 4 – 5-fold increase in 
reading depth for this sequence would suggest 4 – 5 LbrM.23.1110 copies per 
OHL.  One  of  these  is  the  most  downstream  copy  of  LbrM.23.1110,  which  is 
flanked  downstream  by  the OHL flanking  sequence.  Only two  versions  of this 
copy, distinct by a single SNP, have been identified in this study. 
 
The  identification  of  two  distinct  versions  of  LbrM.23.1120  (1120_v1  and 
1120_v2), both flanked by the same upstream flanking region, which is distinct 
from the intergenic region, suggested that LbrM.23.1120 might be heterozygous. 
Considering that only a 2-fold increase in reading depth was observed for the 
1120 ORF, this suggested that there was only one copy of LbrM.23.1120 per 
allele. Together with the data generated for LbrM.23.1110, I propose that a single 
heterozygous  LbrM.23.1120  copy  and  4  –  5  tandemly  repeated  copies  of 227 
 
LbrM.23.1110 are present within the OHL (Fig.6.19). The band patterns observed 
on the Southern blots of SacI digested LbrOHL sKO clones probed with the OHL I 
probe suggested that the OHL might be heterozygous (Fig.6.17). In this study, I 
attempted to produce a full length PCR product by long range high fidelity PCR 
with  primers  designed  on  the  available  map.  The  PCR  cycle  was  calculated 
based on the fragment sizes for the OHL identified by restriction digest (Fig.6.3; 
Table 6.1), but so far it has not been possible to generate a fragment of this size. 
This could mean that the known sequences of 5’ and 3’ flanking regions of the 
OHL are also heterozygous. Further investigation is required to resolve the OHL 
map in L. (V.) braziliensis. 
 
The high level of sequence conservation found within the intergenic region was 
surprising.  Normally,  non-functional  intergenic  regions  are  more  prone  to 
mutations than the flanking genes, but in the OHL, the inverse was observed. 
This could mean that a yet to be identified orthologue of SHERP may be present 
within that region. Based on the currently available sequence on GeneDB, verified 
by  subcloning  and  sequencing,  the  intergenic  region  measures  ~1  Kb  and  a 
potential  402  bp  ORF  is  present.  Considering  that  the  SHERP  ORF  only 
measures 174 bp, it is possible that another gene is present in the intergenic 
region. Further analysis would be required to show if the ORF corresponded to a 
functional  mRNA,  translated  into  a  functional  protein  and  had  any  structural, 
biochemical and functional similarities to SHERP. 
 
The attempts to generate an OHL double deletion mutant have failed so far. This 
could mean that the OHL is essential in L. (V.) braziliensis, which would be an 
important  difference  to  the  cDNA16  locus  of  L.  (Leishmania)  spp.,  but  the 
functionality of the three SAT-, BSD- and NEO-deletion constructs still needs to 
be proven in a single OHL deletion mutant generation. Further investigation is 
required to address the essentiality of the OHL in L. (V.) braziliensis.     228 
 
 
 
Fig.6.19 – Proposed L. (V.) braziliensis 2904 OHL map 
The proposed map shows heterozygous versions of the OHL indicated by the two 
distinct LbrM.23.1120 copies (1120_v1 & 1120_v2; red). In this case five copies of 
LbrM.23.1110 are proposed (four flanked on both sides by the conserved intergenic 
region  and  one  flanked  downstream  by  the  3’  flanking  region  of  the  OHL).  The 
proposed map measures ~13.5 Kb from the XhoI restriction sites in the OHL flanking 
regions based on the accumulative lengths of the individual fragments, which is close 
to the estimated ~13.6 Kb for the fragment generated by XhoI digest (Fig.6.4). The 
individual LbrM.23.1110 genes are distinct from one another as indicated by specific 
SNP patterns in the ORFs. Two suggested sequences for the heterozygous OHL can 
be found in Appendices 15 & 16. 
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7.  Chapter VII. – Discussion 
 
7.1. Part One: Metacyclogenesis of L. (L.) major HASP and SHERP mutants 
in the sand fly vector 
 
 Data summary  7.1.1.
Chapter III described the generation and analysis of newly generated HASP 
and SHERP replacement mutant lines by homologous recombination into the 
original cDNA16 locus based on previously established protocols (146, 332). 
All mutant lines were grown in M199 culture and checked by PCR, Southern 
blot  and  qPCR  for  correct  integration  of  a  single  HASP  and/or  SHERP 
construct into the cDNA16 locus in the null background of the LmjcDNA16 
dKO  mutant  line  (Fig.3.5;  Fig.3.7  &  Fig.3.8,  respectively),  previously 
generated  and  characterized  by  McKean  et  al.  (2001).  Western  blots 
confirmed  gene  construct  expression  and  regulation  at  parental  line  (FVI) 
levels (Fig.3.9 & 3.10), while a biotinylation assay confirmed HASPB surface 
localization  (Fig.3.11).  Growth  assays  in  M199  culture  identified  no  fitness 
disadvantageous in the newly generated mutant lines (Fig.3.12). Based on 
this thorough mutant characterization two clones were picked per mutant line 
and passaged through BALB/c mice to recover parasite virulence based on 
previously established protocols (293). Mutant lines containing HASPA2, but 
not  HASPA1,  on  a  gene  construct  were  observed  to  develop  lesions  at  a 
much slower rate than all other passaged mutant lines. They also generated 
promastigotes on amastigote inoculation into M199 much slower than all other 
mutant lines. This observation is currently under investigation and a complete 
data set is not yet available. 
 
Results  in  Chapter  IV  showed  that  the  in  vitro  characterized  mutant  lines 
behaved  differently  in  the  sand  fly  midgut  than  expected  from  in  vitro 
observations. The data showed that step-by-step replacement of HASP and 
SHERP  genes  was  insufficient  to  rescue  metacyclogenesis  completion. 
Metacyclics were generated in very low numbers in all mutant lines except for 
LmjcDNA16 sKI, which was the only mutant line to rescue metacyclogenesis 
to completion. In single gene replacement mutant lines, metacyclics derived 
from sand fly midguts had a cell body morphologically distinct from parental 
line  (FVI)  metacyclics.  Reversion  to  the  parental  line  metacyclic  cell  body 
morphology was achieved by the replacement of several HASP and SHERP 
genes.  However,  it  is  not  clear  which  HASP  and/or  SHERP  genes  were 230 
 
required  to  rescue  parental  line  metacyclic  cell  body  morphology.  The 
discovery of few metacyclics with parental line morphology in LmjS2+HB sKI 
and  LmjS2/HB  sKI  suggested  that  a  combination  of  HASPB  and  SHERP 
genes may be sufficient to rescue metacyclic morphology (Fig.4.11B), even 
though not the metacyclic numbers, although HASPB was not upregulated in 
these  mutant  lines.  The  generation  of  metacyclics  and  presumably  also 
haptomonads,  considering  the  lack  of  SV  colonization  in  all  mutant  lines 
except  LmjcDNA16  sKI  (Fig.4.1),  remained  inefficient  in  all  mutant  lines. 
Leptomonad  generation,  however,  could  be  improved  significantly  by 
replacement of combinations of HASP and SHERP genes. Unfortunately, the 
data did not clearly show which HASP and/or SHERP genes were the most 
essential for leptomonad generation, although replacement of HASPA1 and 
HASPA2 in a single construct appeared beneficial for generation of this stage. 
It is possible that improved leptomonad generation was related to the sand fly 
species infected since the vector species had to be changed from Ph. (Ph.) 
papatasi to Ph. (Ph.) duboscqi during the study for technical reasons. Since 
Ph. (Ph.) duboscqi is less specific for the infecting L. (L.) major strain than Ph. 
(Ph.)  papatasi  the  improved  leptomonad  generation  observed  in  the  later 
experiments with Ph. (Ph.) duboscqi could be an artefact related to the sand 
fly species.  
 
In Chapter V, it was revealed by confocal microscopy that HASPB was not up-
regulated  /  expressed  at  detectable  levels  in  all  the  tested  replacement 
mutants (Fig5.1 & Fig.5.3). This was in contrast to the observations made by 
Western blot in culture derived parasites. Attempts to determine the reason for 
the difference in gene expression from the replacement construct within the 
cDNA16 locus were not able to explain this phenomenon conclusively. Neither 
difference in culture conditions (Fig.5.5), nor the addition of midgut extracts to 
M199  cultures  was  able  to  influence  the  expression  of  HASPB  from  the 
construct (Fig.5.6). Interestingly, profiles of HASPB mRNA levels from midgut 
and  culture  derived  parasites  revealed  that,  while  the  profile  and  relative 
levels  of  HASPB  mRNA  in  LmjHASPB  sKI  and  LmjcDNA16  sKI  were 
comparable  to  the  parental  line  (FVI)  in  culture,  in  vivo  LmjHASPB  sKI 
showed considerably lower levels of HASPB mRNA than FVI and LmjcDNA16 
sKI  at  day  6  PBM,  when  HASPB  mRNA  was  upregulated  in  FVI  and 
LmjcDNA16 sKI (Fig.5.7). Also the mRNA profiles for SHERP and HASPA 
were  distinct  for  the  LmjSHERP  sKI  and  LmjHASPA2  sKI,  respectively, 
compared  to  FVI.  Interestingly,  LmjcDNA16  sKI  expression  patterns  for 231 
 
SHERP and HASPA both in vitro and in vivo were similar to the mutant lines 
rather than the parental line (FVI), suggesting that HASPB regulation may be 
the key difference between LmjcDNA16 sKI and all the mutant lines and the 
reason for  rescue of metacyclogenesis completion  in LmjcDNA16 sKI. The 
osmotaxis of tested mutant lines was not compromised (Fig.5.10), while the 
secretion of fPPG for the PSG gel plug generation was abolished in all mutant 
lines  except  LmjcDNA16  sKI  (Fig.5.11  &  Fig.5.12).  The  fPPG  synthesis 
pathway has not been described in detail in Leishmania yet. Synthesis and 
secretion  of  glycan-modified  proteins  and  lipids  usually  involves  secretion 
pathways  through  the  ER  and  Golgi  in  other  eukaryotic  cells  (376).  Since 
Leishmania HASP and SHERP genes have no known orthologues in other 
eukaryotic  systems  and  neither  protein  ever  enters  the  ER  or  Golgi,  it  is 
difficult to predict how the HASP and/or SHERP proteins may influence fPPG 
synthesis and secretion. It has been hypothesised that HASPB may be shed 
in the midgut lumen from the Leishmania cell surface and that it may bind the 
fPPG  supporting the PSG formation. However, it has not  been  possible to 
verify this hypothesis, because of the comparatively low parasite numbers in 
midguts,  which  causes  HASPB  levels  to  be  too  low  for  clear  detection 
(Fig.7.1).  
 
 The HASPs and SHERPs in metacyclogenesis  7.1.2.
The  cDNA16  locus  on  chromosome  23  has  been  shown  to  be  specific  to 
members  of the  L.  (Leishmania)  subgenus  (294).  It  contains genes  of  two 
unusual  and  unrelated  gene  families  coding  for  the  HASPs  and  SHERPs. 
These  are  stage  specifically  upregulated  genes  and  with  the  exception  of 
HASPA1,  which  is  shown  in  this  study  to  be  amastigote-specific,  they  are 
preferentially expressed in promastigotes (329), although HASPB continues to 
be expressed in amastigotes weeks after mammalian host infection. In vivo 
HASPB and SHERP are expressed predominantly in metacyclics in  L. (L.) 
major, although SHERP is detected at low levels in late leptomonads (146).  
 
This thesis carries on the work on the HASP and SHERP genes of the L. (L.) 
major cDNA16 locus published by Sádlová et al. (2010), who demonstrated 
the  essentiality  of  the  cDNA16  locus  in  the  sand  fly  midgut  for 
metacyclogenesis completion (146). The aim of this thesis was to determine 
whether one or a subset of the HASP and /or SHERP genes were sufficient 
for metacyclogenesis completion, or if the whole locus was required. Sand fly 
infection studies by Sádlová et al. (2010), carried out with episomal HASPB232 
 
 
 
Fig.7.1 – HASPB detection in midgut extracts 
All samples were prepared in 25 µl PBS + 25 µl Laemmli buffer. 15 µl of lysate from 
the parasite/midgut debris cell pellets from the extraction of midgut extracts from 20 
sand fly midguts and 15 µl of midgut extracts from 20 midguts were loaded onto a 
12% SDS-PAGE gel for a Western blot. Only 2 µl of a parasite cell lysate (8x 10
5 
parasite cells) from culture were loaded as an antibody control. The blots show that 
HASPB concentrations are extremely low in the parasite cell pellet preparations from 
sand fly midguts. Only the FVI cell pellet gave a discernible band, which, however, is 
barely stronger than the background signal shown in the lanes of LmjcDNA16 dKO. 
This is attributed to the low parasite numbers in the sand fly midgut (5x10
3 – 2x10
4 
per midgut) compared to a M199 culture. The 2 µl FVI cell lysate contains at least an 
estimated 6.5-25.5 times more parasite cells than the 15 µl of the parasite cell pellets. 
That would require a minimum of 130 heavily infected midguts to get a comparable 
signal to the 2 µl of FVI cell lysate. 
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and  SHERP  replacement  mutant  lines,  suggested  that  HASPB  may  be 
essential for metacyclogenesis. However, gene expression from episomes is 
unregulated  and  often  overexpressed.  It  was  shown  that  both  of  these 
characteristics  can  cause  overexpression  phenotypes,  which  can  vary 
significantly  from  the  wild  type  phenotype  (332).  It  had  been  shown  that 
replacement  by  homologous  recombination  into  the  cDNA16  locus  could 
recover  wild  type  gene  regulation  (146,  332).  Therefore,  the  approach  for 
mutant generation was the replacement of HASP and/or SHERP genes into 
the cDNA16 locus in the null background of LmjcDNA16 dKO by homologous 
recombination,  since  individual  gene  deletion  from  the  locus  was  not 
applicable due to the high level of sequence repetitiveness in the cDNA16 
locus. All selected mutant lines had been rigorously tested in culture to verify 
genomic  integration  and  re-establishment  of  wild-type  gene  expression 
regulation.  
 
HASPB is a N-terminally dual-acylated protein targeted for the cell surface via 
membrane shedding (335, 336, 345). The previously demonstrated surface 
localization of HASPB was verified in a subset of replacement mutant lines 
too. The current hypothesis suggests that HASPB may be shed from the cell 
surface and is a target for B-1 B cell-derived natural antibodies (377). Whether 
HASPB is shed in the sand fly vector was addressed in this study, but it could 
not  be  proven  that  HASPB  is  present  in  midgut  extracts  (Fig.7.1).  The 
suggested  key  function  of  HASPB  in  metacyclogenesis  could  also  not  be 
confirmed  in  this  study,  although  it  is  suggested  by  the  data  generated. 
However, this is related to the lack of HASPB expression from the integrated 
construct, when the mutant lines were infected into the sand fly midgut. 
 
Using mutant lines with individual HASPA1 and HASPA2 genes replaced into 
the cDNA16 locus, it was possible to show for the first time that HASPA2 is 
expressed  in  the  promastigote  stage,  while  HASPA1  expression  is 
amastigote-specific, suggesting life-cycle specific functions for HASPA2 and 
HASPA1,  while  alternating  their  expression  between  promastigote  and 
amastigote  stage,  respectively.  Although  HASPA1  and  HASPA2  have  the 
same ORF and are only distinct in their 3’ UTRs, differences were observed in 
the behaviour of HASPA1 or HASPA2 containing mutant lines in the BALB/c 
mouse model. HASPA2 containing mutant lines without a HASPA1 gene copy 
developed  lesions  much  more  slowly  and  were  much  slower  to  produce 
promastigotes  after  amastigote  inoculation  into  M199  medium  than  mutant 234 
 
lines  lacking  HASPA2,  including  the  cDNA16  null  mutant  line,  LmjcDNA16 
dKO.  Interestingly,  introducing  a  HASPA1  copy  into  HASPA2  containing 
mutant lines abolished this phenotype. This may suggest a specific function 
for the HASPA1 in amastigotes that complements the HASPA2 function in 
promastigotes. Mutant lines containing only HASPA2 produced significantly 
more  leptomonads than  those  containing  only  HASPA1  (P<0.001;  Fig.4.8), 
while  mutant  lines  containing  both  HASPA  genes  were  among  the  most 
efficient leptomonad generators and formed lesions at a similar rate as FVI 
(detailed analysis still underway).  
 
SHERP is a peripheral membrane protein that localizes to the cytosolic face of 
the ER and mitochondrion (341). It has previously been shown that interaction 
with anionic phospholipids is essential for SHERP to assume a globular form, 
which may be important for SHERP function (348). SHERP is proposed to 
form  a  complex  with  the  subunit  B  of  the  vacuole  H
+-ATP  synthase  (V-
ATPase)  potentially  promoting  V-ATPase  assembly  or  preventing  its 
disassembly  (348).  V-ATPases  are  important  in  the  acidification  of  internal 
compartments  like  the  endosomal/lysosomal  system  (378).  It  has  been 
hypothesised that SHERP interaction with the V-ATPase may be important for 
parasite autophagy, based on SHERP’s localization to the cytosolic face of 
the  ER  and mitochondrial  membranes. These membranes  are  a  source of 
phagophores that form the autophagosomes of the autophagic system (350). 
Autophagy  was  found  to  be  important  for  parasite  differentiation  into 
metacyclics  (298,  349),  which  could  make  SHERP  a  key  regulator  for 
metacyclogenesis.  However,  data  from  this  study  did  not  confirm  this 
hypothesis. 
 
 Differences in mutant parasite behaviour in vitro and in vivo  7.1.3.
This study showed differences in mutant parasite behaviour between culture 
and sand fly midgut conditions. Unexpectedly, HASP and SHERP were not 
stage-specifically upregulated, when the mutant lines were infected into the 
sand fly vector, although gene expression and regulation had been confirmed 
in culture (Fig.3.9). This was interesting, since the phenotype of LmjcDNA16 
dKO only becomes apparent in the sand fly vector, but not in culture (146, 
332).  It  is  not  clear  what  causes  these  differences  in  mutant  parasite 
behaviour between culture and midgut conditions, but it is possible that the 
parasites takes cues by midgut environment sensing for the upregulation of 
the HASP and SHERP genes. These cues would be absent in culture. 235 
 
The  in-/vertebrate  hosts  play  important  parts  in  the  Leishmania  life-cycle. 
Mammalian  infective  Leishmania  spp.  are  digenetic  kinetoplastid  parasites 
and  rely  on  an  invertebrate  vector  to  be  spread  from  one  long  term 
mammalian host to another in nature. Parasites do not usually simply evade 
the  in-/vertebrate  host  immune  system  until  they  have  a  chance  for 
transmission. Instead, they make use of carefully regulated mechanisms to 
sense  their  environment  and  regulate  their  genetic  programming  for 
development  according  to  detected  changes  in  the  host  environment,  to 
optimize their survival and chances for transmission. Better studied examples 
of parasites taking cues from the sensed host environment can be found in 
other  parasite  systems.  For  example,  Trypanosoma  brucei  can  detect  the 
density of the T. brucei population in the blood stream of a mammalian host 
via a hypothesised stumpy induction factor (SIF) secreted by the parasite, a 
mechanism comparable to bacterial quorum sensing (379). T. brucei will only 
induce the production of stumpy forms, which are transmissible to tsetse flies, 
but are cell-cycle arrested, when the population of slender, proliferative forms 
is sufficiently dense, which is hypothesised to be indicated to the parasite by 
SIF  concentrations  in  the  blood  stream.  The  generation  of  Plasmodium 
gametocytes transmissible to the invertebrate host is also hypothesised to be 
dependent  on  sensed  changes  in  the  parasite’s  environment  (reviewed  in 
(380)). More is known about parasite behaviour in vertebrate hosts than in 
invertebrate  hosts,  but  it  can  be  assumed  that  parasites  monitor  their 
environment  just  as  carefully  in  the  invertebrate  host  to  time  their 
development. Little is known, however, about the molecular mechanisms of 
parasite environmental sensing. One of the few well characterized coupled 
parasite sensing/development pathways in the invertebrate host is the CCA 
(citrate  and/or  cis-aconitate)  signal-dependent  differentiation  initiation  of  T. 
brucei  stumpy forms in the tsetse fly (reviewed in  (381)). The temperature 
drop to ~20 °C on entry into the tsetse fly stimulates PAD (protein associated 
with differentiation) expression in T. brucei. PAD is a carboxylate transporter 
for CCA released from the blood meal and secreted by the tsetse fly (322, 
382,  383).  Only  the  combination  of  temperature  drop  and  CCA  presence 
induces stumpy form differentiation initiation. In Leishmania, the mechanism 
of purine scavenging in promastigotes has been described (384). Leishmania 
metacyclogenesis completion is dependent on scavenging purines from the 
sand  fly  midgut  lumen;  if  levels  are  too  low,  Leishmania  differentiation  is 
arrested. The mechanism for detection of environmental purine levels is only 
now being unravelled. Leishmania detects environmental purine levels only 236 
 
indirectly  by  detection  of  internal  stores  of  scavenged  purines  (N.  Carter, 
Kinetoplastid Molecular Cell Biology meeting, Woods Hole, 2013). 
 
The regulation of HASP and SHERP genes could also be influenced by yet 
unknown  environmental  cues,  which  need  to  work  synchronously  to  allow 
stable  upregulation  in  vivo.  The  sand  fly  midgut  is  a  very  dynamic 
environment. Changes in pH, temperature, amino acid and enzyme content 
are being experienced by the parasites throughout their promastigote stages 
in  the  midgut.  These  changes  do  not  occur  in  a  culture  unless  artificially 
induced. Since parasites sense their environment to adapt quickly to changing 
conditions  and  promote  their  survival,  changes  in  parasite  behaviour  have 
been observed in culture adapted stains versus natural strains. For example, 
culture  adapted  T.  brucei  were  observed  to  have  a  1,000x  lower  antigen 
switching rate for their variable surface glycoproteins (VSG) than in natural 
isolates (385, 386). So far, it has not been possible to identify a potential sand 
fly  midgut  related  trigger  for  HASPB  regulation  from  the  replacement 
constructs. The addition of midgut extracts from blood fed female sand flies to 
cultures was insufficient to markedly influence HASPB expression. This could 
suggest that another factor apart from sand fly midgut molecules/metabolites 
is  required  for  HASPB  upregulation.  Multiple  triggers  that  need  to  work 
synchronously for parasite gene regulation were shown in the example of T. 
brucei stumpy form differentiation initiation in the tsetse fly, where temperature 
drop  and  CCA  detection  need  to  occur  together  to  induce  stumpy  form 
differentiation  (322,  382,  383).  Requiring  multiple  triggers  tightens  the 
parasites  control  over  essential  mechanisms.  However,  in  case  of  the 
experimental set up of the midgut extract inoculation into M199 Leishmania 
cultures in this study, it is possible that the concentration of midgut extract per 
culture (1:80 dilution) was too low, that the relevant component was degraded 
or had been lost during the midgut extract filtering. Protein compounds can 
potentional bind to filter membranes and are so lost from the extract prior to 
dilution  in  M199.  Refinement  of  the  experimental  approach  is  required  to 
conclusively prove that construct expression is not suppressed by only midgut 
molecules and/or metabolites. 
 
The differences in mutant line behaviour could also be of more technical in 
nature. The  LmjcDNA16  sKI mutant  line  has  been  the  only  one  to rescue 
metacyclogenesis  completion.  LmjcDNA16 sKI contains the  whole  cDNA16 
locus in a single construct and was the only tested mutant line to contain all 237 
 
HASP  and  SHERP  genes  in  their  natural  order  and  context.  The  HASPB 
mRNA expression pattern of LmjcDNA16 sKI was the only one similar to FVI 
in vivo, although not for SHERP and HASPA. However, if HASPB is the key 
element  for  metacyclogenesis  completion,  as  suggested  by  Sádlová  et  al. 
(2010), it could be that the order and context in which the HASP and SHERP 
genes occur in the cDNA16 locus are relevant for gene regulation in vivo. It 
has already been shown in vitro that genomic location is important for gene 
regulation in Leishmania (146, 332). Gene regulation in Leishmania occurs 
primarily post-transcriptionally and translationally (reviewed in (315, 316)). It 
could be that mRNA stability is affected differently in vitro versus in vivo due to 
environmental  conditions  and/or  signalling  pathways.  mRNA  stability  is 
determined through elements and secondary structures within 3’ UTRs. It has 
been  proposed  that  the  5’  trans-splice  site  of  a  downstream  gene  can 
influence the determination of the 3’ poly(A)-site of the upstream gene due to 
the coupled nature of these two processes in  Leishmania  (313,  314). This 
could mean that the distance of 3’ poly(A)-site and following 5’ trans-splice 
site is fixed for a gene in Leishmania. If that is correct then moving the 5’ 
trans-splice site following a 3’ poly(A)-site farther downstream in a locus may 
also relocate the position of the 3’ poly(A)-site of the gene upstream of the 
altered 5’ trans-splice site. Within the replacement constructs, the HASP and 
SHERP genes are not within their natural locus context. The 5’ trans-splice 
site following the HASPs and SHERP genes in the construct is the one of the 
antibiotic resistance genes, which is 2-3x further downstream of the known 
HASP and SHERP 3’ poly(A)-sites than the 5’ trans-splice site that normally 
follows them in the cDNA16 locus context (Fig.5.8A &B). This could mean that 
the HASP and SHERP mRNAs become longer, because the 3’ poly(A)-sites 
are relocated farther downstream from their known locations. This could make 
the  mRNA  less  stable  due  to  3’  UTR  extension.  Potentially,  this  effect  is 
amplified in vivo due to the sand fly midgut environmental conditions versus 
the stable culture conditions. It must also be considered that the phenotype of 
the cDNA16 null mutant is only observed in the sand fly midgut, but not in 
culture, which suggests that the midgut environment plays a vital role in the 
function of this locus. This possibility is currently still under investigation. 
 
In  many  eukaryotic  cells,  gene  regulation  is  supported  at  the  post-
transcriptional  level  by  micro-RNAs  (miRNAs),  which  are  a  class  of 
endogenous  non-coding  short  RNAs  (reviewed    in  (387)).  Since  post-
transcriptional  gene  regulation  is  the  primary  means  of  gene  regulation  in 238 
 
Leishmania, miRNA seems like a reasonable mechanism for gene regulation 
in  these  parasites.  However,  post-transcriptional  regulation  via  miRNA 
requires a functional RNA interference pathway, to which proteins like Dicer 
and argonoute belong, that process  pre-miRNA and load it onto the RNA-
induced  silencing  complex,  respectively.  It  has  been  shown  that  only 
members of the L. (Viannia) subgenus possess a functional RNAi pathway, 
while proteins like Dicer and argonoute have no identifiable homologues in L. 
(Leishmania) spp. (reviewed in (388)). It was concluded that members of the 
L. (Leishmania) subgenus do not use miRNA for gene regulation (389). This 
seems to exclude the possibility of miRNA genes within the cDNA16 locus 
intergenic regions that allow HASP and SHERP regulation in vivo. Although 
RNAi  has  been  demonstrated  to  be  functional  in  L.  (Viannia)  braziliensis 
(390), its  involvement in gene regulation and its evolution in these species 
are only now beginning to be revealed (391). 
 
Another  interesting  observation  regarding  the  regulation  from  the  cDNA16 
locus was made in this study, when a set of HASPB-GFP fusion gene mutant 
lines were generated. The HASPB-GFP fusion construct was transfected into 
several mutant backgrounds (LmjcDNA16 dKO, LmjSHERP sKI, LmjHASPA1 
sKI, LmjHASPA1/2 sKI, LmjHASPA2 sKI and LmjcDNA16 sKI) into the second 
cDNA16 locus allele. The mutant lines were designed to be passaged through 
sand flies to detect the moment of HASPB upregulation. All mutant lines were 
rigorously tested by the same approaches as all other mutants in this study. 
However, whenever the construct was integrated into the cDNA16 locus, the 
HASPB-GFP fusion gene was never expressed efficiently in culture and GFP 
fluorescence was undetectable. When an episomal integration had occurred 
in  any  mutant  background,  however,  the  HASPB-GFP  fusion  gene  was 
expressed at detectable levels by FACS and confocal microscopy, suggesting 
that the construct was intact and functionally sound (Fig.7.2). It is unclear, why 
the construct was not upregulated when integrated into the cDNA16 locus, but 
this  observation  points  out  that  facets  of  mechanisms  governing  gene 
regulation in Leishmania remain unexplored. A demonstration of the in vivo 
specific suppression of expression of HASP and SHERP would be possible by 
inoculating mutant lines from the sand fly midgut into M199 culture to see if 
HASP  and/or  SHERP  expression  can  be  rescued  after  culture  inoculation. 
Attempts for this have been made in this study, but so far the overgrowth of 
the cultures by some antibiotic resistant bacterium or fungus has prevented 
successful parasite growth after inoculation. It may be interesting to integrate239 
 
 
Fig.7.2 – Differences in HASPB-GFP fusion gene expression 
The confocal images show the differences in fluorescence of the HASPB-GFP fusion 
protein expressed from a construct integrated into the cDNA16 locus (e-h) and the 
same construct transfected as an episome (i-l), while FVI (a-d) served as a negative 
control. Metacyclics are shown, as determined by measurement, of two clones of the 
LmjHA2+HB-GFP  sKI  line  as  an  example.  While  the  clone  with  the  integrated 
construct does not express the HASPB-GFP fusion gene, the episomal mutant has a 
strong positive signal from the flagellum and cell surface. FACS analysis of the same 
mutant confirmed that the LmjHA2+HB-GFP sKI 10 (integrated construct) does not 
express  HASPB-GFP.  Graph  n  shows  only  a  fluorescent  negative  cell  population 
(fluorescent cells in the boxed area) and no second peak in graph o. Conversely, 
LmjHA2+HB-GFP sKI 11 (episomal expressor) had a large fluorescent population (r; 
boxed area & s; right hand peak).   240 
 
reporter genes into different loci of known regulated genes in Leishmania and 
see how that affects the reporter gene expression in vitro and in vivo. This 
may  provide  some  insight  into  whether  the  differential  expression  from 
constructs  in  regulated  loci  is  a  common  theme  in  Leishmania.  Whether 
epigenetics  are  involved  in  the  differences  in  HASP  and  SHERP  gene 
expression  has  not  been  excluded  yet.  The  observation  that  SHERP  was 
detectable  in  LmjS2+HB  sKI  mutants  in  midgut  smears  in  the  absence  of 
HASPB expression, while SHERP was undetected in LmjSHERP sKI, which 
served  as  a  precursor  for  LmjS2+HB  sKI,  does  not  suggest  epigenetic 
involvement. The HASPB construct was integrated into the second allele and, 
since HASPB remained downregulated, it would not explain changes to the 
chromatin fold of the chromatid containing the SHERP construct. 
 
Differences in parasite behaviour between natural and artificial systems have 
been  described  before  for  Leishmania.  In  laboratory  settings,  experimental 
infections in mammals are conveniently done by subcutaneous or intravenous 
injection of cultured late stationary stage parasites (needle inoculation). This 
approach has been questioned since considerable discrepancies in infection 
outcome have been observed between needle inoculation and transmission 
by  sand  fly  bite  (54,  392,  393).  For  instance,  mice  vaccinated  with  killed 
Leishmania  parasites  show  protection  to  needle  inoculation,  but  not  to 
transmission  by  sand  fly  bite  (392,  393).  Other  studies  have  shown  that 
components  of  sand  fly  saliva  and the  PSG  enhance  Leishmania  infection 
establishment  and  disease  progression  (106,  254,  255,  394). The  problem 
here is the broad variety in the development of transmissible infections both 
within  and  between  sand  fly  species  that  undermine  the  practicality  and 
physiological  relevance  of  sand  fly  transmission  when  studying  disease 
outcomes  (32,  146,  373,  395).  Inoculation  by  sand  fly  bite  may  transmit 
anything  between  10  –  100,000  parasites  per  bite,  although  only  1  in  4 
infected sand flies are likely to transmit significantly more than 1000 parasites 
per bite  (32, 253, 395). High dosage transmission correlated to high parasite 
burdens in the respective vector (>30,000 parasite per midgut). Another key 
factor in successful transmission is the proportion of metacyclics of the total 
parasite burden at the point of insect blood feeding. It was shown that sand 
flies  with  ≥70%  metacyclics  in  their  midgut  were  more  successful  in 
transmission to a mammalian host (>70%) (395). These results need to be 
looked at cautiously, though, when making assumptions about transmission in 
nature, because under laboratory conditions, experiments are often performed 241 
 
only on individual sand flies. Lu. (Lu.) longipalpis sand flies, however, were 
observed to feed cooperatively in aggregates rather than individually, which 
promoted their efficiency in blood uptake and reduced the individual’s use of 
saliva (396). It is not known if this is a common trait of sand fly behaviour. 
There  are  no  observations  as  to  how  this  behaviour  may  impact  on  the 
transmission  of  Leishmania,  whether  less  PSG  is  regurgitated  too  and 
whether the presence of uninfected sand flies is beneficial to transmission or 
not.  This  demonstrates,  however,  the  importance  of  verifying  in  vitro 
observations in the natural system. 
 
I have made the observation in this study that all my mutant lines can infect 
BALB/c mice and cause lesion formation, if the inoculum with late stationary 
stage  parasites  from  culture  is  sufficiently  high.  Considering  that  PSG 
secretion,  SV  colonization  and  metacyclic  generation  in  the  replacement 
mutant lines of this study are impaired in the sand fly vector, it is questionable 
if  transmission  from  a  sand  fly  to  a  new  mammalian  host  can  occur.  The 
investigation of this question is currently underway with our collaborators at 
the NIH, but the expectation is that the mutant lines are not transmissible in a 
natural setting. This again suggests that it is important to be critical towards in 
vitro data and confirm them in in vivo settings. 
 
 Using parasite morphology for promastigote stage identification  7.1.4.
The problems in using parasite morphology as a tool for promastigote stage 
determination were already addressed in section 4.2.6. The natural plasticity 
of  Leishmania  morphology  makes  a  clear  division  between  developmental 
stages by morphology difficult. Due to undefined intermediate promastigote 
stages,  there  is  always  a  gradient  in  the  defining  cell  body  and  flagellum 
measurements, which shows no clear break-off points (Fig.4.9). Instead the 
majority  of  measurements  appear  to  accumulate  around  the  artificially 
introduced  break  off  point,  like for  example  ≥14  μm  in  cell  body  length  to 
determine  a  nectomonad  (Fig.7.3).  The  range  in  cell  body  lengths  of 
nectomonads, however, is large reaching >30 μm in length and the longer the 
cell body, the greater the confidence in the identification of the nectomonad 
stage becomes. However, how can we judge with confidence that parasites 
measuring  14μm  are  any  different  in  their  developmental  state  than  those 
measuring  13.99  μm?  The  same  goes  for  the  distinction  between 
leptomonads and metacyclics, where the defining factor is a two time longer 
flagellum than the cell body. Fig.7.3.C & E shows two examples where the242 
 
 
Fig.7.3 – Problems with plasticity of parasite morphology 
A) compares two FVI parasite cells that are very similar in length. One just below and 
the other just above the 14 μm threshold that distinguishes between nectomonads 
and leptomonads. B) looks at the extreme range of nectomonad cell body lengths. C) 
compares an FVI leptomonad with a metacyclic which is just below and above the 2x 
flagella length compared to cell body length threshold, respectively. D) compares two 
metacyclics  by  measurement  from  FVI  and  LmjcDNA16  sdKO.  E)  looks  at  a 
LmjcDNA16 dKO leptomonad and metacyclic. 
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leptomonad  is  just  below  and  the  metacyclic  just  above  the  threshold. 
Whether  in  fact  both  cells  are  truly  distinct  forms  molecularly  or  not  is 
impossible  to  judge  just  by  measurement.  Also,  parasite  forms,  which  we 
have to classify as the same form, may in fact be different from one another. 
Fig.7.3.D  shows  a  metacyclic  by  measurement  from  FVI  and  one  from 
LmjcDNA16 dKO. The cell body shape of these two metacyclics is distinct as 
the  cell  body  of  the  LmjcDNA16  dKO  metacyclic  is  broad  with  a  rounded 
posterior, while the FVI metacyclic is narrow with a pointed posterior. The only 
way  to  overcome  this  problem  is  by  identifying  more  promastigote  stage 
specific  markers.  To  date  the  only  accepted  stage-specific  promastigote 
markers are SHERP and HASPB, which are specific to the metacyclic stage 
(333, 341). But there is no way of distinguishing procyclics, nectomonads and 
leptomonads by marker. 
 
 Model of HASP and SHERP regulation mechanism  7.1.5.
The  current  model  suggests  that  HASPB  is  the  key  gene  for 
metacyclogenesis completion. Although this could not be proven directly in 
this  study,  the  qPCR  data  on  mRNA  extracted  from  sand  fly  midgut  and 
culture derived parasites suggested HASPB to be important. Whether HASPB 
expression is dependent on prior SHERP or HASPA2 expression in the sand 
fly midgut could not be shown due to the unexpected differences in HASP and 
SHERP regulation between sand fly midgut and culture conditions. What is 
clear is that HASPB function is not essential in culture for metacyclogenesis 
completion. However, it is feasible the HASPA2 expression and/or SHERP 
expression supports HASPB upregulation  in vivo. The surface exposure of 
HASPB and its disordered  structure may suggest that it binds to a ligand, 
which  allows  HASPB  to  fold  properly.  Since,  despite  previous  efforts,  no 
HASPB binding partner could be identified in the mammalian host, it remains 
possible that HASPB detects something in the sand fly midgut, which may cue 
the parasites development. Conversely, being a true metacyclic could be a 
prerequisite  in  vivo  for  HASPB  expression,  since  HASPB  is  metacyclic 
specific  in  the  sand  fly  midgut.  SHERP  may  support  metacyclogenesis  by 
inducing  autophagy  in  differentiating  parasites  (348),  potentially  supporting 
HASPB  upregulation  indirectly  by  supporting  metacyclic  generation  via 
autophagy in vivo. However, this could not be shown in this study.  
 
So far, it has not been possible to find any evidence that HASPB is shed in 
the sand fly midgut, which suggests that shedding may only occur after entry 244 
 
into the mammalian host skin, perhaps due to HASPB recognition by B-1 B 
cell-derived natural antibodies (377). HASPA2 and HASPA1 promastigote and 
amastigote specific expression, respectively, may bear some sort of switch 
function,  defining  promastigote  and  amastigote  stage  by  their  expression, 
respectively, in vivo. The HASPAs are hypothesised to be dual acylated like 
HASPB,  because  of  the  conserved  SH4  domain  at  the  N-terminus  of  the 
HASPs, and trafficked to the cell surface too. Although they are missing the 
central  repeats  of  HASPB,  they  could  also  be  binding  to  some  ligand  to 
perform their function. The hypothesised HASPA and demonstrated HASPB 
surface exposure in particular on the flagellum would suggest a function in 
sensing, although the lack of transmembrane domains does not suggest how 
the signal may be internalized. Perhaps the HASPs act as a co-factor in a 
signalling complex on ligand binding.  
 
I hypothesis that the differentiation from procyclics into nectomonads occurs 
independently from the HASPs and SHERP in vivo, because nectomonads 
were always generated efficiently in all mutant lines in the sand fly midgut, 
including  LmjcDNA16  dKO  (Fig.7.4).  Leptomonad  generation  may  be 
influenced  by  the  HASPs  and  SHERP,  as  was  shown  by  the  improved 
leptomonad  generation  by  the  replacement  of  multiple  HASP  and  SHERP 
genes.  However,  it  is  not  clear  which  HASP  and/or  SHERP  gene(s)  may 
support  leptomonad  generation.  It  needs  to  be  considered  that  low  level 
leptomonad  generation  also  occurs  in  the  LmjcDNA16  dKO  line.  The 
generation of true metacyclics is then dependent on HASPB and potentially 
SHERP,  since  it  was  shown  that  HASPB  and  SHERP  replacement  was 
sufficient to recover metacyclic cell body shape. Also, episomal expression of 
HASPB  seemed  to  rescue  metacyclogenesis  completion  in  Sádlová  et  al. 
(2010). The lack of HASPB upregulation in mutant lines in vivo, could explain 
why  the  metacyclic  generation  was  so  inefficient  in  all  the  mutant  lines, 
assuming that HASPB is the driver for the final step in metacyclogenesis. The 
transformation  into  amastigotes  may  not  be  dependent  on  the  HASPs, 
because LmjcDNA16 dKO can infect BALB/c mice on needle inoculation and 
form amastigotes. However, HASPA2 expression in the absence of HASPA1 
influences  parasite  infectivity  in  BALB/c  mice.  HASPA1  function  may  be 
relevant to complement HASPA2 function in amastigotes to counteract the 
negative effect HASPA2 has in the mutant lines once they are infected into 
BALB/c  mice.  Interestingly,  not  having  any  HASPA  gene  at  all  is  just  as 
beneficial as having HASPA1 and better than having HASPA2 in the mouse245 
 
 
 
Fig.7.4 – Model for HASP & SHERP regulation in vivo during metacyclogenesis 
[A] (a) Amastigotes expressing HASPA1 and HASPB are internalized with the blood 
meal  (pale  red).  1)  As  amastigotes  differentiate  into  (b)  procyclics  HASPA1  and 
HASPB are downregulated to undetectable protein levels, while HASPA2 beginning 
to be upregulated. 2) HASPA2 continues to be expressed in (c) nectomonads before 
and after escape from the PM and during midgut epithelium attachment. 3) SHERP 
begins to be up-regulated in late (d) leptomonads prior to (e) metacyclic generation in 
vivo. 4) HASPB is then upregulated in (e) metacyclics, which can detach from the 
midgut wall and are transmitted with the PSG into the mammalian host skin during 
the  next  sand  fly  blood  meal.  5)  (f)  Haptomonads  are  also  formed  from  (d) 
leptomonads, but it is not known whether these express SHERP or HASPB. 6) (e) 
Metacyclics  entering  the  mammalian  host  skin  infect  resident  macrophages  and 
transform back into (a) amastigotes. During this process HASPA2 and SHERP are 
downregulated  and  HASPA1  is  upregulated,  while  HASPB  continuous  to  be 
expressed. [B] The stage-specific upregulation of the HASPs and SHERP may be 
governed  by  a  set  of  mechanisms  in  vivo,  which  react  to  different  stimuli,  like 
changes in temperature and pH, midgut molecules and metabolites, internal nutrient 
stores, etc.   246 
 
model. Whether the switch from HASPA1 to HASPA2 on the transformation 
from amastigotes into procyclic promastigote is essential in vivo is not known, 
but at least in culture, they are not required for this process. Then again the 
cDNA16 locus is also not essential in culture for metacyclogenesis, but only in 
the sand fly midgut. 
 
Why  the  difference  in  HASP  and  SHERP  construct  expression  occurred 
between  in  vitro  and  in  vivo  conditions  is  not  clear.  It  is  possible  that  the 
problem  is mRNA stability. At least in the  case of HASPB,  a difference in 
mRNA levels of 2.5 – 5-fold were observed at day 6 PBM in vivo. Since gene 
regulation is primarily post-transcriptionally, this reduction in HASPB mRNA 
could prevent the genes stage-specific upregulation in the construct mutants. 
Potentially,  locus  organization  is  also  important  for  gene  regulation  in 
Leishmania.  
 
 Perspective on future studies  7.1.6.
The differences in parasite behaviour between sand fly midgut and culture 
settings shown in this study emphasise the need for researchers in this field to 
verify their in vitro findings in the in vivo settings. Parasites are designed to 
adapt  to  their  given  environment  and  it  appears  that  the  adaptation  of 
Leishmania to culture obscures natural phenotypes. Naturally, this does not 
mean  that  culture  work  should  be  abandoned  altogether,  considering  the 
technical limitations of parasite work in the sand fly vector. But culture work on 
Leishmania parasites should always be complemented with in vivo work. It 
becomes  also  increasingly  important  to  step  away  from  the 
promastigote/amastigote  paradigm  and  accept  that  there  are  at  least  five 
morphologically  and  functionally  distinct  promastigote  forms:  procyclic, 
nectomonad,  leptomonad,  metacyclic  and  haptomonad  promastigotes  (145, 
397). More than one amastigote form may exist too (141, 142). 
 
For the work on the HASPs and SHERP, it would be interesting to investigate 
if the HASPA2 and HASPB have a binding partner in the sand fly midgut and 
if HASPA1 has one in mammalian macrophages by pull-down assays. The 
generation  of  a  specific  anti-HASPA  antibody  would  be  very  beneficial  to 
investigate  these  relatively  little  investigated  proteins.  In  this  study,  two 
attempts  have  been  made  to  generate  an  anti-HASPA  antibody  via  two 
distinct protocols, one using a recombinant-expressed full HASPA protein for 
immunization and the other using only the HASPA-specific central 19 amino 247 
 
acid sequence. Neither approach generated an antibody specific for the native 
HASPA  protein,  although  the  recombinant  HASPA  protein  was  detected. 
Further investigation into this is required before it will be possible to isolate an 
anti-HASPA antibody. 
 
It may be interesting to try to investigate the essentiality of the gene order 
within  the  cDNA16  locus  for  HASP  and  SHERP  upregulation  in  vivo.  One 
could  try  to  randomly  delete  parts  of  the  locus  or  integrate  stretches  of 
sequence into the intergenic regions and verify in the sand fly vector how that 
would  influences  parasite  differentiation  and  expression  of  the  remaining 
genes. The investigation whether mRNA length is influenced by coupled 5’ 
trans-splicing  and  3’  polyadenylation  is  still  underway  and  may  reveal 
difference in HASP and SHERP mRNA lengths expressed from recombinant 
constructs in vivo. 
 
 Conclusion  7.1.7.
Transmission of mammalian-infective Leishmania metacyclics by the bite of 
the sand fly vector is one of the key events in the carefully timed life-cycle of 
mammalian-infective Leishmania spp. Prior to transmission, the generation of 
metacyclic parasite forms is essential to re-establish parasite infectivity to a 
mammalian  host.  Parasite  metacyclogenesis  is  the  process  in  which 
metacyclics are generated from procyclic promastigotes via the intermediate 
nectomonad  and  leptomonad  forms.  The  HASP  and  SHERP  genes  are 
essential  to  metacyclogenesis  within  in  the  sand  fly  vector,  although  their 
functions remain unknown. The studies presented here on the involvement of 
the HASPs and SHERPs in L. (L.) major metacyclogenesis showed various 
differences in HASP and SHERP mutant behaviour between culture and the 
sand fly midgut, showing the necessity to observe metacyclogenesis in vivo 
rather than in vitro. The data presented here suggest a function for HASPB, 
SHERP and HASPA2 in parasite differentiation in the sand fly midgut, while 
HASPA1  function  is  likely  to  be  amastigote-specific.  The  problems 
encountered in this study with the stable upregulation of HASP and SHERP 
genes from homologous recombination constructs in vivo, were suggested to 
be a problem with mRNA stability pointing towards yet unknown regulation 
mechanisms of HASP and SHERP genes only active in vivo. These studies 
may  offer  a  base  for  further  investigations  into  the  cDNA16  locus,  its 
regulation in vivo and the stage specific functions of the HASPs and SHERP. 
New  techniques  will  be  required  to  deal  with  limitations  encountered  in 248 
 
working within a sand fly midgut, but these may offer a new opportunity to 
investigate  vector-borne  parasites  in  the  natural  environment,  which  could 
offer brand new insights into the natural behaviour of parasites. 
 
7.2. Part Two: The Orthologous HASP Locus of L. (V.) braziliensis 
 
 Data Summary  7.2.1.
The data generated on the L. (V.) braziliensis OHL in this study confirmed the 
misassembly due to repeat collapses previously suggested by Depledge et al. 
(2010)  (294).  By  subcloning,  few  polymorphisms  were  identified  in  the 
LbrM.23.1110 gene and the data suggested tandem repeats of these genes, 
while  the  LbrM.23.1120  gene  was  shown  to  be  single  heterozygous gene. 
Intraspecies variation in the digestion profile of the OHL suggested variation in 
the OHL content between L. (V.) braziliensis strains (Fig.6.6). 
 
Several attempts to produce a full L. (V.) braziliensis OHL deletion mutant 
failed for yet  unknown reasons. Fig.6.17 suggested  that all three expected 
OHL alleles may have been targeted. However, a double deletion of OHL was 
not possible. This could mean that the OHL is in fact on a diploid chromosome 
and not a triploid one as suggested by Rogers et al. (2011) (109). The OHL 
could  be  essential for the  parasites  survival,  which  would  be  an  important 
difference  to  the  cDNA16  locus  in  L.  (Leishmania)  spp.,  which  could  be 
deleted  in  L.  (L.)  major  without  any  fitness  disadvantage  and  significant 
phenotype in culture for the parasites.  
 
 The L. (V.) braziliensis orthologous HASP locus  7.2.2.
The  orthologous  HASP  locus  is  specific  to  members  of  the  L.  (Viannia) 
subgenus and is found in the same chromosomal region on chromosome 23 
as the cDNA16 locus of L. (Leishmania) spp. (294). The currently available 
sequence  shows  the  presence  of  two  proteins  of  unknown  function, 
LbrM.23.1110  and  LbrM.23.1120.  These  genes  were  shown  to  bear 
remarkable  structural  and  biochemical  similarities  to  HASPB  in  L. 
(Leishmania)  spp.,  both  containing  central  highly  antigenic  and  variable 
sequence repeats (294). It was proposed that L. (Leishmania) HASPs and the 
L. (Viannia) orthologous HASP genes (oHASP) have a common origin based 
on genome comparison data to the closely related monogenetic Leptomonas 
seymouri, which parasitizes insects, ciliates and nematodes (294). Therefore, 
it  was  proposed  that  HASPB  and  the  two  L.  (Viannia)  oHASPs  have 249 
 
conserved  functions,  despite  the  sequence  differences  (294).  Hybridization 
analysis  of  the  OHL  in  L.  (V.)  braziliensis,  L.  (V.)  guyanensis  and  L.  (V.) 
peruviana  showed  inter-  and  intraspecies  variations  of  the  length  of  OHL, 
which was also observed for the cDNA16 locus in L. (Leishmania) spp. (294, 
331, 334). The observed numbers of distinct 30nt repeat domains per strain 
lay between 2 to 6 with 6-15 repeats per oHASP. The observed variation of 
the OHL SacI digestion profile between tested L. (V.) braziliensis strains in 
this thesis suggested intraspecies variation of this locus too (Fig.6.6). Perhaps 
the  function  of  the  OHL  genes  invites  repeat  variations  due  to  antigenic 
pressure,  like  in  the  case  of  VSG  in  Trypanosoma  spp.  (398).  Sequence 
comparisons of this region of several L. (V.) braziliensis strains may reveal 
variations of 30 nt repeat numbers in the Lbr M.23.1110. Fig.6.13 showed a 
case of repeat loss in one of the sequenced 1110 copies from Lbr2904. 
 
Depledge showed in his thesis that the currently available L. (V.) braziliensis 
OHL sequence suffers from repeat collapses due to highly conserved tandem 
repeat sequences. The OHL was mapped against the L. (L.) major cDNA16 
locus sequence during the assembly. However, this region on chromosome 
23  was  already  misassembled  in  L.  (L.)  major,  because  of  sequence 
repetitiveness in the cDNA16 locus (107), and has not been corrected yet, 
despite the submission of rectified assembly by the Smith lab (accession no. 
AJ237587). Leishmania genomes (107), just as the related  T. brucei (285) 
and T. cruzi genomes (286), have a high level of sequence repetition, making 
genome assemblies difficult (109). Manual sequencing approaches may be 
needed for such regions to provide an accurate assembled sequence.  
 
While Depledge suggested in his thesis that the ORF of LbrM.23.1120 was 
longer than suggested in the annotated sequence on GeneDB and TriTrypDB, 
this study showed that LbrM.23.1120 exists in two heterozygous copies and 
that both the currently available ORF of 1120 and the adjusted 1120 ORF 
from Depledge are in fact correct. This study also showed that LbrM.23.1110 
occurred as multiple copies with distinct SNPs per OHL. 1110 may occur as 
4-5  sequentially  repeated  copies  downstream  of  1120.  Interestingly,  the 
intergenic region, which appears to be repeated between the 1110 copies, is 
highly conserved. This is unusual for non-coding regions, and it suggests that 
some selective pressure may rest on the intergenic region. Potentially, a yet-
to-be-identified  SHERP  orthologue  is  present  in  the  intergenic  region. 
Although it was out of the scope of this study to perform an in depth analysis 250 
 
of the intergenic region to confirm this hypothesis, a brief analysis, identified 4 
potential ORFs of 1-2.5x the length of the SHERP ORF in the cDNA16 locus 
(Appendix 12). Further analysis is required to determine, whether an actual 
gene exists in the intergenic region of the OHL. 
 
 Current Orthologous HASP Locus model  7.2.3.
The data generated in this study together with the work done by Depledge et 
al. (2009 & 2010), would suggest a heterozygous copy of LbrM.23.1120 and 
4-5 copies of LbrM.23.1110 per allele with few polymorphism between them 
(Fig.6.19).  All  LbrM.23.1110  copies  are  suggested  to  be  flanked  up-  and 
downstream by the conserved intergenic region with the exception of the most 
downstream 1110 gene copy, which is flanked downstream by the unique 3’ 
flanking region of the OHL. A SHERP orthologue may be contained within the 
intergenic regions explaining the high level of sequence conservation.  
 
 Perspective on future studies  7.2.4.
Future work may focus on the manual sequence assembly of the OHL. An 
accurate OHL map may help with the generation of a full OHL deletion mutant 
line and the PCR amplification of the whole locus for replacement construct 
generation,  which  had  both  failed  in  this  study.  It  would  be  interesting  to 
conclusively prove the essentiality of the OHL for L. (V.) braziliensis survival, 
which  would  be  a  significant  difference  to  the  cDNA16  locus  in  L. 
(Leishmania) spp. If, however, the full deletion of OHL should be possible, 
then the infection of the full OHL deletion mutant into sand flies would be very 
interesting to observe is metacyclogenesis is going to get stalled too. If yes, 
the cDNA16 locus and the OHL may prove to be the reason for the distinct 
supra- and peripylarian development of L. (Leishmania) spp. and L. (Viannia) 
spp., respectively. The identification of a SHERP orthologue would be of high 
interest to establish further functional similarities between the OHL and the 
cDNA16 locus and to determine where their differences lie. Commonly, genes 
found in Leishmania genomes in the same chromosomal region have often a 
similar function (107, 109) and it would be interesting to see if it is true for the 
OHL and the cDNA16 locus. 
 
 Conclusion  7.2.5.
A lot less is known about the development of members of the L. (Viannia) 
subgenus  than  the  L.  (Leishmania)  subgenus.  While  difference  in  the 
development  of  these  two  species  have  been  shown  in  the  past, 251 
 
metacyclogenesis in  L. (Viannia)  spp.  is much less well studied than in  L. 
(Leishmania) spp. Since the cDNA16 locus has been shown to be essential 
for metacyclogenesis of L. (L.) major, it remains a possibility that the OHL is 
involved  in  metacyclogenesis  too.  Potentially,  the  OHL  could  promote  the 
peripylarian  development  of  L.  (Viannia)  spp.,  while  the  cDNA16  locus 
promotes  the  suprapylarian  development  of  L.  (Leishmania)  spp.,  since 
genetic differences between L. (Leishmania) and L. (Viannia) spp. are only 
few (108). However, Depledge et al. (2010) showed that LbrM.23.1110 and 
1120 are preferentially expressed in amastigotes, like HASPA1, which does 
not suggest a function in the sand fly vector. The failure to generate a full 
deletion  mutant  for  the  OHL  suggested,  however,  that  the  OHL  may  be 
essential for parasite survival even in the promastigote stage. The correction 
of the sequence of the OHL will be important for the generation of full OHL 
deletion  and  replacement  mutant  lines  in  L.  (V.)  braziliensis.  The  data 
generated in this study may help as a base for future investigations into the 
OHL assembly. 
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List of abbreviations 
 
A    Adenosine 
AAMФ   Alternatively activating macrophage 
AIDS    Acquired Immunodeficiency Syndrome 
AMB    Amphotericin B 
AMG    Abdominal Midgut 
AMP    Antimicrobial peptide 
APC    Antigen Presenting Cell 
ATP    Adenosine Triphosphate 
BLAST   Basis Local Alignment Search Tool 
BSD    Blasticidin 
CAMФ   Classically Activating macrophage 
cDNA    Complementary DNA 
CL    Cutaneous Leishmaniasis 
DAPI    4', 6-diamidino-2-phenylindole 
DCL    Diffuse Cutaneous Leishmaniasis 
DIG    Digoxigenin 
DL    Disseminated Cutaneous Leishmaniasis 
DNA    Deoxyribonucleic Acid 
dNTPs   Deoxyribonucleic Acid Triphosphates 
DPMS   Dolichol-phosphate-mannose Synthase 
dKI    Double Knock-in (= double replacement of the same gene/locus) 
dKO    Double Knock-out (= double deletion of the same gene/locus) 
ELISA   Enzyme Linked Immunosorbent Assay 
EnS    Endoperitrophic space 
ER    Endoplasmatic Reticulum 
EU    European Union 
FCS    Foetal calf serum 
FG    Foregut 
fPPG    filamentous proteophosphoglycan 
Gal    Galaktose 
gDNA    Genomic DNA 
Glc    Glucose 
GPI    Glycosylphosphatidylinositol 
H
+    Hydrogen cation 
HAART  Highly Active Anti-Retroviral Therapy 
HASP    Hydrophilic Acylated Surface Protein 254 
 
HG    Hindgut 
HIV    Human Immunodeficiency Virus 
HSPs    High-scoring Sequence Pairs 
HTH    Helix-turn-helix 
HYG     Hygromycin 
iC3b     Inactive C3b 
IFN    Interferon 
IgG    Immunoglobulin G 
IL    Interleukin 
ISP     Serine Protease Inhibitors 
IVDU    Intravenous Drug User 
Kb     Kilo base pair 
KDa     Kilo Daltons 
KI    Knock-in (= replacement mutant) 
KO     Knock-out (= deletion mutant) 
L.    Leishmania 
LACK    Leishmania homologue for receptors of activated C kinase 
L-AMB   Lipid formulation of Amphotericin B 
LAMP    Loop-mediated Isothermal Amplification 
LB     Luria-Bertani medium 
LCL    Localized Cutaneous Leishmaniasis 
LPG    Lipophosphoglycan 
LRC    Leishmaniasis Recidiva Cutis 
Lu.    Lutzomyia 
M199    Medium 199 
Man    Mannose 
MCL    Mucocutaneous Leishmaniasis 
miRNA   micro-RNA 
ML    Mucosal Leishmaniasis 
MoFlo    Modular Flow Cytometer 
MPL-SE  Monophosphoryl Lipid and Squalene in a stable Emulsion 
mRNA   messenger RNA 
MQ H2O  Milli-Q water 
MYA     Million Years Ago 
NEO    Neomycin (=Geneticin) 
NHS     N-hydroxysulfosuccinimide 
NMT     N-myristoyl transferase 
NO    Nitric Oxide 255 
 
NOS2    Nitric Oxide Synthase 2 
nt    Nucleotides 
OC    Oligochromatography 
oHASP   Orthologous HASP 
OHL    Orthologous HASP Locus 
ORF    Open Reading Frame 
PAB1    Poly(A)-Binding Protein 1 
PAC     Puromycin 
PAGE    Polyacrylamide Gel Electrophoresis 
PBM    Post Blood Meal 
PBS     Phosphate Buffered Saline Solution 
PCR    Polymerase Chain Reaction 
PCR-OC  PCR-oligochromatography 
PGCs    Polycistronic Gene Clusters 
PGRP   Peptidoglycan Recognition Proteins 
Ph.    Phlebotomus 
p.i.    post inoculum 
PKDL    Post Kala-azar Dermal Leishmaniasis 
PM    Peritrophic Matrix or Peritrophic Membrane 
PPG    Proteophosphoglycan 
PSG    Parasite Secretory Gel 
qPCR    Quantitative Real Time – PCR 
RFLP    Restriction Fragment Length Polymorphism 
RNA    Ribonucleic Acid 
RT-PCR  Reverse Transcription – Polymerase Chain Reaction 
SDS    Sodium Dodecyl Sulphate 
SHERP  Small Hydrophilic Endoplasmatic Reticulum Associated Protein 
S.    Sauroleishmania 
sKI    Single Knock-in (stands for single replacement of a gene/locus) 
sKO    Single Knock-out (stands for single replacement of a gene/locus) 
SAT    Streptothricin 
SIF     Stumpy Induction Factor 
SL    Splice-leader 
SNPs    Single-Nucleotide Polymorphisms 
spp.    Species 
SSRs    Strand Switch Regions 
SV    Stomodeal Valve 
TAE     Tris acetate EDTA buffer 256 
 
TBS    Tris Buffered Saline 
TEP1    Thioester-containing Protein 1 
TGF    Transforming Growth Factor 
Th    T helper 
TMG    Thoracic Midgut 
TNF    Tumour Necrosis Factor 
Treg     T regulator 
U    Units 
UTR    Untranslated Region 
V.    Viannia 
V-ATPase   Vacuole H
+-ATP Synthase 
VL    Visceral Leishmaniasis 
VSG     Variable Surface Glycoproteins 
WHO    World Health Organisation 257 
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